OMIM_disease,OMIM_phen_key,OMIM_orgene,OMIM_id,OMIM_pos,OMIM_gene
"17-alpha-hydroxylase/17,20-lyase deficiency, 202110 ",3,"CYP17A1, CYP17, P450C17",609300,10q24.32,CYP17A1
"17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 ",3,"HSD17B10, HADH2, ERAB, MRXS10",300256,Xp11.22,HSD17B10
"Mental retardation, X-linked syndromic 10, 300220 ",3,"HSD17B10, HADH2, ERAB, MRXS10",300256,Xp11.22,HSD17B10
"3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 ",3,"HADHSC, SCHAD, HHF4",601609,4q25,HADHSC
"Hyperinsulinemic hypoglycemia, familial, 4, 609975 ",3,"HADHSC, SCHAD, HHF4",601609,4q25,HADHSC
"3-M syndrome 2, 612921 ",3,"OBSL1, KIAA0657, 3M2",610991,2q35,OBSL1
"3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 ",3,"MCCC1, MCCA",609010,3q27.1,MCCC1
"3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 ",3,"MCCC2, MCCB",609014,5q13.2,MCCC2
"3-methylglutaconic aciduria, type III, 258501 ",3,"OPA3, MGA3",606580,19q13.32,OPA3
"Optic atrophy 3 with cataract, 165300 ",3,"OPA3, MGA3",606580,19q13.32,OPA3
"46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 ",3,"DHH, SRXY7, GDXYM",605423,12q13.12,DHH
"46XY sex reversal 7, 233420 ",3,"DHH, SRXY7, GDXYM",605423,12q13.12,DHH
"46XY sex reversal 1, 400044 ",3,"SRY, TDF, TDY, SRXX1, SRXY1",480000,Yp11.2,SRY
"46XX sex reversal 1, 400045 ",3,"SRY, TDF, TDY, SRXX1, SRXY1",480000,Yp11.2,SRY
"46XY sex reversal 3, 612965 ",3,"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8",184757,9q33.3,NR5A1
"Premature ovarian failure 7, 612964 ",3,"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8",184757,9q33.3,NR5A1
"Spermatogenic failure 8, 613957 ",3,"NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8",184757,9q33.3,NR5A1
"46XY sex reversal 2, dosage-sensitive, 300018 ",3,"DAX1, AHC, AHX, NR0B1, SRXY2",300473,Xp21.2,DAX1
"46XY sex reversal 9, 616067 ",3,"ZFPM2, FOG2, DIH3, SRXY9",603693,8q23.1,ZFPM2
"5-fluorouracil toxicity, 274270 ",3,"DPYD, DPD",612779,1p21.3,DPYD
"Abruzzo-Erickson syndrome, 302905 ",3,"TBX22, CPX, ABERS",300307,Xq21.1,TBX22
"Acromesomelic dysplasia, Hunter-Thompson type, 201250 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Agammaglobulinemia 5, 613506 ",3,"LRRC8A, KIAA1437, AGM5",608360,9q34.11,LRRC8A
"Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 ",3,"RBM28, ANES",612074,7q32.1,RBM28
"Amyloidosis, familial visceral, 105200 ",3,"B2M, IMD43",109700,15q21.1,B2M
"Ataxia-telangiectasia-like disorder, 615919 ",3,"PCNA, ATLD2",176740,20p12.3,PCNA
"Atrial fibrillation 15, 615770 ",3,"NUP155, KIAA0791, ATFB15",606694,5p13.2,NUP155
"Autoimmune lymphoproliferative syndrome, type IIB, 607271 ",3,"CASP8, MCH5, ALPS2B",601763,2q33.1,CASP8
"Bardet-Biedl syndrome 11, 615988 ",3,"TRIM32, HT2A, LGMD2H, BBS11",602290,9q33.1,TRIM32
"Bardet-Biedl syndrome 14, 615991 ",3,"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14",610142,12q21.32,CEP290
"Brachydactyly-syndactyly syndrome, 610713 ",3,"HOXD13, HOX4I, SPD1, BDSD",142989,2q31.1,HOXD13
"CHARGE syndrome, 214800 ",3,"SEMA3E, SEMAH, KIAA0331",608166,7q21.11,SEMA3E
"Cardiomyopathy, dilated, 1M, 607482 ",3,"CSRP3, CRP3, CLP, CMD1M, CMH12",600824,11p15.1,CSRP3
"Cardiomyopathy, dilated, 2A, 611880 ",3,"TNNI3, CMH7, CMD2A, RCM1, CMD1FF",191044,19q13.42,TNNI3
"Cataract 30, pulverulent, 116300 ",3,"VIM, CTRCT30",193060,10p13,VIM
"Cataract 41, 116400 ",3,"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",606201,4p16.1,WFS1
"Cataract 45, 616851 ",3,"SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45",616655,19q13.1-q13.2,SIPA1L3
"Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 ",3,"ATP8A2, ATPIB, CAMRQ4",605870,13q12.13,ATP8A2
"Cerebral palsy, spastic quadriplegic, 1, 603513 ",3,"GAD1, SCP, CPSQ1",605363,2q31.1,GAD1
"Ceroid lipofuscinosis, neuronal, 12, 606693 ",3,"ATP13A2, PARK9, KRPPD, CLN12",610513,1p36.13,ATP13A2
"Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 ",3,"JPH1, JP1, CMT2K",605266,8q21.11,JPH1
"Charcot-Marie-Tooth disease, axonal, type 2V, 616491 ",3,"NAGLU, MPS3B, CMT2V",609701,17q21.2,NAGLU
"Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 ",3,"KARS, CMTRIB, DFNB89",601421,16q23.1,KARS
"Charcot-Marie-Tooth disease, type 2A1, 118210 ",3,"KIF1B, CMT2A, CMT2A1, NBLST1",605995,1p36.22,KIF1B
"Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 ",3,"HDAC6, CPBHM",300272,Xp11.23,HDAC6
"Chorea, childhood-onset, with psychomotor retardation, 616939 ",3,"GPR88, STRG, COCPMR",607468,1p21.2,GPR88
"Coenzyme Q10 deficiency, primary, 8, 616733 ",3,"COQ7, CLK1, COQ10D8",601683,16p12.3,COQ7
"Combined oxidative phosphorylation deficiency 22, 616045 ",3,"ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22",164360,18q21.1,ATP5A1
"Complement factor B deficiency, 615561 ",3,"CFB, BF, GBG, AHUS4, ARMD14, CFBD",138470,6p21.33,CFB
"Congenital disorder of glycosylation, type Ii, 607906 ",3,"ALG2, CDGII, CMSTA3, CMS14",607905,9q22.33,ALG2
"Congenital disorder of glycosylation, type Iw, 615596 ",3,"STT3A, ITM1, TMC",601134,11q24.2,STT3A
"Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 ",3,"NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED",606636,17p13.2,NLRP1
"Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 ",3,"FRMD4A, KIAA1294, CCAFCA",616305,10p13,FRMD4A
"Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 ",3,"VSX1, RINX, KTCN1, CAASDS",605020,20p11.21,VSX1
"Cutaneous telangiectasia and cancer syndrome, familial, 614564 ",3,"ATR, FRP1, SCKL1, FCTCS",601215,3q23,ATR
"Deafness, X-linked 6, 300914 ",3,"COL4A6, DELXq22.3, CXDELq22.3, DFNX6",303631,Xq22.3,COL4A6
"Deafness, autosomal dominant 44, 607453 ",3,"CCDC50, C3orf6, DFNA44",611051,3q28,CCDC50
"Deafness, autosomal recessive 44, 610154 ",3,"ADCY1, DFNB44",103072,7p12.3,ADCY1
"Deafness, autosomal recessive 66, 610212 ",3,"DCDC2, RU2, KIAA1154, NPHP19, DFNB66",605755,6p22.3,DCDC2
"Deafness, autosomal recessive 91, 613453 ",3,"SERPINB6, PI6, PTI, SPI3, DFNB91",173321,6p25.2,SERPINB6
"Deafness, autosomal recessive 97, 616705 ",3,"MET, DFNB97, OSFD",164860,7q31.2,MET
"Dystonia 23, 614860 ",3,"CACNA1B, CACNL1A5, DYT23",601012,9q34.3,CACNA1B
"Dystonia, juvenile-onset, 607371 ",3,"ACTB, BRWS1",102630,7p22.1,ACTB
"Epidermolysis bullosa simplex with nail dystrophy, 616487 ",3,"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",601282,8q24.3,PLEC1
"Epilepsy, myoclonic, familial adult, 5, 615400 ",3,"CNTN2, TAX, TAX1, FAME5",190197,1q32.1,CNTN2
"Epileptic encephalopathy, early infantile, 47, 617166 ",3,"FGF12, FHF1, EIEE47",601513,3q28-q29,FGF12
"Epiphyseal dysplasia, multiple, 6, 614135 ",3,"COL9A1, EDM6, STL4",120210,6q13,COL9A1
"Fanconi renotubular syndrome 3, 615605 ",3,"EHHADH, PBFE, LBFP, FRTS3",607037,3q27.2,EHHADH
"Febrile seizures, familial, 4, 604352 ",3,"ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C",602851,5q14.3,ADGRV1
"Fetal akinesia deformation sequence, 208150 ",3,"DOK7, C4orf25, CMS10",610285,4p16.3,DOK7
"Fibromatosis, gingival, 1, 135300 ",3,"SOS1, GINGF, GF1, HGF, NS4",182530,2p22.1,SOS1
"Glycogen storage disease XIII, 612932 ",3,"ENO3, GSD13",131370,17p13.2,ENO3
"Growth restriction, severe, with distinctive facies, 616489 ",3,"IGF2, GRDF",147470,11p15.5,IGF2
"Hemochromatosis, type 5, 615517 ",3,"FTH1, FTHL6, HFE5",134770,11q12.3,FTH1
"Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 ",3,ECE1,600423,1p36.12,ECE1
"Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 ",3,"KISS1, HH13",603286,1q32.1,KISS1
"Hypotrichosis and recurrent skin vesicles, 613102 ",3,"DSC3, DSC4",600271,18q12.1,DSC3
"Immunodeficiency 13, 615518 ",3,"UNC119, HRG4, IMD13",604011,17q11.2,UNC119
"Immunodeficiency 22, 615758 ",3,"LCK, IMD22",153390,1p35.2,LCK
"Immunodeficiency 25, 610163 ",3,"CD247, CD3Z, TCRZ, IMD25",186780,1q24.2,CD247
"Immunodeficiency 45, 616669 ",3,"IFNAR2, IMD45",602376,21q22.11,IFNAR2
"Infantile liver failure syndrome 1, 615438 ",3,"LARS, LFIS, ILFS1",151350,5q32,LARS
"Inflammatory skin and bowel disease, neonatal, 2, 616069 ",3,"EGFR, NISBD2",131550,7p11.2,EGFR
"Joubert syndrome 22, 615665 ",3,"PDE6D, JBTS22",602676,2q37.1,PDE6D
"Juvenile myelomonocytic leukemia, 607785 ",3,"CBL, CBL2, NSLL",165360,11q23.3,CBL
"Keratosis pilaris atrophicans, 604093 ",3,"LRP1, A2MR, KPA",107770,12q13.3,LRP1
"Laurence-Moon syndrome, 245800 ",3,"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",603197,19p13.2,PNPLA6
"Leigh syndrome, 256000 ",3,NDUFA10,603835,2q37.3,NDUFA10
"Lethal congenital contracture syndrome 8, 616287 ",3,"ADCY6, LCCS8",600294,12q13.12,ADCY6
"Leukemia, acute myeloid, 601626 ",3,"CEBPA, CEBP",116897,19q13.11,CEBPA
"Lichtenstein-Knorr syndrome, 616291 ",3,"SLC9A1, NHE1, APNH, LIKNS",107310,1p36.11,SLC9A1
"Lipodystrophy, congenital generalized, type 3, 612526 ",3,"CAV1, BSCL3, CGL3, PPH3, LCCNS",601047,7q31.2,CAV1
"Macular degeneration, age-related, 6, 613757 ",3,"RAX2, RAXL1, QRX, CORD11, ARMD6",610362,19p13.3,RAX2
"Meckel syndrome 12, 616258 ",3,"KIF14, KIAA0042, MKS12",611279,1q32.1,KIF14
"Mental retardation, X-linked, syndromic 11, Shashi type, 300238 ",3,"RBMX, MRXS11",300199,Xq26.3,RBMX
"Mental retardation, X-linked, syndromic, Hedera type, 300423 ",3,"ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS",300556,Xp11.4,ATP6AP2
"Mental retardation, autosomal dominant 22, 612337 ",3,"ZBTB18, ZNF238, RP58, MRD22",608433,1q44,ZBTB18
"Mental retardation, autosomal recessive 43, 615817 ",3,"KIAA1033, SWIP, MRT43",615748,12q23.3,KIAA1033
"Methemoglobinemia, type IV, 250790 ",3,"CYB5A, MCB5",613218,18q22.3,CYB5A
"Microcephaly 12, primary, autosomal recessive, 616080 ",3,"CDK6, PLSTIRE, MCPH12",603368,7q21.2,CDK6
"Mitochondrial complex I deficiency, 252010 ",3,"NDUFB9, UQOR22",601445,8q24.13,NDUFB9
"Mitochondrial complex IV deficiency, 220110 ",3,"COX14, C12orf62",614478,12q13.12,COX14
"Mitochondrial complex IV deficiency, 220110 ",3,COX8A,123870,11q13.1,COX8A
"Mitochondrial complex IV deficiency, 220110 ",3,"FASTKD2, KIAA0971",612322,2q33.3,FASTKD2
"Monilethrix, 158000 ",3,"KRT83, KRTHB3, HB3",602765,12q13.13,KRT83
"Morning glory disc anomaly, 120430 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Mucopolysaccharidosis type IX, 601492 ",3,"HYAL1, MPS9",607071,3p21.31,HYAL1
"Muscular dystrophy, limb-girdle, type 2R, 615325 ",3,"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",125660,2q35,DES
"Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 ",3,"CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C",100710,17p13.1,CHRNB1
"Myasthenic syndrome, congenital, 3A, slow-channel, 616321 ",3,"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C",100720,2q37.1,CHRND
"Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 ",3,"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C",100720,2q37.1,CHRND
"Myofibromatosis, infantile 2, 615293 ",3,"NOTCH3, CADASIL1, CASIL, IMF2, LMNS",600276,19p13.12,NOTCH3
"Myopathy, scapulohumeroperoneal, 616852 ",3,"ACTA1, ASMA, NEM3, CFTD1, SHPM",102610,1q42.13,ACTA1
"Myosclerosis, congenital, 255600 ",3,"COL6A2, BTHLM1, UCMD1",120240,21q22.3,COL6A2
"Narcolepsy 7, 614250 ",3,"MOG, NRCLP7",159465,6p22.1,MOG
"Neurodegeneration with optic atrophy, childhood onset, 615491 ",3,"UCHL1, PARK5, NDGOA",191342,4p13,UCHL1
"Neuropathy, hereditary sensory and autonomic, type VI, 614653 ",3,"DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2",113810,6p12.1,DST
"Neutropenia, nonimmune chronic idiopathic, of adults, 607847 ",3,"GFI1, ZNF163, SCN2",600871,1p22.1,GFI1
"Neutropenia, severe congenital 2, autosomal dominant, 613107 ",3,"GFI1, ZNF163, SCN2",600871,1p22.1,GFI1
"Night blindness, congenital stationary, type 1G, 616389 ",3,"GNAT1, CSNBAD3, CSNB1G",139330,3p21.31,GNAT1
"Obesity, hyperphagia, and developmental delay, 613886 ",3,"NTRK2, TRKB",600456,9q21.33,NTRK2
"Optic atrophy 9, 616289 ",3,"ACO2, ICRD, OPA9",100850,22q13.2,ACO2
"Otofaciocervical syndrome 2, 615560 ",3,"PAX1, OFC2",167411,20p11.22,PAX1
"Otofaciocervical syndrome, 166780 ",3,"EYA1, BOR, BOS1, OFC1",601653,8q13.3,EYA1
"Parkinsonism with spasticity, X-linked, 300911 ",3,"ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS",300556,Xp11.4,ATP6AP2
"Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 ",3,"CAV1, BSCL3, CGL3, PPH3, LCCNS",601047,7q31.2,CAV1
"Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 ",3,"MYH14, KIAA2034, DFNA4A, PNMHH",608568,19q13.33,MYH14
"Pontocerebellar hypoplasia, type 3, 608027 ",3,"PCLO, PCH3",604918,7q21.11,PCLO
"Precocious puberty, central, 1, 176400 ",3,"KISS1R, GPR54, HH8, CPPB1",604161,19p13.3,KISS1R
"Premature ovarian failure 10, 612885 ",3,"MCM8, POF10",608187,20p12.3,MCM8
"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3, 617069 ",3,"TK2, MTDPS2, PEOB3",188250,16q21,TK2
"RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Renal hypodysplasia/aplasia 2, 615721 ",3,"FGF20, RHDA2",605558,8p22,FGF20
"Retinal arteries, tortuosity of, 180000 ",3,"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR",120130,13q34,COL4A1
"Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 ",3,"RDH11, PSDR1, RALR1, RDJCSS",607849,14q24.1,RDH11
"Retinitis pigmentosa 23, 300424 ",3,"OFD1, CXorf5, SGBS2, JBTS10, RP23",300170,Xp22.2,OFD1
"Retinitis pigmentosa 55, 613575 ",3,"ARL6, BBS3, RP55",608845,3q11.2,ARL6
"Retinitis pigmentosa 66, 615233 ",3,"RBP3, RP66",180290,10q11.22,RBP3
"Retinitis pigmentosa 67, 615565 ",3,"NEK2, RP67",604043,1q32.3,NEK2
"Retinitis pigmentosa 9, 180104 ",3,"RP9, PAP1",607331,7p14.3,RP9
"Reynolds syndrome, 613471 ",3,"LBR, PHA",600024,1q42.12,LBR
"Sarcoma, synovial, 300813 ",3,"SSX1, SSRC",312820,Xp11.23,SSX1
"Sarcoma, synovial, 300813 ",3,SSX2,300192,Xp11.22,SSX2
"Seckel syndrome 4, 613676 ",3,"CENPJ, CPAP, MCPH6, SCKL4",609279,13q12.12-q12.13,CENPJ
"Seizures, scoliosis, and macrocephaly syndrome, 616682 ",3,"EXT2, SSMS",608210,11p11.2,EXT2
"Slowed nerve conduction velocity, AD, 608236 ",3,"ARHGEF10, KIAA0294, SNCV",608136,8p23.3,ARHGEF10
"Sotos syndrome 3, 617169 ",3,"APC2, APCL, SOTOS3",612034,19p13.3,APC2
"Spastic paraplegia 63, 615686 ",3,"AMPD2, SPG63, PCH9",102771,1p13.3,AMPD2
"Spermatogenic failure 6, 102530 ",3,"SPATA16, SPGF6",609856,3q26.31,SPATA16
"Spinocerebellar ataxia 26, 609306 ",3,"EEF2, EF2, SCA26",130610,19p13.3,EEF2
"Spinocerebellar ataxia 43, 617018 ",3,"MME, CD10, CALLA, NEP, CMT2T, SCA43",120520,3q25.2,MME
"Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 ",3,"DLX5, SHFM1D",600028,7q21.3,DLX5
"Spondylocostal dysostosis 3, autosomal recessive, 609813 ",3,"LFNG, SCDO3",602576,7p22.3,LFNG
"Stickler syndrome, type V, 614284 ",3,"COL9A2, EDM2, STL5",120260,1p34.2,COL9A2
"Stocco dos Santos X-linked mental retardation syndrome, 300434 ",3,"SHROOM4, KIAA1202, SDSX",300579,Xp11.22,SHROOM4
"Testicular anomalies with or without congenital heart disease, 615542 ",3,"GATA4, ASD2, VSD1, TACHD, TOF",600576,8p23.1,GATA4
"Tetra-amelia syndrome, 273395 ",3,"WNT3, INT4, TETAMS",165330,17q21.31-q21.32,WNT3
"Thrombocytopenia 6, 616937 ",3,"SRC, ASV, SRC1, THC6",190090,20q11.23,SRC
"Trichothiodystrophy 5, nonphotosensitive, 300953 ",3,"RNF113A, ZNF183, TTD5",300951,Xq24,RNF113A
"Waisman syndrome, 311510 ",3,"RAB39B, MRX72, WSMN",300774,Xq28,RAB39B
"Webb-Dattani syndrome, 615926 ",3,"ARNT2, WEDAS",606036,15q25.1,ARNT2
"XFE progeroid syndrome, 610965 ",3,"ERCC4, XPF, FANCQ, XFEPS",133520,16p13.12,ERCC4
"Amyotrophic lateral sclerosis, susceptibility to, 105400 ",3,"NEFH, CMT2CC",162230,22q12.2,NEFH
"Autism susceptibility 16, 613410 ",3,"SLC9A9, AUTS16",608396,3q24,SLC9A9
"Parkinson disease 5, susceptibility to, 613643 ",3,"UCHL1, PARK5, NDGOA",191342,4p13,UCHL1
"ABCD syndrome, 600501 ",3,"EDNRB, HSCR2, ABCDS, WS4A",131244,13q22.3,EDNRB
"ACTH-independent macronodular adrenal hyperplasia, 219080 ",3,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C",139320,20q13.32,GNAS
"ADULT syndrome, 103285 ",3,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",603273,3q28,TP63
"Aarskog-Scott syndrome, 305400 ",3,"FGD1, FGDY, AAS, MRXS16",300546,Xp11.22,FGD1
"Abdominal obesity-metabolic syndrome 3, 615812 ",3,"DYRK1B, MIRK, AOMS3",604556,19q13.2,DYRK1B
"Acampomelic campomelic dysplasia, 114290 ",3,"SOX9, CMD1, SRA1",608160,17q24.3,SOX9
"Acatalasemia, 614097 ",3,CAT,115500,11p13,CAT
"Achalasia-addisonianism-alacrimia syndrome, 231550 ",3,"AAAS, AAA",605378,12q13.13,AAAS
"Acheiropody, 200500 ",3,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS",605522,7q36.3,LMBR1
"Achondrogenesis Ib, 600972 ",3,"SLC26A2, DTD, DTDST, D5S1708, EDM4",606718,5q32,SLC26A2
"Achondrogenesis, type IA, 200600 ",3,"TRIP11, TRIP230, CEV14, ACG1A",604505,14q32.12,TRIP11
"Achondrogenesis, type II or hypochondrogenesis, 200610 ",3,COL2A1,120140,12q13.11,COL2A1
"Achondroplasia, 100800 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Achromatopsia 3, 262300 ",3,"CNGB3, ACHM3, ACHM1",605080,8q21.3,CNGB3
"Achromatopsia 4, 613856 ",3,"GNAT2, ACHM4",139340,1p13.3,GNAT2
"Achromatopsia 6, 610024 ",3,"PDE6H, RCD3, ACHM6",601190,12p12.3,PDE6H
"Acne inversa, familial, 3, 613737 ",3,"PSEN1, AD3",104311,14q24.2,PSEN1
"Acrocapitofemoral dysplasia, 607778 ",3,"IHH, BDA1",600726,2q35,IHH
"Acrodermatitis enteropathica, 201100 ",3,"SLC39A4, ZIP4",607059,8q24.3,SLC39A4
"Acrodysostosis 1, with or without hormone resistance, 101800 ",3,"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1",188830,17q24.2,PRKAR1A
"Acrodysostosis 2, with or without hormone resistance, 614613 ",3,"PDE4D, DPDE3, STRK1, ACRDYS2",600129,5q11.2-q12.1,PDE4D
"Acrokeratosis verruciformis, 101900 ",3,"ATP2A2, ATP2B, DAR",108740,12q24.11,ATP2A2
"Acromegaly, somatic, 102200 ",3,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C",139320,20q13.32,GNAS
"Acromelic frontonasal dysostosis, 603671 ",3,"ZSWIM6, KIAA1577, AFND",615951,5q12.1,ZSWIM6
"Acromicric dysplasia, 102370 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 ",3,"ACADS, SCAD",606885,12q24.31,ACADS
"Adams-Oliver syndrome 5, 616028 ",3,"NOTCH1, TAN1, AOS5, AOVD1",190198,9q34.3,NOTCH1
"Adenine phosphoribosyltransferase deficiency, 614723 ",3,"APRT, APRTD",102600,16q24.3,APRT
"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 ",3,"EGFR, NISBD2",131550,7p11.2,EGFR
"Adenocarcinoma of lung, somatic, 211980 ",3,"BRAF, NS7",164757,7q34,BRAF
"Adenocarcinoma of lung, somatic, 211980 ",3,"ERBB2, NGL, NEU, HER2",164870,17q12,ERBB2
"Adenocarcinoma of lung, somatic, 211980 ",3,"PRKN, PARK2, PDJ, LPRS2",602544,6q26,PRKN
"Adenocarcinoma, ovarian, somatic, 167000 ",3,"PRKN, PARK2, PDJ, LPRS2",602544,6q26,PRKN
"Adenomas, salivary gland pleomorphic, somatic, 181030 ",3,"PLAG1, SGPA, PSA",603026,8q12.1,PLAG1
"Adenomatous polyposis coli, 175100 ",3,"APC, GS, FPC, BTPS2",611731,5q22.2,APC
"Adenosine deaminase deficiency, partial, 102700 ",3,ADA,608958,20q13.12,ADA
"Adenosine triphosphate, elevated, of erythrocytes, 102900 ",3,"PKLR, PK1",609712,1q22,PKLR
"Adenylosuccinase deficiency, 103050 ",3,ADSL,608222,22q13.1,ADSL
"Adrenal cortical carcinoma, 202300 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 ",3,"CYP11B1, P450C11, FHI",610613,8q24.3,CYP11B1
"Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 ",3,"CYP21A2, CYP21, CA21H",613815,6p21.33,CYP21A2
"Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 ",3,HSD3B2,613890,1p12,HSD3B2
"Adrenal hypoplasia, congenital, 300200 ",3,"DAX1, AHC, AHX, NR0B1, SRXY2",300473,Xp21.2,DAX1
"Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 ",3,"CYP11A1, P450SCC",118485,15q24.1,CYP11A1
"Adrenoleukodystrophy, 300100 ",3,"ABCD1, ALD, AMN",300371,Xq28,ABCD1
"Adrenomyeloneuropathy, adult, 300100 ",3,"ABCD1, ALD, AMN",300371,Xq28,ABCD1
"Adult i phenotype without cataract, 110800 ",3,"GCNT2, Ii, CTRCT13",600429,6p24.3-p24.2,GCNT2
"Advanced sleep-phase syndrome, familial, 2, 615224 ",3,"CSNK1D, ASPS, FASPS2",600864,17q25.3,CSNK1D
"Afibrinogenemia, congenital, 202400 ",3,FGA,134820,4q31.3,FGA
"Afibrinogenemia, congenital, 202400 ",3,FGB,134830,4q31.3,FGB
"Afibrinogenemia, congenital, 202400 ",3,FGG,134850,4q32.1,FGG
"Agammaglobulinemia 1, 601495 ",3,"IGHM, MU, AGM1",147020,14q32.33,IGHM
"Agammaglobulinemia 2, 613500 ",3,"IGLL1, IGO, IGL5, VPREB2, AGM2",146770,22q11.23,IGLL1
"Agammaglobulinemia 8, autosomal dominant, 616941 ",3,"TCF3, E2A, AGM8",147141,19p13.3,TCF3
"Agammaglobulinemia and isolated hormone deficiency, 307200 ",3,"BTK, AGMX1, IMD1, XLA, AT",300300,Xq22.1,BTK
"Agammaglobulinemia, X-linked 1, 300755 ",3,"BTK, AGMX1, IMD1, XLA, AT",300300,Xq22.1,BTK
"Agenesis of the corpus callosum with peripheral neuropathy, 218000 ",3,"SLC12A6, KCC3A, KCC3B, KCC3, ACCPN",604878,15q14,SLC12A6
"Agnathia-otocephaly complex, 202650 ",3,"PRRX1, PMX1, PHOX1, AGOTC",167420,1q24.2,PRRX1
"Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 ",3,"TREX1, AGS1, CRV, HERNS",606609,3p21.31,TREX1
"Aicardi-Goutieres syndrome 4, 610333 ",3,"RNASEH2A, RNHIA, AGS4",606034,19p13.13,RNASEH2A
"Aicardi-Goutieres syndrome 6, 615010 ",3,"ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6",146920,1q21.3,ADAR
"Aicardi-Goutieres syndrome 7, 615846 ",3,"IFIH1, MDA5, AGS7, SGMRT1",606951,2q24.2,IFIH1
"Alagille syndrome 1, 118450 ",3,"JAG1, AGS1, AHD",601920,20p12.2,JAG1
"Aland Island eye disease, 300600 ",3,"CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2",300110,Xp11.23,CACNA1F
"Albinism, brown oculocutaneous, 203200 ",3,"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1",611409,15q12-q13,OCA2
"Albinism, oculocutaneous, type IA, 203100 ",3,"TYR, SHEP3, CMM8, OCA1A, ATN",606933,11q14.3,TYR
"Albinism, oculocutaneous, type IB, 606952 ",3,"TYR, SHEP3, CMM8, OCA1A, ATN",606933,11q14.3,TYR
"Albinism, oculocutaneous, type II, 203200 ",3,"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1",611409,15q12-q13,OCA2
"Albinism, oculocutaneous, type III, 203290 ",3,"TYRP1, CAS2, GP75, SHEP11",115501,9p23,TYRP1
"Alcohol sensitivity, acute, 610251 ",3,ALDH2,100650,12q24.12,ALDH2
"Aldosteronism, glucocorticoid-remediable, 103900 ",3,"CYP11B1, P450C11, FHI",610613,8q24.3,CYP11B1
"Alexander disease, 203450 ",3,"GFAP, ALXDRD",137780,17q21.31,GFAP
"Alkaptonuria, 203500 ",3,"HGD, AKU",607474,3q13.33,HGD
"Allan-Herndon-Dudley syndrome, 300523 ",3,"SLC16A2, DXS128, XPCT",300095,Xq13.2,SLC16A2
"Alopecia universalis, 203655 ",3,"HR, AU, MUHH1, HYPT4",602302,8p21.3,HR
"Alpha-fetoprotein deficiency, 615969 ",3,"AFP, HPAFP, AFPD",104150,4q13.3,AFP
"Alpha-methylacetoacetic aciduria, 203750 ",3,ACAT1,607809,11q22.3,ACAT1
"Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 ",3,"ATRX, XH2, XNP, SHS, SFM1, MRXHF1",300032,Xq21.1,ATRX
"Alpha-thalassemia/mental retardation syndrome, 301040 ",3,"ATRX, XH2, XNP, SHS, SFM1, MRXHF1",300032,Xq21.1,ATRX
"Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 ",3,RAG1,179615,11p12,RAG1
"Alport syndrome, 301050 ",3,"COL4A5, ATS, ASLN",303630,Xq22.3,COL4A5
"Alport syndrome, autosomal dominant, 104200 ",3,COL4A3,120070,2q36.3,COL4A3
"Alport syndrome, autosomal recessive, 203780 ",3,COL4A3,120070,2q36.3,COL4A3
"Alport syndrome, autosomal recessive, 203780 ",3,COL4A4,120131,2q36.3,COL4A4
"Alstrom syndrome, 203800 ",3,"ALMS1, ALSS, KIAA0328",606844,2p13.1,ALMS1
"Alternating hemiplegia of childhood 2, 614820 ",3,"ATP1A3, DYT12, RDP, AHC2, CAPOS",182350,19q13.2,ATP1A3
"Alternating hemiplegia of childhood, 104290 ",3,"ATP1A2, FHM2, MHP2",182340,1q23.2,ATP1A2
"Alzheimer disease 1, familial, 104300 ",3,"APP, AAA, CVAP, AD1",104760,21q21.3,APP
"Alzheimer disease, type 3, 607822 ",3,"PSEN1, AD3",104311,14q24.2,PSEN1
"Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 ",3,"PSEN1, AD3",104311,14q24.2,PSEN1
"Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 ",3,"PSEN1, AD3",104311,14q24.2,PSEN1
"Alzheimer disease-2, 104310 ",3,"APOE, AD2, LPG, LDLCQ5",107741,19q13.32,APOE
"Alzheimer disease-4, 606889 ",3,"PSEN2, AD4, STM2, CMD1V",600759,1q42.13,PSEN2
"Amelogenesis imperfecta, type 1E, 301200 ",3,"AMELX, AMG, AIH1, AMGX, AI1E",300391,Xp22.2,AMELX
"Amelogenesis imperfecta, type IB, 104500 ",3,"ENAM, AIH2, AI1C",606585,4q13.3,ENAM
"Amelogenesis imperfecta, type IC, 204650 ",3,"ENAM, AIH2, AI1C",606585,4q13.3,ENAM
"Amelogenesis imperfecta, type IF, 616270 ",3,"AMBN, AI1F",601259,4q13.3,AMBN
"Amelogenesis imperfecta, type IIA1, 204700 ",3,"KLK4, EMSP1, PRSS17, AI2A1",603767,19q13.41,KLK4
"Amelogenesis imperfecta, type IIA5, 615887 ",3,"SLC24A4, NCKX4, SHEP6, AI2A5",609840,14q32.12,SLC24A4
"Amelogenesis imperfecta, type IV, 104510 ",3,"DLX3, TDO, AI4",600525,17q21.33,DLX3
"Aminoacylase 1 deficiency, 609924 ",3,"ACY1, ACY1D",104620,3p21.2,ACY1
"Amyloidosis, 3 or more types, 105200 ",3,APOA1,107680,11q23.3,APOA1
"Amyloidosis, familial visceral, 105200 ",3,FGA,134820,4q31.3,FGA
"Amyloidosis, hereditary, transthyretin-related, 105210 ",3,"TTR, PALB",176300,18q12.1,TTR
"Amyloidosis, primary localized cutaneous, 1, 105250 ",3,"OSMR, OSMRB, PLCA1",601743,5p13.1,OSMR
"Amyloidosis, renal, 105200 ",3,LYZ,153450,12q15,LYZ
"Amyotrophic lateral sclerosis 1, 105400 ",3,"SOD1, ALS1",147450,21q22.11,SOD1
"Amyotrophic lateral sclerosis 10, with or without FTD, 612069 ",3,"TARDBP, TDP43, ALS10",605078,1p36.22,TARDBP
"Amyotrophic lateral sclerosis 12, 613435 ",3,"OPTN, GLC1E, FIP2, HYPL, NRP, ALS12",602432,10p13,OPTN
"Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 ",3,"VCP, IBMPFD1, ALS14, CMT2Y",601023,9p13.3,VCP
"Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 ",3,"UBQLN2, PLIC2, CHAP1, ALS15",300264,Xp11.21,UBQLN2
"Amyotrophic lateral sclerosis 17, 614696 ",3,"CHMP2B, DMT1, VPS2B, ALS17",609512,3p11.2,CHMP2B
"Amyotrophic lateral sclerosis 2, juvenile, 205100 ",3,"ALS2, ALSJ, PLSJ, IAHSP",606352,2q33.1,ALS2
"Amyotrophic lateral sclerosis 4, juvenile, 602433 ",3,"SETX, SCAR1, AOA2, ALS4",608465,9q34.13,SETX
"Amyotrophic lateral sclerosis 5, juvenile, 602099 ",3,"SPG11, KIAA1840, FLJ21439, ALS5, CMT2X",610844,15q21.1,SPG11
"Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 ",3,"FUS, TLS, ALS6, ETM4",137070,16p11.2,FUS
"Amyotrophic lateral sclerosis 8, 608627 ",3,"VAPB, VAPC, ALS8",605704,20q13.32,VAPB
"Amyotrophic lateral sclerosis 9, 611895 ",3,"ANG, RNASE5, ALS9",105850,14q11.2,ANG
"Amyotrophy, hereditary neuralgic, 162100 ",3,"SEPT9, MSF, MSF1, NAPB",604061,17q25.3,SEPT9
"Analbuminemia, 616000 ",3,"ALB, ANALBA, FDAH",103600,4q13.3,ALB
"Anauxetic dysplasia, 607095 ",3,"RMRP, RMRPR, CHH",157660,9p13.3,RMRP
"Andersen syndrome, 170390 ",3,"KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9",600681,17q24.3,KCNJ2
"Androgen insensitivity, 300068 ",3,"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",313700,Xq12,AR
"Androgen insensitivity, partial, with or without breast cancer, 312300 ",3,"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",313700,Xq12,AR
"Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 ",3,"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",305371,Xp11.23,GATA1
"Anemia, hemolytic, Rh-null, regulator type, 268150 ",3,"RHAG, RH50A, OHST",180297,6p12.3,RHAG
"Anemia, sideroblastic, 1, 300751 ",3,"ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1",301300,Xp11.21,ALAS2
"Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 ",3,"GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC",609588,14q32.13,GLRX5
"Angelman syndrome, 105830 ",3,"UBE3A, ANCR",601623,15q11.2,UBE3A
"Angioedema, hereditary, type III, 610618 ",3,"F12, HAF, HAE3",610619,5q35.3,F12
"Angioedema, hereditary, types I and II, 106100 ",3,"C1NH, HAE1, HAE2, SERPING1",606860,11q12.1,C1NH
"Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 ",3,"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR",120130,13q34,COL4A1
"Aniridia, 106210 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Anterior segment anomalies with or without cataract, 113650 ",3,"EYA1, BOR, BOS1, OFC1",601653,8q13.3,EYA1
"Anterior segment mesenchymal dysgenesis, 107250 ",3,"FOXE3, FKHL12, ASMD",601094,1p33,FOXE3
"Anterior segment mesenchymal dysgenesis, 107250 ",3,"PITX3, CTPP4, CTRCT11",602669,10q24.32,PITX3
"Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 ",3,POR,124015,7q11.23,POR
"Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Aortic aneurysm, familial thoracic 10, 617168 ",3,"LOX, AAT10",153455,5q23.1,LOX
"Aortic aneurysm, familial thoracic 4, 132900 ",3,"MYH11, AAT4, FAA4",160745,16p13.11,MYH11
"Aortic aneurysm, familial thoracic 6, 611788 ",3,"ACTA2, ACTSA, AAT6, MYMY5",102620,10q23.31,ACTA2
"Aortic aneurysm, familial thoracic 7, 613780 ",3,"MYLK, MLCK, AAT7",600922,3q21.1,MYLK
"Aortic valve disease 1, 109730 ",3,"NOTCH1, TAN1, AOS5, AOVD1",190198,9q34.3,NOTCH1
"Apert syndrome, 101200 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Aphasia, primary progressive, 607485 ",3,"GRN, CLN11",138945,17q21.31,GRN
"Aplasia of lacrimal and salivary glands, 180920 ",3,FGF10,602115,5p12,FGF10
"Aplastic anemia, 609135 ",3,"NBN, NBS1",602667,8q21.3,NBN
"Aplastic anemia, 609135 ",3,"PRF1, HPLH2, FLH2",170280,10q22.1,PRF1
"Apolipoprotein C-III deficiency, 614028 ",3,"APOC3, HALP2",107720,11q23.3,APOC3
"Apparent mineralocorticoid excess, 218030 ",3,"HSD11B2, HSD11K, AME",614232,16q22.1,HSD11B2
"Argininemia, 207800 ",3,ARG1,608313,6q23.2,ARG1
"Argininosuccinic aciduria, 207900 ",3,ASL,608310,7q11.21,ASL
"Aromatase deficiency, 613546 ",3,"CYP19A1, CYP19, ARO",107910,15q21.2,CYP19A1
"Aromatase excess syndrome, 139300 ",3,"CYP19A1, CYP19, ARO",107910,15q21.2,CYP19A1
"Aromatic L-amino acid decarboxylase deficiency, 608643 ",3,DDC,107930,7p12.2-p12.1,DDC
"Arrhythmogenic right ventricular dysplasia 1, 107970 ",3,"TGFB3, ARVD1, RNHF, LDS5",190230,14q24.3,TGFB3
"Arrhythmogenic right ventricular dysplasia 10, 610193 ",3,"DSG2, ARVD10, ARVC10, CMD1BB",125671,18q12.1,DSG2
"Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 ",3,"DSC2, DSC3, ARVD11",125645,18q12.1,DSC2
"Arrhythmogenic right ventricular dysplasia 11, 610476 ",3,"DSC2, DSC3, ARVD11",125645,18q12.1,DSC2
"Arrhythmogenic right ventricular dysplasia 12, 611528 ",3,"JUP, DP3, PDGB, ARVD12",173325,17q21.2,JUP
"Arrhythmogenic right ventricular dysplasia 2, 600996 ",3,"RYR2, VTSIP, ARVD2, ARVC2",180902,1q43,RYR2
"Arrhythmogenic right ventricular dysplasia 5, 604400 ",3,"TMEM43, ARVD5, ARVC5, EDMD7",612048,3p25.1,TMEM43
"Arrhythmogenic right ventricular dysplasia 8, 607450 ",3,"DSP, KPPS2, PPKS2, DCWHKTA",125647,6p24.3,DSP
"Arrhythmogenic right ventricular dysplasia 9, 609040 ",3,"PKP2, ARVD9",602861,12p11.21,PKP2
"Arterial calcification, generalized, of infancy, 1, 208000 ",3,"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED",173335,6q23.2,ENPP1
"Arterial calcification, generalized, of infancy, 2, 614473 ",3,"ABCC6, ARA, ABC34, MLP1, PXE, GACI2",603234,16p13.11,ABCC6
"Arterial tortuosity syndrome, 208050 ",3,"SLC2A10, GLUT10, ATS",606145,20q13.12,SLC2A10
"Arthrogryposis multiplex congenita, distal, type 1, 108120 ",3,"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4",190990,9p13.3,TPM2
"Arthrogryposis multiplex congenita, distal, type 2B, 601680 ",3,"TNNI2, AMCD2B, DA2B, FSSV",191043,11p15.5,TNNI2
"Arthrogryposis, distal, type 2A, 193700 ",3,"MYH3, DA2A, DA2B, DA8",160720,17p13.1,MYH3
"Arthrogryposis, distal, type 2B, 601680 ",3,"MYH3, DA2A, DA2B, DA8",160720,17p13.1,MYH3
"Arthrogryposis, distal, type 2B, 601680 ",3,"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4",190990,9p13.3,TPM2
"Arthrogryposis, distal, type 8, 178110 ",3,"MYH3, DA2A, DA2B, DA8",160720,17p13.1,MYH3
"Arthrogryposis, lethal, with anterior horn cell disease, 611890 ",3,"GLE1, GLE1L, LCCS, LCCS1",603371,9q34.11,GLE1
"Arthropathy, progressive pseudorheumatoid, of childhood, 208230 ",3,"WISP3, PPAC, PPD",603400,6q21,WISP3
"Arthyrgryposis, distal, type 2B, 601680 ",3,"TNNT3, AMCD2B, DA2B, FSSV",600692,11p15.5,TNNT3
"Arts syndrome, 301835 ",3,"PRPS1, CMTX5, DFNX1, DFN2",311850,Xq22.3,PRPS1
"Asparagine synthetase deficiency, 615574 ",3,"ASNS, ASNSD",108370,7q21.3,ASNS
"Aspartate aminotransferase, serum level of, QTL1, 614419 ",3,"GOT1, ASTQTL1",138180,10q24.2,GOT1
"Aspartylglucosaminuria, 208400 ",3,AGA,613228,4q34.3,AGA
"Asthma and nasal polyps, 208550 ",3,"TBX21, TBET",604895,17q21.32,TBX21
"Ataxia with isolated vitamin E deficiency, 277460 ",3,"TTPA, TTP1, AVED",600415,8q12.3,TTPA
"Ataxia, cerebellar, Cayman type, 601238 ",3,"ATCAY, CLAC, KIAA1872",608179,19p13.3,ATCAY
"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 ",3,"APTX, AOA, AOA1",606350,9p21.1,APTX
"Ataxia-oculomotor apraxia 4, 616267 ",3,"PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4",605610,19q13.33,PNKP
"Ataxia-telangiectasia, 208900 ",3,"ATM, ATA, AT1",607585,11q22.3,ATM
"Atelosteogenesis II, 256050 ",3,"SLC26A2, DTD, DTDST, D5S1708, EDM4",606718,5q32,SLC26A2
"Atelosteogenesis, type I, 108720 ",3,"FLNB, SCT, AOI, LRS1",603381,3p14.3,FLNB
"Atelosteogenesis, type III, 108721 ",3,"FLNB, SCT, AOI, LRS1",603381,3p14.3,FLNB
"Athabaskan brainstem dysgenesis syndrome, 601536 ",3,"HOXA1, HOX1F, BSAS",142955,7p15.2,HOXA1
"Atopy, 147050 ",3,"SPINK5, LEKTI",605010,5q32,SPINK5
"Atransferrinemia, 209300 ",3,"TF, TFQTL1",190000,3q22.1,TF
"Atrial fibrillation, familial, 10, 614022 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Atrial fibrillation, familial, 11, 614049 ",3,"GJA5, CX40, ATFB11",121013,1q21.2,GJA5
"Atrial fibrillation, familial, 13, 615377 ",3,"SCN1B, GEFSP1, BRGDA5, ATFB13",600235,19q13.11,SCN1B
"Atrial fibrillation, familial, 14, 615378 ",3,"SCN2B, ATFB14",601327,11q23.3,SCN2B
"Atrial fibrillation, familial, 3, 607554 ",3,"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2",607542,11p15.5-p15.4,KCNQ1
"Atrial fibrillation, familial, 4, 611493 ",3,"KCNE2, MIRP1, LQT6, ATFB4",603796,21q22.11,KCNE2
"Atrial fibrillation, familial, 6, 612201 ",3,"NPPA, PND, ANP, ATFB6, ATRST2",108780,1p36.22,NPPA
"Atrial fibrillation, familial, 7, 612240 ",3,"KCNA5, ATFB7",176267,12p13.32,KCNA5
"Atrial fibrillation, familial, 9, 613980 ",3,"KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9",600681,17q24.3,KCNJ2
"Atrial septal defect 2, 607941 ",3,"GATA4, ASD2, VSD1, TACHD, TOF",600576,8p23.1,GATA4
"Atrial septal defect 3, 614089 ",3,"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3",160710,14q11.2,MYH6
"Atrial septal defect 4, 611363 ",3,"TBX20, ASD4",606061,7p14.2,TBX20
"Atrial septal defect 5, 612794 ",3,"ACTC1, CMD1R, CMH11, ASD5, LVNC4",102540,15q14,ACTC1
"Atrial septal defect 7, with or without AV conduction defects, 108900 ",3,"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",600584,5q35.1,NKX2-5
"Atrial standstill 2, 615745 ",3,"NPPA, PND, ANP, ATFB6, ATRST2",108780,1p36.22,NPPA
"Atrichia with papular lesions, 209500 ",3,"HR, AU, MUHH1, HYPT4",602302,8p21.3,HR
"Atrioventricular septal defect 3, 600309 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Atrioventricular septal defect 4, 614430 ",3,"GATA4, ASD2, VSD1, TACHD, TOF",600576,8p23.1,GATA4
"Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 ",3,"CRELD1, AVSD2",607170,3p25.3,CRELD1
"Au-Kline syndrome, 616580 ",3,"HNRNPK, HNRPK, AUKS",600712,9q21.32,HNRNPK
"Auditory neuropathy, autosomal recessive, 1, 601071 ",3,"OTOF, DFNB9, NSRD9, AUNB1",603681,2p23.3,OTOF
"Auriculocondylar syndrome 1, 602483 ",3,"GNAI3, ARCND1",139370,1p13.3,GNAI3
"Auriculocondylar syndrome 3, 615706 ",3,"EDN1, ARCND3, QME, HDLCQ7",131240,6p24.1,EDN1
"Autoimmune disease, multisystem, infantile-onset, 2, 617006 ",3,"ZAP70, SRK, ADMIO2, IMD48",176947,2q11.2,ZAP70
"Autoimmune lymphoproliferative syndrome, type IA, 601859 ",3,"FAS, TNFRSF6, APT1, CD95, ALPS1A",134637,10q23.31,FAS
"Autoimmune lymphoproliferative syndrome, type IB, 601859 ",3,"FASLG, TNFSF6, APT1LG1, FASL, ALPS1B",134638,1q24.3,FASLG
"Autoimmune lymphoproliferative syndrome, type V, 616100 ",3,"CTLA4, IDDM12, CELIAC3, ALPS5",123890,2q33.2,CTLA4
"Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 ",3,"AIRE, APECED, APS1",607358,21q22.3,AIRE
"Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 ",3,"PSMB8, LMP7, RING10, JMP, NKJO, ALDD",177046,6p21.32,PSMB8
"Avascular necrosis of the femoral head, 608805 ",3,COL2A1,120140,12q13.11,COL2A1
"Axenfeld-Rieger syndrome, type 1, 180500 ",3,"PITX2, IDG2, RIEG1, RGS, IGDS2",601542,4q25,PITX2
"Axenfeld-Rieger syndrome, type 3, 602482 ",3,"FOXC1, FKHL7, FREAC3, IRID1, RIEG3",601090,6p25.3,FOXC1
"Bamforth-Lazarus syndrome, 241850 ",3,"FOXE1, FKHL15, TITF2, TTF2, NMTC4",602617,9q22.33,FOXE1
"Band-like calcification with simplified gyration and polymicrogyria, 251290 ",3,"OCLN, BLCPMG",602876,5q13.2,OCLN
"Bannayan-Riley-Ruvalcaba syndrome, 153480 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Baraitser-Winter syndrome 1, 243310 ",3,"ACTB, BRWS1",102630,7p22.1,ACTB
"Baraitser-Winter syndrome 2, 614583 ",3,"ACTG1, DFNA20, DFNA26, BRWS2",102560,17q25.3,ACTG1
"Bardet-Biedl syndrome 1, 209900 ",3,BBS1,209901,11q13.2,BBS1
"Bardet-Biedl syndrome 10, 615987 ",3,"BBS10, C12orf58, FLJ23560",610148,12q21.2,BBS10
"Bardet-Biedl syndrome 12, 615989 ",3,"BBS12, FLJ35630, C4orf24",610683,4q27,BBS12
"Bardet-Biedl syndrome 13, 615990 ",3,"MKS1, MKS, BBS13, JBTS28",609883,17q22,MKS1
"Bardet-Biedl syndrome 2, 615981 ",3,"BBS2, RP74",606151,16q13,BBS2
"Bardet-Biedl syndrome 3, 600151 ",3,"ARL6, BBS3, RP55",608845,3q11.2,ARL6
"Bardet-Biedl syndrome 4, 615982 ",3,BBS4,600374,15q24.1,BBS4
"Bardet-Biedl syndrome 5, 615983 ",3,BBS5,603650,2q31.1,BBS5
"Bardet-Biedl syndrome 6, 605231 ",3,"MKKS, HMCS, KMS, MKS, BBS6",604896,20p12.2,MKKS
"Bardet-Biedl syndrome 7, 615984 ",3,BBS7,607590,4q27,BBS7
"Bardet-Biedl syndrome 9, 615986 ",3,"PTHB1, BBS9",607968,7p14.3,PTHB1
"Bare lymphocyte syndrome, type I, 604571 ",3,"TAP1, ABCB2, TAP1, RING4, PSF1",170260,6p21.32,TAP1
"Bare lymphocyte syndrome, type I, 604571 ",3,"TAPBP, TPSN",601962,6p21.32,TAPBP
"Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 ",3,"TAP2, ABCB3, PSF2, RING11",170261,6p21.32,TAP2
"Bare lymphocyte syndrome, type II, complementation group A, 209920 ",3,"CIITA, MHC2TA, C2TA",600005,16p13.13,CIITA
"Bare lymphocyte syndrome, type II, complementation group C, 209920 ",3,RFX5,601863,1q21.3,RFX5
"Bare lymphocyte syndrome, type II, complementation group D, 209920 ",3,RFXAP,601861,13q13.3,RFXAP
"Bare lymphocyte syndrome, type II, complementation group E, 209920 ",3,RFX5,601863,1q21.3,RFX5
"Barrett esophagus/esophageal adenocarcinoma, 614266 ",3,"ASCC1, p50, SMABF2",614215,10q22.1,ASCC1
"Barrett esophagus/esophageal adenocarcinoma, 614266 ",3,CTHRC1,610635,8q22.3,CTHRC1
"Barrett esophagus/esophageal adenocarcinoma, 614266 ",3,"MSR1, SCARA1, SRA",153622,8p22,MSR1
"Bart-Pumphrey syndrome, 149200 ",3,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID",121011,13q12.11,GJB2
"Barth syndrome, 302060 ",3,"TAZ, EFE2, BTHS, CMD3A, LVNCX",300394,Xq28,TAZ
"Bartter syndrome, type 1, 601678 ",3,"SLC12A1, NKCC2",600839,15q21.1,SLC12A1
"Bartter syndrome, type 2, 241200 ",3,"KCNJ1, ROMK1",600359,11q24.3,KCNJ1
"Bartter syndrome, type 3, 607364 ",3,CLCNKB,602023,1p36.13,CLCNKB
"Bartter syndrome, type 4b, digenic, 613090 ",3,CLCNKA,602024,1p36.13,CLCNKA
"Bartter syndrome, type 4b, digenic, 613090 ",3,CLCNKB,602023,1p36.13,CLCNKB
"Bartter syndrome, type 5, antenatal, transient, 300971 ",3,"MAGED2, MAGED, BARTS5",300470,Xp11.21,MAGED2
"Basal cell carcinoma, somatic, 605462 ",3,"PTCH1, NBCCS, BCNS, HPE7",601309,9q22.32,PTCH1
"Basal cell carcinoma, somatic, 605462 ",3,PTCH2,603673,1p34.1,PTCH2
"Basal cell carcinoma, somatic, 605462 ",3,"RASA1, GAP, CMAVM, PKWS",139150,5q14.3,RASA1
"Basal cell carcinoma, somatic, 605462 ",3,"SMOH, SMO, CRJS",601500,7q32.1,SMOH
"Basal cell nevus syndrome, 109400 ",3,"PTCH1, NBCCS, BCNS, HPE7",601309,9q22.32,PTCH1
"Basal cell nevus syndrome, 109400 ",3,PTCH2,603673,1p34.1,PTCH2
"Basal cell nevus syndrome, 109400 ",3,"SUFU, SUFUXL, SUFUH",607035,10q24.32,SUFU
"Basal ganglia calcification, idiopathic, 1, 213600 ",3,"SLC20A2, MLVAR, GLVR2, IBGC1",158378,8p11.21,SLC20A2
"Basal ganglia calcification, idiopathic, 4, 615007 ",3,"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS",173410,5q32,PDGFRB
"Basal ganglia calcification, idiopathic, 5, 615483 ",3,"PDGFB, SIS, IBGC5",190040,22q13.1,PDGFB
"Basal laminar drusen, 126700 ",3,"CFH, HF1, HUS, ARMD4, AHUS1",134370,1q31.3,CFH
"Beare-Stevenson cutis gyrata syndrome, 123790 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Becker muscular dystrophy, 300376 ",3,"DMD, BMD, CMD3B",300377,Xp21.2-p21.1,DMD
"Beckwith-Wiedemann syndrome, 130650 ",3,"CDKN1C, KIP2, BWS, IMAGE",600856,11p15.4,CDKN1C
"Beckwith-Wiedemann syndrome, 130650 ",3,"H19, D11S813E, ASM1, BWS, WT2",103280,11p15.5,H19
"Beckwith-Wiedemann syndrome, 130650 ",3,ICR1,616186,11p15.5,ICR1
"Beckwith-Wiedemann syndrome, 130650 ",3,"KCNQ1OT1, LIT1",604115,11p15.5,KCNQ1OT1
"Beckwith-Wiedemann syndrome, 130650 ",3,"NSD1, ARA267, STO, SOTOS1",606681,5q35.3,NSD1
"Behr syndrome, 210000 ",3,"OPA1, NTG, NPG, BERHS, MTDPS14",605290,3q29,OPA1
"Bent bone dysplasia syndrome, 614592 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Bernard-Soulier syndrome, type B, 231200 ",3,"GP1BB, BS, BDPLT1",138720,22q11.21,GP1BB
"Bernard-Soulier syndrome, type C, 231200 ",3,GP9,173515,3q21.3,GP9
"Bestrophinopathy, autosomal recessive, 611809 ",3,"BEST1, VMD2, ARB, RP50",607854,11q12.3,BEST1
"Bethlem myopathy 1, 158810 ",3,"COL6A1, BTHLM1, UCHMD1",120220,21q22.3,COL6A1
"Bethlem myopathy 1, 158810 ",3,"COL6A2, BTHLM1, UCMD1",120240,21q22.3,COL6A2
"Bethlem myopathy 1, 158810 ",3,"COL6A3, DYT27, BTHLM1, UCMD1",120250,2q37.3,COL6A3
"Bietti crystalline corneoretinal dystrophy, 210370 ",3,"CYP4V2, BCD",608614,4q35.1-q35.2,CYP4V2
"Bile acid malabsorption, primary, 613291 ",3,"SLC10A2, NTCP2, PBAM",601295,13q33.1,SLC10A2
"Bile acid synthesis defect, congenital, 1, 607765 ",3,"HSD3B7, CBAS1",607764,16p11.2,HSD3B7
"Bile acid synthesis defect, congenital, 3, 613812 ",3,"CYP7B1, CBAS3, SPG5A",603711,8q12.3,CYP7B1
"Birk-Barel mental retardation dysmorphism syndrome, 612292 ",3,"KCNK9, TASK3",605874,8q24.3,KCNK9
"Birt-Hogg-Dube syndrome, 135150 ",3,"FLCN, BHD",607273,17p11.2,FLCN
"Bjornstad syndrome, 262000 ",3,"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1",603647,2q35,BCS1L
"Bladder cancer, somatic, 109800 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Bladder cancer, somatic, 109800 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Bladder cancer, somatic, 109800 ",3,RB1,614041,13q14.2,RB1
"Blau syndrome, 186580 ",3,"NOD2, CARD15, IBD1, CD, ACUG, PSORAS1",605956,16q12.1,NOD2
"Bleeding disorder, platelet-type, 11, 614201 ",3,"GP6, GPIV, BDPLT11",605546,19q13.42,GP6
"Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 ",3,"ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16",607759,17q21.31,ITGA2B
"Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 ",3,"ITGB3, GP3A, GT, BDPLT2, BDPLT16",173470,17q21.32,ITGB3
"Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 ",3,"FOXL2, BPES, BPES1, PFRK, POF3",605597,3q22.3,FOXL2
"Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 ",3,"FOXL2, BPES, BPES1, PFRK, POF3",605597,3q22.3,FOXL2
"Bloom syndrome, 210900 ",3,"RECQL3, RECQ2, BLM, BS",604610,15q26.1,RECQL3
"Blue cone monochromacy, 303700 ",3,"OPN1LW, RCP, CBP, CBBM",300822,Xq28,OPN1LW
"Blue cone monochromacy, 303700 ",3,"OPN1MW, GCP, CBD, CBBM",300821,Xq28,OPN1MW
"Bone marrow failure syndrome 3, 617052 ",3,"DNAJC21, DNAJA5, BMFS3",617048,5p13.2,DNAJC21
"Boomerang dysplasia, 112310 ",3,"FLNB, SCT, AOI, LRS1",603381,3p14.3,FLNB
"Borjeson-Forssman-Lehmann syndrome, 301900 ",3,"PHF6, BFLS",300414,Xq26.2,PHF6
"Bosley-Salih-Alorainy syndrome, 601536 ",3,"HOXA1, HOX1F, BSAS",142955,7p15.2,HOXA1
"Boucher-Neuhauser syndrome, 215470 ",3,"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",603197,19p13.2,PNPLA6
"Brachydactyly, type A1, 112500 ",3,"IHH, BDA1",600726,2q35,IHH
"Brachydactyly, type A1, C, 615072 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Brachydactyly, type A2, 112600 ",3,"BMP2, BMP2A, BDA2",112261,20p12.3,BMP2
"Brachydactyly, type A2, 112600 ",3,"BMPR1B, ALK6, AMDD, BDA2, BDA1D",603248,4q22.3,BMPR1B
"Brachydactyly, type A2, 112600 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Brachydactyly, type B1, 113000 ",3,"ROR2, BDB1, BDB, NTRKR2",602337,9q22.31,ROR2
"Brachydactyly, type B2, 611377 ",3,"NOG, SYM1, SYNS1A",602991,17q22,NOG
"Brachydactyly, type C, 113100 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Brachydactyly, type D, 113200 ",3,"HOXD13, HOX4I, SPD1, BDSD",142989,2q31.1,HOXD13
"Brachydactyly, type E, 113300 ",3,"HOXD13, HOX4I, SPD1, BDSD",142989,2q31.1,HOXD13
"Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 ",3,"PAPSS2, ATPSK2, BCYM4",603005,10q23.2-q23.3,PAPSS2
"Brachyolmia type 3, 113500 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Bradyopsia, 608415 ",3,"RGS9, PERRS",604067,17q24.1,RGS9
"Bradyopsia, 608415 ",3,"RGS9BP, R9AP, RGS9, PERRS",607814,19q13.11,RGS9BP
"Brain small vessel disease with or without ocular anomalies, 607595 ",3,"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR",120130,13q34,COL4A1
"Brain tumor-polyposis syndrome 2, 175100 ",3,"APC, GS, FPC, BTPS2",611731,5q22.2,APC
"Branchiooculofacial syndrome, 113620 ",3,"TFAP2A, AP2TF, BOFS",107580,6p24.3,TFAP2A
"Branchiootic syndrome 1, 602588 ",3,"EYA1, BOR, BOS1, OFC1",601653,8q13.3,EYA1
"Branchiootic syndrome 3, 608389 ",3,"SIX1, BOS3, DFNA23",601205,14q23.1,SIX1
"Branchiootorenal syndrome 1, with or without cataracts, 113650 ",3,"EYA1, BOR, BOS1, OFC1",601653,8q13.3,EYA1
"Breast cancer, 114480 ",3,"PPM1D, WIP1",605100,17q23.2,PPM1D
"Breast cancer, 114480 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Breast cancer, early-onset, 114480 ",3,"BRIP1, BACH1, FANCJ",605882,17q23.2,BRIP1
"Breast cancer, somatic, 114480 ",3,"AKT1, CWS6",164730,14q32.33,AKT1
"Breast cancer, somatic, 114480 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Breast cancer, somatic, 114480 ",3,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5",171834,3q26.32,PIK3CA
"Breast cancer, somatic, 114480 ",3,"RB1CC1, CC1, KIAA0203",606837,8q11.23,RB1CC1
"Breast cancer, somatic, 114480 ",3,"SLC22A1L, BWSCR1A, IMPT1",602631,11p15.4,SLC22A1L
"Breast cancer, somatic, 114480 ",3,TSG101,601387,11p15.1,TSG101
"Brittle cornea syndrome 1, 229200 ",3,"ZNF469, KIAA1858, BCS1",612078,16q24.2,ZNF469
"Brody myopathy, 601003 ",3,"ATP2A1, SERCA1",108730,16p11.2,ATP2A1
"Bronchiectasis with or without elevated sweat chloride 1, 211400 ",3,"SCNN1B, BESC1",600760,16p12.2,SCNN1B
"Bronchiectasis with or without elevated sweat chloride 2, 613021 ",3,"SCNN1A, BESC2",600228,12p13.31,SCNN1A
"Bronchiectasis with or without elevated sweat chloride 3, 613071 ",3,"SCNN1G, PHA1, BESC3",600761,16p12.2,SCNN1G
"Bruck syndrome 2, 609220 ",3,"PLOD2, LH2, TLH, BRKS2",601865,3q24,PLOD2
"Brugada syndrome 1, 601144 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Brugada syndrome 3, 611875 ",3,"CACNA1C, CACNL1A1, CCHL1A1, TS",114205,12p13.33,CACNA1C
"Brugada syndrome 4, 611876 ",3,CACNB2,600003,10p12.33-p12.31,CACNB2
"Brugada syndrome 5, 612838 ",3,"SCN1B, GEFSP1, BRGDA5, ATFB13",600235,19q13.11,SCN1B
"Brugada syndrome 9, 616399 ",3,"KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9",605411,1p13.2,KCND3
"Brunner syndrome, 300615 ",3,"MAOA, BRNRS",309850,Xp11.3,MAOA
"Burkitt lymphoma, 113970 ",3,MYC,190080,8q24.21,MYC
"Buschke-Ollendorff syndrome, 166700 ",3,"LEMD3, MAN1",607844,12q14.3,LEMD3
"C syndrome, 211750 ",3,"CD96, TACTILE",606037,3q13.1-q13.2,CD96
"C1q deficiency, 613652 ",3,C1QA,120550,1p36.12,C1QA
"C1q deficiency, 613652 ",3,C1QB,120570,1p36.12,C1QB
"C1q deficiency, 613652 ",3,"C1QC, C1QG",120575,1p36.12,C1QC
"C1s deficiency, 613783 ",3,"C1S, EDSPD2",120580,12p13.31,C1S
"C2 deficiency, 217000 ",3,"C2, ARMD14",613927,6p21.33,C2
"C3 deficiency, 613779 ",3,"C3, ARMD9, AHUS5",120700,19p13.3,C3
"C4B deficiency, 614379 ",3,"C4B, C4F, C4BD",120820,6p21.33,C4B
"C4a deficiency, 614380 ",3,"C4A, C4S, C4AD",120810,6p21.33,C4A
"C5 deficiency, 609536 ",3,"C5, C5D, ECLZB",120900,9q33.2,C5
"C6 deficiency, 612446 ",3,C6,217050,5p13.1,C6
"C7 deficiency, 610102 ",3,C7,217070,5p13.1,C7
"C8 deficiency, type I, 613790 ",3,C8A,120950,1p32.2,C8A
"C8 deficiency, type II, 613789 ",3,C8B,120960,1p32.2,C8B
"C9 deficiency, 613825 ",3,"C9, C9D, ARMD15",120940,5p13.1,C9
"CAP myopathy 1, 609284 ",3,"TPM3, NEM1, CFTD, CAPM1",191030,1q21.3,TPM3
"CAP myopathy 2, 609285 ",3,"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4",190990,9p13.3,TPM2
"CAPOS syndrome, 601338 ",3,"ATP1A3, DYT12, RDP, AHC2, CAPOS",182350,19q13.2,ATP1A3
"CATSHL syndrome, 610474 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"CD8 deficiency, familial, 608957 ",3,CD8A,186910,2p11.2,CD8A
"CHARGE syndrome, 214800 ",3,"CHD7, HH5",608892,8q12.2,CHD7
"CINCA syndrome, 607115 ",3,"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1",606416,1q44,NLRP3
"COACH syndrome, 216360 ",3,"CC2D2A, KIAA1345, MKS6",612013,4p15.32,CC2D2A
"COACH syndrome, 216360 ",3,"RPGRIP1L, KIAA1005, JBTS7, MKS5",610937,16q12.2,RPGRIP1L
"COACH syndrome, 216360 ",3,"TMEM67, MKS3, JBTS6, NPHP11",609884,8q22.1,TMEM67
"COPD, rate of decline of lung function in, 606963 ",3,"MMP1, CLG",120353,11q22.2,MMP1
"CPT II deficiency, lethal neonatal, 608836 ",3,"CPT2, IIAE4",600650,1p32.3,CPT2
"CPT deficiency, hepatic, type IA, 255120 ",3,CPT1A,600528,11q13.3,CPT1A
"CPT deficiency, hepatic, type II, 600649 ",3,"CPT2, IIAE4",600650,1p32.3,CPT2
"CRASH syndrome, 303350 ",3,"L1CAM, CAML1, HSAS1, MASA, SPG1",308840,Xq28,L1CAM
"Caffey disease, 114000 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Calcification of joints and arteries, 211800 ",3,"NT5E, NT5",129190,6q14.3,NT5E
"Campomelic dysplasia with autosomal sex reversal, 114290 ",3,"SOX9, CMD1, SRA1",608160,17q24.3,SOX9
"Campomelic dysplasia, 114290 ",3,"SOX9, CMD1, SRA1",608160,17q24.3,SOX9
"Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 ",3,"PRG4, CACP, MSF, SZP, HAPO",604283,1q31.1,PRG4
"Camurati-Engelmann disease, 131300 ",3,"TGFB1, DPD1, CED",190180,19q13.2,TGFB1
"Canavan disease, 271900 ",3,ASPA,608034,17p13.2,ASPA
"Candidiasis, familial, 4, autosomal recessive, 613108 ",3,"CLEC7A, CLECSF12, DECTIN1, CANDF4",606264,12p13.2,CLEC7A
"Capillary malformation-arteriovenous malformation, 608354 ",3,"RASA1, GAP, CMAVM, PKWS",139150,5q14.3,RASA1
"Carbamoylphosphate synthetase I deficiency, 237300 ",3,"CPS1, PHN",608307,2q34,CPS1
"Carboxypeptidase N deficiency, 212070 ",3,"CPN1, SCPN, CPN",603103,10q24.2,CPN1
"Carcinoid tumors, intestinal, 114900 ",3,"SDHD, PGL1, CWS3",602690,11q23.1,SDHD
"Cardiac arrhythmia, ankyrin-B-related, 600919 ",3,"ANK2, LQT4",106410,4q25-q26,ANK2
"Cardiac conduction defect, nonspecific, 612838 ",3,"SCN1B, GEFSP1, BRGDA5, ATFB13",600235,19q13.11,SCN1B
"Cardiac valvular dysplasia, X-linked, 314400 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 ",3,"SCO2, CEMCOX1, MYP6",604272,22q13.33,SCO2
"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 ",3,"COX15, CEMCOX2",603646,10q24.2,COX15
"Cardiofaciocutaneous syndrome 2, 615278 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Cardiofaciocutaneous syndrome 3, 615279 ",3,"MAP2K1, PRKMK1, MKK1, MEK1, CFC3",176872,15q22.31,MAP2K1
"Cardiofaciocutaneous syndrome, 115150 ",3,"BRAF, NS7",164757,7q34,BRAF
"Cardiomyopathy, dilated, 1A, 115200 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 ",3,"ACTN2, CMD1AA, CMH23",102573,1q43,ACTN2
"Cardiomyopathy, dilated, 1BB, 612877 ",3,"DSG2, ARVD10, ARVC10, CMD1BB",125671,18q12.1,DSG2
"Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 ",3,"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",605906,10q23.2,LDB3
"Cardiomyopathy, dilated, 1D, 601494 ",3,"TNNT2, CMH2, CMD1D, RCM3, LVNC6",191045,1q32.1,TNNT2
"Cardiomyopathy, dilated, 1E, 601154 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Cardiomyopathy, dilated, 1EE, 613252 ",3,"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3",160710,14q11.2,MYH6
"Cardiomyopathy, dilated, 1FF, 613286 ",3,"TNNI3, CMH7, CMD2A, RCM1, CMD1FF",191044,19q13.42,TNNI3
"Cardiomyopathy, dilated, 1G, 604145 ",3,"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC",188840,2q31.2,TTN
"Cardiomyopathy, dilated, 1GG, 613642 ",3,"SDHA, SDH1, SDHF, CMD1GG, PGL5",600857,5p15.33,SDHA
"Cardiomyopathy, dilated, 1I, 604765 ",3,"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",125660,2q35,DES
"Cardiomyopathy, dilated, 1II, 615184 ",3,"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2",123590,11q23.1,CRYAB
"Cardiomyopathy, dilated, 1J, 605362 ",3,"EYA4, DFNA10, CMD1J",603550,6q23.2,EYA4
"Cardiomyopathy, dilated, 1L, 606685 ",3,"SGCD, SGD, LGMD2F, CMD1L",601411,5q33.2-q33.3,SGCD
"Cardiomyopathy, dilated, 1MM, 615396 ",3,"MYBPC3, CMH4, CMD1MM, LVNC10",600958,11p11.2,MYBPC3
"Cardiomyopathy, dilated, 1NN, 615916 ",3,"RAF1, CRAF, NS5, CMD1NN",164760,3p25.2,RAF1
"Cardiomyopathy, dilated, 1P, 609909 ",3,"PLN, PLB, CMD1P, CMH18",172405,6q22.31,PLN
"Cardiomyopathy, dilated, 1R, 613424 ",3,"ACTC1, CMD1R, CMH11, ASD5, LVNC4",102540,15q14,ACTC1
"Cardiomyopathy, dilated, 1S, 613426 ",3,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD",160760,14q11.2,MYH7
"Cardiomyopathy, dilated, 1U, 613694 ",3,"PSEN1, AD3",104311,14q24.2,PSEN1
"Cardiomyopathy, dilated, 1V, 613697 ",3,"PSEN2, AD4, STM2, CMD1V",600759,1q42.13,PSEN2
"Cardiomyopathy, dilated, 1W, 611407 ",3,"VCL, CMD1W, CMH15",193065,10q22.2,VCL
"Cardiomyopathy, dilated, 1X, 611615 ",3,"FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4",607440,9q31.2,FKTN
"Cardiomyopathy, dilated, 1Y, 611878 ",3,"TPM1, CMH3, CMD1Y , LVNC9",191010,15q22.2,TPM1
"Cardiomyopathy, dilated, 1Z, 611879 ",3,"TNNC1, CMD1Z, CMH13",191040,3p21.1,TNNC1
"Cardiomyopathy, dilated, 3B, 302045 ",3,"DMD, BMD, CMD3B",300377,Xp21.2-p21.1,DMD
"Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 ",3,"DSP, KPPS2, PPKS2, DCWHKTA",125647,6p24.3,DSP
"Cardiomyopathy, familial hypertrophic, 192600 ",3,"CAV3, LGMD1C, LQT9",601253,3p25.3,CAV3
"Cardiomyopathy, familial hypertrophic, 26 ",3,"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",102565,7q32.1,FLNC
"Cardiomyopathy, familial hypertrophic, 9, 613765 ",3,"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC",188840,2q31.2,TTN
"Cardiomyopathy, familial restrictive 5, 617047 ",3,"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",102565,7q32.1,FLNC
"Cardiomyopathy, familial restrictive, 1, 115210 ",3,"TNNI3, CMH7, CMD2A, RCM1, CMD1FF",191044,19q13.42,TNNI3
"Cardiomyopathy, familial restrictive, 3, 612422 ",3,"TNNT2, CMH2, CMD1D, RCM3, LVNC6",191045,1q32.1,TNNT2
"Cardiomyopathy, hypertrophic 6, 600858 ",3,"PRKAG2, WPWS, CMH6",602743,7q36.1,PRKAG2
"Cardiomyopathy, hypertrophic, 1, 192600 ",3,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD",160760,14q11.2,MYH7
"Cardiomyopathy, hypertrophic, 1, digenic, 192600 ",3,"MYLK2, MLCK",606566,20q11.21,MYLK2
"Cardiomyopathy, hypertrophic, 10, 608758 ",3,"MYL2, CMH10",160781,12q24.11,MYL2
"Cardiomyopathy, hypertrophic, 11, 612098 ",3,"ACTC1, CMD1R, CMH11, ASD5, LVNC4",102540,15q14,ACTC1
"Cardiomyopathy, hypertrophic, 12, 612124 ",3,"CSRP3, CRP3, CLP, CMD1M, CMH12",600824,11p15.1,CSRP3
"Cardiomyopathy, hypertrophic, 13, 613243 ",3,"TNNC1, CMD1Z, CMH13",191040,3p21.1,TNNC1
"Cardiomyopathy, hypertrophic, 14, 613251 ",3,"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3",160710,14q11.2,MYH6
"Cardiomyopathy, hypertrophic, 15, 613255 ",3,"VCL, CMD1W, CMH15",193065,10q22.2,VCL
"Cardiomyopathy, hypertrophic, 18, 613874 ",3,"PLN, PLB, CMD1P, CMH18",172405,6q22.31,PLN
"Cardiomyopathy, hypertrophic, 2, 115195 ",3,"TNNT2, CMH2, CMD1D, RCM3, LVNC6",191045,1q32.1,TNNT2
"Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 ",3,"ACTN2, CMD1AA, CMH23",102573,1q43,ACTN2
"Cardiomyopathy, hypertrophic, 24, 601493 ",3,"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",605906,10q23.2,LDB3
"Cardiomyopathy, hypertrophic, 25, 607487 ",3,"TCAP, LGMD2G, CMH25",604488,17q12,TCAP
"Cardiomyopathy, hypertrophic, 3, 115196 ",3,"TPM1, CMH3, CMD1Y , LVNC9",191010,15q22.2,TPM1
"Cardiomyopathy, hypertrophic, 4, 115197 ",3,"MYBPC3, CMH4, CMD1MM, LVNC10",600958,11p11.2,MYBPC3
"Cardiomyopathy, hypertrophic, 7, 613690 ",3,"TNNI3, CMH7, CMD2A, RCM1, CMD1FF",191044,19q13.42,TNNI3
"Cardiomyopathy, hypertrophic, 8, 608751 ",3,"MYL3, CMH8",160790,3p21.31,MYL3
"Carney complex variant, 608837 ",3,"MYH8, DA7",160741,17p13.1,MYH8
"Carney complex, type 1, 160980 ",3,"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1",188830,17q24.2,PRKAR1A
"Carnitine deficiency, systemic primary, 212140 ",3,"SLC22A5, OCTN2, CDSP, SCD",603377,5q31.1,SLC22A5
"Carotid intimal medial thickness 1, 609338 ",3,"PPARG, PPARG1, PPARG2, CIMT1, GLM1",601487,3p25.2,PPARG
"Carpal tunnel syndrome, familial, 115430 ",3,"TTR, PALB",176300,18q12.1,TTR
"Carpenter syndrome, 201000 ",3,RAB23,606144,6p12.1-p11.2,RAB23
"Cartilage-hair hypoplasia, 250250 ",3,"RMRP, RMRPR, CHH",157660,9p13.3,RMRP
"Cataract 1, multiple types, 116200 ",3,"GJA8, CX50, CTRCT1, CZP1, CAE1",600897,1q21.2,GJA8
"Cataract 10, multiple types, 600881 ",3,"CRYBA1, CRYB1, CTRCT10",123610,17q11.2,CRYBA1
"Cataract 11, multiple types, 610623 ",3,"PITX3, CTPP4, CTRCT11",602669,10q24.32,PITX3
"Cataract 11, syndromic, 610623 ",3,"PITX3, CTPP4, CTRCT11",602669,10q24.32,PITX3
"Cataract 12, multiple types, 611597 ",3,"BFSP2, CP49, CP47, CTRCT12",603212,3q22.1,BFSP2
"Cataract 13 with adult i phenotype, 116700 ",3,"GCNT2, Ii, CTRCT13",600429,6p24.3-p24.2,GCNT2
"Cataract 14, multiple types, 601885 ",3,"GJA3, CX46, CZP3, CAE3, CTRCT14",121015,13q12.11,GJA3
"Cataract 15, multiple types, 615274 ",3,"MIP, AQP0, CTRCT15",154050,12q13.3,MIP
"Cataract 16, multiple types, 613763 ",3,"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2",123590,11q23.1,CRYAB
"Cataract 19, multiple types, 615277 ",3,"LIM2, MP19, CTRCT19",154045,19q13.41,LIM2
"Cataract 2, multiple types, 604307 ",3,"CRYGC, CRYG3, CTRCT2, CCL",123680,2q33.3,CRYGC
"Cataract 20, multiple types, 116100 ",3,"CRYGS, CRYG8, CTRCT20",123730,3q27.3,CRYGS
"Cataract 22, autosomal recessive, 609741 ",3,"CRYBB3, CRYB3, CATCN2, CTRCT22",123630,22q11.23,CRYBB3
"Cataract 23, 610425 ",3,"CRYBA4, CTRCT23",123631,22q12.1,CRYBA4
"Cataract 3, multiple types, 601547 ",3,"CRYBB2, CRYB2, CTRCT3, CCA2",123620,22q11.23,CRYBB2
"Cataract 31, multiple types, 605387 ",3,"CHMP4B, SNF7, CTPP3, CTRCT31",610897,20q11.22,CHMP4B
"Cataract 36, 613887 ",3,"TDRD7, KIAA1529, TRAP, CATC4, CTRCT36",611258,9q22.33,TDRD7
"Cataract 39, multiple types, autosomal dominant, 615188 ",3,"CRYGB, CRYG2, CTRCT39",123670,2q33.3,CRYGB
"Cataract 4, multiple types, 115700 ",3,"CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC",123690,2q33.3,CRYGD
"Cataract 40, X-linked, 302200 ",3,"NHS, CXN, CTRCT40",300457,Xp22.2-p22.1,NHS
"Cataract 47, juvenile, with microcornea, 612018 ",3,"SLC16A12, MCT12, CTRCT47",611910,10q23.31,SLC16A12
"Cataract 5, multiple types, 116800 ",3,"HSF4, CTM, CTRCT5",602438,16q22.1,HSF4
"Cataract 6, multiple types, 116600 ",3,"EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6",176946,1p36.13,EPHA2
"Cataract 9, multiple types, 604219 ",3,"CRYAA, CRYA1, CTRCT9",123580,21q22.3,CRYAA
"Cataract with late-onset corneal dystrophy, 106210 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Cavernous malformations of CNS and retina, 116860 ",3,"CCM1, CAM, KRIT1",604214,7q21.2,CCM1
"Central core disease, 117000 ",3,"RYR1, MHS, CCO",180901,19q13.2,RYR1
"Central hypoventilation syndrome, 209880 ",3,"GDNF, HSCR3",600837,5p13.2,GDNF
"Central hypoventilation syndrome, congenital, 209880 ",3,"ASCL1, ASH1",100790,12q23.2,ASCL1
"Central hypoventilation syndrome, congenital, 209880 ",3,"BDNF, BULN2, ANON2",113505,11p14.1,BDNF
"Central hypoventilation syndrome, congenital, 209880 ",3,"EDN3, WS4B, HSCR4",131242,20q13.32,EDN3
"Central hypoventilation syndrome, congenital, 209880 ",3,"RET, MEN2A, HSCR1",164761,10q11.21,RET
"Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 ",3,"PMX2B, NBPHOX, PHOX2B, NBLST2",603851,4p13,PMX2B
"Cerebellar ataxia, 604290 ",3,CP,117700,3q24-q25,CP
"Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 ",3,"DNMT1, MCMT, HSN1E, ADCADN",126375,19p13.2,DNMT1
"Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 ",3,"VLDLR, CAMRQ1",192977,9p24.2,VLDLR
"Cerebral amyloid angiopathy, 105150 ",3,"CST3, ARMD11",604312,20p11.21,CST3
"Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 ",3,"APP, AAA, CVAP, AD1",104760,21q21.3,APP
"Cerebral amyloid angiopathy, PRNP-related, 137440 ",3,"PRNP, PRIP, KURU, CJD",176640,20p13,PRNP
"Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 ",3,"NOTCH3, CADASIL1, CASIL, IMF2, LMNS",600276,19p13.12,NOTCH3
"Cerebral cavernous malformations-1, 116860 ",3,"CCM1, CAM, KRIT1",604214,7q21.2,CCM1
"Cerebral cavernous malformations-2, 603284 ",3,"C7orf22, CCM2, MGC4067",607929,7p13,C7orf22
"Cerebral creatine deficiency syndrome 1, 300352 ",3,"SLC6A8, CRTR, CCDS1",300036,Xq28,SLC6A8
"Cerebral creatine deficiency syndrome 3, 612718 ",3,"GATM, AGAT, CCDS3",602360,15q21.1,GATM
"Cerebral palsy, spastic quadriplegic, 2, 612900 ",3,"KANK1, KANK, ANKRD15, KIAA0172, CPSQ2",607704,9p24.3,KANK1
"Cerebral palsy, spastic quadriplegic, 3, 617008 ",3,"ADD3, ADDL, CPSQ3",601568,10q25.1-q25.2,ADD3
"Cerebrooculofacioskeletal syndrome 1, 214150 ",3,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11",609413,10q11.23,ERCC6
"Cerebrooculofacioskeletal syndrome 2, 610756 ",3,"ERCC2, EM9, XPD, COFS2, TTD1",126340,19q13.32,ERCC2
"Cerebrooculofacioskeletal syndrome 3, 616570 ",3,"ERCC5, XPG, COFS3",133530,13q33.1,ERCC5
"Cerebrooculofacioskeletal syndrome 4, 610758 ",3,"ERCC1, UV20, COFS4",126380,19q13.32,ERCC1
"Ceroid lipofuscinosis, neuronal, 1, 256730 ",3,"PPT1, CLN1",600722,1p34.2,PPT1
"Ceroid lipofuscinosis, neuronal, 10, 610127 ",3,"CTSD, CPSD, CLN10",116840,11p15.5,CTSD
"Ceroid lipofuscinosis, neuronal, 11, 614706 ",3,"GRN, CLN11",138945,17q21.31,GRN
"Ceroid lipofuscinosis, neuronal, 2, 204500 ",3,"TPP1, CLN2, SCAR7",607998,11p15.4,TPP1
"Ceroid lipofuscinosis, neuronal, 3, 204200 ",3,"CLN3, BTS",607042,16p12.1,CLN3
"Ceroid lipofuscinosis, neuronal, 5, 256731 ",3,CLN5,608102,13q22.3,CLN5
"Ceroid lipofuscinosis, neuronal, 6, 601780 ",3,"CLN6, CLN4A",606725,15q23,CLN6
"Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 ",3,"CLN6, CLN4A",606725,15q23,CLN6
"Cervical cancer, somatic, 603956 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Chanarin-Dorfman syndrome, 275630 ",3,"ABHD5, CGI58, IECN2, NCIE2",604780,3p21.33,ABHD5
"Char syndrome, 169100 ",3,"TFAP2B, CHAR, PDA2",601601,6p12.3,TFAP2B
"Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 ",3,"PRPS1, CMTX5, DFNX1, DFN2",311850,Xq22.3,PRPS1
"Charcot-Marie-Tooth disease, axonal, type 20, 614228 ",3,"DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1",600112,14q32.31,DYNC1H1
"Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 ",3,"MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B",608507,1p36.22,MFN2
"Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 ",3,"MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B",608507,1p36.22,MFN2
"Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 ",3,"NEFH, CMT2CC",162230,22q12.2,NEFH
"Charcot-Marie-Tooth disease, axonal, type 2F, 606595 ",3,"HSPB1, HSP27, CMT2F, HMN2B",602195,7q11.23,HSPB1
"Charcot-Marie-Tooth disease, axonal, type 2K, 607831 ",3,"GDAP1, CMT4A, CMT2K, CMTRIA",606598,8q21.11,GDAP1
"Charcot-Marie-Tooth disease, axonal, type 2L, 608673 ",3,"HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A",608014,12q24.23,HSPB8
"Charcot-Marie-Tooth disease, axonal, type 2M, 606482 ",3,"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",602378,19p13.2,DNM2
"Charcot-Marie-Tooth disease, axonal, type 2N, 613287 ",3,"AARS, CMT2N, EIEE29",601065,16q22.1,AARS
"Charcot-Marie-Tooth disease, axonal, type 2T, 617017 ",3,"MME, CD10, CALLA, NEP, CMT2T, SCA43",120520,3q25.2,MME
"Charcot-Marie-Tooth disease, axonal, type 2X, 616668 ",3,"SPG11, KIAA1840, FLJ21439, ALS5, CMT2X",610844,15q21.1,SPG11
"Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 ",3,"MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z",616661,22q12.2,MORC2
"Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 ",3,"GDAP1, CMT4A, CMT2K, CMTRIA",606598,8q21.11,GDAP1
"Charcot-Marie-Tooth disease, dominant intermediate B, 606482 ",3,"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",602378,19p13.2,DNM2
"Charcot-Marie-Tooth disease, dominant intermediate C, 608323 ",3,"YARS, CMTDIC, TYRRS, YTS, YRS",603623,1p35.1,YARS
"Charcot-Marie-Tooth disease, dominant intermediate D, 607791 ",3,"MPZ, CMT1B, CMTDID, CHM, DSS",159440,1q23.3,MPZ
"Charcot-Marie-Tooth disease, foot deformity of, 192950 ",3,"HOXD10, HOX4D",142984,2q31.1,HOXD10
"Charcot-Marie-Tooth disease, recessive intermediate C, 615376 ",3,"PLEKHG5, KIAA0720, DSMA4, CMTRIC",611101,1p36.31,PLEKHG5
"Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 ",3,"GDAP1, CMT4A, CMT2K, CMTRIA",606598,8q21.11,GDAP1
"Charcot-Marie-Tooth disease, type 1A, 118220 ",3,"PMP22, CMT1A, CMT1E, DSS",601097,17p12,PMP22
"Charcot-Marie-Tooth disease, type 1B, 118200 ",3,"MPZ, CMT1B, CMTDID, CHM, DSS",159440,1q23.3,MPZ
"Charcot-Marie-Tooth disease, type 1C, 601098 ",3,"LITAF, CMT1C",603795,16p13.13,LITAF
"Charcot-Marie-Tooth disease, type 1E, 118300 ",3,"PMP22, CMT1A, CMT1E, DSS",601097,17p12,PMP22
"Charcot-Marie-Tooth disease, type 1F, 607734 ",3,"NEFL, CMT2E, CMT1F",162280,8p21.2,NEFL
"Charcot-Marie-Tooth disease, type 2B, 600882 ",3,"RAB7, CMT2B, PSN",602298,3q21.3,RAB7
"Charcot-Marie-Tooth disease, type 2B1, 605588 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Charcot-Marie-Tooth disease, type 2D, 601472 ",3,"GARS, SMAD1, CMT2D, HMN5",600287,7p14.3,GARS
"Charcot-Marie-Tooth disease, type 2E, 607684 ",3,"NEFL, CMT2E, CMT1F",162280,8p21.2,NEFL
"Charcot-Marie-Tooth disease, type 2I, 607677 ",3,"MPZ, CMT1B, CMTDID, CHM, DSS",159440,1q23.3,MPZ
"Charcot-Marie-Tooth disease, type 2J, 607736 ",3,"MPZ, CMT1B, CMTDID, CHM, DSS",159440,1q23.3,MPZ
"Charcot-Marie-Tooth disease, type 2R, 615490 ",3,"TRIM2, KIAA0517, CMT2R",614141,4q31.3,TRIM2
"Charcot-Marie-Tooth disease, type 2Y, 616687 ",3,"VCP, IBMPFD1, ALS14, CMT2Y",601023,9p13.3,VCP
"Charcot-Marie-Tooth disease, type 4A, 214400 ",3,"GDAP1, CMT4A, CMT2K, CMTRIA",606598,8q21.11,GDAP1
"Charcot-Marie-Tooth disease, type 4B1, 601382 ",3,"MTMR2, CMT4B1",603557,11q21,MTMR2
"Charcot-Marie-Tooth disease, type 4B2, 604563 ",3,"SBF2, MTMR13, CMT4B2",607697,11p15.4,SBF2
"Charcot-Marie-Tooth disease, type 4H, 609311 ",3,"FGD4, FRABIN, CMT4H",611104,12p11.21,FGD4
"Charcot-Marie-Tooth disease, type 4K, 616684 ",3,"SURF1, CMT4K",185620,9q34.2,SURF1
"Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 ",3,"GJB1, CX32, CMTX1",304040,Xq13.1,GJB1
"Chediak-Higashi syndrome, 214500 ",3,"LYST, CHS1",606897,1q42.3,LYST
"Cherubism, 118400 ",3,"SH3BP2, CRPM",602104,4p16.3,SH3BP2
"Chilblain lupus, 610448 ",3,"TREX1, AGS1, CRV, HERNS",606609,3p21.31,TREX1
"Chitayat syndrome, 617180 ",3,"ERF, PE2, CRS4, CHYTS",611888,19q13.2,ERF
"Choanal atresia and lymphedema, 613611 ",3,"PTPN14, PEZ",603155,1q32-q41,PTPN14
"Cholestasis, benign recurrent intrahepatic, 2, 605479 ",3,"ABCB11, BSEP, SPGP, PFIC2, BRIC2",603201,2q31.1,ABCB11
"Cholestasis, intrahepatic, of pregnancy, 3, 614972 ",3,"ABCB4, PGY3, MDR3, ICP3",171060,7q21.12,ABCB4
"Cholestasis, progressive familial intrahepatic 2, 601847 ",3,"ABCB11, BSEP, SPGP, PFIC2, BRIC2",603201,2q31.1,ABCB11
"Cholestasis, progressive familial intrahepatic 3, 602347 ",3,"ABCB4, PGY3, MDR3, ICP3",171060,7q21.12,ABCB4
"Cholesteryl ester storage disease, 278000 ",3,"LIPA, CESD",613497,10q23.31,LIPA
"Chondrocalcinosis 2, 118600 ",3,"ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD",605145,5p15.2,ANKH
"Chondrodysplasia punctata, X-linked recessive, 302950 ",3,"ARSE, CDPX1, CDPXR",300180,Xp22.33,ARSE
"Chondrodysplasia, Blomstrand type, 215045 ",3,"PTHR1, PTHR, PFE",168468,3p21.31,PTHR1
"Chondrodysplasia, Grebe type, 200700 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Chondrosarcoma, 215300 ",3,EXT1,608177,8q24.11,EXT1
"Chondrosarcoma, extraskeletal myxoid, 612237 ",3,CSMF,600542,9q31.1,CSMF
"Choreoacanthocytosis, 200150 ",3,"VPS13A, CHAC",605978,9q21.2,VPS13A
"Choriodal dystrophy, central areolar 2, 613105 ",3,"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1",179605,6p21.1,PRPH2
"Choroid plexus papilloma, 260500 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Choroideremia, 303100 ",3,"CHM, TCD",300390,Xq21.2,CHM
"Chronic granulomatous disease due to deficiency of NCF-2, 233710 ",3,NCF2,608515,1q25.3,NCF2
"Chronic granulomatous disease, X-linked, 306400 ",3,"CYBB, CGD, AMCBX2, IMD34",300481,Xp21.1-p11.4,CYBB
"Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 ",3,CYBA,608508,16q24.2,CYBA
"Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 ",3,"DNAI1, CILD1, ICS, PCD",604366,9p13.3,DNAI1
"Ciliary dyskinesia, primary, 25, 615482 ",3,"DYX1C1, DYXC1, DYX1, CILD25",608706,15q21.3,DYX1C1
"Ciliary dyskinesia, primary, 29, 615872 ",3,"CCNO, UNG2, CILD29",607752,5q11.2,CCNO
"Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 ",3,"DNAH5, HL1, PCD, CILD3",603335,5p15.2,DNAH5
"Ciliary dyskinesia, primary, 5, 608647 ",3,"HYDIN, HYDIN1, CILD5",610812,16q22.2,HYDIN
"Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 ",3,"DNAH11, DNAHC11, CILD7, DNAHBL",603339,7p15.3,DNAH11
"Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 ",3,"DNAI2, CILD9",605483,17q25.1,DNAI2
"Cirrhosis, cryptogenic, 215600 ",3,KRT18,148070,12q13.13,KRT18
"Cirrhosis, cryptogenic, 215600 ",3,KRT8,148060,12q13.13,KRT8
"Citrullinemia, 215700 ",3,"ASS1, ASS",603470,9q34.11,ASS1
"Cleft lip/palate-ectodermal dysplasia syndrome, 225060 ",3,"NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1",600644,11q23.3,NECTIN1
"Cleft palate with ankyloglossia, 303400 ",3,"TBX22, CPX, ABERS",300307,Xq21.1,TBX22
"Cleidocranial dysplasia, 119600 ",3,"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",600211,6p21.1,RUNX2
"Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 ",3,"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",600211,6p21.1,RUNX2
"Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 ",3,"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",600211,6p21.1,RUNX2
"Clopidogrel, impaired responsiveness to, 609535 ",3,"CYP2C, CYP2C19",124020,10q23.33,CYP2C
"Cockayne syndrome, type A, 216400 ",3,"ERCC8, CKN1, CSA, UVSS2",609412,5q12.1,ERCC8
"Cockayne syndrome, type B, 133540 ",3,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11",609413,10q11.23,ERCC6
"Cocoon syndrome, 613630 ",3,"CHUK, IKBKA, NFKBIKA, IKKA, IKK1",600664,10q24.31,CHUK
"Coenzyme Q10 deficiency, primary, 3, 614652 ",3,"PDSS2, DLP1, C6orf210, COQ10D3",610564,6q21,PDSS2
"Coenzyme Q10 deficiency, primary, 4, 612016 ",3,"ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4",606980,1q42.13,ADCK3
"Coffin-Lowry syndrome, 303600 ",3,"RPS6KA3, RSK2, MRX19",300075,Xp22.12,RPS6KA3
"Coffin-Siris syndrome 1, 135900 ",3,"ARID1B, BAF250B, KIAA1235, MRD12, CSS1",614556,6q25.3,ARID1B
"Coffin-Siris syndrome 3, 614608 ",3,"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3",601607,22q11.23,SMARCB1
"Cohen syndrome, 216550 ",3,"VPS13B, KIAA0532, COH1",607817,8q22.2,VPS13B
"Cold-induced sweating syndrome 1, 272430 ",3,"CRLF1, CISS1",604237,19p13.11,CRLF1
"Cold-induced sweating syndrome 2, 610313 ",3,"CLCF1, BSF3, CLC, CISS2",607672,11q13.2,CLCF1
"Cole disease, 615522 ",3,"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED",173335,6q23.2,ENPP1
"Cole-Carpenter syndrome 1, 112240 ",3,"P4HB, PROHB, CLCRP1",176790,17q25.3,P4HB
"Coloboma of optic nerve, 120430 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Coloboma, ocular, 120200 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Colon cancer, advanced, somatic, 114500 ",3,"SRC, ASV, SRC1, THC6",190090,20q11.23,SRC
"Colon cancer, somatic, 114500 ",3,"PTPN12, PTPG1",600079,7q11.23,PTPN12
"Colon cancer, somatic, 114500 ",3,"PTPRJ, DEP1",600925,11p11.2,PTPRJ
"Colon cancer, somatic, 114500 ",3,RAD54B,604289,8q22.1,RAD54B
"Colorblindness, deutan, 303800 ",3,"OPN1MW, GCP, CBD, CBBM",300821,Xq28,OPN1MW
"Colorblindness, protan, 303900 ",3,"OPN1LW, RCP, CBP, CBBM",300822,Xq28,OPN1LW
"Colorblindness, tritan, 190900 ",3,"OPN1SW, BCP, CBT",613522,7q32.1,OPN1SW
"Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 ",3,"MUTYH, MYH",604933,1p34.1,MUTYH
"Colorectal cancer, 114500 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Colorectal cancer, hereditary nonpolyposis, type 1, 120435 ",3,"MSH2, COCA1, FCC1, HNPCC1",609309,2p21-p16,MSH2
"Colorectal cancer, hereditary nonpolyposis, type 2, 609310 ",3,"MLH1, COCA2, HNPCC2",120436,3p22.2,MLH1
"Colorectal cancer, hereditary nonpolyposis, type 4, 614337 ",3,"PMS2, PMSL2, HNPCC4",600259,7p22.1,PMS2
"Colorectal cancer, hereditary nonpolyposis, type 5, 614350 ",3,"MSH6, GTBP, HNPCC5",600678,2p16.3,MSH6
"Colorectal cancer, hereditary nonpolyposis, type 6, 614331 ",3,"TGFBR2, HNPCC6, AAT3, MFS2, LDS2",190182,3p24.1,TGFBR2
"Colorectal cancer, hereditary nonpolyposis, type 7, 614385 ",3,"MLH3, HNPCC7",604395,14q24.3,MLH3
"Colorectal cancer, hereditary nonpolyposis, type 8, 613244 ",3,"EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8",185535,2p21,EPCAM
"Colorectal cancer, somatic, 114500 ",3,"AKT1, CWS6",164730,14q32.33,AKT1
"Colorectal cancer, somatic, 114500 ",3,"APC, GS, FPC, BTPS2",611731,5q22.2,APC
"Colorectal cancer, somatic, 114500 ",3,"AXIN2, ODCRCS",604025,17q24.1,AXIN2
"Colorectal cancer, somatic, 114500 ",3,BAX,600040,19q13.33,BAX
"Colorectal cancer, somatic, 114500 ",3,"BUB1B, BUBR1, MVA1",602860,15q15.1,BUB1B
"Colorectal cancer, somatic, 114500 ",3,"CTNNB1, MRD19",116806,3p22.1,CTNNB1
"Colorectal cancer, somatic, 114500 ",3,"DCC, MRMV1",120470,18q21.2,DCC
"Colorectal cancer, somatic, 114500 ",3,DLC1,604258,8p22,DLC1
"Colorectal cancer, somatic, 114500 ",3,"EP300, RSTS2",602700,22q13.2,EP300
"Colorectal cancer, somatic, 114500 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Colorectal cancer, somatic, 114500 ",3,"FLCN, BHD",607273,17p11.2,FLCN
"Colorectal cancer, somatic, 114500 ",3,MCC,159350,5q22.2,MCC
"Colorectal cancer, somatic, 114500 ",3,"MLH3, HNPCC7",604395,14q24.3,MLH3
"Colorectal cancer, somatic, 114500 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Colorectal cancer, somatic, 114500 ",3,"PDGFRL, PDGRL, PRLTS",604584,8p22,PDGFRL
"Colorectal cancer, somatic, 114500 ",3,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5",171834,3q26.32,PIK3CA
"Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 ",3,"SLC25A1, SLC20A3, CTP, D2L2AD",190315,22q11.21,SLC25A1
"Combined SAP deficiency, 611721 ",3,"PSAP, SAP1",176801,10q22.1,PSAP
"Combined cellular and humoral immune defects with granulomas, 233650 ",3,RAG1,179615,11p12,RAG1
"Combined cellular and humoral immune defects with granulomas, 233650 ",3,RAG2,179616,11p12,RAG2
"Combined factor V and VIII deficiency, 227300 ",3,"LMAN1, ERGIC53, F5F8D, MCFD1",601567,18q21.32,LMAN1
"Combined hyperlipidemia, familial, 144250 ",3,"LPL, LIPD, HDLCQ11",609708,8p21.3,LPL
"Combined immunodeficiency, X-linked, moderate, 312863 ",3,"IL2RG, SCIDX1, SCIDX, IMD4",308380,Xq13.1,IL2RG
"Combined oxidative phosphorylation deficiency 1, 609060 ",3,"GFM1, EFG1, GFM, COXPD1",606639,3q25.32,GFM1
"Combined oxidative phosphorylation deficiency 13, 614932 ",3,"PNPT1, OLD35, COXPD13, DFNB70",610316,2p16.1,PNPT1
"Combined oxidative phosphorylation deficiency 17, 615440 ",3,"ELAC2, HPC2, COXPD17",605367,17p12,ELAC2
"Combined oxidative phosphorylation deficiency 18, 615578 ",3,"SFXN4, COXPD18",615564,10q26.11,SFXN4
"Combined oxidative phosphorylation deficiency 2, 610498 ",3,"MRPS16, COXPD2",609204,10q22.2,MRPS16
"Combined oxidative phosphorylation deficiency 26, 616539 ",3,"TRMT5, TRM5, KIAA1393, COXPD26",611023,14q23.1,TRMT5
"Combined oxidative phosphorylation deficiency 3, 610505 ",3,"TSFM, COXPD3",604723,12q14.1,TSFM
"Combined oxidative phosphorylation deficiency 4, 610678 ",3,"TUFM, EFTU, COXPD4",602389,16p11.2,TUFM
"Combined oxidative phosphorylation deficiency 5, 611719 ",3,"MRPS22, C3orf5, COXPD5",605810,3q23,MRPS22
"Combined oxidative phosphorylation deficiency 6, 300816 ",3,"AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5",300169,Xq26.1,AIFM1
"Complement component 4, partial deficiency of, 120790 ",3,"C1NH, HAE1, HAE2, SERPING1",606860,11q12.1,C1NH
"Complement factor D deficiency, 613912 ",3,"CFD, ADN",134350,19p13.3,CFD
"Complement factor H deficiency, 609814 ",3,"CFH, HF1, HUS, ARMD4, AHUS1",134370,1q31.3,CFH
"Complement factor I deficiency, 610984 ",3,"CFI, FI, AHUS3, ARMD13",217030,4q25,CFI
"Cone-rod dystrophy 11, 610381 ",3,"RAX2, RAXL1, QRX, CORD11, ARMD6",610362,19p13.3,RAX2
"Cone-rod dystrophy 12, 612657 ",3,"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",604365,4p15.32,PROM1
"Cone-rod dystrophy 13, 608194 ",3,"RPGRIP1, LCA6, CORD13",605446,14q11.2,RPGRIP1
"Cone-rod dystrophy 15, 613660 ",3,"CDHR1, PCDH21, PRCAD, CORD15, RP65",609502,10q23.1,CDHR1
"Cone-rod dystrophy 3, 604116 ",3,"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2",601691,1p22.1,ABCA4
"Cone-rod dystrophy 5, 600977 ",3,"PITPNM3, NIR1, CORD5",608921,17p13.2-p13.1,PITPNM3
"Cone-rod dystrophy 6, 601777 ",3,"GUCY2D, GUC2D, LCA1, CORD6, RCD2",600179,17p13.1,GUCY2D
"Cone-rod dystrophy 7, 603649 ",3,"RIMS1, RIM1, RIM, KIAA0340, CORD7",606629,6q13,RIMS1
"Cone-rod dystrophy, 604393 ",3,"AIPL1, LCA4",604392,17p13.2,AIPL1
"Cone-rod dystrophy, X-linked, 1, 304020 ",3,"RPGR, RP3, CRD, RP15, COD1, CORDX1",312610,Xp11.4,RPGR
"Cone-rod dystrophy, X-linked, 3, 300476 ",3,"CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2",300110,Xp11.23,CACNA1F
"Cone-rod retinal dystrophy-2, 120970 ",3,"CRX, CORD2, CRD, LCA7",602225,19q13.33,CRX
"Congenital bilateral absence of vas deferens, 277180 ",3,"CFTR, ABCC7, CF, MRP7",602421,7q31.2,CFTR
"Congenital cataracts, hearing loss, and neurodegeneration, 614482 ",3,"SLC33A1, ACATN, AT1, SPG42, CCHLND",603690,3q25.31,SLC33A1
"Congenital disorder of glycosylation, type IIc, 266265 ",3,"SLC35C1, FUCT1, CDG2C",605881,11p11.2,SLC35C1
"Congenital disorder of glycosylation, type IIe, 608779 ",3,"COG7, CDG2E",606978,16p12.2,COG7
"Congenital disorder of glycosylation, type IIf, 603585 ",3,"SLC35A1, CST, CDG2F",605634,6q15,SLC35A1
"Congenital disorder of glycosylation, type IIg, 611209 ",3,"COG1, LDLB, KIAA1381, CDG2G",606973,17q25.1,COG1
"Congenital disorder of glycosylation, type IIh, 611182 ",3,"COG8, DOR1, CDG2H",606979,16q22.1,COG8
"Congenital disorder of glycosylation, type Ia, 212065 ",3,"PMM2, CDG1A",601785,16p13.2,PMM2
"Congenital disorder of glycosylation, type Ib, 602579 ",3,"MPI, PMI1, CDG1B",154550,15q24.1,MPI
"Congenital disorder of glycosylation, type If, 609180 ",3,"MPDU1, SL15, CDGIF",604041,17p13.1,MPDU1
"Congenital disorder of glycosylation, type Ig, 607143 ",3,"ALG12, CDG1G",607144,22q13.33,ALG12
"Congenital disorder of glycosylation, type Ij, 608093 ",3,"DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13",191350,11q23.3,DPAGT1
"Congenital disorder of glycosylation, type Il, 608776 ",3,"ALG9, DIBD1, CDG1L, GIKANIS",606941,11q23.1,ALG9
"Congenital disorder of glycosylation, type In, 612015 ",3,"RFT1, CDG1N",611908,3p21.1,RFT1
"Congenital disorder of glycosylation, type Iq, 612379 ",3,"SRD5A3, SRD5A2L, CDG1Q, KRIZI",611715,4q12,SRD5A3
"Congenital disorder of glycosylation, type It, 614921 ",3,"PGM1, GSD14, CDG1T",171900,1p31.3,PGM1
"Congenital heart defects, nonsyndromic, 1, X-linked, 306955 ",3,"ZIC3, HTX1, HTX, VACTERLX",300265,Xq26.3,ZIC3
"Congenital myopathy with excess of muscle spindles, 218040 ",3,HRAS,190020,11p15.5,HRAS
"Congenital short bowel syndrome, 300048 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Conotruncal anomaly face syndrome, 217095 ",3,"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",602054,22q11.21,TBX1
"Conotruncal heart malformations, 217095 ",3,"NKX2-6, CSX2, CTHM",611770,8p21.2,NKX2-6
"Conotruncal heart malformations, variable, 217095 ",3,"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",600584,5q35.1,NKX2-5
"Cornea plana 2, autosomal recessive, 217300 ",3,"KERA, CNA2",603288,12q21.33,KERA
"Corneal dystrophy, Avellino type, 607541 ",3,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD",601692,5q31.1,TGFBI
"Corneal dystrophy, Fuchs endothelial, 1, 136800 ",3,"COL8A2, FECD1, PPCD2",120252,1p34.3,COL8A2
"Corneal dystrophy, Fuchs endothelial, 3, 613267 ",3,"TCF4, SEF2, ITF2, PTHS, FECD3",602272,18q21.2,TCF4
"Corneal dystrophy, Fuchs endothelial, 4, 613268 ",3,"SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4",610206,20p13,SLC4A11
"Corneal dystrophy, Fuchs endothelial, 6, 613270 ",3,"ZEB1, TCF8, NIL2A, PPCD3, FECD6",189909,10p11.22,ZEB1
"Corneal dystrophy, Fuchs endothelial, 8, 615523 ",3,"AGBL1, CCP4, FECD8",615496,15q25.3,AGBL1
"Corneal dystrophy, Groenouw type I, 121900 ",3,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD",601692,5q31.1,TGFBI
"Corneal dystrophy, Reis-Bucklers type, 608470 ",3,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD",601692,5q31.1,TGFBI
"Corneal dystrophy, Schnyder type, 121800 ",3,"UBIAD1, TERE1, SCCD",611632,1p36.22,UBIAD1
"Corneal dystrophy, Thiel-Behnke type, 602082 ",3,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD",601692,5q31.1,TGFBI
"Corneal dystrophy, congenital stromal, 610048 ",3,"DCN, CSCD",125255,12q21.33,DCN
"Corneal dystrophy, epithelial basement membrane, 121820 ",3,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD",601692,5q31.1,TGFBI
"Corneal dystrophy, gelatinous drop-like, 204870 ",3,"TACSTD2, TROP2, M1S1",137290,1p32.1,TACSTD2
"Corneal dystrophy, lattice type I, 122200 ",3,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD",601692,5q31.1,TGFBI
"Corneal dystrophy, lattice type IIIA, 608471 ",3,"TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD",601692,5q31.1,TGFBI
"Corneal dystrophy, posterior polymorphous 2, 609140 ",3,"COL8A2, FECD1, PPCD2",120252,1p34.3,COL8A2
"Corneal dystrophy, posterior polymorphous, 3, 609141 ",3,"ZEB1, TCF8, NIL2A, PPCD3, FECD6",189909,10p11.22,ZEB1
"Corneal endothelial dystrophy and perceptive deafness, 217400 ",3,"SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4",610206,20p13,SLC4A11
"Corneal endothelial dystrophy, autosomal recessive, 217700 ",3,"SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4",610206,20p13,SLC4A11
"Corneal fleck dystrophy, 121850 ",3,"PIKFYVE, PIP5K3",609414,2q34,PIKFYVE
"Corneal opacification and other ocular anomalies, 269400 ",3,"PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA",605158,2p25.3,PXDN
"Cornelia de Lange syndrome 1, 122470 ",3,"NIPBL, CDLS1",608667,5p13.2,NIPBL
"Cornelia de Lange syndrome 4, 614701 ",3,"RAD21, SCC1, NXP1, KIAA0078, CDLS4",606462,8q24.11,RAD21
"Cornelia de Lange syndrome 5, 300882 ",3,"HDAC8, MRXS6, CDLS5",300269,Xq13.1,HDAC8
"Corpus callosum, partial agenesis of, 304100 ",3,"L1CAM, CAML1, HSAS1, MASA, SPG1",308840,Xq28,L1CAM
"Cortical dysplasia, complex, with other brain malformations 6, 615771 ",3,"TUBB, TUBB5, M40, CDCBM6, CSCSC1",191130,6p21.33,TUBB
"Cortical dysplasia-focal epilepsy syndrome, 610042 ",3,"CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1",604569,7q35-q36,CNTNAP2
"Corticosteroid-binding globulin deficiency, 611489 ",3,"CBG, SERPINA6",122500,14q32.13,CBG
"Cortisone reductase deficiency 1, 604931 ",3,"H6PD, GDH, G6PDH, CORTRD1",138090,1p36.22,H6PD
"Cortisone reductase deficiency 2, 614662 ",3,"HSD11B1, HSD11, HSD11L, CORTRD2",600713,1q32.2,HSD11B1
"Costello syndrome, 218040 ",3,HRAS,190020,11p15.5,HRAS
"Coumarin resistance, 122700 ",3,"CYP2A6, CYP2A3, CYP2A, P450C2A",122720,19q13.2,CYP2A6
"Cowchock syndrome, 310490 ",3,"AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5",300169,Xq26.1,AIFM1
"Cowden syndrome 1, 158350 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Cowden syndrome 2, 612359 ",3,"SDHB, SDH2, SDHIP, PGL4, CWS2",185470,1p36.13,SDHB
"Cowden syndrome 3, 615106 ",3,"SDHD, PGL1, CWS3",602690,11q23.1,SDHD
"Cowden syndrome 6, 615109 ",3,"AKT1, CWS6",164730,14q32.33,AKT1
"Craniodiaphyseal dysplasia, autosomal dominant, 122860 ",3,"SOST, VBCH, CDD, SOST1",605740,17q21.31,SOST
"Craniofacial-deafness-hand syndrome, 122880 ",3,"PAX3, WS1, HUP2, CDHS, WS3",606597,2q36.1,PAX3
"Craniofacial-skeletal-dermatologic dysplasia, 101600 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Craniofrontonasal dysplasia, 304110 ",3,"EFNB1, EPLG2, CFNS, CFND",300035,Xq13.1,EFNB1
"Craniolenticulosutural dysplasia, 607812 ",3,"SEC23A, CLSD",610511,14q21.1,SEC23A
"Craniometaphyseal dysplasia, 123000 ",3,"ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD",605145,5p15.2,ANKH
"Craniometaphyseal dysplasia, autosomal recessive, 218400 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Craniosynostosis 1, 123100 ",3,"TWIST1, ACS3, SCS, CRS1",601622,7p21.1,TWIST1
"Craniosynostosis 2, 604757 ",3,"MSX2, CRS2, HOX8",123101,5q35.2,MSX2
"Craniosynostosis 3, 615314 ",3,"TCF12, HTF4, CRS3",600480,15q21.3,TCF12
"Craniosynostosis 4, 600775 ",3,"ERF, PE2, CRS4, CHYTS",611888,19q13.2,ERF
"Craniosynostosis 6, 616602 ",3,"ZIC1, CRS6",600470,3q24,ZIC1
"Craniosynostosis and dental anomalies, 614188 ",3,"IL11RA, CRSDA",600939,9p13.3,IL11RA
"Creatine phosphokinase, elevated serum, 123320 ",3,"CAV3, LGMD1C, LQT9",601253,3p25.3,CAV3
"Creutzfeldt-Jakob disease, 123400 ",3,"PRNP, PRIP, KURU, CJD",176640,20p13,PRNP
"Crigler-Najjar syndrome, type I, 218800 ",3,"UGT1A1, UGT1, GNT1, BILIQTL1",191740,2q37.1,UGT1A1
"Crigler-Najjar syndrome, type II, 606785 ",3,"UGT1A1, UGT1, GNT1, BILIQTL1",191740,2q37.1,UGT1A1
"Crouzon syndrome with acanthosis nigricans, 612247 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Crouzon syndrome, 123500 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Cryohydrocytosis, 185020 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Culler-Jones syndrome, 615849 ",3,"GLI2, HPE9, CJS",165230,2q14.2,GLI2
"Currarino syndrome, 176450 ",3,"MNX1, HLXB9, HOXHB9, SCRA1",142994,7q36.3,MNX1
"Cutis laxa, AD, 123700 ",3,ELN,130160,7q11.23,ELN
"Cutis laxa, autosomal dominant 2, 614434 ",3,"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",604580,14q32.12,FBLN5
"Cutis laxa, autosomal dominant 3, 616603 ",3,"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3",138250,10q24.1,ALDH18A1
"Cutis laxa, autosomal recessive, type IA, 219100 ",3,"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",604580,14q32.12,FBLN5
"Cutis laxa, autosomal recessive, type IIA, 219200 ",3,"ATP6V0A2, WSS, ARCL2A",611716,12q24.31,ATP6V0A2
"Cutis laxa, autosomal recessive, type IIIA, 219150 ",3,"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3",138250,10q24.1,ALDH18A1
"Cyanosis, transient neonatal, 613977 ",3,"HBG2, TNCY",142250,11p15.4,HBG2
"Cystathioninuria, 219500 ",3,CTH,607657,1p31.1,CTH
"Cystic fibrosis, 219700 ",3,"CFTR, ABCC7, CF, MRP7",602421,7q31.2,CFTR
"Cystinosis, atypical nephropathic, 219800 ",3,CTNS,606272,17p13.2,CTNS
"Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 ",3,CTNS,606272,17p13.2,CTNS
"Cystinosis, nephropathic, 219800 ",3,CTNS,606272,17p13.2,CTNS
"Cystinosis, ocular nonnephropathic, 219750 ",3,CTNS,606272,17p13.2,CTNS
"Cystinuria, 220100 ",3,"SLC3A1, ATR1, D2H, NBAT",104614,2p21,SLC3A1
"Cystinuria, 220100 ",3,"SLC7A9, CSNU3",604144,19q13.11,SLC7A9
"Czech dysplasia, 609162 ",3,COL2A1,120140,12q13.11,COL2A1
"D-2-hydroxyglutaric aciduria 2, 613657 ",3,"IDH2, IDPM, D2HGA2",147650,15q26.1,IDH2
"Danon disease, 300257 ",3,"LAMP2, LAMPB, LGP110",309060,Xq24,LAMP2
"Darier disease, 124200 ",3,"ATP2A2, ATP2B, DAR",108740,12q24.11,ATP2A2
"De Sanctis-Cacchione syndrome, 278800 ",3,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11",609413,10q11.23,ERCC6
"De la Chapelle dysplasia, 256050 ",3,"SLC26A2, DTD, DTDST, D5S1708, EDM4",606718,5q32,SLC26A2
"Deafness, X-linked 1, 304500 ",3,"PRPS1, CMTX5, DFNX1, DFN2",311850,Xq22.3,PRPS1
"Deafness, X-linked 4, 300066 ",3,"SMPX, DFNX4",300226,Xp22.12,SMPX
"Deafness, X-linked 5, 300614 ",3,"AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5",300169,Xq26.1,AIFM1
"Deafness, autosomal dominant 1, 124900 ",3,"DIAPH1, DFNA1, LFHL1, SCBMS",602121,5q31.3,DIAPH1
"Deafness, autosomal dominant 10, 601316 ",3,"EYA4, DFNA10, CMD1J",603550,6q23.2,EYA4
"Deafness, autosomal dominant 11, 601317 ",3,"MYO7A, USH1B, DFNB2, DFNA11",276903,11q13.5,MYO7A
"Deafness, autosomal dominant 13, 601868 ",3,"COL11A2, STL3, DFNA13, DFNB53, FBCG2",120290,6p21.32,COL11A2
"Deafness, autosomal dominant 15, 602459 ",3,"POU4F3, BRN3C",602460,5q32,POU4F3
"Deafness, autosomal dominant 17, 603622 ",3,"MYH9, MHA, FTNS, DFNA17, BDPLT6",160775,22q12.3,MYH9
"Deafness, autosomal dominant 20/26, 604717 ",3,"ACTG1, DFNA20, DFNA26, BRWS2",102560,17q25.3,ACTG1
"Deafness, autosomal dominant 22, 606346 ",3,"MYO6, DFNA22, DFNB37",600970,6q14.1,MYO6
"Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 ",3,"MYO6, DFNA22, DFNB37",600970,6q14.1,MYO6
"Deafness, autosomal dominant 23, 605192 ",3,"SIX1, BOS3, DFNA23",601205,14q23.1,SIX1
"Deafness, autosomal dominant 25, 605583 ",3,"SLC17A8, VGLUT3, DFNA25",607557,12q23.1,SLC17A8
"Deafness, autosomal dominant 2B, 612644 ",3,"GJB3, CX31, DFNA2B",603324,1p34.3,GJB3
"Deafness, autosomal dominant 36, 606705 ",3,"TMC1, DFNB7, DFNB11, DFNA36",606706,9q21.13,TMC1
"Deafness, autosomal dominant 39, with dentinogenesis, 605594 ",3,"DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q22.1,DSPP
"Deafness, autosomal dominant 3A, 601544 ",3,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID",121011,13q12.11,GJB2
"Deafness, autosomal dominant 3B, 612643 ",3,"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2",604418,13q12.11,GJB6
"Deafness, autosomal dominant 41, 608224 ",3,"P2RX2, P2X2, DFNA41",600844,12q24.33,P2RX2
"Deafness, autosomal dominant 4A, 600652 ",3,"MYH14, KIAA2034, DFNA4A, PNMHH",608568,19q13.33,MYH14
"Deafness, autosomal dominant 5, 600994 ",3,DFNA5,608798,7p15.3,DFNA5
"Deafness, autosomal dominant 56, 615629 ",3,"TNC, HXB, DFNA56",187380,9q33.1,TNC
"Deafness, autosomal dominant 6/14/38, 600965 ",3,"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",606201,4p16.1,WFS1
"Deafness, autosomal dominant 67, 616340 ",3,"OSBPL2, ORP2, KIAA0772, DNFA67",606731,20q13.33,OSBPL2
"Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 ",3,"KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69",184745,12q21.32,KITLG
"Deafness, autosomal dominant 8/12, 601543 ",3,"TECTA, DFNA8, DFNA12, DFNB21",602574,11q23.3,TECTA
"Deafness, autosomal dominant 9, 601369 ",3,"COCH, DFNA9",603196,14q12,COCH
"Deafness, autosomal recessive 12, 601386 ",3,"CDH23, USH1D",605516,10q22.1,CDH23
"Deafness, autosomal recessive 16, 603720 ",3,"STRC, DFNB16",606440,15q15.3,STRC
"Deafness, autosomal recessive 18A, 602092 ",3,"USH1C, DFNB18A",605242,11p15.1,USH1C
"Deafness, autosomal recessive 1A, 220290 ",3,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID",121011,13q12.11,GJB2
"Deafness, autosomal recessive 1B, 612645 ",3,"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2",604418,13q12.11,GJB6
"Deafness, autosomal recessive 2, 600060 ",3,"MYO7A, USH1B, DFNB2, DFNA11",276903,11q13.5,MYO7A
"Deafness, autosomal recessive 21, 603629 ",3,"TECTA, DFNA8, DFNA12, DFNB21",602574,11q23.3,TECTA
"Deafness, autosomal recessive 23, 609533 ",3,"PCDH15, DFNB23, USH1F",605514,10q21.1,PCDH15
"Deafness, autosomal recessive 24, 611022 ",3,"RDX, DFNB24",179410,11q22.3,RDX
"Deafness, autosomal recessive 29, 614035 ",3,"CLDN14, DFNB29",605608,21q22.13,CLDN14
"Deafness, autosomal recessive 3, 600316 ",3,"MYO15A, DFNB3",602666,17p11.2,MYO15A
"Deafness, autosomal recessive 30, 607101 ",3,"MYO3A, DFNB30",606808,10p12.1,MYO3A
"Deafness, autosomal recessive 31, 607084 ",3,"WHRN, CIP98, KIAA1526, DFNB31, USH2D",607928,9q32,WHRN
"Deafness, autosomal recessive 35, 608565 ",3,"ESRRB, ESRL2, DFNB35",602167,14q24.3,ESRRB
"Deafness, autosomal recessive 37, 607821 ",3,"MYO6, DFNA22, DFNB37",600970,6q14.1,MYO6
"Deafness, autosomal recessive 39, 608265 ",3,"HGF, DFNB39",142409,7q21.11,HGF
"Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 ",3,"SLC26A4, PDS, DFNB4, EVA, TDH2B",605646,7q22.3,SLC26A4
"Deafness, autosomal recessive 48, 609439 ",3,"CIB2, KIP2",605564,15q25.1,CIB2
"Deafness, autosomal recessive 49, 610153 ",3,"MARVELD2, MARVD2, TRIC, DFNB49",610572,5q13.2,MARVELD2
"Deafness, autosomal recessive 53, 609706 ",3,"COL11A2, STL3, DFNA13, DFNB53, FBCG2",120290,6p21.32,COL11A2
"Deafness, autosomal recessive 6, 600971 ",3,"TMIE, DFNB6",607237,3p21.31,TMIE
"Deafness, autosomal recessive 67, 610265 ",3,"LHFPL5, TMHS, DFNB67",609427,6p21.31,LHFPL5
"Deafness, autosomal recessive 7, 600974 ",3,"TMC1, DFNB7, DFNB11, DFNA36",606706,9q21.13,TMC1
"Deafness, autosomal recessive 70, 614934 ",3,"PNPT1, OLD35, COXPD13, DFNB70",610316,2p16.1,PNPT1
"Deafness, autosomal recessive 8/10, 601072 ",3,"TMPRSS3, ECHOS1, DFNB8, DFNB10",605511,21q22.3,TMPRSS3
"Deafness, autosomal recessive 89, 613916 ",3,"KARS, CMTRIB, DFNB89",601421,16q23.1,KARS
"Deafness, autosomal recessive 9, 601071 ",3,"OTOF, DFNB9, NSRD9, AUNB1",603681,2p23.3,OTOF
"Deafness, autosomal recessive 93, 614899 ",3,"CABP2, DFNB93",607314,11q13.2,CABP2
"Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 ",3,"FGF3, INT2",164950,11q13.3,FGF3
"Deafness, digenic GJB2/GJB6, 220290 ",3,"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2",604418,13q12.11,GJB6
"Deafness, digenic, GJB2/GJB3, 220290 ",3,"GJB3, CX31, DFNA2B",603324,1p34.3,GJB3
"Dejerine-Sottas disease, 145900 ",3,"EGR2, KROX20",129010,10q21.3,EGR2
"Dejerine-Sottas disease, 145900 ",3,"MPZ, CMT1B, CMTDID, CHM, DSS",159440,1q23.3,MPZ
"Dejerine-Sottas disease, 145900 ",3,"PMP22, CMT1A, CMT1E, DSS",601097,17p12,PMP22
"Dejerine-Sottas disease, 145900 ",3,"PRX, CMT4F",605725,19q13.2,PRX
"Delta-beta thalassemia, 141749 ",3,HBB,141900,11p15.4,HBB
"Dementia, Lewy body, 127750 ",3,"SNCA, NACP, PARK1, PARK4",163890,4q22.1,SNCA
"Dementia, Lewy body, 127750 ",3,SNCB,602569,5q35.2,SNCB
"Dementia, familial, nonspecific, 600795 ",3,"CHMP2B, DMT1, VPS2B, ALS17",609512,3p11.2,CHMP2B
"Dementia, frontotemporal, 600274 ",3,"PSEN1, AD3",104311,14q24.2,PSEN1
"Dementia, frontotemporal, with or without parkinsonism, 600274 ",3,"MAPT, MTBT1, DDPAC, MSTD",157140,17q21.31,MAPT
"Dent disease 2, 300555 ",3,"OCRL, LOCR, OCRL1, NPHL2",300535,Xq26.1,OCRL
"Dent disease, 300009 ",3,"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",300008,Xp11.23,CLCN5
"Dental anomalies and short stature, 601216 ",3,"LTBP3, LTBP2, DASS",602090,11q13.1,LTBP3
"Dentatorubro-pallidoluysian atrophy, 125370 ",3,"ATN1, DRPLA, HRS, NOD",607462,12p13.31,ATN1
"Dentin dysplasia, type II, 125420 ",3,"DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q22.1,DSPP
"Dentinogenesis imperfecta, Shields type II, 125490 ",3,"DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q22.1,DSPP
"Dentinogenesis imperfecta, Shields type III, 125500 ",3,"DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q22.1,DSPP
"Denys-Drash syndrome, 194080 ",3,"WT1, NPHS4",607102,11p13,WT1
"Dermatofibrosarcoma protuberans, 607907 ",3,"PDGFB, SIS, IBGC5",190040,22q13.1,PDGFB
"Dermatopathia pigmentosa reticularis, 125595 ",3,KRT14,148066,17q21.2,KRT14
"Desmoid disease, hereditary, 135290 ",3,"APC, GS, FPC, BTPS2",611731,5q22.2,APC
"Desmosterolosis, 602398 ",3,"DHCR24, KIAA0018",606418,1p32.3,DHCR24
"DiGeorge syndrome, 188400 ",3,"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",602054,22q11.21,TBX1
"Diabetes insipidus, nephrogenic, 125800 ",3,AQP2,107777,12q13.12,AQP2
"Diabetes insipidus, nephrogenic, 304800 ",3,"AVPR2, DIR, DI1, ADHR",300538,Xq28,AVPR2
"Diabetes insipidus, neurohypophyseal, 125700 ",3,"AVP, AVRP, VP",192340,20p13,AVP
"Diabetes mellitus, insulin-dependent, 2, 125852 ",3,"INS, MODY10, IDDM2",176730,11p15.5,INS
"Diabetes mellitus, insulin-dependent, 20, 612520 ",3,"HNF1A, TCF1, MODY3, IDDM20",142410,12q24.31,HNF1A
"Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 ",3,"INSR, HHF5",147670,19p13.2,INSR
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2",600509,11p15.1,ABCC8
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,"HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11",189907,17q12,HNF1B
"Diabetes mellitus, noninsulin-dependent, late onset, 125853 ",3,"GCK, HHF3",138079,7p13,GCK
"Diabetes mellitus, permanent neonatal, 606176 ",3,"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2",600509,11p15.1,ABCC8
"Diabetes mellitus, permanent neonatal, 606176 ",3,"GCK, HHF3",138079,7p13,GCK
"Diabetes mellitus, permanent neonatal, 606176 ",3,"INS, MODY10, IDDM2",176730,11p15.5,INS
"Diabetes mellitus, permanent neonatal, with neurologic features, 606176 ",3,"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13",600937,11p15.1,KCNJ11
"Diabetes mellitus, transient neonatal 2, 610374 ",3,"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2",600509,11p15.1,ABCC8
"Diabetes mellitus, transient neonatal, 1, 601410 ",3,"ZFP57, TNDM1",612192,6p22.1,ZFP57
"Diabetes mellitus, transient neonatal, 3, 610582 ",3,"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13",600937,11p15.1,KCNJ11
"Diabetes mellitus, type 2, 125853 ",3,"PAX4, MODY9, KPD",167413,7q32.1,PAX4
"Diabetes mellitus, type II, 125853 ",3,"AKT2, HIHGHH",164731,19q13.2,AKT2
"Diabetes, permanent neonatal, 606176 ",3,"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13",600937,11p15.1,KCNJ11
"Diamond-Blackfan anemia 1, 105650 ",3,"RPS19, DBA, DBA1",603474,19q13.2,RPS19
"Diamond-Blackfan anemia 6, 612561 ",3,"RPL5, DBA6",603634,1p22.1,RPL5
"Diamond-Blackfan anemia 7, 612562 ",3,"RPL11, DBA7",604175,1p36.11,RPL11
"Diamond-Blackfan anemia 8, 612563 ",3,"RPS7, DBA8",603658,2p25.3,RPS7
"Diamond-blackfan anemia 3, 610629 ",3,"RPS24, DBA3",602412,10q22.3,RPS24
"Diaphragmatic hernia 3, 610187 ",3,"ZFPM2, FOG2, DIH3, SRXY9",603693,8q23.1,ZFPM2
"Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 ",3,"MTAP, DMSMFH",156540,9p21.3,MTAP
"Diarrhea 1, secretory chloride, congenital, 214700 ",3,"SLC26A3, DRA, CLD",126650,7q22.3-q31.1,SLC26A3
"Diarrhea 5, with tufting enteropathy, congenital, 613217 ",3,"EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8",185535,2p21,EPCAM
"Diarrhea 8, secretory sodium, congenital, 616868 ",3,"SLC9A3, NHE3, DIAR8",182307,5p15.33,SLC9A3
"Diastrophic dysplasia, 222600 ",3,"SLC26A2, DTD, DTDST, D5S1708, EDM4",606718,5q32,SLC26A2
"Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 ",3,"SLC26A2, DTD, DTDST, D5S1708, EDM4",606718,5q32,SLC26A2
"Digital arthropathy-brachydactyly, familial, 606835 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Dihydrolipoamide dehydrogenase deficiency, 246900 ",3,"DLD, LAD, PHE3, DLDD",238331,7q31.1,DLD
"Dihydropyrimidine dehydrogenase deficiency, 274270 ",3,"DPYD, DPD",612779,1p21.3,DPYD
"Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 ",3,"DSP, KPPS2, PPKS2, DCWHKTA",125647,6p24.3,DSP
"Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 ",3,POR,124015,7q11.23,POR
"Donnai-Barrow syndrome, 222448 ",3,"LRP2, DBS",600073,2q31.1,LRP2
"Dopamine beta-hydroxylase deficiency, 223360 ",3,DBH,609312,9q34.2,DBH
"Double-outlet right ventricle, 217095 ",3,"GDF1, DTGA3, DORV, RAI",602880,19p13.11,GDF1
"Dowling-Degos disease 1, 179850 ",3,"KRT5, DDD1",148040,12q13.13,KRT5
"Doyne honeycomb degeneration of retina, 126600 ",3,"EFEMP1, FBNL, DHRD",601548,2p16.1,EFEMP1
"Dravet syndrome, 607208 ",3,"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3",182389,2q24.3,SCN1A
"Du Pan syndrome, 228900 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Duane retraction syndrome 2, 604356 ",3,"CHN1, CHN, ARHGAP2, RHOGAP2, DURS2",118423,2q31.1,CHN1
"Duane-radial ray syndrome, 607323 ",3,"SALL4, HSAL4",607343,20q13.2,SALL4
"Duchenne muscular dystrophy, 310200 ",3,"DMD, BMD, CMD3B",300377,Xp21.2-p21.1,DMD
"Dyggve-Melchior-Clausen disease, 223800 ",3,"DYM, FLJ90130, DMC, SMC",607461,18q21.1,DYM
"Dysautonomia, familial, 223900 ",3,"IKBKAP, IKAP",603722,9q31.3,IKBKAP
"Dyschromatosis symmetrica hereditaria, 127400 ",3,"ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6",146920,1q21.3,ADAR
"Dyserythropoietic anemia, congenital, type Ia, 224120 ",3,"CDAN1, CDA1, CDAN1A",607465,15q15.2,CDAN1
"Dysfibrinogenemia, congenital, 616004 ",3,FGA,134820,4q31.3,FGA
"Dysfibrinogenemia, congenital, 616004 ",3,FGB,134830,4q31.3,FGB
"Dysfibrinogenemia, congenital, 616004 ",3,FGG,134850,4q32.1,FGG
"Dyskeratosis congenita, X-linked, 305000 ",3,"DKC1, DKCX",300126,Xq28,DKC1
"Dyskeratosis congenita, autosomal dominant 4, 615190 ",3,"RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3",608833,20q13.33,RTEL1
"Dyskeratosis congenita, autosomal recessive 1, 224230 ",3,"NOLA3, NOP10, DKCB1",606471,15q14,NOLA3
"Dyskeratosis congenita, autosomal recessive 5, 615190 ",3,"RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3",608833,20q13.33,RTEL1
"Dyskinesia, familial, with facial myokymia, 606703 ",3,"ADCY5, FDFM",600293,3q21.1,ADCY5
"Dyskinesia, limb and orofacial, infantile-onset, 616921 ",3,"PDE10A, IOLOD, ADSD2",610652,6q27,PDE10A
"Dysplasminogenemia, 217090 ",3,PLG,173350,6q26,PLG
"Dysprothrombinemia, 613679 ",3,"F2, THPH1, RPRGL2",176930,11p11.2,F2
"Dyssegmental dysplasia, Silverman-Handmaker type, 224410 ",3,"HSPG2, PLC, SJS, SJA, SJS1",142461,1p36.12,HSPG2
"Dystonia 16, 612067 ",3,"PRKRA, PACT, RAX, DYT16",603424,2q31.2,PRKRA
"Dystonia 25, 615073 ",3,"GNAL, DYT25",139312,18p11.21,GNAL
"Dystonia 27, 616411 ",3,"COL6A3, DYT27, BTHLM1, UCMD1",120250,2q37.3,COL6A3
"Dystonia 9, 601042 ",3,"SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN",138140,1p34.2,SLC2A1
"Dystonia-1, torsion, 128100 ",3,"DYT1, TOR1A",605204,9q34.11,DYT1
"Dystonia-11, myoclonic, 159900 ",3,"SGCE, DYT11",604149,7q21.3,SGCE
"Dystonia-12, 128235 ",3,"ATP1A3, DYT12, RDP, AHC2, CAPOS",182350,19q13.2,ATP1A3
"Dystonia-Parkinsonism, X-linked, 314250 ",3,"TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33",313650,Xq13.1,TAF1
"EBD inversa, 226600 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"EBD, Bart type, 132000 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 ",3,"EDA, ED1, ECTD1, EDA, HED1, STHAGX1",300451,Xq13.1,EDA
"Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 ",3,"EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B",604095,2q13,EDAR
"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 ",3,"EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B",604095,2q13,EDAR
"Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 ",3,"EDARADD, ED3, EDA3, ECTD11B, ECTD11A",606603,1q42-q43,EDARADD
"Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 ",3,"EDARADD, ED3, EDA3, ECTD11B, ECTD11A",606603,1q42-q43,EDARADD
"Ectodermal dysplasia 2, Clouston type, 129500 ",3,"GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2",604418,13q12.11,GJB6
"Ectodermal dysplasia 3, Witkop type, 189500 ",3,"MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3",142983,4p16.2,MSX1
"Ectodermal dysplasia 9, hair/nail type, 614931 ",3,"HOXC13, HOX3G, ECTD9",142976,12q13.13,HOXC13
"Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 ",3,"NFKBIA, IKBA",164008,14q13.2,NFKBIA
"Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 ",3,"CDH3, CDHP, PCAD, HJMD",114021,16q22.1,CDH3
"Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 ",3,"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33",300248,Xq28,IKBKG
"Ectodermal dysplasia/skin fragility syndrome, 604536 ",3,PKP1,601975,1q32.1,PKP1
"Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 ",3,"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33",300248,Xq28,IKBKG
"Ectopia lentis, familial, 129600 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 ",3,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",603273,3q28,TP63
"Efavirenz, poor metabolism of, 614546 ",3,"CYP2B6, CYP2B, EFVM",123930,19q13.2,CYP2B6
"Ehlers-Danlos syndrome with short stature and limb anomalies, 130070 ",3,"B4GALT7, XGALT1, XGPT1, EDSSLA",604327,5q35.3,B4GALT7
"Ehlers-Danlos syndrome, cardiac valvular form, 225320 ",3,COL1A2,120160,7q21.3,COL1A2
"Ehlers-Danlos syndrome, classic type, 130000 ",3,"COL5A1, EDSC",120215,9q34.3,COL5A1
"Ehlers-Danlos syndrome, classic type, 130000 ",3,"COL5A2, EDSC",120190,2q32.2,COL5A2
"Ehlers-Danlos syndrome, classic, 130000 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Ehlers-Danlos syndrome, periodontal type, 1, 130080 ",3,"C1R, EDSPD1",613785,12p13.31,C1R
"Ehlers-Danlos syndrome, periodontal type, 2, 617174 ",3,"C1S, EDSPD2",120580,12p13.31,C1S
"Ehlers-Danlos syndrome, type IV, 130050 ",3,COL3A1,120180,2q32.2,COL3A1
"Ehlers-Danlos syndrome, type VIIA, 130060 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Ehlers-Danlos syndrome, type VIIB, 130060 ",3,COL1A2,120160,7q21.3,COL1A2
"Eiken syndrome, 600002 ",3,"PTHR1, PTHR, PFE",168468,3p21.31,PTHR1
"Elliptocytosis-1, 611804 ",3,"EPB41, EL1",130500,1p35.3,EPB41
"Elliptocytosis-2, 130600 ",3,"SPTA1, EL2, SPH3, HS3, HPP",182860,1q23.1,SPTA1
"Ellis-van Creveld syndrome, 225500 ",3,EVC,604831,4p16.2,EVC
"Ellis-van Creveld syndrome, 225500 ",3,"LBN, EVC2, WAD",607261,4p16.2,LBN
"Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 ",3,"EMD, EDMD, STA",300384,Xq28,EMD
"Emery-Dreifuss muscular dystrophy 2, AD, 181350 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Emery-Dreifuss muscular dystrophy 3, AR, 616516 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 ",3,"SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4",608441,6q25.2,SYNE1
"Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 ",3,"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B",300163,Xq26.3,FHL1
"Emery-Dreifuss muscular dystrophy 7, AD, 614302 ",3,"TMEM43, ARVD5, ARVC5, EDMD7",612048,3p25.1,TMEM43
"Emphysema due to AAT deficiency, 613490 ",3,"SERPINA1, PI, AAT",107400,14q32.13,SERPINA1
"Emphysema-cirrhosis, due to AAT deficiency, 613490 ",3,"SERPINA1, PI, AAT",107400,14q32.13,SERPINA1
"Encephalocraniocutaneous lipomatosis, 613001 ",3,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",136350,8p11.23,FGFR1
"Encephalopathy, neonatal severe, 300673 ",3,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16",300005,Xq28,MECP2
"Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 ",3,"TBCD, PEBAT",604649,17q25.3,TBCD
"Encephalopathy, progressive, with or without lipodystrophy, 615924 ",3,"BSCL2, SPG17, HMN5, PELD",606158,11q12.3,BSCL2
"Endometrial cancer, familial, 608089 ",3,"MSH6, GTBP, HNPCC5",600678,2p16.3,MSH6
"Endometrial carcinoma, somatic, 608089 ",3,"CDH1, UVO, LCAM, ECAD",192090,16q22.1,CDH1
"Endometrial carcinoma, somatic, 608089 ",3,"MSH3, FAP4",600887,5q14.1,MSH3
"Endometrial carcinoma, somatic, 608089 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Enhanced S-cone syndrome, 268100 ",3,"NR2E3, PNR, ESCS, RP37",604485,15q23,NR2E3
"Enlarged vestibular aqueduct, 600791 ",3,"FOXI1, FKHL10, FREAC6",601093,5q35.1,FOXI1
"Enlarged vestibular aqueduct, digenic, 600791 ",3,"KCNJ10, SESAME",602208,1q23.2,KCNJ10
"Enterokinase deficiency, 226200 ",3,"PRSS7, ENTK",606635,21q21.1,PRSS7
"Epidermal nevus, somatic, 162900 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Epidermodysplasia verruciformis, 226400 ",3,"TMC6, EVER1, EV1",605828,17q25.3,TMC6
"Epidermodysplasia verruciformis, 226400 ",3,"TMC8, EVER2, EV2",605829,17q25.3,TMC8
"Epidermolysis bullosa dystrophica, AD, 131750 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"Epidermolysis bullosa dystrophica, AR, 226600 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"Epidermolysis bullosa of hands and feet, 131800 ",3,ITGB4,147557,17q25.1,ITGB4
"Epidermolysis bullosa pruriginosa, 604129 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"Epidermolysis bullosa simplex with muscular dystrophy, 226670 ",3,"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",601282,8q24.3,PLEC1
"Epidermolysis bullosa simplex with pyloric atresia, 612138 ",3,"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",601282,8q24.3,PLEC1
"Epidermolysis bullosa simplex, Dowling-Meara type, 131760 ",3,KRT14,148066,17q21.2,KRT14
"Epidermolysis bullosa simplex, Dowling-Meara type, 131760 ",3,"KRT5, DDD1",148040,12q13.13,KRT5
"Epidermolysis bullosa simplex, Koebner type, 131900 ",3,KRT14,148066,17q21.2,KRT14
"Epidermolysis bullosa simplex, Koebner type, 131900 ",3,"KRT5, DDD1",148040,12q13.13,KRT5
"Epidermolysis bullosa simplex, Ogna type, 131950 ",3,"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",601282,8q24.3,PLEC1
"Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 ",3,KRT14,148066,17q21.2,KRT14
"Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 ",3,"KRT5, DDD1",148040,12q13.13,KRT5
"Epidermolysis bullosa simplex, autosomal recessive 2, 615425 ",3,"DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2",113810,6p12.1,DST
"Epidermolysis bullosa simplex, recessive 1, 601001 ",3,KRT14,148066,17q21.2,KRT14
"Epidermolysis bullosa simplex, recessive 1, 601001 ",3,"KRT5, DDD1",148040,12q13.13,KRT5
"Epidermolysis bullosa simplex-MP, 131960 ",3,"KRT5, DDD1",148040,12q13.13,KRT5
"Epidermolysis bullosa, generalized atrophic benign, 226650 ",3,"LAMA3, LOCS",600805,18q11.2,LAMA3
"Epidermolysis bullosa, junctional, Herlitz type, 226700 ",3,"LAMA3, LOCS",600805,18q11.2,LAMA3
"Epidermolysis bullosa, junctional, Herlitz type, 226700 ",3,"LAMB3, AI1A",150310,1q32.2,LAMB3
"Epidermolysis bullosa, junctional, Herlitz type, 226700 ",3,"LAMC2, LAMNB2, LAMB2T",150292,1q25.3,LAMC2
"Epidermolysis bullosa, junctional, localisata variant, 226650 ",3,"COL17A1, BPAG2, ERED",113811,10q25.1,COL17A1
"Epidermolysis bullosa, junctional, non-Herlitz type, 226650 ",3,"COL17A1, BPAG2, ERED",113811,10q25.1,COL17A1
"Epidermolysis bullosa, junctional, non-Herlitz type, 226650 ",3,ITGB4,147557,17q25.1,ITGB4
"Epidermolysis bullosa, junctional, non-Herlitz type, 226650 ",3,"LAMB3, AI1A",150310,1q32.2,LAMB3
"Epidermolysis bullosa, junctional, non-Herlitz type, 226650 ",3,"LAMC2, LAMNB2, LAMB2T",150292,1q25.3,LAMC2
"Epidermolysis bullosa, junctional, with pyloric atresia, 226730 ",3,ITGB4,147557,17q25.1,ITGB4
"Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 ",3,ITGA6,147556,2q31.1,ITGA6
"Epidermolysis bullosa, lethal acantholytic, 609638 ",3,"DSP, KPPS2, PPKS2, DCWHKTA",125647,6p24.3,DSP
"Epidermolysis bullosa, pretibial, 131850 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"Epidermolytic hyperkeratosis, 113800 ",3,"KRT1, EPPK, NEPPK, EHK",139350,12q13.13,KRT1
"Epidermolytic hyperkeratosis, 113800 ",3,"KRT10, EHK, BCIE, BIE",148080,17q21.2,KRT10
"Epidermylysis bullosa simplex-MCR, 609352 ",3,"KRT5, DDD1",148040,12q13.13,KRT5
"Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 ",3,SYN1,313440,Xp11.3-p11.2,SYN1
"Epilepsy, familial focal, with variable foci 1, 604364 ",3,"DEPDC5, KIAA0645, FFEVF1",614191,22q12.2-q12.3,DEPDC5
"Epilepsy, familial temporal lobe, 1, 600512 ",3,"LGI1, EPT, ETL1, ADLTE, ADPEAF",604619,10q23.33,LGI1
"Epilepsy, generalized, with febrile seizures plus, type 1, 604233 ",3,"SCN1B, GEFSP1, BRGDA5, ATFB13",600235,19q13.11,SCN1B
"Epilepsy, generalized, with febrile seizures plus, type 2, 604403 ",3,"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3",182389,2q24.3,SCN1A
"Epilepsy, generalized, with febrile seizures plus, type 3, 611277 ",3,"GABRG2, GEFSP3, CAE2, ECA2",137164,5q34,GABRG2
"Epilepsy, generalized, with febrile seizures plus, type 7, 613863 ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Epilepsy, myoclonic, familial adult, 2, 607876 ",3,"ADRA2B, ADRA2L1, FAME2",104260,2q11.2,ADRA2B
"Epilepsy, nocturnal frontal lobe, 1, 600513 ",3,"CHRNA4, ENFL1",118504,20q13.33,CHRNA4
"Epilepsy, nocturnal frontal lobe, 3, 605375 ",3,"CHRNB2, EFNL3",118507,1q21.3,CHRNB2
"Epilepsy, nocturnal frontal lobe, type 4, 610353 ",3,CHRNA2,118502,8p21.2,CHRNA2
"Epilepsy, progressive myoclonic 1B, 612437 ",3,"PRICKLE1, RILP, EPM1B",608500,12q12,PRICKLE1
"Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 ",3,"SCARB2, CD36L2, LIMPII, AMRF, EPM4",602257,4q21.1,SCARB2
"Epilepsy, progressive myoclonic 7, 616187 ",3,"KCNC1, EPM7",176258,11p15.1,KCNC1
"Epilepsy, pyridoxine-dependent, 266100 ",3,"ALDH7A1, ATQ1, EPD, PDE",107323,5q23.2,ALDH7A1
"Epileptic encephalopathy, early infantile, 1, 308350 ",3,"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32",300382,Xp21.3,ARX
"Epileptic encephalopathy, early infantile, 11, 613721 ",3,"SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS",182390,2q24.3,SCN2A
"Epileptic encephalopathy, early infantile, 12, 613722 ",3,"PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12",607120,20p12.3,PLCB1
"Epileptic encephalopathy, early infantile, 19, 615744 ",3,"GABRA1, EJM5, ECA4, EIEE19",137160,5q34,GABRA1
"Epileptic encephalopathy, early infantile, 2, 300672 ",3,"CDKL5, STK9, ISSX, EIEE2",300203,Xp22.13,CDKL5
"Epileptic encephalopathy, early infantile, 25, 615905 ",3,"SLC13A5, NACT, EIEE25",608305,17p13.1,SLC13A5
"Epileptic encephalopathy, early infantile, 28, 616211 ",3,"WWOX, FOR, SCAR12, EIEE28",605131,16q23.1-q23.2,WWOX
"Epileptic encephalopathy, early infantile, 29, 616339 ",3,"AARS, CMT2N, EIEE29",601065,16q22.1,AARS
"Epileptic encephalopathy, early infantile, 34, 616645 ",3,"SLC12A5, KCC2, KIAA1176, EIEE34, EIG14",606726,20q13.12,SLC12A5
"Epileptic encephalopathy, early infantile, 35, 616647 ",3,"ITPA, EIEE35",147520,20p13,ITPA
"Epileptic encephalopathy, early infantile, 37, 616981 ",3,"FRRS1L, C9orf4, CG6, EIEE37",604574,9q31.3,FRRS1L
"Epileptic encephalopathy, early infantile, 39, 612949 ",3,"SLC25A12, ARALAR, EIEE39",603667,2q31.1,SLC25A12
"Epileptic encephalopathy, early infantile, 4, 612164 ",3,"STXBP1, UNC18, EIEE4",602926,9q34.11,STXBP1
"Epileptic encephalopathy, early infantile, 41, 617105 ",3,"SLC1A2, EAAT2, EIEE41",600300,11p13,SLC1A2
"Epileptic encephalopathy, early infantile, 42, 617106 ",3,"CACNA1A, CACNL1A4, SCA6, EIEE42",601011,19p13.13,CACNA1A
"Epileptic encephalopathy, early infantile, 43, 617113 ",3,"GABRB3, ECA5, EIEE43",137192,15q12,GABRB3
"Epileptic encephalopathy, early infantile, 5, 613477 ",3,"SPTAN1, NEAS, EIEE5",182810,9q34.11,SPTAN1
"Epileptic encephalopathy, early infantile, 7, 613720 ",3,"KCNQ2, EBN1, EIEE7, BFNS1",602235,20q13.33,KCNQ2
"Epileptic encephalopathy, early infantile, 8, 300607 ",3,"ARHGEF9, PEM2, KIAA0424, EIEE8",300429,Xq11.1,ARHGEF9
"Epileptic encephalopathy, early infantile, 9, 300088 ",3,"PCDH19, KIAA1313, EFMR, EIEE9",300460,Xq22.1,PCDH19
"Epiphyseal dysplasia, multiple, 2, 600204 ",3,"COL9A2, EDM2, STL5",120260,1p34.2,COL9A2
"Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 ",3,"COL9A3, EDM3, IDD",120270,20q13.33,COL9A3
"Epiphyseal dysplasia, multiple, 4, 226900 ",3,"SLC26A2, DTD, DTDST, D5S1708, EDM4",606718,5q32,SLC26A2
"Epiphyseal dysplasia, multiple, 5, 607078 ",3,"MATN3, EDM5, HOA, OS2",602109,2p24.1,MATN3
"Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 ",3,COL2A1,120140,12q13.11,COL2A1
"Episodic ataxia, type 2, 108500 ",3,"CACNA1A, CACNL1A4, SCA6, EIEE42",601011,19p13.13,CACNA1A
"Episodic ataxia, type 5, 613855 ",3,"CACNB4, EJM6, EA5, EIG9",601949,2q23.3,CACNB4
"Episodic ataxia, type 6, 612656 ",3,"SLC1A3, EAAT1, EA6",600111,5p13.2,SLC1A3
"Episodic ataxia/myokymia syndrome, 160120 ",3,"KCNA1, AEMK, EA1",176260,12p13.32,KCNA1
"Episodic pain syndrome, familial, 2, 615551 ",3,"SCN10A, FEPS2",604427,3p22.2,SCN10A
"Episodic pain syndrome, familial, 3, 615552 ",3,"SCN11A, HSAN7, FEPS3",604385,3p22.2,SCN11A
"Epithelial recurrent erosion dystrophy, 122400 ",3,"COL17A1, BPAG2, ERED",113811,10q25.1,COL17A1
"Epstein syndrome, 153650 ",3,"MYH9, MHA, FTNS, DFNA17, BDPLT6",160775,22q12.3,MYH9
"Erythermalgia, primary, 133020 ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Erythrocytosis, familial, 2, 263400 ",3,VHL,608537,3p25.3,VHL
"Erythrocytosis, familial, 3, 609820 ",3,"EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH",606425,1q42.2,EGLN1
"Erythrocytosis, familial, 4, 611783 ",3,"EPAS1, MOP2, HIF2A, ECYT4",603349,2p21,EPAS1
"Erythrocytosis, somatic, 133100 ",3,"JAK2, THCYT3",147796,9p24.1,JAK2
"Erythrocytosis, somatic, 133100 ",3,"SH2B3, LNK",605093,12q24.12,SH2B3
"Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 ",3,"DSG1, PPKS1, SPPK1, EPKHE",125670,18q12.1,DSG1
"Erythrokeratodermia variabilis et progressiva, 133200 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Erythrokeratodermia variabilis et progressiva, 133200 ",3,"GJB3, CX31, DFNA2B",603324,1p34.3,GJB3
"Erythrokeratodermia variabilis with erythema gyratum repens, 133200 ",3,"GJB4, CX30.3",605425,1p34.3,GJB4
"Escobar syndrome, 265000 ",3,"CHRNG, ACHRG",100730,2q37.1,CHRNG
"Esophageal cancer, somatic, 133239 ",3,"TGFBR2, HNPCC6, AAT3, MFS2, LDS2",190182,3p24.1,TGFBR2
"Esophageal carcinoma, somatic, 133239 ",3,RNF6,604242,13q12.13,RNF6
"Esophageal squamous cell carcinoma, 133239 ",3,"LZTS1, F37, FEZ1",606551,8p21.3,LZTS1
"Esophageal squamous cell carcinoma, somatic, 133239 ",3,"WWOX, FOR, SCAR12, EIEE28",605131,16q23.1-q23.2,WWOX
"Estrogen resistance, 615363 ",3,"ESR1, ESR, ESTRR",133430,6q25.1-q25.2,ESR1
"Ewing sarcoma, 612219 ",3,"EWSR1, EWS",133450,22q12.2,EWSR1
"Exostoses, multiple, type 1, 133700 ",3,EXT1,608177,8q24.11,EXT1
"Exostoses, multiple, type 2, 133701 ",3,"EXT2, SSMS",608210,11p11.2,EXT2
"Exudative vitreoretinopathy 1, 133780 ",3,"FZD4, EVR1",604579,11q14.2,FZD4
"Exudative vitreoretinopathy 2, X-linked, 305390 ",3,"NDP, ND, EVR2",300658,Xp11.3,NDP
"Exudative vitreoretinopathy 4, 601813 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"FG syndrome 2, 300321 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"FG syndrome 4, 300422 ",3,"CASK, MICPCH, FGS4, CMG, MRXSNA",300172,Xp11.4,CASK
"Fabry disease, 301500 ",3,GLA,300644,Xq22.1,GLA
"Fabry disease, cardiac variant, 301500 ",3,GLA,300644,Xq22.1,GLA
"Facial paresis, hereditary congenital, 3, 614744 ",3,"HOXB1, HOX2I, HCFP3",142968,17q21.32,HOXB1
"Factor V deficiency, 227400 ",3,"F5, THPH2, RPRGL1",612309,1q24.2,F5
"Factor VII deficiency, 227500 ",3,F7,613878,13q34,F7
"Factor X deficiency, 227600 ",3,F10,613872,13q34,F10
"Factor XI deficiency, autosomal dominant, 612416 ",3,F11,264900,4q35.2,F11
"Factor XI deficiency, autosomal recessive, 612416 ",3,F11,264900,4q35.2,F11
"Factor XII deficiency, 234000 ",3,"F12, HAF, HAE3",610619,5q35.3,F12
"Factor XIIIA deficiency, 613225 ",3,"F13A1, F13A",134570,6p25.1,F13A1
"Factor XIIIB deficiency, 613235 ",3,F13B,134580,1q31.3,F13B
"Failure of tooth eruption, primary, 125350 ",3,"PTHR1, PTHR, PFE",168468,3p21.31,PTHR1
"Familial Mediterranean fever, AD, 134610 ",3,"MEFV, MEF, FMF",608107,16p13.3,MEFV
"Familial Mediterranean fever, AR, 249100 ",3,"MEFV, MEF, FMF",608107,16p13.3,MEFV
"Familial cold autoinflammatory syndrome 2, 611762 ",3,"NLRP12, NALP12, PYPAF7, RNO, FCAS2",609648,19q13.42,NLRP12
"Familial cold-induced inflammatory syndrome 1, 120100 ",3,"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1",606416,1q44,NLRP3
"Fanconi anemia, complementation group A, 227650 ",3,"FANCA, FACA, FA1, FA, FAA",607139,16q24.3,FANCA
"Fanconi anemia, complementation group B, 300514 ",3,"FAAP95, FAAP90, FLJ34064, FANCB",300515,Xp22.2,FAAP95
"Fanconi anemia, complementation group C, 227645 ",3,"FANCC, FACC",613899,9q22.32,FANCC
"Fanconi anemia, complementation group D1, 605724 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Fanconi anemia, complementation group G, 614082 ",3,"XRCC9, FANCG",602956,9p13.3,XRCC9
"Fanconi anemia, complementation group J, 609054 ",3,"BRIP1, BACH1, FANCJ",605882,17q23.2,BRIP1
"Fanconi anemia, complementation group Q, 615272 ",3,"ERCC4, XPF, FANCQ, XFEPS",133520,16p13.12,ERCC4
"Fanconi renotubular syndrome 2, 613388 ",3,"SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2",182309,5q35.3,SLC34A1
"Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 ",3,"HNF4A, TCF14, MODY1, FRTS4",600281,20q13.12,HNF4A
"Fanconi-Bickel syndrome, 227810 ",3,"SLC2A2, GLUT2",138160,3q26.2,SLC2A2
"Fatty liver, acute, of pregnancy, 609016 ",3,"HADHA, MTPA",600890,2p23.3,HADHA
"Favism, 134700 ",3,"G6PD, G6PD1",305900,Xq28,G6PD
"Febrile seizures, familial, 3A, 604403 ",3,"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3",182389,2q24.3,SCN1A
"Febrile seizures, familial, 3B, 613863 ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Febrile seizures, familial, 8, 611277 ",3,"GABRG2, GEFSP3, CAE2, ECA2",137164,5q34,GABRG2
"Fechtner syndrome, 153640 ",3,"MYH9, MHA, FTNS, DFNA17, BDPLT6",160775,22q12.3,MYH9
"Feingold syndrome, 164280 ",3,"MYCN, NMYC, ODED, MODED",164840,2p24.3,MYCN
"Fetal akinesia deformation sequence, 208150 ",3,"MUSK, CMS9, FADS",601296,9q31.3,MUSK
"Fetal akinesia deformation sequence, 208150 ",3,"RAPSN, CMS1D, CMS11, FADS",601592,11p11.2,RAPSN
"Fetal hemoglobin quantitative trait locus 1, 141749 ",3,HBG1,142200,11p15.4,HBG1
"Fetal hemoglobin quantitative trait locus 1, 141749 ",3,"HBG2, TNCY",142250,11p15.4,HBG2
"Fibrochondrogenesis 1, 228520 ",3,"COL11A1, STL2",120280,1p21.1,COL11A1
"Fibrochondrogenesis 2, 614524 ",3,"COL11A2, STL3, DFNA13, DFNB53, FBCG2",120290,6p21.32,COL11A2
"Fibrodysplasia ossificans progressiva, 135100 ",3,"ACVR1, ACVRLK2, ALK2, FOP",102576,2q24.1,ACVR1
"Fibrosis of extraocular muscles, congenital, 1, 135700 ",3,"KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B",608283,12q12,KIF21A
"Fibrosis of extraocular muscles, congenital, 2, 602078 ",3,"PHOX2A, ARIX, CFEOM2",602753,11q13.4,PHOX2A
"Fibrosis of extraocular muscles, congenital, 3B, 135700 ",3,"KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B",608283,12q12,KIF21A
"Fish-eye disease, 136120 ",3,LCAT,606967,16q22.1,LCAT
"Focal dermal hypoplasia, 305600 ",3,"PORCN, PORC, DHOF, FODH",300651,Xp11.23,PORCN
"Foveal hypoplasia 1, 136520 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Fragile X syndrome, 300624 ",3,"FMR1, FRAXA, POF1",309550,Xq27.3,FMR1
"Fragile X tremor/ataxia syndrome, 300623 ",3,"FMR1, FRAXA, POF1",309550,Xq27.3,FMR1
"Frasier syndrome, 136680 ",3,"WT1, NPHS4",607102,11p13,WT1
"Friedreich ataxia with retained reflexes, 229300 ",3,"FXN, FRDA, FARR, X25",606829,9q21.11,FXN
"Friedreich ataxia, 229300 ",3,"FXN, FRDA, FARR, X25",606829,9q21.11,FXN
"Frontometaphyseal dysplasia 1, 305620 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 ",3,"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",601530,5q35.3,SQSTM1
"Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 ",3,"GRN, CLN11",138945,17q21.31,GRN
"Frontotemporal lobar degeneration, TARDBP-related, 612069 ",3,"TARDBP, TDP43, ALS10",605078,1p36.22,TARDBP
"Fructose intolerance, 229600 ",3,ALDOB,612724,9q31.1,ALDOB
"Fructose-1,6-bisphosphatase deficiency, 229700 ",3,FBP1,611570,9q22.32,FBP1
"Fucosidosis, 230000 ",3,FUCA1,612280,1p36.11,FUCA1
"Fuhrmann syndrome, 228930 ",3,WNT7A,601570,3p25.1,WNT7A
"Fumarase deficiency, 606812 ",3,"FH, HLRCC, MCUL1, FMRD",136850,1q43,FH
"Fundus albipunctatus, 136880 ",3,RDH5,601617,12q13.2,RDH5
"Fundus albipunctatus, 136880 ",3,RLBP1,180090,15q26.1,RLBP1
"Fundus flavimaculatus, 248200 ",3,"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2",601691,1p22.1,ABCA4
"GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 ",3,"SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN",138140,1p34.2,SLC2A1
"GLUT1 deficiency syndrome 2, childhood onset, 612126 ",3,"SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN",138140,1p34.2,SLC2A1
"GM1-gangliosidosis, type I, 230500 ",3,"GLB1, MPS4B",611458,3p22.3,GLB1
"GM1-gangliosidosis, type II, 230600 ",3,"GLB1, MPS4B",611458,3p22.3,GLB1
"GM1-gangliosidosis, type III, 230650 ",3,"GLB1, MPS4B",611458,3p22.3,GLB1
"GM2-gangliosidosis, AB variant, 272750 ",3,GM2A,613109,5q33.1,GM2A
"GM2-gangliosidosis, several forms, 272800 ",3,"HEXA, TSD",606869,15q23,HEXA
"GRACILE syndrome, 603358 ",3,"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1",603647,2q35,BCS1L
"Galactokinase deficiency with cataracts, 230200 ",3,GALK1,604313,17q25.1,GALK1
"Galactose epimerase deficiency, 230350 ",3,GALE,606953,1p36.11,GALE
"Galactosemia, 230400 ",3,GALT,606999,9p13.3,GALT
"Galactosialidosis, 256540 ",3,"CTSA, PPGB, GSL, NGBE, GLB2",613111,20q13.12,CTSA
"Gallbladder disease 1, 600803 ",3,"ABCB4, PGY3, MDR3, ICP3",171060,7q21.12,ABCB4
"Gardner syndrome, 175100 ",3,"APC, GS, FPC, BTPS2",611731,5q22.2,APC
"Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 ",3,"CDH1, UVO, LCAM, ECAD",192090,16q22.1,CDH1
"Gastric cancer, somatic, 137215 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Gastric cancer, somatic, 613659 ",3,"APC, GS, FPC, BTPS2",611731,5q22.2,APC
"Gastric cancer, somatic, 613659 ",3,"CASP10, MCH4, ALPS2",601762,2q33.1,CASP10
"Gastric cancer, somatic, 613659 ",3,"ERBB2, NGL, NEU, HER2",164870,17q12,ERBB2
"Gastric cancer, somatic, 613659 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Gastric cancer, somatic, 613659 ",3,"IRF1, MAR",147575,5q31.1,IRF1
"Gastric cancer, somatic, 613659 ",3,"KLF6, COPEB, BCD1, ZF9",602053,10p15.2,KLF6
"Gastric cancer, somatic, 613659 ",3,"MUTYH, MYH",604933,1p34.1,MUTYH
"Gastric cancer, somatic, 613659 ",3,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5",171834,3q26.32,PIK3CA
"Gastrointestinal stromal tumor, 606764 ",3,"SDHB, SDH2, SDHIP, PGL4, CWS2",185470,1p36.13,SDHB
"Gastrointestinal stromal tumor, 606764 ",3,"SDHC, PGL3",602413,1q23.3,SDHC
"Gastrointestinal stromal tumor, familial, 606764 ",3,"KIT, PBT",164920,4q12,KIT
"Gastrointestinal stromal tumor, somatic, 606764 ",3,PDGFRA,173490,4q12,PDGFRA
"Gaucher disease, atypical, 610539 ",3,"PSAP, SAP1",176801,10q22.1,PSAP
"Gaucher disease, perinatal lethal, 608013 ",3,GBA,606463,1q22,GBA
"Gaucher disease, type I, 230800 ",3,GBA,606463,1q22,GBA
"Gaucher disease, type II, 230900 ",3,GBA,606463,1q22,GBA
"Gaucher disease, type III, 231000 ",3,GBA,606463,1q22,GBA
"Gaucher disease, type IIIC, 231005 ",3,GBA,606463,1q22,GBA
"Gaze palsy, horizontal, with progressive scoliosis, 607313 ",3,"ROBO3, RBIG1, RIG1, HGPPS",608630,11q24.2,ROBO3
"Geleophysic dysplasia 2, 614185 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"Generalized epilepsy and paroxysmal dyskinesia, 609446 ",3,"KCNMA1, SLO",600150,10q22.3,KCNMA1
"Germ cell tumors, 273300 ",3,"KIT, PBT",164920,4q12,KIT
"Gerstmann-Straussler disease, 137440 ",3,"PRNP, PRIP, KURU, CJD",176640,20p13,PRNP
"Ghosal hematodiaphyseal syndrome, 231095 ",3,"TBXAS1, GHOSAL, CYP5, BDPLT14",274180,7q34,TBXAS1
"Giant axonal neuropathy-1, 256850 ",3,"GAN, GAN1",605379,16q23.2,GAN
"Giant platelet disorder, isolated, 231200 ",3,"GP1BB, BS, BDPLT1",138720,22q11.21,GP1BB
"Gillespie syndrome, 206700 ",3,"ITPR1, SCA15, SCA16, SCA29",147265,3p26.1,ITPR1
"Gillessen-Kaesbach-Nishimura syndrome, 263210 ",3,"ALG9, DIBD1, CDG1L, GIKANIS",606941,11q23.1,ALG9
"Gitelman syndrome, 263800 ",3,"SLC12A3, NCCT, TSC",600968,16q13,SLC12A3
"Glanzmann thrombasthenia, 273800 ",3,"ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16",607759,17q21.31,ITGA2B
"Glanzmann thrombasthenia, 273800 ",3,"ITGB3, GP3A, GT, BDPLT2, BDPLT16",173470,17q21.32,ITGB3
"Glass syndrome, 612313 ",3,"SATB2, KIAA1034, GLSS",608148,2q33.1,SATB2
"Glaucoma 1, open angle, 1O, 613100 ",3,"NTF4 , NTF5, NT5, NT4, GLC1O",162662,19q13.33,NTF4 
"Glaucoma 1, open angle, E, 137760 ",3,"OPTN, GLC1E, FIP2, HYPL, NRP, ALS12",602432,10p13,OPTN
"Glaucoma 1A, primary open angle, 137750 ",3,"MYOC, TIGR, GLC1A, JOAG, GPOA",601652,1q24.3,MYOC
"Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 ",3,"CYP1B1, GLC3A",601771,2p22.2,CYP1B1
"Glioblastoma, somatic, 137800 ",3,"ERBB2, NGL, NEU, HER2",164870,17q12,ERBB2
"Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 ",3,"UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2",191845,16p12.3,UMOD
"Glomerulopathy with fibronectin deposits 2, 601894 ",3,"FN1, FN, LETS, FNZ, GFND2",135600,2q35,FN1
"Glomerulosclerosis, focal segmental, 1, 603278 ",3,"ACTN4, FSGS1, FSGS",604638,19q13.2,ACTN4
"Glomerulosclerosis, focal segmental, 2, 603965 ",3,"TRPC6, TRP6, FSGS2",603652,11q22.1,TRPC6
"Glomerulosclerosis, focal segmental, 3, 607832 ",3,"CD2AP, CMS",604241,6p12.3,CD2AP
"Glomerulosclerosis, focal segmental, 7, 616002 ",3,"PAX2, PAPRS, FSGS7",167409,10q24.31,PAX2
"Glomuvenous malformations, 138000 ",3,"GLML, GVM, VMGLOM",601749,1p22.1,GLML
"Glucocorticoid deficiency 2, 607398 ",3,"MRAP, FALP, C21orf61, GCCD2, FGD2",609196,21q22.11,MRAP
"Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 ",3,MC2R,607397,18p11.21,MC2R
"Glucocorticoid resistance, 615962 ",3,"NR3C1, GCR, GRL, GCRST",138040,5q31.3,NR3C1
"Glucose/galactose malabsorption, 606824 ",3,"SLC5A1, SGLT1",182380,22q12.3,SLC5A1
"Glutamate formiminotransferase deficiency, 229100 ",3,FTCD,606806,21q22.3,FTCD
"Glutamine deficiency, congenital, 610015 ",3,"GLUL, GLNS",138290,1q25.3,GLUL
"Glutaric acidemia IIA, 231680 ",3,"ETFA, GA2, MADD",608053,15q24.2-q24.3,ETFA
"Glutaric acidemia IIB, 231680 ",3,"ETFB, MADD",130410,19q13.41,ETFB
"Glutaric acidemia IIC, 231680 ",3,"ETFDH, MADD",231675,4q32.1,ETFDH
"Glutaricaciduria, type I, 231670 ",3,GCDH,608801,19p13.13,GCDH
"Glycerol kinase deficiency, 307030 ",3,GK,300474,Xp21.2,GK
"Glycine encephalopathy, 605899 ",3,"AMT, NKH, GCE",238310,3p21.31,AMT
"Glycine encephalopathy, 605899 ",3,"GCSH, NKH",238330,16q23.2,GCSH
"Glycine encephalopathy, 605899 ",3,"GLDC, HYGN1, GCSP, GCE, NKH",238300,9p24.1,GLDC
"Glycogen storage disease 0, liver, 240600 ",3,GYS2,138571,12p12.1,GYS2
"Glycogen storage disease 0, muscle, 611556 ",3,"GYS1, GYS",138570,19q13.33,GYS1
"Glycogen storage disease II, 232300 ",3,GAA,606800,17q25.3,GAA
"Glycogen storage disease IIIa, 232400 ",3,"AGL, GDE",610860,1p21.2,AGL
"Glycogen storage disease IIIb, 232400 ",3,"AGL, GDE",610860,1p21.2,AGL
"Glycogen storage disease Ia, 232200 ",3,"G6PC, G6PT",613742,17q21.31,G6PC
"Glycogen storage disease Ib, 232220 ",3,"SLC37A4, G6PT1",602671,11q23.3,SLC37A4
"Glycogen storage disease Ic, 232240 ",3,"SLC37A4, G6PT1",602671,11q23.3,SLC37A4
"Glycogen storage disease VI, 232700 ",3,PYGL,613741,14q22.1,PYGL
"Glycogen storage disease VII, 232800 ",3,"PFKM, GSD7",610681,12q13.11,PFKM
"Glycogen storage disease X, 261670 ",3,"PGAM2, PGAMM, GSD10",612931,7p13,PGAM2
"Glycogen storage disease XI, 612933 ",3,"LDHA, LDH1, GSD11",150000,11p15.1,LDHA
"Glycogen storage disease XII, 611881 ",3,"ALDOA, GSD12",103850,16p11.2,ALDOA
"Glycogen storage disease of heart, lethal congenital, 261740 ",3,"PRKAG2, WPWS, CMH6",602743,7q36.1,PRKAG2
"Glycogen storage disease, type IXa1, 306000 ",3,"PHKA2, PHK, XLG, PHK, PYKL, GSD9A",300798,Xp22.13,PHKA2
"Glycogen storage disease, type IXa2, 306000 ",3,"PHKA2, PHK, XLG, PHK, PYKL, GSD9A",300798,Xp22.13,PHKA2
"Gnathodiaphyseal dysplasia, 166260 ",3,"ANO5, TMEM16E, GDD1, LGMD2L",608662,11p14.3,ANO5
"Gout, PRPS-related, 300661 ",3,"PRPS1, CMTX5, DFNX1, DFN2",311850,Xq22.3,PRPS1
"Greenberg skeletal dysplasia, 215140 ",3,"LBR, PHA",600024,1q42.12,LBR
"Greig cephalopolysyndactyly syndrome, 175700 ",3,"GLI3, PAPA, PAPB",165240,7p14.1,GLI3
"Griscelli syndrome, type 1, 214450 ",3,"MYO5A, MYH12, GS1",160777,15q21.2,MYO5A
"Growth hormone deficiency, isolated, type IA, 262400 ",3,"GH1, GHN, IGHD1B",139250,17q23.3,GH1
"Growth hormone deficiency, isolated, type IB, 612781 ",3,"GH1, GHN, IGHD1B",139250,17q23.3,GH1
"Growth hormone deficiency, isolated, type IB, 612781 ",3,"GHRHR, GHRFR, IGHD1B",139191,7p14.3,GHRHR
"Growth hormone deficiency, isolated, type II, 173100 ",3,"GH1, GHN, IGHD1B",139250,17q23.3,GH1
"Growth hormone insensitivity, partial, 604271 ",3,"GHR, GHIP",600946,5p13-p12,GHR
"Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 ",3,IGF1,147440,12q23.2,IGF1
"Guttmacher syndrome, 176305 ",3,"HOXA13, HOX1J",142959,7p15.2,HOXA13
"Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 ",3,"OAT, GACR",613349,10q26.13,OAT
"HDL deficiency, type 2, 604091 ",3,"ABCA1, ABC1, HDLDT1, TGD",600046,9q31.1,ABCA1
"HELLP syndrome, maternal, of pregnancy, 609016 ",3,"HADHA, MTPA",600890,2p23.3,HADHA
"HMG-CoA synthase-2 deficiency, 605911 ",3,HMGCS2,600234,1p12,HMGCS2
"HPRT-related gout, 300323 ",3,"HPRT1, HPRT",308000,Xq26.2-q26.3,HPRT1
"HSAN2D, autosomal recessive, 243000 ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Haddad syndrome, 209880 ",3,"ASCL1, ASH1",100790,12q23.2,ASCL1
"Hailey-Hailey disease, 169600 ",3,"ATP2C1, BCPM, HHD",604384,3q22.1,ATP2C1
"Haim-Munk syndrome, 245010 ",3,"CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD",602365,11q14.2,CTSC
"Hand-foot-uterus syndrome, 140000 ",3,"HOXA13, HOX1J",142959,7p15.2,HOXA13
"Hartnup disorder, 234500 ",3,"SLC6A19, HND",608893,5p15.33,SLC6A19
"Hartsfield syndrome, 615465 ",3,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",136350,8p11.23,FGFR1
"Hawkinsinuria, 140350 ",3,HPD,609695,12q24.31,HPD
"Hay-Wells syndrome, 106260 ",3,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",603273,3q28,TP63
"Heart block, nonprogressive, 113900 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Heart block, progressive, type IA, 113900 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Heart-hand syndrome, Slovenian type, 610140 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Heimler syndrome 1, 234580 ",3,"PEX1, ZWS1, PBD1A, PBD1B, HMLR1",602136,7q21.2,PEX1
"Heimler syndrome 2, 616617 ",3,"PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2",601498,6p21.1,PEX6
"Heinz body anemia, 140700 ",3,"HBA2, HBH",141850,16p13.3,HBA2
"Heinz body anemias, alpha-, 140700 ",3,"HBA1, HBH",141800,16p13.3,HBA1
"Heinz body anemias, beta-, 140700 ",3,HBB,141900,11p15.4,HBB
"Hemangioma, capillary infantile, somatic, 602089 ",3,"FLT4, VEGFR3, PCL, LMPH1A",136352,5q35.3,FLT4
"Hemangioma, capillary infantile, somatic, 602089 ",3,KDR,191306,4q12,KDR
"Hematuria, benign familial, 141200 ",3,COL4A3,120070,2q36.3,COL4A3
"Heme oxygenase-1 deficiency, 614034 ",3,"HMOX1, HMOX1D",141250,22q12.3,HMOX1
"Hemochromatosis, 235200 ",3,"HFE, HLA-H, HFE1, MVCD7, TFQTL2",613609,6p22.2,HFE
"Hemochromatosis, type 2A, 602390 ",3,"HJV, HFE2A",608374,1q21.1,HJV
"Hemochromatosis, type 2B, 613313 ",3,"HAMP, LEAP1, HEPC, HFE2B",606464,19q13.12,HAMP
"Hemochromatosis, type 4, 606069 ",3,"SLC40A1, SLC11A3, FPN1, IREG1, HFE4",604653,2q32.2,SLC40A1
"Hemoglobin H disease, nondeletional, 613978 ",3,"HBA1, HBH",141800,16p13.3,HBA1
"Hemoglobin H disease, nondeletional, 613978 ",3,"HBA2, HBH",141850,16p13.3,HBA2
"Hemolytic anemia due to G6PD deficiency, 300908 ",3,"G6PD, G6PD1",305900,Xq28,G6PD
"Hemolytic anemia due to adenylate kinase deficiency, 612631 ",3,AK1,103000,9q34.11,AK1
"Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 ",3,"GCLC, GLCLC",606857,6p12.1,GCLC
"Hemolytic anemia due to hexokinase deficiency, 235700 ",3,"HK1, HKD, HMSNR",142600,10q22.1,HK1
"Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 ",3,"TPI1, TPID",190450,12p13.31,TPI1
"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 ",3,"CD59, MIC11",107271,11p13,CD59
"Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 ",3,GPI,172400,19q13.11,GPI
"Hemophagocytic lymphohistiocytosis, familial, 2, 603553 ",3,"PRF1, HPLH2, FLH2",170280,10q22.1,PRF1
"Hemophagocytic lymphohistiocytosis, familial, 3, 608898 ",3,"UNC13D, MUNC13-4, HPLH3, HLH3, FHL3",608897,17q25.1,UNC13D
"Hemophagocytic lymphohistiocytosis, familial, 4, 603552 ",3,"STX11, FHL4, HPLH4, HLH4",605014,6q24.2,STX11
"Hemophilia A, 306700 ",3,"F8, F8C, HEMA",300841,Xq28,F8
"Hemophilia B, 306900 ",3,"F9, HEMB, THPH8",300746,Xq27.1,F9
"Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 ",3,"SERPINA1, PI, AAT",107400,14q32.13,SERPINA1
"Hemosiderosis, systemic, due to aceruloplasminemia, 604290 ",3,CP,117700,3q24-q25,CP
"Hepatic adenoma, somatic, 142330 ",3,"HNF1A, TCF1, MODY3, IDDM20",142410,12q24.31,HNF1A
"Hepatic lipase deficiency, 614025 ",3,"LIPC, HL, LIPH, HDLCQ12",151670,15q21.3,LIPC
"Hepatic venoocclusive disease with immunodeficiency, 235550 ",3,"SP110, IFI41, IFI75, VODI",604457,2q37.1,SP110
"Hepatoblastoma, somatic, 114550 ",3,"APC, GS, FPC, BTPS2",611731,5q22.2,APC
"Hepatocellular cancer, somatic, 114550 ",3,"PDGFRL, PDGRL, PRLTS",604584,8p22,PDGFRL
"Hepatocellular carcinoma, 114550 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Hepatocellular carcinoma, childhood type, somatic, 114550 ",3,"MET, DFNB97, OSFD",164860,7q31.2,MET
"Hepatocellular carcinoma, somatic, 114550 ",3,"AXIN1, AXIN",603816,16p13.3,AXIN1
"Hepatocellular carcinoma, somatic, 114550 ",3,"CASP8, MCH5, ALPS2B",601763,2q33.1,CASP8
"Hepatocellular carcinoma, somatic, 114550 ",3,"CTNNB1, MRD19",116806,3p22.1,CTNNB1
"Hepatocellular carcinoma, somatic, 114550 ",3,"IGF2R, MPRI",147280,6q25.3,IGF2R
"Hepatocellular carcinoma, somatic, 114550 ",3,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5",171834,3q26.32,PIK3CA
"Hereditary motor and sensory neuropathy VIA, 601152 ",3,"MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B",608507,1p36.22,MFN2
"Hereditary motor and sensory neuropathy, type IIc, 606071 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Hereditary persistence of fetal hemoglobin, 141749 ",3,HBB,141900,11p15.4,HBB
"Hermansky-Pudlak syndrome 1, 203300 ",3,HPS1,604982,10q24.2,HPS1
"Heterotaxy, visceral, 1, X-linked 306955 ",3,"ZIC3, HTX1, HTX, VACTERLX",300265,Xq26.3,ZIC3
"Heterotaxy, visceral, 4, autosomal, 613751 ",3,"ACVR2B, ACTRIIB, HTX4",602730,3p22.2,ACVR2B
"Heterotopia, periventricular, 300049 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Histiocytoma, angiomatoid fibrous, somatic, 612160 ",3,CREB1,123810,2q33.3,CREB1
"Holocarboxylase synthetase deficiency, 253270 ",3,"HLCS, HCS",609018,21q22.13,HLCS
"Holoprosencephaly 11, 614226 ",3,"CDON, CDO, HPE11",608707,11q24.2,CDON
"Holoprosencephaly 2, 157170 ",3,"SIX3, HPE2",603714,2p21,SIX3
"Holoprosencephaly 3, 142945 ",3,"SHH, HPE3, HLP3, SMMCI, MCOPCB5",600725,7q36.3,SHH
"Holoprosencephaly 4, 142946 ",3,"TGIF, HPE4",602630,18p11.31,TGIF
"Holoprosencephaly 7, 610828 ",3,"PTCH1, NBCCS, BCNS, HPE7",601309,9q22.32,PTCH1
"Holoprosencephaly 9, 610829 ",3,"GLI2, HPE9, CJS",165230,2q14.2,GLI2
"Holt-Oram syndrome, 142900 ",3,TBX5,601620,12q24.21,TBX5
"Homocystinuria, B6-responsive and nonresponsive types, 236200 ",3,CBS,613381,21q22.3,CBS
"Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 ",3,"MTR, HMAG",156570,1q43,MTR
"Huntington disease, 143100 ",3,"HTT, HD, IT15",613004,4p16.3,HTT
"Huntington disease-like 1, 603218 ",3,"PRNP, PRIP, KURU, CJD",176640,20p13,PRNP
"Huntington disease-like 2, 606438 ",3,"JPH3, JP3, HDL2",605268,16q24.2,JPH3
"Hutchinson-Gilford progeria, 176670 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Hydatidiform mole, recurrent, 1, 231090 ",3,"NALP7, NOD12, PYPAF3, HYDM",609661,19q13.42,NALP7
"Hydranencephaly with abnormal genitalia, 300215 ",3,"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32",300382,Xp21.3,ARX
"Hydrocephalus due to aqueductal stenosis, 307000 ",3,"L1CAM, CAML1, HSAS1, MASA, SPG1",308840,Xq28,L1CAM
"Hydrocephalus with Hirschsprung disease, 307000 ",3,"L1CAM, CAML1, HSAS1, MASA, SPG1",308840,Xq28,L1CAM
"Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 ",3,"L1CAM, CAML1, HSAS1, MASA, SPG1",308840,Xq28,L1CAM
"Hydrocephalus, nonsyndromic, autosomal recessive 2, 615219 ",3,"MPDZ, MUPP1, HYC2",603785,9p23,MPDZ
"Hydrolethalus syndrome, 236680 ",3,"HYLS1, FLJ32915",610693,11q24.2,HYLS1
"Hyper-IgD syndrome, 260920 ",3,"MVK, MVLK, POROK3",251170,12q24.11,MVK
"Hyperalphalipoproteinemia, 143470 ",3,"CETP, HDLCQ10",118470,16q13,CETP
"Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 ",3,"CA5A, CA5AD",114761,16q24.2,CA5A
"Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 ",3,"CYP21A2, CYP21, CA21H",613815,6p21.33,CYP21A2
"Hyperbilirubinemia, familial transient neonatal, 237900 ",3,"UGT1A1, UGT1, GNT1, BILIQTL1",191740,2q37.1,UGT1A1
"Hyperbiliverdinemia, 614156 ",3,BLVRA,109750,7p13,BLVRA
"Hypercalcemia, infantile, 1, 143880 ",3,"CYP24A1, CYP24, HCINF1",126065,20q13.2,CYP24A1
"Hypercalcemia, infantile, 2, 616963 ",3,"SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2",182309,5q35.3,SLC34A1
"Hypercholanemia, familial, 607748 ",3,BAAT,602938,9q31.1,BAAT
"Hypercholanemia, familial, 607748 ",3,EPHX1,132810,1q42.12,EPHX1
"Hypercholanemia, familial, 607748 ",3,"TJP2, ZO2, PFIC4",607709,9q21.11,TJP2
"Hypercholesterolemia, due to ligand-defective apo B, 144010 ",3,"APOB, FLDB, LDLCQ4",107730,2p24.1,APOB
"Hypercholesterolemia, familial, 143890 ",3,"LDLR, FHC, FH, LDLCQ2",606945,19p13.2,LDLR
"Hypercholesterolemia, familial, 3, 603776 ",3,"PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1",607786,1p32.3,PCSK9
"Hypercholesterolemia, familial, autosomal recessive, 603813 ",3,"LDLRAP1, ARH, FHCB2, FHCB1",605747,1p36.11,LDLRAP1
"Hyperchylomicronemia, late-onset, 144650 ",3,APOA5,606368,11q23.3,APOA5
"Hyperekplexia 2, autosomal recessive, 614619 ",3,"GLRB, HKPX2",138492,4q32.1,GLRB
"Hyperekplexia 3, 614618 ",3,"SLC6A5, GLYT2, HKPX3",604159,11p15.1,SLC6A5
"Hyperekplexia, hereditary 1, autosomal dominant or recessive, 149400 ",3,"GLRA1, STHE, HKPX1",138491,5q33.1,GLRA1
"Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 ",3,PDGFRA,173490,4q12,PDGFRA
"Hyperferritinemia-cataract syndrome, 600886 ",3,"FTL, NBIA3, LFTD",134790,19q13.33,FTL
"Hyperglycinuria, 138500 ",3,"SLC36A2, PAT2",608331,5q33.1,SLC36A2
"Hyperglycinuria, 138500 ",3,"SLC6A19, HND",608893,5p15.33,SLC6A19
"Hyperglycinuria, 138500 ",3,"SLC6A20, XT3",605616,3p21.31,SLC6A20
"Hyperinsulinemic hypoglycemia, familial, 1, 256450 ",3,"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2",600509,11p15.1,ABCC8
"Hyperinsulinemic hypoglycemia, familial, 2, 601820 ",3,"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13",600937,11p15.1,KCNJ11
"Hyperinsulinemic hypoglycemia, familial, 3, 602485 ",3,"GCK, HHF3",138079,7p13,GCK
"Hyperinsulinemic hypoglycemia, familial, 5, 609968 ",3,"INSR, HHF5",147670,19p13.2,INSR
"Hyperinsulinism-hyperammonemia syndrome, 606762 ",3,GLUD1,138130,10q23.2,GLUD1
"Hyperkalemic periodic paralysis, type 2, 170500 ",3,"SCN4A, HYPP, NAC1A, HOKPP2, CMS16",603967,17q23.3,SCN4A
"Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 ",3,"CCM1, CAM, KRIT1",604214,7q21.2,CCM1
"Hyperlipoproteinemia, type Ib, 207750 ",3,APOC2,608083,19q13.32,APOC2
"Hypermethioninemia due to adenosine kinase deficiency, 614300 ",3,ADK,102750,10q22.2,ADK
"Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 ",3,"AHCY, SAHH",180960,20q11.22,AHCY
"Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 ",3,"SLC25A15, ORNT1, HHH",603861,13q14.11,SLC25A15
"Hyperostosis, endosteal, 144750 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"Hyperoxaluria, primary, type 1, 259900 ",3,"AGXT, SPAT",604285,2q37.3,AGXT
"Hyperoxaluria, primary, type II, 260000 ",3,"GRHPR, GLXR",604296,9p13.2,GRHPR
"Hyperparathyroidism, familial primary, 145000 ",3,"HRPT2, C1orf28",607393,1q31.2,HRPT2
"Hyperparathyroidism, neonatal, 239200 ",3,"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",601199,3q13.3-q21.1,CASR
"Hyperparathyroidism-jaw tumor syndrome, 145001 ",3,"HRPT2, C1orf28",607393,1q31.2,HRPT2
"Hyperphenylalaninemia, BH4-deficient, C, 261630 ",3,"QDPR, DHPR",612676,4p15.32,QDPR
"Hyperphenylalaninemia, BH4-deficient, D, 264070 ",3,"PCBD1, DCOH",126090,10q22.1,PCBD1
"Hyperpigmentation with or without hypopigmentation, 145250 ",3,"KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69",184745,12q21.32,KITLG
"Hyperproinsulinemia, 616214 ",3,"INS, MODY10, IDDM2",176730,11p15.5,INS
"Hyperprolinemia, type I, 239500 ",3,"PRODH, PRODH2, SCZD4",606810,22q11.21,PRODH
"Hypertension and brachydactyly syndrome, 112410 ",3,"PDE3A, HTNB",123805,12p12.2,PDE3A
"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 ",3,"NR3C2, MLR, MCR",600983,4q31.23,NR3C2
"Hypertension, essential, 145500 ",3,"PTGIS, CYP8A1, PGIS, CYP8",601699,20q13.13,PTGIS
"Hyperthyroidism, familial gestational, 603373 ",3,"TSHR, CHNG1",603372,14q31.1,TSHR
"Hyperthyroidism, nonautoimmune, 609152 ",3,"TSHR, CHNG1",603372,14q31.1,TSHR
"Hypertriglyceridemia, transient infantile, 614480 ",3,"GPD1, HTGTI",138420,12q13.12,GPD1
"Hyperuricemic nephropathy, familial juvenile 1, 162000 ",3,"UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2",191845,16p12.3,UMOD
"Hyperuricemic nephropathy, familial juvenile 2, 613092 ",3,"REN, HNFJ2",179820,1q32.1,REN
"Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 ",3,CYP11B2,124080,8q24.3,CYP11B2
"Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 ",3,CYP11B2,124080,8q24.3,CYP11B2
"Hypoalphalipoproteinemia, 604091 ",3,APOA1,107680,11q23.3,APOA1
"Hypobetalipoproteinemia, 615558 ",3,"APOB, FLDB, LDLCQ4",107730,2p24.1,APOB
"Hypobetalipoproteinemia, familial, 2, 605019 ",3,"ANGPTL3, ANGPT5, FHBL2",604774,1p31.3,ANGPTL3
"Hypocalcemia, autosomal dominant 2, 615361 ",3,"GNA11, HHC2, HYPOC2",139313,19p13.3,GNA11
"Hypocalcemia, autosomal dominant, 601198 ",3,"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",601199,3q13.3-q21.1,CASR
"Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 ",3,"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",601199,3q13.3-q21.1,CASR
"Hypocalciuric hypercalcemia, familial, type III, 600740 ",3,"AP2S1, CLAPS2, AP17, HHC3",602242,19q13.32,AP2S1
"Hypocalciuric hypercalcemia, type I, 145980 ",3,"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",601199,3q13.3-q21.1,CASR
"Hypocalciuric hypercalcemia, type II, 145981 ",3,"GNA11, HHC2, HYPOC2",139313,19p13.3,GNA11
"Hypochondroplasia, 146000 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Hypodysfibrinogenemia, 616004 ",3,FGG,134850,4q32.1,FGG
"Hypodysfibrinogenemia, congenital, 616004 ",3,FGA,134820,4q31.3,FGA
"Hypofibrinogenemia, congenital, 202400 ",3,FGB,134830,4q31.3,FGB
"Hypofibrinogenemia, congenital, 202400 ",3,FGG,134850,4q32.1,FGG
"Hypoglycemia of infancy, leucine-sensitive, 240800 ",3,"ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2",600509,11p15.1,ABCC8
"Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 ",3,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",136350,8p11.23,FGFR1
"Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 ",3,"LHB, HH23",152780,19q13.33,LHB
"Hypogonadotropic hypogonadism 24 without anosmia, 229070 ",3,"FSHB, HH24",136530,11p14.1,FSHB
"Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 ",3,"PROK2, PK2, BV8, HH4",607002,3p13,PROK2
"Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 ",3,"CHD7, HH5",608892,8q12.2,CHD7
"Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 ",3,"FGF8, HH6",600483,10q24.32,FGF8
"Hypogonadotropic hypogonadism 7 without anosmia, 146110 ",3,"GNRHR, LHRHR, HH7",138850,4q13.2,GNRHR
"Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 ",3,"KISS1R, GPR54, HH8, CPPB1",604161,19p13.3,KISS1R
"Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 ",3,"NSMF, NELF, HH9",608137,9q34.3,NSMF
"Hypokalemic periodic paralysis, type 1, 170400 ",3,"CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1",114208,1q32.1,CACNA1S
"Hypokalemic periodic paralysis, type 2, 613345 ",3,"SCN4A, HYPP, NAC1A, HOKPP2, CMS16",603967,17q23.3,SCN4A
"Hypomagnesemia 1, intestinal, 602014 ",3,"TRPM6, CHAK2, HOMG1",607009,9q21.13,TRPM6
"Hypomagnesemia 2, renal, 154020 ",3,"FXYD2, ATP1G1, HOMG2",601814,11q23.3,FXYD2
"Hypomagnesemia 3, renal, 248250 ",3,"CLDN16, PCLN1, HOMG3",603959,3q28,CLDN16
"Hypomagnesemia 4, renal, 611718 ",3,"EGF, URG, HOMG4",131530,4q25,EGF
"Hypomagnesemia 5, renal, with ocular involvement, 248190 ",3,"CLDN19, HOMG5",610036,1p34.2,CLDN19
"Hypomagnesemia 6, renal, 613882 ",3,"CNNM2, ACDP2, HOMG6, HOMGSMR",607803,10q24.32,CNNM2
"Hypomagnesemia, seizures, and mental retardation, 616418 ",3,"CNNM2, ACDP2, HOMG6, HOMGSMR",607803,10q24.32,CNNM2
"Hypoparathyroidism, autosomal dominant, 146200 ",3,PTH,168450,11p15.3,PTH
"Hypoparathyroidism, autosomal recessive, 146200 ",3,PTH,168450,11p15.3,PTH
"Hypoparathyroidism, familial isolated, 146200 ",3,"GCM2, GCMB",603716,6p24.2,GCM2
"Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 ",3,"GATA3, HDR, HDRS",131320,10p14,GATA3
"Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 ",3,"TBCE, KCS, KCS1, HRD",604934,1q42.3,TBCE
"Hypophosphatasia, adult, 146300 ",3,"ALPL, HOPS, TNSALP",171760,1p36.12,ALPL
"Hypophosphatasia, childhood, 241510 ",3,"ALPL, HOPS, TNSALP",171760,1p36.12,ALPL
"Hypophosphatasia, infantile, 241500 ",3,"ALPL, HOPS, TNSALP",171760,1p36.12,ALPL
"Hypophosphatemic rickets with hypercalciuria, 241530 ",3,"SLC34A3, NPTIIC, HHRH",609826,9q34.3,SLC34A3
"Hypophosphatemic rickets, 300554 ",3,"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",300008,Xp11.23,CLCN5
"Hypophosphatemic rickets, AR, 241520 ",3,"DMP1, ARHR, ARHP",600980,4q22.1,DMP1
"Hypophosphatemic rickets, X-linked dominant, 307800 ",3,"PHEX, HYP, HPDR1, LXHR",300550,Xp22.11,PHEX
"Hypophosphatemic rickets, autosomal dominant, 193100 ",3,"FGF23, ADHR, HPDR2, PHPTC",605380,12p13.32,FGF23
"Hypophosphatemic rickets, autosomal recessive, 2, 613312 ",3,"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED",173335,6q23.2,ENPP1
"Hypoplastic left heart syndrome 1, 241550 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Hypoplastic left heart syndrome 2, 614435 ",3,"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",600584,5q35.1,NKX2-5
"Hypoplastic or aplastic tibia with polydactyly, 188740 ",3,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS",605522,7q36.3,LMBR1
"Hypoprothrombinemia, 613679 ",3,"F2, THPH1, RPRGL2",176930,11p11.2,F2
"Hypospadias 1, X-linked, 300633 ",3,"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",313700,Xq12,AR
"Hypospadias 2, X-linked, 300758 ",3,"MAMLD1, CXorf6, F18, HYSP2",300120,Xq28,MAMLD1
"Hypothryoidism, congenital, nongoitrous 4, 275100 ",3,"TSHB, CHNG4",188540,1p13.2,TSHB
"Hypothyroidism, congenital nongoitrous, 5, 225250 ",3,"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",600584,5q35.1,NKX2-5
"Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 ",3,PAX8,167415,2q14.1,PAX8
"Hypothyroidism, congenital, nongoitrous, 1 275200 ",3,"TSHR, CHNG1",603372,14q31.1,TSHR
"Hypothyroidism, congenital, nongoitrous, 6, 614450 ",3,"THRA, ERBA1, THRA1, CHNG6",190120,17q21.1,THRA
"Hypotonia, infantile, with psychomotor retardation, 616816 ",3,"CCDC174, HSPC212, IHPM",616735,3p25.1,CCDC174
"Hypotrichosis 11, 615059 ",3,"SNRPE, HYPT11",128260,1q32.1,SNRPE
"Hypotrichosis 12, 615885 ",3,"RPL21, HYPT12",603636,13q12.2,RPL21
"Hypotrichosis 2, 146520 ",3,"CDSN, HTSS1, HYPT2, PSS1",602593,6p21.33,CDSN
"Hypotrichosis 4, 146550 ",3,"HR, AU, MUHH1, HYPT4",602302,8p21.3,HR
"Hypotrichosis 7, 604379 ",3,"LIPH, LAH2, ARWH2, HYPT7",607365,3q27.2,LIPH
"Hypotrichosis 8, 278150 ",3,"LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8",609239,13q14.2,LPAR6
"Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 ",3,"CDH3, CDHP, PCAD, HJMD",114021,16q22.1,CDH3
"Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 ",3,"SOX18, HLTS, HLTRS",601618,20q13.33,SOX18
"Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 ",3,"SOX18, HLTS, HLTRS",601618,20q13.33,SOX18
"Hystrix-like ichthyosis with deafness, 602540 ",3,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID",121011,13q12.11,GJB2
"IMAGE syndrome, 614732 ",3,"CDKN1C, KIP2, BWS, IMAGE",600856,11p15.4,CDKN1C
"IVIC syndrome, 147750 ",3,"SALL4, HSAL4",607343,20q13.2,SALL4
"Ichthyosis histrix, Curth-Macklin type, 146590 ",3,"KRT1, EPPK, NEPPK, EHK",139350,12q13.13,KRT1
"Ichthyosis vulgaris, 146700 ",3,"FLG, ATOD2",135940,1q21.3,FLG
"Ichthyosis with confetti, 609165 ",3,"KRT10, EHK, BCIE, BIE",148080,17q21.2,KRT10
"Ichthyosis, X-linked, 308100 ",3,"STS, ARSC1, ARSC, SSDD, XLI",300747,Xp22.31,STS
"Ichthyosis, congenital, autosomal recessive 1, 242300 ",3,"TGM1, ICR2, ARCI1",190195,14q12,TGM1
"Ichthyosis, congenital, autosomal recessive 11, 602400 ",3,"ST14, MTSP1, ARCI11",606797,11q24.3,ST14
"Ichthyosis, congenital, autosomal recessive 2, 242100 ",3,"ALOX12B, ARCI2",603741,17p13.1,ALOX12B
"Ichthyosis, congenital, autosomal recessive 4A, 601277 ",3,"ABCA12, ARCI4A, ARCI4B, ICR2B, LI2",607800,2q35,ABCA12
"Ichthyosis, congenital, autosomal recessive 5, 604777 ",3,"CYP4F22, ARCI5, LI3",611495,19p13.12,CYP4F22
"Ichthyosis, congenital, autosomal recessive 6, 612281 ",3,"NIPAL4, ICHYN, ARCI6",609383,5q33.3,NIPAL4
"Ichthyosis, congenital, autosomal recessive 9, 615023 ",3,"CERS3, LASS3, ARCI9",615276,15q26.3,CERS3
"Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 ",3,"KRT1, EPPK, NEPPK, EHK",139350,12q13.13,KRT1
"Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 ",3,"KRT10, EHK, BCIE, BIE",148080,17q21.2,KRT10
"Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 ",3,"CLDN1, SEMP1, ILVASC",603718,3q28,CLDN1
"Iminoglycinuria, digenic, 242600 ",3,"SLC36A2, PAT2",608331,5q33.1,SLC36A2
"Iminoglycinuria, digenic, 242600 ",3,"SLC6A19, HND",608893,5p15.33,SLC6A19
"Iminoglycinuria, digenic, 242600 ",3,"SLC6A20, XT3",605616,3p21.31,SLC6A20
"Immunodeficiency 15, 615592 ",3,"IKBKB, NFKBIKB, IMD15",603258,8p11.21,IKBKB
"Immunodeficiency 17, CD3 gamma deficient, 615607 ",3,"CD3G, IMD17",186740,11q23.3,CD3G
"Immunodeficiency 19, 615617 ",3,"CD3D, T3D, IMD19",186790,11q23.3,CD3D
"Immunodeficiency 20, 615707 ",3,"FCGR3A, CD16, IGFR3, IMD20",146740,1q23.3,FCGR3A
"Immunodeficiency 23, 615816 ",3,"PGM3, AGM1, IMD23",172100,6q14.1,PGM3
"Immunodeficiency 24, 615897 ",3,"CTPS1, CTPS, IMD24",123860,1p34.2,CTPS1
"Immunodeficiency 26, with or without neurologic abnormalities, 615966 ",3,"PRKDC, HYRC1, DNPK1, IMD26",600899,8q11.21,PRKDC
"Immunodeficiency 27A, mycobacteriosis, AR, 209950 ",3,"IFNGR1, IMD27A, IMD27B",107470,6q23.3,IFNGR1
"Immunodeficiency 27B, mycobacteriosis, AD, 615978 ",3,"IFNGR1, IMD27A, IMD27B",107470,6q23.3,IFNGR1
"Immunodeficiency 28, mycobacteriosis, 614889 ",3,"IFNGR2, IFNGT1, IFGR2, IMD28",147569,21q22.11,IFNGR2
"Immunodeficiency 29, mycobacteriosis, 614890 ",3,"IL12B, NKSF2, IMD29",161561,5q33.3,IL12B
"Immunodeficiency 33, 300636 ",3,"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33",300248,Xq28,IKBKG
"Immunodeficiency 34, mycobacteriosis, X-linked, 300645 ",3,"CYBB, CGD, AMCBX2, IMD34",300481,Xp21.1-p11.4,CYBB
"Immunodeficiency 35, 611521 ",3,"TYK2, IMD35",176941,19p13.2,TYK2
"Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 ",3,"IL2RA, CD25, IL2R, IDDM10, IMD41",147730,10p15.1,IL2RA
"Immunodeficiency 43, 241600 ",3,"B2M, IMD43",109700,15q21.1,B2M
"Immunodeficiency 46, 616740 ",3,"TFRC, TFR, CD71, IMD46",190010,3q29,TFRC
"Immunodeficiency 47, 300972 ",3,"ATP6AP1, ATP6IP1, ATP6S1, VATPS1",300197,Xq28,ATP6AP1
"Immunodeficiency 48, 269840 ",3,"ZAP70, SRK, ADMIO2, IMD48",176947,2q11.2,ZAP70
"Immunodeficiency 7, TCR-alpha/beta deficient, 615387 ",3,"TRAC, TRCA, TRA, IMD7",186880,14q11.2,TRAC
"Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 ",3,"PNP, NP",164050,14q11.2,PNP
"Immunodeficiency with hyper IgM, type 5, 608106 ",3,"UNG, DGU, HIGM5",191525,12q24.11,UNG
"Immunodeficiency with hyper-IgM, type 2, 605258 ",3,"AICDA, AID, HIGM2",605257,12p13.31,AICDA
"Immunodeficiency with hyper-IgM, type 3, 606843 ",3,"CD40, TNFRSF5",109535,20q13.12,CD40
"Immunodeficiency, X-linked, with hyper-IgM, 308230 ",3,"TNFSF5, CD40LG, HIGM1, IGM",300386,Xq26.3,TNFSF5
"Immunodeficiency, common variable, 10, 615577 ",3,"NFKB2, LYT10, CVID10",164012,10q24.32,NFKB2
"Immunodeficiency, common variable, 12, 616576 ",3,"NFKB1, CVID12",164011,4q24,NFKB1
"Immunodeficiency, common variable, 5, 613495 ",3,"MS4A1, CD20, CVID5",112210,11q12.2,MS4A1
"Immunodeficiency, common variable, 7, 614699 ",3,"CR2, C3DR, SLEB9, CVID7",120650,1q32.2,CR2
"Immunodeficiency, isolated, 300584 ",3,"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33",300248,Xq28,IKBKG
"Immunodeficiency, primary, autosomal recessive, IL21R-related, 615207 ",3,IL21R,605383,16p12.1,IL21R
"Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 ",3,"DNMT3B, ICF1",602900,20q11.21,DNMT3B
"Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 ",3,"ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2",614064,6q21,ZBTB24
"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 ",3,"FOXP3, IPEX, AIID, XPID, PIDX",300292,Xp11.23,FOXP3
"Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 ",3,"VCP, IBMPFD1, ALS14, CMT2Y",601023,9p13.3,VCP
"Incontinentia pigmenti, 308300 ",3,"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33",300248,Xq28,IKBKG
"Infantile cerebellar-retinal degeneration, 614559 ",3,"ACO2, ICRD, OPA9",100850,22q13.2,ACO2
"Infantile neuroaxonal dystrophy 1, 256600 ",3,"PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14",603604,22q13.1,PLA2G6
"Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations, 613759 ",3,FADD,602457,11q13.3,FADD
"Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 ",3,"CRFB4, IBD25",123889,21q22.11,CRFB4
"Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 ",3,"IL10RA, IL10R, IBD28",146933,11q23.3,IL10RA
"Insensitivity to pain, congenital, 243000 ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Insensitivity to pain, congenital, with anhidrosis, 256800 ",3,"NTRK1, TRKA, MTC",191315,1q23.1,NTRK1
"Insomnia, fatal familial, 600072 ",3,"PRNP, PRIP, KURU, CJD",176640,20p13,PRNP
"Insulin resistance, severe, digenic, 125853 ",3,"PPP1R3A, PPP1R3",600917,7q31.1,PPP1R3A
"Insulin resistance, severe, digenic, 604367 ",3,"PPARG, PPARG1, PPARG2, CIMT1, GLM1",601487,3p25.2,PPARG
"Insulin-like growth factor I, resistance to, 270450 ",3,IGF1R,147370,15q26.3,IGF1R
"Interleukin 1 receptor antagonist deficiency, 612852 ",3,"IL1RN, MVCD4, DIRA",147679,2q14.1,IL1RN
"Intestinal pseudoobstruction, neuronal, 300048 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Intrinsic factor deficiency, 261000 ",3,"GIF, IF",609342,11q12.1,GIF
"Invasive pneumococcal disease, recurrent isolated, 2, 300640 ",3,"IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33",300248,Xq28,IKBKG
"Iridogoniodysgenesis, type 1, 601631 ",3,"FOXC1, FKHL7, FREAC3, IRID1, RIEG3",601090,6p25.3,FOXC1
"Iridogoniodysgenesis, type 2, 137600 ",3,"PITX2, IDG2, RIEG1, RGS, IGDS2",601542,4q25,PITX2
"Iris hypoplasia and glaucoma, 601631 ",3,"FOXC1, FKHL7, FREAC3, IRID1, RIEG3",601090,6p25.3,FOXC1
"Iron-refractory iron deficiency anemia, 206200 ",3,"TMPRSS6, IRIDA",609862,22q12.3,TMPRSS6
"Jackson-Weiss syndrome, 123150 ",3,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",136350,8p11.23,FGFR1
"Jackson-Weiss syndrome, 123150 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Jalili syndrome, 217080 ",3,"CNNM4, ACDP4",607805,2q11.2,CNNM4
"Jervell and Lange-Nielsen syndrome 2, 612347 ",3,"KCNE1, JLNS, LQT5, JLNS2",176261,21q22.12,KCNE1
"Jervell and Lange-Nielsen syndrome, 220400 ",3,"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2",607542,11p15.5-p15.4,KCNQ1
"Johanson-Blizzard syndrome, 243800 ",3,"UBR1, JBS",605981,15q15.2,UBR1
"Joubert syndrome 10, 300804 ",3,"OFD1, CXorf5, SGBS2, JBTS10, RP23",300170,Xp22.2,OFD1
"Joubert syndrome 2, 608091 ",3,"TMEM216, JBTS2, CORS2, MKS2",613277,11q12.2,TMEM216
"Joubert syndrome 25, 616781 ",3,"CEP104, GLYBP, KIAA0562, JBTS25",616690,1p36.32,CEP104
"Joubert syndrome 28, 617121 ",3,"MKS1, MKS, BBS13, JBTS28",609883,17q22,MKS1
"Joubert syndrome 4, 609583 ",3,"NPHP1, NPH1, SLSN1, JBTS4",607100,2q13,NPHP1
"Joubert syndrome 5, 610188 ",3,"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14",610142,12q21.32,CEP290
"Joubert syndrome 6, 610688 ",3,"TMEM67, MKS3, JBTS6, NPHP11",609884,8q22.1,TMEM67
"Joubert syndrome 7, 611560 ",3,"RPGRIP1L, KIAA1005, JBTS7, MKS5",610937,16q12.2,RPGRIP1L
"Joubert syndrome 8, 612291 ",3,"ARL13B, ARL2L1, JBTS8",608922,3q11.1-q11.2,ARL13B
"Joubert syndrome 9, 612285 ",3,"CC2D2A, KIAA1345, MKS6",612013,4p15.32,CC2D2A
"Joubert syndrome-3, 608629 ",3,AHI1,608894,6q23.3,AHI1
"Juvenile polyposis syndrome, infantile form, 174900 ",3,"BMPR1A, ACVRLK3, ALK3",601299,10q23.2,BMPR1A
"Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 ",3,"SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS",600993,18q21.2,SMAD4
"Kahrizi syndrome, 612713 ",3,"SRD5A3, SRD5A2L, CDG1Q, KRIZI",611715,4q12,SRD5A3
"Kanzaki disease, 609242 ",3,NAGA,104170,22q13.2,NAGA
"Kappa light chain deficiency, 614102 ",3,"IGKC, IGKCD",147200,2p11.2,IGKC
"Kenny-Caffey syndrome, type 1, 244460 ",3,"TBCE, KCS, KCS1, HRD",604934,1q42.3,TBCE
"Keratitis, 148190 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Keratitis-ichthyosis-deafness syndrome, 148210 ",3,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID",121011,13q12.11,GJB2
"Keratoconus 1, 148300 ",3,"VSX1, RINX, KTCN1, CAASDS",605020,20p11.21,VSX1
"Keratoderma, palmoplantar, with deafness, 148350 ",3,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID",121011,13q12.11,GJB2
"Keratosis palmoplantaris striata I, AD, 148700 ",3,"DSG1, PPKS1, SPPK1, EPKHE",125670,18q12.1,DSG1
"Keratosis palmoplantaris striata II, 612908 ",3,"DSP, KPPS2, PPKS2, DCWHKTA",125647,6p24.3,DSP
"Keratosis palmoplantaris striata III, 607654 ",3,"KRT1, EPPK, NEPPK, EHK",139350,12q13.13,KRT1
"Keutel syndrome, 245150 ",3,MGP,154870,12p12.3,MGP
"Kindler syndrome, 173650 ",3,"KIND1, URP1, C20orf42",607900,20p12.3,KIND1
"King-Denborough syndrome, 145600 ",3,"RYR1, MHS, CCO",180901,19q13.2,RYR1
"Kleefstra syndrome, 610253 ",3,"EHMT1, EUHMTASE1, DEL9q34",607001,9q34.3,EHMT1
"Klippel-Feil syndrome 2, 214300 ",3,"MEOX1, MOX1, KFS2",600147,17q21.31,MEOX1
"Kniest dysplasia, 156550 ",3,COL2A1,120140,12q13.11,COL2A1
"Knobloch syndrome, type 1, 267750 ",3,"COL18A1, KNO1",120328,21q22.3,COL18A1
"Kosaki overgrowth syndrome, 616592 ",3,"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS",173410,5q32,PDGFRB
"Kowarski syndrome, 262650 ",3,"GH1, GHN, IGHD1B",139250,17q23.3,GH1
"Krabbe disease, 245200 ",3,GALC,606890,14q31.3,GALC
"Krabbe disease, atypical, 611722 ",3,"PSAP, SAP1",176801,10q22.1,PSAP
"Kufor-Rakeb syndrome, 606693 ",3,"ATP13A2, PARK9, KRPPD, CLN12",610513,1p36.13,ATP13A2
"L-2-hydroxyglutaric aciduria, 236792 ",3,"L2HGDH, C14orf160, L2HGA",609584,14q21.3,L2HGDH
"L-ferritin deficiency, dominant and recessive, 615604 ",3,"FTL, NBIA3, LFTD",134790,19q13.33,FTL
"LADD syndrome, 149730 ",3,FGF10,602115,5p12,FGF10
"LADD syndrome, 149730 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"LADD syndrome, 149730 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"LCHAD deficiency, 609016 ",3,"HADHA, MTPA",600890,2p23.3,HADHA
"LDL cholesterol level QTL2, 143890 ",3,"LDLR, FHC, FH, LDLCQ2",606945,19p13.2,LDLR
"LEOPARD syndrome 1, 151100 ",3,"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS",176876,12q24.13,PTPN11
"LEOPARD syndrome 2, 611554 ",3,"RAF1, CRAF, NS5, CMD1NN",164760,3p25.2,RAF1
"LEOPARD syndrome 3, 613707 ",3,"BRAF, NS7",164757,7q34,BRAF
"Lactase deficiency, congenital, 223000 ",3,"LCT, LAC, LPH",603202,2q21.3,LCT
"Lactase persistence/nonpersistence, 223100 ",3,MCM6,601806,2q21.3,MCM6
"Lacticacidemia due to PDX1 deficiency, 245349 ",3,PDX1,608769,11p13,PDX1
"Laing distal myopathy, 160500 ",3,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD",160760,14q11.2,MYH7
"Langer mesomelic dysplasia, 249700 ",3,"SHOX, GCFX, SS, PHOG",312865,Xp22.33,SHOX
"Langer mesomelic dysplasia, 249700 ",3,SHOXY,400020,Yp11.2,SHOXY
"Laron dwarfism, 262500 ",3,"GHR, GHIP",600946,5p13-p12,GHR
"Larsen syndrome, 150250 ",3,"FLNB, SCT, AOI, LRS1",603381,3p14.3,FLNB
"Lateral meningocele syndrome, 130720 ",3,"NOTCH3, CADASIL1, CASIL, IMF2, LMNS",600276,19p13.12,NOTCH3
"Lathosterolosis, 607330 ",3,"SC5DL, ERG3",602286,11q23.3-q24.1,SC5DL
"Laurin-Sandrow syndrome, 135750 ",3,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS",605522,7q36.3,LMBR1
"Leber congenital amaurosis 1, 204000 ",3,"GUCY2D, GUC2D, LCA1, CORD6, RCD2",600179,17p13.1,GUCY2D
"Leber congenital amaurosis 10, 611755 ",3,"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14",610142,12q21.32,CEP290
"Leber congenital amaurosis 11, 613837 ",3,"IMPDH1, RP10, LCA11",146690,7q32.1,IMPDH1
"Leber congenital amaurosis 13, 612712 ",3,"RDH12, LCA13",608830,14q24.1,RDH12
"Leber congenital amaurosis 14, 613341 ",3,"LRAT, LCA14",604863,4q32.1,LRAT
"Leber congenital amaurosis 15, 613843 ",3,"TULP1, RP14, LCA15",602280,6p21.31,TULP1
"Leber congenital amaurosis 16, 614186 ",3,"KCNJ13, SVD, LCA16",603208,2q37.1,KCNJ13
"Leber congenital amaurosis 18, 608133 ",3,"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1",179605,6p21.1,PRPH2
"Leber congenital amaurosis 2, 204100 ",3,"RPE65, RP20, LCA2",180069,1p31.3,RPE65
"Leber congenital amaurosis 3, 604232 ",3,"SPATA7, HSD3, LCA3",609868,14q31.3,SPATA7
"Leber congenital amaurosis 4, 604393 ",3,"AIPL1, LCA4",604392,17p13.2,AIPL1
"Leber congenital amaurosis 6, 613826 ",3,"RPGRIP1, LCA6, CORD13",605446,14q11.2,RPGRIP1
"Leber congenital amaurosis 7, 613829 ",3,"CRX, CORD2, CRD, LCA7",602225,19q13.33,CRX
"Leber congenital amaurosis 8, 613835 ",3,"CRB1, RP12, LCA8",604210,1q31.3,CRB1
"Leber congenital amaurosis 9, 608553 ",3,"NMNAT1, NMNAT, PNAT1, LCA9",608700,1p36.22,NMNAT1
"Left ventricular noncompaction 10, 615396 ",3,"MYBPC3, CMH4, CMD1MM, LVNC10",600958,11p11.2,MYBPC3
"Left ventricular noncompaction 3, 601493 ",3,"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",605906,10q23.2,LDB3
"Left ventricular noncompaction 4, 613424 ",3,"ACTC1, CMD1R, CMH11, ASD5, LVNC4",102540,15q14,ACTC1
"Left ventricular noncompaction 5, 613426 ",3,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD",160760,14q11.2,MYH7
"Left ventricular noncompaction 6, 601494 ",3,"TNNT2, CMH2, CMD1D, RCM3, LVNC6",191045,1q32.1,TNNT2
"Left ventricular noncompaction 9, 611878 ",3,"TPM1, CMH3, CMD1Y , LVNC9",191010,15q22.2,TPM1
"Legg-Calve-Perthes disease, 150600 ",3,COL2A1,120140,12q13.11,COL2A1
"Legius syndrome, 611431 ",3,"SPRED1, NFLS",609291,15q14,SPRED1
"Leigh syndrome due to cytochrome c oxidase deficiency, 256000 ",3,"COX15, CEMCOX2",603646,10q24.2,COX15
"Leigh syndrome due to mitochondrial COX4 deficiency, 256000 ",3,COX10,602125,17p12,COX10
"Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 ",3,NDUFA12,614530,12q22,NDUFA12
"Leigh syndrome due to mitochondrial complex I deficiency, 256000 ",3,FOXRED1,613622,11q24.2,FOXRED1
"Leigh syndrome due to mitochondrial complex I deficiency, 256000 ",3,NDUFA2,602137,5q31.3,NDUFA2
"Leigh syndrome due to mitochondrial complex I deficiency, 256000 ",3,NDUFA9,603834,12p13.32,NDUFA9
"Leigh syndrome due to mitochondrial complex I deficiency, 256000 ",3,"NDUFAF6, C8orf38",612392,8q22.1,NDUFAF6
"Leigh syndrome due to mitochondrial complex I deficiency, 256000 ",3,NDUFS3,603846,11p11.2,NDUFS3
"Leigh syndrome due to mitochondrial complex I deficiency, 256000 ",3,NDUFS8,602141,11q13.2,NDUFS8
"Leigh syndrome, 256000 ",3,"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1",603647,2q35,BCS1L
"Leigh syndrome, 256000 ",3,"NDUFAF2, NDUFA12L, MMTN, B17.2L",609653,5q12.1,NDUFAF2
"Leigh syndrome, 256000 ",3,"NDUFS4, AQDQ",602694,5q11.2,NDUFS4
"Leigh syndrome, 256000 ",3,"NDUFS7, PSST",601825,19p13.3,NDUFS7
"Leigh syndrome, 256000 ",3,"SDHA, SDH1, SDHF, CMD1GG, PGL5",600857,5p15.33,SDHA
"Leigh syndrome, French-Canadian type, 220111 ",3,"LRPPRC, LRP130, LSFC",607544,2p21,LRPPRC
"Leigh syndrome, due to COX IV deficiency, 256000 ",3,"SURF1, CMT4K",185620,9q34.2,SURF1
"Leiomyomatosis and renal cell cancer, 150800 ",3,"FH, HLRCC, MCUL1, FMRD",136850,1q43,FH
"Lenz-Majewski hyperostotic dwarfism, 151050 ",3,"PTDSS1, PSS1, KIAA0024, LMHD",612792,8q22.1,PTDSS1
"Leprechaunism, 246200 ",3,"INSR, HHF5",147670,19p13.2,INSR
"Leri-Weill dyschondrosteosis, 127300 ",3,"SHOX, GCFX, SS, PHOG",312865,Xp22.33,SHOX
"Leri-Weill dyschondrosteosis, 127300 ",3,SHOXY,400020,Yp11.2,SHOXY
"Lesch-Nyhan syndrome, 300322 ",3,"HPRT1, HPRT",308000,Xq26.2-q26.3,HPRT1
"Lethal congenital contractural syndrome 2, 607598 ",3,"ERBB3, LCCS2",190151,12q13.2,ERBB3
"Lethal congenital contracture syndrome 1, 253310 ",3,"GLE1, GLE1L, LCCS, LCCS1",603371,9q34.11,GLE1
"Lethal congenital contracture syndrome 5, 615368 ",3,"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",602378,19p13.2,DNM2
"Lethal congenital contracture syndrome 9, 616503 ",3,"ADGRG6, PR126, VIGR, LCCS9",612243,6q24.2,ADGRG6
"Leukemia, T-cell acute lymphoblastic, somatic, 613065 ",3,"NUP214, D9S46E, CAN, CAIN",114350,9q34.13,NUP214
"Leukemia, T-cell acute lymphocytic, somatic, 613065 ",3,"TAL1, TCL5, SCL",187040,1p33,TAL1
"Leukemia, T-cell acute lymphocytic, somatic, 613065 ",3,TAL2,186855,9q31.2,TAL2
"Leukemia, acute lymphoblastic, 613065 ",3,"NBN, NBS1",602667,8q21.3,NBN
"Leukemia, acute lymphoblastic, somatic, 613065 ",3,FLT3,136351,13q12.2,FLT3
"Leukemia, acute lymphoblastic, somatic, 613065 ",3,"GNB1, MRD42",139380,1p36.33,GNB1
"Leukemia, acute lymphocytic, somatic, 613065 ",3,"BCR, CML, PHL, ALL",151410,22q11.23,BCR
"Leukemia, acute myeloid, 601626 ",3,AF10,602409,10p12.31,AF10
"Leukemia, acute myeloid, 601626 ",3,"KIT, PBT",164920,4q12,KIT
"Leukemia, acute myeloid, 601626 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Leukemia, acute myeloid, 601626 ",3,LPP,600700,3q27-q28,LPP
"Leukemia, acute myeloid, 601626 ",3,"RUNX1, CBFA2, AML1",151385,21q22.12,RUNX1
"Leukemia, acute myeloid, 601626 ",3,"WHSC1L1, NSD3",607083,8p11.23,WHSC1L1
"Leukemia, acute myeloid, reduced survival in, somatic, 601626 ",3,FLT3,136351,13q12.2,FLT3
"Leukemia, acute myeloid, somatic, 601626 ",3,"CEBPA, CEBP",116897,19q13.11,CEBPA
"Leukemia, acute myeloid, somatic, 601626 ",3,"ETV6, TEL, THC5",600618,12p13.2,ETV6
"Leukemia, acute myeloid, somatic, 601626 ",3,FLT3,136351,13q12.2,FLT3
"Leukemia, acute myeloid, somatic, 601626 ",3,"JAK2, THCYT3",147796,9p24.1,JAK2
"Leukemia, acute myeloid, somatic, 601626 ",3,NPM1,164040,5q35.1,NPM1
"Leukemia, acute myeloid, somatic, 601626 ",3,"NUP214, D9S46E, CAN, CAIN",114350,9q34.13,NUP214
"Leukemia, acute myeloid, somatic, 601626 ",3,"PICALM, CALM, CLTH, LAP",603025,11q14.2,PICALM
"Leukemia, acute promyelocytic, somatic, 102578 ",3,STAT5B,604260,17q21.2,STAT5B
"Leukemia, acute promyelocytic, somatic, 612376 ",3,NUMA1,164009,11q13.4,NUMA1
"Leukemia, chronic myeloid, somatic, 608232 ",3,"BCR, CML, PHL, ALL",151410,22q11.23,BCR
"Leukemia, juvenile myelomonocytic, 607785 ",3,"NF1, VRNF, WSS, NFNS",613113,17q11.2,NF1
"Leukemia, juvenile myelomonocytic, somatic, 607785 ",3,"ARHGAP26, GRAF",605370,5q31.3,ARHGAP26
"Leukemia, juvenile myelomonocytic, somatic, 607785 ",3,"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS",176876,12q24.13,PTPN11
"Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 ",3,"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",305371,Xp11.23,GATA1
"Leukemia/lymphoma, B-cell, 2 ",3,BCL2,151430,18q21.33,BCL2
"Leukocyte adhesion deficiency, 116920 ",3,"ITGB2, CD18, LCAMB, LAD",600065,21q22.3,ITGB2
"Leukocyte adhesion deficiency, type III, 612840 ",3,"KIND3, URP2, MIG2B, FERMT3",607901,11q13.1,KIND3
"Leukodystrophy, adult-onset, autosomal dominant, 169500 ",3,"LMNB1, ADLD",150340,5q23.2,LMNB1
"Leukodystrophy, hypomyelinating, 2, 608804 ",3,"GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C",608803,1q42.13,GJC2
"Leukodystrophy, hypomyelinating, 4, 612233 ",3,"HSPD1, SPG13, HSP60, HLD4",118190,2q33.1,HSPD1
"Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 ",3,"POLR3A, RPC1, RPC155, ADDH, HLD7",614258,10q22.3,POLR3A
"Leukodystrophy, hypomyelinating, 9, 616140 ",3,"RARS, HLD9",107820,5q34,RARS
"Leukoencephalopathy with ataxia, 615651 ",3,"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",600570,3q27.1,CLCN2
"Leukoencephalopathy with dystonia and motor neuropathy, 613724 ",3,SCP2,184755,1p32.3,SCP2
"Leukoencephalopathy with vanishing white matter, 603896 ",3,"EIF2B1, EIF2BA",606686,12q24.31,EIF2B1
"Leukoencephalopathy with vanishing white matter, 603896 ",3,EIF2B2,606454,14q24.3,EIF2B2
"Leukoencephalopathy with vanishing white matter, 603896 ",3,EIF2B3,606273,1p34.1,EIF2B3
"Leukoencephalopathy with vanishing white matter, 603896 ",3,"EIF2B5, LVWM, CACH, CLE",603945,3q27.1,EIF2B5
"Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 ",3,"CSF1R, FMS, HDLS",164770,5q32,CSF1R
"Leukoencephaly with vanishing white matter, 603896 ",3,EIF2B4,606687,2p23.3,EIF2B4
"Lhermitte-Duclos syndrome, 158350 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Li-Fraumeni syndrome, 151623 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Liddle syndrome, 177200 ",3,"SCNN1B, BESC1",600760,16p12.2,SCNN1B
"Liddle syndrome, 177200 ",3,"SCNN1G, PHA1, BESC3",600761,16p12.2,SCNN1G
"Limb-mammary syndrome, 603543 ",3,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",603273,3q28,TP63
"Linear skin defects with multiple congenital anomalies 1, 309801 ",3,"HCCS, MCOPS7, LSDMCA1",300056,Xp22.2,HCCS
"Lipodystrophy, congenital generalized, type 1, 608594 ",3,"AGPAT2, LPAAB, BSCL, BSCL1",603100,9q34.3,AGPAT2
"Lipodystrophy, congenital generalized, type 2, 269700 ",3,"BSCL2, SPG17, HMN5, PELD",606158,11q12.3,BSCL2
"Lipodystrophy, familial partial, type 2, 151660 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Lipodystrophy, familial partial, type 3, 604367 ",3,"PPARG, PPARG1, PPARG2, CIMT1, GLM1",601487,3p25.2,PPARG
"Lipodystrophy, familial partial, type 4, 613877 ",3,"PLIN1, PLIN, FPLD4",170290,15q26.1,PLIN1
"Lipodystrophy, familial partial, type 6, 615980 ",3,"LIPE, LHS, FPLD6",151750,19q13.2,LIPE
"Lipoprotein glomerulopathy, 611771 ",3,"APOE, AD2, LPG, LDLCQ5",107741,19q13.32,APOE
"Lipoprotein lipase deficiency, 238600 ",3,"LPL, LIPD, HDLCQ11",609708,8p21.3,LPL
"Lissencephaly 1, 607432 ",3,"PAFAH1B1, LIS1",601545,17p13.3,PAFAH1B1
"Lissencephaly 5, 615191 ",3,"LAMB1, LIS5",150240,7q31.1,LAMB1
"Lissencephaly, X-linked 2, 300215 ",3,"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32",300382,Xp21.3,ARX
"Lissencephaly, X-linked, 300067 ",3,"DCX, DBCN, LISX",300121,Xq23,DCX
"Loeys-Dietz syndrome 1, 609192 ",3,"TGFBR1, ALK5, AAT5, LDS1, MSSE",190181,9q22.33,TGFBR1
"Loeys-Dietz syndrome 2, 610168 ",3,"TGFBR2, HNPCC6, AAT3, MFS2, LDS2",190182,3p24.1,TGFBR2
"Loeys-Dietz syndrome 4, 614816 ",3,"TGFB2, LDS4",190220,1q41,TGFB2
"Loeys-Dietz syndrome 5, 615582 ",3,"TGFB3, ARVD1, RNHF, LDS5",190230,14q24.3,TGFB3
"Long QT syndrome 1, 192500 ",3,"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2",607542,11p15.5-p15.4,KCNQ1
"Long QT syndrome 12, 612955 ",3,"SNTA1, SNT1, TACIP1, LQT12",601017,20q11.21,SNTA1
"Long QT syndrome 14, 616247 ",3,"CALM1, PHKD, CPVT4, LQT14",114180,14q32.11,CALM1
"Long QT syndrome 2, 613688 ",3,"KCNH2, LQT2, HERG, SQT1",152427,7q36.1,KCNH2
"Long QT syndrome 4, 600919 ",3,"ANK2, LQT4",106410,4q25-q26,ANK2
"Long QT syndrome 5, 613695 ",3,"KCNE1, JLNS, LQT5, JLNS2",176261,21q22.12,KCNE1
"Long QT syndrome 6, 613693 ",3,"KCNE2, MIRP1, LQT6, ATFB4",603796,21q22.11,KCNE2
"Long QT syndrome 9, 611818 ",3,"CAV3, LGMD1C, LQT9",601253,3p25.3,CAV3
"Long QT syndrome-3, 603830 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Lowe syndrome, 309000 ",3,"OCRL, LOCR, OCRL1, NPHL2",300535,Xq26.1,OCRL
"Lujan-Fryns syndrome, 309520 ",3,"MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX",300188,Xq13.1,MED12
"Lung cancer, 211980 ",3,PPP2R1B,603113,11q23.1,PPP2R1B
"Lung cancer, somatic, 211980 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Lung cancer, somatic, 211980 ",3,"MAP3K8, COT, EST, TPL2",191195,10p11.23,MAP3K8
"Lung cancer, somatic, 211980 ",3,"SLC22A1L, BWSCR1A, IMPT1",602631,11p15.4,SLC22A1L
"Lymphangioleiomyomatosis, 606690 ",3,"TSC1, LAM",605284,9q34.13,TSC1
"Lymphangioleiomyomatosis, somatic, 606690 ",3,"TSC2, LAM",191092,16p13.3,TSC2
"Lymphedema, hereditary, IA, 153100 ",3,"FLT4, VEGFR3, PCL, LMPH1A",136352,5q35.3,FLT4
"Lymphedema, hereditary, IC, 613480 ",3,"GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C",608803,1q42.13,GJC2
"Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 ",3,"FOXC2, FKHL14, MFH1",602402,16q24.1,FOXC2
"Lymphedema-distichiasis syndrome, 153400 ",3,"FOXC2, FKHL14, MFH1",602402,16q24.1,FOXC2
"Lymphoma, non-Hodgkin, 605027 ",3,"PRF1, HPLH2, FLH2",170280,10q22.1,PRF1
"Lymphoma, non-Hodgkin, somatic, 605027 ",3,"CASP10, MCH4, ALPS2",601762,2q33.1,CASP10
"Lymphoma, non-Hodgkin, somatic, 605027 ",3,RAD54B,604289,8q22.1,RAD54B
"Lymphoma, non-Hodgkin, somatic, 605027 ",3,"RAD54L, HR54, HRAD54",603615,1p34.1,RAD54L
"Lymphoproliferative syndrome 1, 613011 ",3,"ITK, EMT, LPFS1",186973,5q33.3,ITK
"Lymphoproliferative syndrome, X-linked, 1, 308240 ",3,"SH2D1A, LYP, IMD5, XLP, XLPD1",300490,Xq25,SH2D1A
"Lymphoproliferative syndrome, X-linked, 2, 300635 ",3,"XIAP, BIRC4, API3, XLP2",300079,Xq25,XIAP
"Lysinuric protein intolerance, 222700 ",3,"SLC7A7, LPI",603593,14q11.2,SLC7A7
"MASA syndrome, 303350 ",3,"L1CAM, CAML1, HSAS1, MASA, SPG1",308840,Xq28,L1CAM
"MASS syndrome, 604308 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"MHC class II deficiency, complementation group B, 209920 ",3,RFXANK,603200,19p13.11,RFXANK
"MIRAGE syndrome, 617053 ",3,"SAMD9, NFTC, MIRAGE",610456,7q21.2,SAMD9
"MODY, type I, 125850 ",3,"HNF4A, TCF14, MODY1, FRTS4",600281,20q13.12,HNF4A
"MODY, type II, 125851 ",3,"GCK, HHF3",138079,7p13,GCK
"MODY, type III, 600496 ",3,"HNF1A, TCF1, MODY3, IDDM20",142410,12q24.31,HNF1A
"Machado-Joseph disease, 109150 ",3,"ATXN3, MJD, SCA3",607047,14q32.12,ATXN3
"Macrocephaly/autism syndrome, 605309 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 ",3,"RPS14, EMTB",130620,5q33.1,RPS14
"Macrothrombocytopenia and progressive sensorineural deafness, 600208 ",3,"MYH9, MHA, FTNS, DFNA17, BDPLT6",160775,22q12.3,MYH9
"Macular degeneration, X-linked atrophic, 300834 ",3,"RPGR, RP3, CRD, RP15, COD1, CORDX1",312610,Xp11.4,RPGR
"Macular degeneration, age-related, 3, 608895 ",3,"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",604580,14q32.12,FBLN5
"Macular degeneration, juvenile, 248200 ",3,"CNGB3, ACHM3, ACHM1",605080,8q21.3,CNGB3
"Macular dystrophy, patterned, 1, 169150 ",3,"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1",179605,6p21.1,PRPH2
"Macular dystrophy, patterned, 2, 608970 ",3,"CTNNA1, MDPT2",116805,5q31.2,CTNNA1
"Macular dystrophy, retinal, 2, 608051 ",3,"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",604365,4p15.32,PROM1
"Macular dystrophy, vitelliform, 2, 153700 ",3,"BEST1, VMD2, ARB, RP50",607854,11q12.3,BEST1
"Macular dystrophy, vitelliform, 3, 608161 ",3,"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1",179605,6p21.1,PRPH2
"Malignant melanoma, somatic, 155600 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Malouf syndrome, 212112 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 ",3,"POLD1, CRCS10, MDPL",174761,19q13.33,POLD1
"Mandibuloacral dysplasia with type B lipodystrophy, 608612 ",3,"ZMPSTE24, FACE1, STE24, MADB",606480,1p34.2,ZMPSTE24
"Mandibuloacral dysplasia, 248370 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Mandibulofacial dysostosis with alopecia, 616367 ",3,"EDNRA, MFDA",131243,4q31.22-q31.23,EDNRA
"Mannosidosis, alpha-, types I and II, 248500 ",3,"MAN2B1, MANB",609458,19p13.13,MAN2B1
"Mannosidosis, beta, 248510 ",3,"MANBA, MANB1",609489,4q24,MANBA
"Maple syrup urine disease, type II, 248600 ",3,"DBT, BCATE2",248610,1p21.2,DBT
"Maple syrup urine disease, type Ia, 248600 ",3,"BCKDHA, MSUD1",608348,19q13.2,BCKDHA
"Maple syrup urine disease, type Ib, 248600 ",3,"BCKDHB, E1B",248611,6q14.1,BCKDHB
"Marfan lipodystrophy syndrome, 616914 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"Marfan syndrome, 154700 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"Marinesco-Sjogren syndrome, 248800 ",3,"SIL1, BAP, MSS",608005,5q31.2,SIL1
"Marshall syndrome, 154780 ",3,"COL11A1, STL2",120280,1p21.1,COL11A1
"Marshall-Smith syndrome, 602535 ",3,"NFIX, NF1A, SOTOS2, MRSHSS",164005,19p13.13,NFIX
"Mast cell disease, 154800 ",3,"KIT, PBT",164920,4q12,KIT
"Mast syndrome, 248900 ",3,"ACP33, MAST, SPG21",608181,15q22.31,ACP33
"Maturity-onset diabetes of the young 6, 606394 ",3,"NEUROD1, NIDDM",601724,2q31.3,NEUROD1
"Maturity-onset diabetes of the young, type 10, 613370 ",3,"INS, MODY10, IDDM2",176730,11p15.5,INS
"Maturity-onset diabetes of the young, type 13, 616329 ",3,"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13",600937,11p15.1,KCNJ11
"Maturity-onset diabetes of the young, type IX, 612225 ",3,"PAX4, MODY9, KPD",167413,7q32.1,PAX4
"Maturity-onset diabetes of the young, type VIII, 609812 ",3,"CEL, BSSL, CELL, MODY8",114840,9q34.13,CEL
"May-Hegglin anomaly, 155100 ",3,"MYH9, MHA, FTNS, DFNA17, BDPLT6",160775,22q12.3,MYH9
"McArdle disease, 232600 ",3,PYGM,608455,11q13.1,PYGM
"McKusick-Kaufman syndrome, 236700 ",3,"MKKS, HMCS, KMS, MKS, BBS6",604896,20p12.2,MKKS
"McLeod syndrome with or without chronic granulomatous disease, 300842 ",3,"XK, MCLDS",314850,Xp21.1,XK
"Meacham syndrome, 608978 ",3,"WT1, NPHS4",607102,11p13,WT1
"Meckel syndrome 1, 249000 ",3,"MKS1, MKS, BBS13, JBTS28",609883,17q22,MKS1
"Meckel syndrome 2, 603194 ",3,"TMEM216, JBTS2, CORS2, MKS2",613277,11q12.2,TMEM216
"Meckel syndrome 3, 607361 ",3,"TMEM67, MKS3, JBTS6, NPHP11",609884,8q22.1,TMEM67
"Meckel syndrome 4, 611134 ",3,"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14",610142,12q21.32,CEP290
"Meckel syndrome 5, 611561 ",3,"RPGRIP1L, KIAA1005, JBTS7, MKS5",610937,16q12.2,RPGRIP1L
"Meckel syndrome 6, 612284 ",3,"CC2D2A, KIAA1345, MKS6",612013,4p15.32,CC2D2A
"Meckel syndrome 7, 267010 ",3,"NPHP3, NPH3, RHPD1, MKS7",608002,3q22.1,NPHP3
"Medullary cystic kidney disease 1, 174000 ",3,"MUC1, PUM, MCKD1",158340,1q22,MUC1
"Medullary cystic kidney disease 2, 603860 ",3,"UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2",191845,16p12.3,UMOD
"Medullary thyroid carcinoma, 155240 ",3,"RET, MEN2A, HSCR1",164761,10q11.21,RET
"Medullary thyroid carcinoma, familial, 155240 ",3,"NTRK1, TRKA, MTC",191315,1q23.1,NTRK1
"Medulloblastoma, 155255 ",3,PTCH2,603673,1p34.1,PTCH2
"Medulloblastoma, desmoplastic, 155255 ",3,"SUFU, SUFUXL, SUFUH",607035,10q24.32,SUFU
"Meesmann corneal dystrophy, 122100 ",3,KRT12,601687,17q21.2,KRT12
"Meesmann corneal dystrophy, 122100 ",3,KRT3,148043,12q13.13,KRT3
"Megalencephalic leukoencephalopathy with subcortical cysts, 604004 ",3,"MLC1, LVM, VL",605908,22q13.33,MLC1
"Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 ",3,"CCND2, MPPH3",123833,12p13.32,CCND2
"Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 ",3,DHFR,126060,5q14.1,DHFR
"Megaloblastic anemia-1, Finnish type, 261100 ",3,"CUBN, IFCR, MGA1",602997,10p13,CUBN
"Megaloblastic anemia-1, Norwegian type, 261100 ",3,AMN,605799,14q32.32,AMN
"Meier-Gorlin syndrome 4, 613804 ",3,CDT1,605525,16q24.3,CDT1
"Meier-Gorlin syndrome 7, 617063 ",3,"CDC45L, CDC45L2, MGORS7",603465,22q11.21,CDC45L
"Melanocytic nevus syndrome, congenital, somatic, 137550 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Melanoma and neural system tumor syndrome, 155755 ",3,"CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21.3,CDKN2A
"Meleda disease, 248300 ",3,"SLURP1, MDM",606119,8q24.3,SLURP1
"Melnick-Needles syndrome, 309350 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Melorheostosis with osteopoikilosis, 155950 ",3,"LEMD3, MAN1",607844,12q14.3,LEMD3
"Meningioma, 607174 ",3,"MN1, MGCR",156100,22q12.1,MN1
"Meningioma, NF2-related, somatic, 607174 ",3,NF2,607379,22q12.2,NF2
"Meningioma, SIS-related, 607174 ",3,"PDGFB, SIS, IBGC5",190040,22q13.1,PDGFB
"Menkes disease, 309400 ",3,"ATP7A, MNK, MK, OHS, SMAX3",300011,Xq21.1,ATP7A
"Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 ",3,"CASK, MICPCH, FGS4, CMG, MRXSNA",300172,Xp11.4,CASK
"Mental retardation syndrome, X-linked, Siderius type, 300263 ",3,"PHF8, ZNF422, KIAA1111, MRXSSD",300560,Xp11.22,PHF8
"Mental retardation, X-linked 103, 300982 ",3,"KLHL15, KIAA1677",300980,Xp22.11,KLHL15
"Mental retardation, X-linked 19, 300844 ",3,"RPS6KA3, RSK2, MRX19",300075,Xp22.12,RPS6KA3
"Mental retardation, X-linked 21/34, 300143 ",3,"IL1RAPL1, IL1R8, MRX21, MRX34",300206,Xp21.3-p21.2,IL1RAPL1
"Mental retardation, X-linked 29 and others, 300419 ",3,"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32",300382,Xp21.3,ARX
"Mental retardation, X-linked 30/47, 300558 ",3,"PAK3, MRX30, MRX47",300142,Xq23,PAK3
"Mental retardation, X-linked 45, 300498 ",3,"ZNF81, MRX45",314998,Xp11.23,ZNF81
"Mental retardation, X-linked 46, 300436 ",3,"ARHGEF6, MRX46, COOL2",300267,Xq26.3,ARHGEF6
"Mental retardation, X-linked 58, 300210 ",3,"TSPAN7, TM4SF2, MXS1, A15, MRX58",300096,Xp11.4,TSPAN7
"Mental retardation, X-linked 63, 300387 ",3,"ACSL4, FACL4, ACS4, MRX63",300157,Xq23,ACSL4
"Mental retardation, X-linked 72, 300271 ",3,"RAB39B, MRX72, WSMN",300774,Xq28,RAB39B
"Mental retardation, X-linked 9/44, 309549 ",3,"FTSJ1, JM23, SPB1, MRX44, MRX9",300499,Xp11.23,FTSJ1
"Mental retardation, X-linked 94, 300699 ",3,"GRIA3, GLUR3, MRX94",305915,Xq25,GRIA3
"Mental retardation, X-linked syndromic 16, 305400 ",3,"FGD1, FGDY, AAS, MRXS16",300546,Xp11.22,FGD1
"Mental retardation, X-linked syndromic 5, 304340 ",3,"AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS",300629,Xp22.2,AP1S2
"Mental retardation, X-linked syndromic, Christianson type, 300243 ",3,"SLC9A6, NHE6",300231,Xq26.3,SLC9A6
"Mental retardation, X-linked syndromic, Lubs type, 300260 ",3,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16",300005,Xq28,MECP2
"Mental retardation, X-linked syndromic, Raymond type, 300799 ",3,"ZDHHC9, DHHC9, MRXSZ",300646,Xq26.1,ZDHHC9
"Mental retardation, X-linked, Snyder-Robinson type, 309583 ",3,"SMS, SRS, MRSR",300105,Xp22.11,SMS
"Mental retardation, X-linked, syndromic 13, 300055 ",3,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16",300005,Xq28,MECP2
"Mental retardation, X-linked, syndromic 33, 300966 ",3,"TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33",313650,Xq13.1,TAF1
"Mental retardation, X-linked, syndromic 34, 300967 ",3,"NONO, NRB54, MRXS34",300084,Xq13.1,NONO
"Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 ",3,"KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ",314690,Xp11.22,KDM5C
"Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 ",3,"SOX3, MRGH",313430,Xq27.1,SOX3
"Mental retardation, autosomal dominant 10, 614256 ",3,"CACNG2, MRD10",602911,22q12.3,CACNG2
"Mental retardation, autosomal dominant 13, 614563 ",3,"DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1",600112,14q32.31,DYNC1H1
"Mental retardation, autosomal dominant 19, 615075 ",3,"CTNNB1, MRD19",116806,3p22.1,CTNNB1
"Mental retardation, autosomal dominant 29, 616078 ",3,"SETBP1, KIAA0437, SEB, MRD29",611060,18q12.3,SETBP1
"Mental retardation, autosomal dominant 32, 616268 ",3,"KAT6A, MYST3, MOZ, ZNF220, MRD32",601408,8p11.21,KAT6A
"Mental retardation, autosomal dominant 42, 616973 ",3,"GNB1, MRD42",139380,1p36.33,GNB1
"Mental retardation, autosomal dominant 5, 612621 ",3,"SYNGAP1, MRD5",603384,6p21.32,SYNGAP1
"Mental retardation, autosomal dominant 7, 614104 ",3,"DYRK1A, MNBH, MNB, MRD7",600855,21q22.13,DYRK1A
"Mental retardation, autosomal dominant 8, 614254 ",3,"GRIN1, NMDAR1, MRD8",138249,9q34.3,GRIN1
"Mental retardation, autosomal recessive 2, 607417 ",3,"CRBN, MRT2",609262,3p26.2,CRBN
"Mental retardation, autosomal recessive 38, 615516 ",3,"HERC2, SHEP1, MRT38",605837,15q13.1,HERC2
"Mental retardation, autosomal recessive 46, 616116 ",3,"NDST1, HSST, MRT46",600853,5q33.1,NDST1
"Mental retardation, autosomal recessive 7, 611093 ",3,"TUSC3, M33, D8S1992, MRT7, MRT22",601385,8p22,TUSC3
"Mental retardation, autosomal recessive, 6, 611092 ",3,"GRIK2, GLUR6, MRT6",138244,6q16.3,GRIK2
"Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 ",3,"MEF2C, C5DELq14.3, DEL5q14.3",600662,5q14.3,MEF2C
"Mental retardation, with or without nystagmus, 300422 ",3,"CASK, MICPCH, FGS4, CMG, MRXSNA",300172,Xp11.4,CASK
"Mental retardation-hypotonic facies syndrome, X-linked, 309580 ",3,"ATRX, XH2, XNP, SHS, SFM1, MRXHF1",300032,Xq21.1,ATRX
"Mephenytoin poor metabolizer, 609535 ",3,"CYP2C, CYP2C19",124020,10q23.33,CYP2C
"Mesothelioma, somatic, 156240 ",3,"WT1, NPHS4",607102,11p13,WT1
"Metachondromatosis, 156250 ",3,"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS",176876,12q24.13,PTPN11
"Metachromatic leukodystrophy due to SAP-b deficiency, 249900 ",3,"PSAP, SAP1",176801,10q22.1,PSAP
"Metachromatic leukodystrophy, 250100 ",3,ARSA,607574,22q13.33,ARSA
"Metaphyseal anadysplasia 1, 602111 ",3,"MMP13, CLG3, MANDP1, MDST",600108,11q22.2,MMP13
"Metaphyseal anadysplasia 2, 613073 ",3,"MMP9, CLG4B, MANDP2",120361,20q13.12,MMP9
"Metaphyseal chondrodysplasia, Murk Jansen type, 156400 ",3,"PTHR1, PTHR, PFE",168468,3p21.31,PTHR1
"Metaphyseal chondrodysplasia, Schmid type, 156500 ",3,COL10A1,120110,6q22.1,COL10A1
"Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 ",3,"RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD",600211,6p21.1,RUNX2
"Metaphyseal dysplasia without hypotrichosis, 250460 ",3,"RMRP, RMRPR, CHH",157660,9p13.3,RMRP
"Metaphyseal dysplasia, Spahr type, 250400 ",3,"MMP13, CLG3, MANDP1, MDST",600108,11q22.2,MMP13
"Metatropic dysplasia, 156530 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Methemoglobinemia, type I, 250800 ",3,"CYB5R3, DIA1, B5R",613213,22q13.2,CYB5R3
"Methemoglobinemia, type II, 250800 ",3,"CYB5R3, DIA1, B5R",613213,22q13.2,CYB5R3
"Methylmalonic aciduria and homocystinuria, cblC type, 277400 ",3,MMACHC,609831,1p34.1,MMACHC
"Methylmalonic aciduria and homocystinuria, cblJ type, 614857 ",3,"ABCD4, PXMP1L, P79R, PMP69, MAHCJ",603214,14q24.3,ABCD4
"Mevalonic aciduria, 610377 ",3,"MVK, MVLK, POROK3",251170,12q24.11,MVK
"Microcephalic osteodysplastic primordial dwarfism, type II, 210720 ",3,"PCNT, PCNT2, KEN, SCKL4, MOPD2",605925,21q22.3,PCNT
"Microcephaly 1, primary, autosomal recessive, 251200 ",3,MCPH1,607117,8p23.1,MCPH1
"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 ",3,"WDR62, C19orf14, MCPH2",613583,19q13.12,WDR62
"Microcephaly 3, primary, autosomal recessive, 604804 ",3,"CDK5RAP2, KIAA1633, MCPH3",608201,9q33.2,CDK5RAP2
"Microcephaly 4, primary, autosomal recessive, 604321 ",3,"CASC5, AF15Q14, KIAA1570, D40, MCPH4",609173,15q15.1,CASC5
"Microcephaly 5, primary, autosomal recessive, 608716 ",3,"ASPM, MCPH5",605481,1q31.3,ASPM
"Microcephaly 6, primary, autosomal recessive, 608393 ",3,"CENPJ, CPAP, MCPH6, SCKL4",609279,13q12.12-q12.13,CENPJ
"Microcephaly 7, primary, autosomal recessive, 612703 ",3,"STIL, SIL, MCPH7",181590,1p33,STIL
"Microcephaly, Amish type, 607196 ",3,"SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4",606521,17q25.1,SLC25A19
"Microcephaly, seizures, and developmental delay, 613402 ",3,"PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4",605610,19q13.33,PNKP
"Microcephaly-capillary malformation syndrome, 614261 ",3,"STAMBP, AMSH, MICCAP",606247,2p13.1,STAMBP
"Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 ",3,"BEST1, VMD2, ARB, RP50",607854,11q12.3,BEST1
"Microphthalmia with coloboma 3, 610092 ",3,"CHX10, HOX10, MCOP2, MCOPCB3",142993,14q24.3,CHX10
"Microphthalmia with coloboma 5, 611638 ",3,"SHH, HPE3, HLP3, SMMCI, MCOPCB5",600725,7q36.3,SHH
"Microphthalmia, isolated 2, 610093 ",3,"CHX10, HOX10, MCOP2, MCOPCB3",142993,14q24.3,CHX10
"Microphthalmia, isolated 3, 611038 ",3,"RAX, RX, MCOP3",601881,18q21.32,RAX
"Microphthalmia, isolated, with coloboma 10, 616428 ",3,"RBP4, RDCCAS, MCOPCB10",180250,10q23.33,RBP4
"Microphthalmia, syndromic 12, 615524 ",3,"RARB, HAP, MCOPS12",180220,3p24.2,RARB
"Microphthalmia, syndromic 2, 300166 ",3,"BCOR, KIAA1575, MCOPS2, MAA2, ANOP2",300485,Xp11.4,BCOR
"Microphthalmia, syndromic 3, 206900 ",3,"SOX2, MCOPS3",184429,3q26.33,SOX2
"Microphthalmia, syndromic 5, 610125 ",3,"OTX2, MCOPS5, CPHD6",600037,14q22.3,OTX2
"Microphthalmia, syndromic 6, 607932 ",3,"BMP4, BMP2B1, BMP2B, MCOPS6, OFC11",112262,14q22.2,BMP4
"Microvillus inclusion disease, 251850 ",3,"MYO5B, KIAA1119",606540,18q21.1,MYO5B
"Migraine, familial basilar, 602481 ",3,"ATP1A2, FHM2, MHP2",182340,1q23.2,ATP1A2
"Migraine, familial hemiplegic, 1, 141500 ",3,"CACNA1A, CACNL1A4, SCA6, EIEE42",601011,19p13.13,CACNA1A
"Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 ",3,"CACNA1A, CACNL1A4, SCA6, EIEE42",601011,19p13.13,CACNA1A
"Migraine, familial hemiplegic, 2, 602481 ",3,"ATP1A2, FHM2, MHP2",182340,1q23.2,ATP1A2
"Migraine, familial hemiplegic, 3, 609634 ",3,"SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3",182389,2q24.3,SCN1A
"Minicore myopathy with external ophthalmoplegia, 255320 ",3,"RYR1, MHS, CCO",180901,19q13.2,RYR1
"Mirror movements 1, 157600 ",3,"DCC, MRMV1",120470,18q21.2,DCC
"Mirror movements 2, 614508 ",3,"RAD51A, RECA, MRMV2",179617,15q15.1,RAD51A
"Mismatch repair cancer syndrome, 276300 ",3,"MLH1, COCA2, HNPCC2",120436,3p22.2,MLH1
"Mismatch repair cancer syndrome, 276300 ",3,"MSH2, COCA1, FCC1, HNPCC1",609309,2p21-p16,MSH2
"Mismatch repair cancer syndrome, 276300 ",3,"MSH6, GTBP, HNPCC5",600678,2p16.3,MSH6
"Mismatch repair cancer syndrome, 276300 ",3,"PMS2, PMSL2, HNPCC4",600259,7p22.1,PMS2
"Mitochondrial complex 1 deficiency, 252010 ",3,"NDUFAF5, C20orf7",612360,20p12.1,NDUFAF5
"Mitochondrial complex I deficiency due to ACAD9 deficiency, 611126 ",3,ACAD9,611103,3q21.3,ACAD9
"Mitochondrial complex I deficiency, 252010 ",3,FOXRED1,613622,11q24.2,FOXRED1
"Mitochondrial complex I deficiency, 252010 ",3,"NDUFA1, MWFE",300078,Xq24,NDUFA1
"Mitochondrial complex I deficiency, 252010 ",3,NDUFA11,612638,19p13.3,NDUFA11
"Mitochondrial complex I deficiency, 252010 ",3,"NDUFAF1, CIA30, CGI65",606934,15q15.1,NDUFAF1
"Mitochondrial complex I deficiency, 252010 ",3,"NDUFAF2, NDUFA12L, MMTN, B17.2L",609653,5q12.1,NDUFAF2
"Mitochondrial complex I deficiency, 252010 ",3,NDUFAF3,612911,3p21.31,NDUFAF3
"Mitochondrial complex I deficiency, 252010 ",3,"NDUFAF4, HRPAP20, C6orf66",611776,6q16.1,NDUFAF4
"Mitochondrial complex I deficiency, 252010 ",3,NDUFB3,603839,2q33.1,NDUFB3
"Mitochondrial complex I deficiency, 252010 ",3,NDUFS1,157655,2q33.3,NDUFS1
"Mitochondrial complex I deficiency, 252010 ",3,NDUFS2,602985,1q23.3,NDUFS2
"Mitochondrial complex I deficiency, 252010 ",3,NDUFS3,603846,11p11.2,NDUFS3
"Mitochondrial complex I deficiency, 252010 ",3,"NDUFS4, AQDQ",602694,5q11.2,NDUFS4
"Mitochondrial complex I deficiency, 252010 ",3,NDUFS6,603848,5p15.33,NDUFS6
"Mitochondrial complex I deficiency, 252010 ",3,"NDUFV1, UQOR1",161015,11q13.2,NDUFV1
"Mitochondrial complex I deficiency, 252010 ",3,NDUFV2,600532,18p11.22,NDUFV2
"Mitochondrial complex I deficiency, 252010 ",3,"NUBPL, IND1",613621,14q12,NUBPL
"Mitochondrial complex I deficiency, 252010 ",3,TMEM126B,615533,11q14.1,TMEM126B
"Mitochondrial complex II deficiency, 252011 ",3,SDHAF1,612848,19q13.12,SDHAF1
"Mitochondrial complex II deficiency, 252011 ",3,"SDHD, PGL1, CWS3",602690,11q23.1,SDHD
"Mitochondrial complex III deficiency, nuclear type 1, 124000 ",3,"BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1",603647,2q35,BCS1L
"Mitochondrial complex III deficiency, nuclear type 6, 615453 ",3,"CYC1, MC3DN6",123980,8q24.3,CYC1
"Mitochondrial complex IV deficiency, 220110 ",3,"APOPT1, APOP",616003,14q32.33,APOPT1
"Mitochondrial complex IV deficiency, 220110 ",3,COX10,602125,17p12,COX10
"Mitochondrial complex IV deficiency, 220110 ",3,"COX20, FAM36A",614698,1q44,COX20
"Mitochondrial complex IV deficiency, 220110 ",3,COX6B1,124089,19q13.12,COX6B1
"Mitochondrial complex IV deficiency, 220110 ",3,"PET100, C19orf79",614770,19p13.2,PET100
"Mitochondrial complex IV deficiency, 220110 ",3,"SCO1, SCOD1",603644,17p13.1,SCO1
"Mitochondrial complex IV deficiency, 220110 ",3,"TACO1, CCDC44",612958,17q23.3,TACO1
"Mitochondrial phosphate carrier deficiency, 610773 ",3,"SLC25A3, PHC",600370,12q23.1,SLC25A3
"Mitochondrial respiratory chain complex II deficiency, 252011 ",3,"SDHA, SDH1, SDHF, CMD1GG, PGL5",600857,5p15.33,SDHA
"Miyoshi muscular dystrophy 1, 254130 ",3,"DYSF, LGMD2B, MMD1",603009,2p13.2,DYSF
"Miyoshi muscular dystrophy 3, 613319 ",3,"ANO5, TMEM16E, GDD1, LGMD2L",608662,11p14.3,ANO5
"Mohr-Tranebjaerg syndrome, 304700 ",3,"TIMM8A, DFN1, DDP, MTS, DDP1",300356,Xq22.1,TIMM8A
"Molybdenum cofactor deficiency A, 252150 ",3,"MOCS1, MOCODA",603707,6p21.2,MOCS1
"Molybdenum cofactor deficiency C, 615501 ",3,"GPHN, GPH, KIAA1385, GEPH, MOCODC",603930,14q23.3-q24.1,GPHN
"Monilethrix, 158000 ",3,"KRT81, KRTHB1, HB1",602153,12q13.13,KRT81
"Monilethrix, 158000 ",3,"KRT86, KRTHB6, HB6",601928,12q13.13,KRT86
"Mosaic variegated aneuploidy syndrome 1, 257300 ",3,"BUB1B, BUBR1, MVA1",602860,15q15.1,BUB1B
"Mowat-Wilson syndrome, 235730 ",3,"ZEB2, ZFHX1B, SMADIP1, SIP1",605802,2q22.3,ZEB2
"Moyamoya disease 5, 614042 ",3,"ACTA2, ACTSA, AAT6, MYMY5",102620,10q23.31,ACTA2
"Muckle-Wells syndrome, 191900 ",3,"NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1",606416,1q44,NLRP3
"Mucolipidosis II alpha/beta, 252500 ",3,"GNPTAB, GNPTA",607840,12q23.2,GNPTAB
"Mucolipidosis III alpha/beta, 252600 ",3,"GNPTAB, GNPTA",607840,12q23.2,GNPTAB
"Mucolipidosis III gamma, 252605 ",3,GNPTAG,607838,16p13.3,GNPTAG
"Mucolipidosis IV, 252650 ",3,"MCOLN1, ML4",605248,19p13.2,MCOLN1
"Mucopolysaccharidosis II, 309900 ",3,"IDS, MPS2, SIDS",300823,Xq28,IDS
"Mucopolysaccharidosis IVA, 253000 ",3,"GALNS, MPS4A",612222,16q24.3,GALNS
"Mucopolysaccharidosis VII, 253220 ",3,"GUSB, MPS7",611499,7q11.21,GUSB
"Muenke syndrome, 602849 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Muir-Torre syndrome, 158320 ",3,"MLH1, COCA2, HNPCC2",120436,3p22.2,MLH1
"Muir-Torre syndrome, 158320 ",3,"MSH2, COCA1, FCC1, HNPCC1",609309,2p21-p16,MSH2
"Mulibrey nanism, 253250 ",3,"TRIM37, MUL, KIAA0898",605073,17q22,TRIM37
"Multicentric osteolysis, nodulosis, and arthropathy, 259600 ",3,"MMP2, CLG4A, MONA",120360,16q12.2,MMP2
"Multiple endocrine neoplasia 1, 131100 ",3,MEN1,613733,11q13.1,MEN1
"Multiple endocrine neoplasia IIA, 171400 ",3,"RET, MEN2A, HSCR1",164761,10q11.21,RET
"Multiple endocrine neoplasia IIB, 162300 ",3,"RET, MEN2A, HSCR1",164761,10q11.21,RET
"Multiple endocrine neoplasia, type IV, 610755 ",3,"CDKN1B, KIP1, CDKN4, MEN4",600778,12p13.1,CDKN1B
"Multiple pterygium syndrome, lethal type, 253290 ",3,"CHRNA1, ACHRD, CMS1B, CMS1A",100690,2q31.1,CHRNA1
"Multiple pterygium syndrome, lethal type, 253290 ",3,"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C",100720,2q37.1,CHRND
"Multiple pterygium syndrome, lethal type, 253290 ",3,"CHRNG, ACHRG",100730,2q37.1,CHRNG
"Multiple synostoses syndrome 1, 186500 ",3,"NOG, SYM1, SYNS1A",602991,17q22,NOG
"Multiple synostoses syndrome 2, 610017 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Multisystemic smooth muscle dysfunction syndrome, 613834 ",3,"ACTA2, ACTSA, AAT6, MYMY5",102620,10q23.31,ACTA2
"Muscle glycogenosis, 300559 ",3,PHKA1,311870,Xq13.1,PHKA1
"Muscular dystrophy, congenital merosin-deficient, 607855 ",3,"LAMA2, LAMM",156225,6q22.33,LAMA2
"Muscular dystrophy, congenital, 613205 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 ",3,"LAMA2, LAMM",156225,6q22.33,LAMA2
"Muscular dystrophy, limb-girdle, type 1A, 159000 ",3,"MYOT, TTOD, MFM3",604103,5q31.2,MYOT
"Muscular dystrophy, limb-girdle, type 1B, 159001 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Muscular dystrophy, limb-girdle, type 1F, 608423 ",3,"TNPO3, TRNSR, LGMD1F",610032,7q32.1,TNPO3
"Muscular dystrophy, limb-girdle, type 2A, 253600 ",3,"CAPN3, CANP3",114240,15q15.1,CAPN3
"Muscular dystrophy, limb-girdle, type 2B, 253601 ",3,"DYSF, LGMD2B, MMD1",603009,2p13.2,DYSF
"Muscular dystrophy, limb-girdle, type 2C, 253700 ",3,"SGCG, LGMD2C, DMDA1, SCG3",608896,13q12.12,SGCG
"Muscular dystrophy, limb-girdle, type 2D, 608099 ",3,"SGCA, ADL, DAG2, LGMD2D, DMDA2",600119,17q21.33,SGCA
"Muscular dystrophy, limb-girdle, type 2E, 604286 ",3,"SGCB, LGMD2E",600900,4q12,SGCB
"Muscular dystrophy, limb-girdle, type 2F, 601287 ",3,"SGCD, SGD, LGMD2F, CMD1L",601411,5q33.2-q33.3,SGCD
"Muscular dystrophy, limb-girdle, type 2G, 601954 ",3,"TCAP, LGMD2G, CMH25",604488,17q12,TCAP
"Muscular dystrophy, limb-girdle, type 2H, 254110 ",3,"TRIM32, HT2A, LGMD2H, BBS11",602290,9q33.1,TRIM32
"Muscular dystrophy, limb-girdle, type 2J, 608807 ",3,"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC",188840,2q31.2,TTN
"Muscular dystrophy, limb-girdle, type 2L, 611307 ",3,"ANO5, TMEM16E, GDD1, LGMD2L",608662,11p14.3,ANO5
"Muscular dystrophy, limb-girdle, type 2Q, 613723 ",3,"PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND",601282,8q24.3,PLEC1
"Muscular dystrophy, limb-girdle, type IC, 607801 ",3,"CAV3, LGMD1C, LQT9",601253,3p25.3,CAV3
"Muscular dystrophy, rigid spine, 1, 602771 ",3,"SELENON, SEPN1, SELN, RSMD1, CFTD",606210,1p36.11,SELENON
"Myasthenia, congenital, 12, with tubular aggregates, 610542 ",3,"GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1",138292,2p13.3,GFPT1
"Myasthenic syndrome, congenital, 10, 254300 ",3,"DOK7, C4orf25, CMS10",610285,4p16.3,DOK7
"Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 ",3,"DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13",191350,11q23.3,DPAGT1
"Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 ",3,"ALG2, CDGII, CMSTA3, CMS14",607905,9q22.33,ALG2
"Myasthenic syndrome, congenital, 16, 614198 ",3,"SCN4A, HYPP, NAC1A, HOKPP2, CMS16",603967,17q23.3,SCN4A
"Myasthenic syndrome, congenital, 19, 616720 ",3,"COL13A1, CMS19",120350,10q22.1,COL13A1
"Myasthenic syndrome, congenital, 1A, slow-channel, 601462 ",3,"CHRNA1, ACHRD, CMS1B, CMS1A",100690,2q31.1,CHRNA1
"Myasthenic syndrome, congenital, 1B, fast-channel, 608930 ",3,"CHRNA1, ACHRD, CMS1B, CMS1A",100690,2q31.1,CHRNA1
"Myasthenic syndrome, congenital, 2A, slow-channel, 616313 ",3,"CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C",100710,17p13.1,CHRNB1
"Myasthenic syndrome, congenital, 3B, fast-channel, 616322 ",3,"CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C",100720,2q37.1,CHRND
"Myasthenic syndrome, congenital, 4A, slow-channel, 605809 ",3,"CHRNE, SCCMS, CMS4A, CMS4B, CMS4C",100725,17p13.2,CHRNE
"Myasthenic syndrome, congenital, 4B, fast-channel, 616324 ",3,"CHRNE, SCCMS, CMS4A, CMS4B, CMS4C",100725,17p13.2,CHRNE
"Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 ",3,"CHRNE, SCCMS, CMS4A, CMS4B, CMS4C",100725,17p13.2,CHRNE
"Myasthenic syndrome, congenital, 5, 603034 ",3,"COLQ, EAD, CMS5",603033,3p25.1,COLQ
"Myasthenic syndrome, congenital, 6, presynaptic, 254210 ",3,"CHAT, CMS6",118490,10q11.23,CHAT
"Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 ",3,"MUSK, CMS9, FADS",601296,9q31.3,MUSK
"Myelofibrosis with myeloid metaplasia, somatic, 254450 ",3,"MPL, TPOR, MPLV, THCYT2",159530,1p34.2,MPL
"Myelofibrosis, somatic, 254450 ",3,"CALR, SSA",109091,19p13.13,CALR
"Myelofibrosis, somatic, 254450 ",3,"JAK2, THCYT3",147796,9p24.1,JAK2
"Myelofibrosis, somatic, 254450 ",3,"SH2B3, LNK",605093,12q24.12,SH2B3
"Myeloperoxidase deficiency, 254600 ",3,MPO,606989,17q22,MPO
"Myhre syndrome, 139210 ",3,"SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS",600993,18q21.2,SMAD4
"Myofibromatosis, infantile, 1, 228550 ",3,"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS",173410,5q32,PDGFRB
"Myokymia, 121200 ",3,"KCNQ2, EBN1, EIEE7, BFNS1",602235,20q13.33,KCNQ2
"Myopathy due to CPT II deficiency, 255110 ",3,"CPT2, IIAE4",600650,1p32.3,CPT2
"Myopathy with lactic acidosis, hereditary, 255125 ",3,"ISCU, HML",611911,12q23.3,ISCU
"Myopathy, X-linked, with postural muscle atrophy, 300696 ",3,"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B",300163,Xq26.3,FHL1
"Myopathy, actin, congenital, with cores, 161800 ",3,"ACTA1, ASMA, NEM3, CFTD1, SHPM",102610,1q42.13,ACTA1
"Myopathy, actin, congenital, with excess of thin myofilaments, 161800 ",3,"ACTA1, ASMA, NEM3, CFTD1, SHPM",102610,1q42.13,ACTA1
"Myopathy, centronuclear, 160150 ",3,"DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5",602378,19p13.2,DNM2
"Myopathy, centronuclear, 3, 614408 ",3,"MYF6, CNM3",159991,12q21.31,MYF6
"Myopathy, congenital, with fiber-type disproportion 1, 255310 ",3,"ACTA1, ASMA, NEM3, CFTD1, SHPM",102610,1q42.13,ACTA1
"Myopathy, congenital, with fiber-type disproportion, 255310 ",3,"SELENON, SEPN1, SELN, RSMD1, CFTD",606210,1p36.11,SELENON
"Myopathy, congenital, with fiber-type disproportion, 255310 ",3,"TPM3, NEM1, CFTD, CAPM1",191030,1q21.3,TPM3
"Myopathy, distal, 4, 614065 ",3,"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",102565,7q32.1,FLNC
"Myopathy, distal, Tateyama type, 614321 ",3,"CAV3, LGMD1C, LQT9",601253,3p25.3,CAV3
"Myopathy, distal, with anterior tibial onset, 606768 ",3,"DYSF, LGMD2B, MMD1",603009,2p13.2,DYSF
"Myopathy, distal, with rimmed vacuoles, 617158 ",3,"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",601530,5q35.3,SQSTM1
"Myopathy, early-onset, with fatal cardiomyopathy, 611705 ",3,"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC",188840,2q31.2,TTN
"Myopathy, myofibrillar, 1, 601419 ",3,"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",125660,2q35,DES
"Myopathy, myofibrillar, 2, 608810 ",3,"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2",123590,11q23.1,CRYAB
"Myopathy, myofibrillar, 3, 609200 ",3,"MYOT, TTOD, MFM3",604103,5q31.2,MYOT
"Myopathy, myofibrillar, 4, 609452 ",3,"LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3",605906,10q23.2,LDB3
"Myopathy, myofibrillar, 5, 609524 ",3,"FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5",102565,7q32.1,FLNC
"Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 ",3,"CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2",123590,11q23.1,CRYAB
"Myopathy, myosin storage, autosomal dominant, 608358 ",3,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD",160760,14q11.2,MYH7
"Myopathy, myosin storage, autosomal recessive, 255160 ",3,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD",160760,14q11.2,MYH7
"Myopathy, proximal, with early respiratory muscle involvement, 603689 ",3,"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC",188840,2q31.2,TTN
"Myopathy, spheroid body, 182920 ",3,"MYOT, TTOD, MFM3",604103,5q31.2,MYOT
"Myopathy, tubular aggregate, 1 160565 ",3,"STIM1, TAM1, IMD10, STRMK",605921,11p15.4,STIM1
"Myopathy, vacuolar, with CASQ1 aggregates, 616231 ",3,"CASQ1, VMCQA",114250,1q23.2,CASQ1
"Myopia 23, autosomal recessive, 615431 ",3,"LRPAP1, A2MRAP, MYP23",104225,4p16.3,LRPAP1
"Myopia 6, 608908 ",3,"SCO2, CEMCOX1, MYP6",604272,22q13.33,SCO2
"Myotonia congenita, atypical, acetazolamide-responsive, 608390 ",3,"SCN4A, HYPP, NAC1A, HOKPP2, CMS16",603967,17q23.3,SCN4A
"Myotonic dystrophy 1, 160900 ",3,"DMPK, DM, DMK",605377,19q13.32,DMPK
"Myotonic dystrophy 2, 602668 ",3,"ZNF9, CNBP1, DM2, PROMM",116955,3q21.3,ZNF9
"Myotubular myopathy, X-linked, 310400 ",3,"MTM1, MTMX",300415,Xq28,MTM1
"Myxoma, intracardiac, 255960 ",3,"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1",188830,17q24.2,PRKAR1A
"N-acetylglutamate synthase deficiency, 237310 ",3,NAGS,608300,17q21.31,NAGS
"Naegeli-Franceschetti-Jadassohn syndrome, 161000 ",3,KRT14,148066,17q21.2,KRT14
"Nail-patella syndrome, 161200 ",3,"LMX1B, NPS1",602575,9q33.3,LMX1B
"Nance-Horan syndrome, 302350 ",3,"NHS, CXN, CTRCT40",300457,Xp22.2-p22.1,NHS
"Nasopharyngeal carcinoma, 607107 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Nasu-Hakola disease, 221770 ",3,TREM2,605086,6p21.1,TREM2
"Nasu-Hakola disease, 221770 ",3,"TYROBP, PLOSL, DAP12",604142,19q13.12,TYROBP
"Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 ",3,"MCM4, NKGCD, NKCD",602638,8q11.21,MCM4
"Naxos disease, 601214 ",3,"JUP, DP3, PDGB, ARVD12",173325,17q21.2,JUP
"Nemaline myopathy 1, autosomal dominant or recessive, 609284 ",3,"TPM3, NEM1, CFTD, CAPM1",191030,1q21.3,TPM3
"Nemaline myopathy 2, autosomal recessive, 256030 ",3,"NEB, NEM2",161650,2q23.3,NEB
"Nemaline myopathy 3, autosomal dominant or recessive, 161800 ",3,"ACTA1, ASMA, NEM3, CFTD1, SHPM",102610,1q42.13,ACTA1
"Nemaline myopathy 4, autosomal dominant, 609285 ",3,"TPM2, TMSB, AMCD1, DA1, DA2B, NEM4",190990,9p13.3,TPM2
"Nemaline myopathy 5, Amish type, 605355 ",3,"TNNT1, ANM, NEM5",191041,19q13.42,TNNT1
"Nemaline myopathy 7, autosomal recessive, 610687 ",3,"CFL2, NEM7",601443,14q13.1,CFL2
"Nephrogenic syndrome of inappropriate antidiuresis, 300539 ",3,"AVPR2, DIR, DI1, ADHR",300538,Xq28,AVPR2
"Nephrolithiasis, type I, 310468 ",3,"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",300008,Xp11.23,CLCN5
"Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 ",3,"SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2",182309,5q35.3,SLC34A1
"Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 ",3,"SLC9A3R1, EBP50, NHERF1, NPHLOP2",604990,17q25.1,SLC9A3R1
"Nephronophthisis 1, juvenile, 256100 ",3,"NPHP1, NPH1, SLSN1, JBTS4",607100,2q13,NPHP1
"Nephronophthisis 11, 613550 ",3,"TMEM67, MKS3, JBTS6, NPHP11",609884,8q22.1,TMEM67
"Nephronophthisis 19, 616217 ",3,"DCDC2, RU2, KIAA1154, NPHP19, DFNB66",605755,6p22.3,DCDC2
"Nephronophthisis 2, infantile, 602088 ",3,"INVS, INV, NPHP2, NPH2",243305,9q31.1,INVS
"Nephronophthisis 3, 604387 ",3,"NPHP3, NPH3, RHPD1, MKS7",608002,3q22.1,NPHP3
"Nephronophthisis 7, 611498 ",3,"GLIS2, NPHP7",608539,16p13.3,GLIS2
"Nephronophthisis-like nephropathy 1, 613159 ",3,"XPNPEP3, APP3, NPHPL1",613553,22q13.2,XPNPEP3
"Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 ",3,"CD151, PETA3, SFA1, MER2",602243,11p15.5,CD151
"Nephrotic syndrome, type 2, 600995 ",3,"PDCN, NPHS2, SRN1",604766,1q25.2,PDCN
"Nephrotic syndrome, type 3, 610725 ",3,"PLCE1, KIAA1516, NPHS3",608414,10q23.33,PLCE1
"Nephrotic syndrome, type 4, 256370 ",3,"WT1, NPHS4",607102,11p13,WT1
"Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 ",3,"LAMB2, LAMS, NPHS5",150325,3p21.31,LAMB2
"Neural tube defects, 182940 ",3,"FUZ, NTD",610622,19q13.33,FUZ
"Neural tube defects, 182940 ",3,"VANGL2, LTAP",600533,1q23.2,VANGL2
"Neuroblastoma, 256700 ",3,"NME1, NM23",156490,17q21.33,NME1
"Neurocutaneous melanosis, somatic, 249400 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Neurodegeneration due to cerebral folate transport deficiency, 613068 ",3,FOLR1,136430,11q13.4,FOLR1
"Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 ",3,"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",601530,5q35.3,SQSTM1
"Neurodegeneration with brain iron accumulation 2B, 610217 ",3,"PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14",603604,22q13.1,PLA2G6
"Neurodegeneration with brain iron accumulation 3, 606159 ",3,"FTL, NBIA3, LFTD",134790,19q13.33,FTL
"Neuroepithelioma, 612219 ",3,"EWSR1, EWS",133450,22q12.2,EWSR1
"Neurofibromatosis, familial spinal, 162210 ",3,"NF1, VRNF, WSS, NFNS",613113,17q11.2,NF1
"Neurofibromatosis, type 1, 162200 ",3,"NF1, VRNF, WSS, NFNS",613113,17q11.2,NF1
"Neurofibromatosis, type 2, 101000 ",3,NF2,607379,22q12.2,NF2
"Neurofibromatosis-Noonan syndrome, 601321 ",3,"NF1, VRNF, WSS, NFNS",613113,17q11.2,NF1
"Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 ",3,"RYR1, MHS, CCO",180901,19q13.2,RYR1
"Neuronopathy, distal hereditary motor, type IID, 615575 ",3,"FBXO38, FBX38, MOKA, HMN2D",608533,5q32,FBXO38
"Neuropathy, congenital hypomyelinating, 1, 605253 ",3,"EGR2, KROX20",129010,10q21.3,EGR2
"Neuropathy, congenital hypomyelinating, 605253 ",3,"MPZ, CMT1B, CMTDID, CHM, DSS",159440,1q23.3,MPZ
"Neuropathy, distal hereditary motor, type IIA, 158590 ",3,"HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A",608014,12q24.23,HSPB8
"Neuropathy, distal hereditary motor, type IIB, 608634 ",3,"HSPB1, HSP27, CMT2F, HMN2B",602195,7q11.23,HSPB1
"Neuropathy, distal hereditary motor, type VA, 600794 ",3,"BSCL2, SPG17, HMN5, PELD",606158,11q12.3,BSCL2
"Neuropathy, distal hereditary motor, type VA, 600794 ",3,"GARS, SMAD1, CMT2D, HMN5",600287,7p14.3,GARS
"Neuropathy, distal hereditary motor, type VIIB, 607641 ",3,"DCTN1, HMN7B",601143,2p13.1,DCTN1
"Neuropathy, hereditary motor and sensory, Russe type, 605285 ",3,"HK1, HKD, HMSNR",142600,10q22.1,HK1
"Neuropathy, hereditary sensory and autonomic, type II, 201300 ",3,"WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2",605232,12p13.33,WNK1
"Neuropathy, hereditary sensory and autonomic, type V, 608654 ",3,"NGF, NGFB, HSAN5",162030,1p13.2,NGF
"Neuropathy, hereditary sensory and autonomic, type VII, 615548 ",3,"SCN11A, HSAN7, FEPS3",604385,3p22.2,SCN11A
"Neuropathy, hereditary sensory, type ID, 613708 ",3,"ATL1, SPG3A, HSN1D",606439,14q22.1,ATL1
"Neuropathy, hereditary sensory, type IE, 614116 ",3,"DNMT1, MCMT, HSN1E, ADCADN",126375,19p13.2,DNMT1
"Neuropathy, hereditary, with or without age-related macular degeneration, 608895 ",3,"FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD",604580,14q32.12,FBLN5
"Neuropathy, inflammatory demyelinating, 139393 ",3,"PMP22, CMT1A, CMT1E, DSS",601097,17p12,PMP22
"Neuropathy, recurrent, with pressure palsies, 162500 ",3,"PMP22, CMT1A, CMT1E, DSS",601097,17p12,PMP22
"Neutropenia, cyclic, 162800 ",3,"ELANE, ELA2, SCN1",130130,19p13.3,ELANE
"Neutropenia, severe congenital 1, autosomal dominant, 202700 ",3,"ELANE, ELA2, SCN1",130130,19p13.3,ELANE
"Neutropenia, severe congenital 3, autosomal recessive, 610738 ",3,"HAX1, SCN3",605998,1q21.3,HAX1
"Neutropenia, severe congenital, 7, autosomal recessive, 617014 ",3,"CSF3R, GCSFR, SCN7",138971,1p34.3,CSF3R
"Neutropenia, severe congenital, X-linked, 300299 ",3,"WAS, IMD2, THC1, SCNX",300392,Xp11.23,WAS
"Neutrophil immunodeficiency syndrome, 608203 ",3,RAC2,602049,22q13.1,RAC2
"Nevus, epidermal, somatic, 162900 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Nevus, epidermal, somatic, 162900 ",3,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5",171834,3q26.32,PIK3CA
"Niemann-Pick disease, type A, 257200 ",3,"SMPD1, NPD",607608,11p15.4,SMPD1
"Niemann-Pick disease, type B, 607616 ",3,"SMPD1, NPD",607608,11p15.4,SMPD1
"Niemann-Pick disease, type C1, 257220 ",3,"NPC1, NPC",607623,18q11.2,NPC1
"Niemann-Pick disease, type D, 257220 ",3,"NPC1, NPC",607623,18q11.2,NPC1
"Niemann-pick disease, type C2, 607625 ",3,"NPC2, HE1",601015,14q24.3,NPC2
"Night blindness, congenital stationary, autosomal dominant 1, 610445 ",3,"RHO, RP4, OPN2, CSNBAD1",180380,3q22.1,RHO
"Night blindness, congenital stationary, autosomal dominant 2, 163500 ",3,"PDE6B, PDEB, RP40, CSNBAD2",180072,4p16.3,PDE6B
"Night blindness, congenital stationary, autosomal dominant 3, 610444 ",3,"GNAT1, CSNBAD3, CSNB1G",139330,3p21.31,GNAT1
"Night blindness, congenital stationary, type 1H, 617024 ",3,"GNB3, CSNB1H",139130,12p13.31,GNB3
"Nijmegen breakage syndrome, 251260 ",3,"NBN, NBS1",602667,8q21.3,NBN
"Nonaka myopathy, 605820 ",3,"GNE, GLCNE, IBM2, DMRV, NM",603824,9p13.3,GNE
"Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 ",3,"EGFR, NISBD2",131550,7p11.2,EGFR
"Nonsmall cell lung cancer, somatic, 211980 ",3,"IRF1, MAR",147575,5q31.1,IRF1
"Nonsmall cell lung cancer, somatic, 211980 ",3,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5",171834,3q26.32,PIK3CA
"Noonan syndrome 1, 163950 ",3,"PTPN11, PTP2C, SHP2, NS1, JMML, METCDS",176876,12q24.13,PTPN11
"Noonan syndrome 3, 609942 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Noonan syndrome 4, 610733 ",3,"SOS1, GINGF, GF1, HGF, NS4",182530,2p22.1,SOS1
"Noonan syndrome 5, 611553 ",3,"RAF1, CRAF, NS5, CMD1NN",164760,3p25.2,RAF1
"Noonan syndrome 6, 613224 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Noonan syndrome 7, 613706 ",3,"BRAF, NS7",164757,7q34,BRAF
"Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 ",3,"CBL, CBL2, NSLL",165360,11q23.3,CBL
"Norrie disease, 310600 ",3,"NDP, ND, EVR2",300658,Xp11.3,NDP
"Norum disease, 245900 ",3,LCAT,606967,16q22.1,LCAT
"Nystagmus 6, congenital, X-linked, 300814 ",3,"GPR143, OA1, NYS6",300808,Xp22.2,GPR143
"OKT4 epitope deficiency, 613949 ",3,CD4,186940,12p13.31,CD4
"Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 ",3,POMC,176830,2p23.3,POMC
"Obesity, autosomal dominant, 601665 ",3,MC4R,155541,18q21.32,MC4R
"Obesity, mild, early-onset, 601665 ",3,"NR0B2, SHP",604630,1p36.11,NR0B2
"Obesity, morbid, due to leptin deficiency, 614962 ",3,"LEP, OB, LEPD",164160,7q32.1,LEP
"Obesity, severe, 601665 ",3,"PPARG, PPARG1, PPARG2, CIMT1, GLM1",601487,3p25.2,PPARG
"Obesity, severe, 601665 ",3,SIM1,603128,6q16.3,SIM1
"Occipital horn syndrome, 304150 ",3,"ATP7A, MNK, MK, OHS, SMAX3",300011,Xq21.1,ATP7A
"Occult macular dystrophy, 613587 ",3,RP1L1,608581,8p23.1,RP1L1
"Ocular albinism, type I, Nettleship-Falls type, 300500 ",3,"GPR143, OA1, NYS6",300808,Xp22.2,GPR143
"Oculodentodigital dysplasia, 164200 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Oculodentodigital dysplasia, autosomal recessive, 257850 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Oculopharyngeal muscular dystrophy, 164300 ",3,"PABPN1, PABP2, PAB2",602279,14q11.2,PABPN1
"Odontohypophosphatasia, 146300 ",3,"ALPL, HOPS, TNSALP",171760,1p36.12,ALPL
"Odontoonychodermal dysplasia, 257980 ",3,"WNT10A, SSPS, STHAG4, OODD",606268,2q35,WNT10A
"Oguchi disease-1, 258100 ",3,"SAG, RP47",181031,2q37.1,SAG
"Ohdo syndrome, X-linked, 300895 ",3,"MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX",300188,Xq13.1,MED12
"Okur-Chung neurodevelopmental syndrome, 617062 ",3,"CSNK2A1, CK2A1, OCNDS",115440,20p13,CSNK2A1
"Oligodontia-colorectal cancer syndrome, 608615 ",3,"AXIN2, ODCRCS",604025,17q24.1,AXIN2
"Oliver-McFarlane syndrome, 275400 ",3,"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",603197,19p13.2,PNPLA6
"Omenn syndrome, 603554 ",3,"DCLRE1C, ARTEMIS, SCIDA",605988,10p13,DCLRE1C
"Omenn syndrome, 603554 ",3,RAG1,179615,11p12,RAG1
"Omenn syndrome, 603554 ",3,RAG2,179616,11p12,RAG2
"Omeprazole poor metabolizer, 609535 ",3,"CYP2C, CYP2C19",124020,10q23.33,CYP2C
"Opitz GBBB syndrome, type I, 300000 ",3,"MID1, OGS1, BBBG1, FXY, OSX",300552,Xp22.2,MID1
"Opitz-Kaveggia syndrome, 305450 ",3,"MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX",300188,Xq13.1,MED12
"Optic atrophy 1, 165500 ",3,"OPA1, NTG, NPG, BERHS, MTDPS14",605290,3q29,OPA1
"Optic atrophy plus syndrome, 125250 ",3,"OPA1, NTG, NPG, BERHS, MTDPS14",605290,3q29,OPA1
"Optic disc anomalies with retinal and/or macular dystrophy, 212550 ",3,"SIX6, ODRMD",606326,14q23.1,SIX6
"Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 ",3,"SOX2, MCOPS3",184429,3q26.33,SOX2
"Optic nerve hypoplasia, 165550 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Ornithine transcarbamylase deficiency, 311250 ",3,OTC,300461,Xp11.4,OTC
"Orofacial cleft 10, 613705 ",3,"SUMO1, UBL1, SMT3, OFC10",601912,2q33.1,SUMO1
"Orofacial cleft 11, 600625 ",3,"BMP4, BMP2B1, BMP2B, MCOPS6, OFC11",112262,14q22.2,BMP4
"Orofacial cleft 5, 608874 ",3,"MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3",142983,4p16.2,MSX1
"Orofacial cleft 7, 225060 ",3,"NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1",600644,11q23.3,NECTIN1
"Orofacial cleft 8, 129400 ",3,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",603273,3q28,TP63
"Orofaciodigital syndrome I, 311200 ",3,"OFD1, CXorf5, SGBS2, JBTS10, RP23",300170,Xp22.2,OFD1
"Orotic aciduria, 258900 ",3,"UMPS, OPRT",613891,3q21.2,UMPS
"Orthostatic intolerance, 604715 ",3,"SLC6A2, NAT1, NET1",163970,16q12.2,SLC6A2
"Osseous heteroplasia, progressive, 166350 ",3,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C",139320,20q13.32,GNAS
"Osteoarthritis with mild chondrodysplasia, 604864 ",3,COL2A1,120140,12q13.11,COL2A1
"Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 ",3,"ACAN, AGC1, CSPG1, MSK16, SEDK",155760,15q26.1,ACAN
"Osteogenesis imperfecta, type I, 166200 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Osteogenesis imperfecta, type II, 166210 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Osteogenesis imperfecta, type II, 166210 ",3,COL1A2,120160,7q21.3,COL1A2
"Osteogenesis imperfecta, type III, 259420 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Osteogenesis imperfecta, type III, 259420 ",3,COL1A2,120160,7q21.3,COL1A2
"Osteogenesis imperfecta, type IV, 166220 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Osteogenesis imperfecta, type IV, 166220 ",3,COL1A2,120160,7q21.3,COL1A2
"Osteogenesis imperfecta, type VI, 613982 ",3,"SERPINF1, PEDF, OI6",172860,17p13.3,SERPINF1
"Osteogenesis imperfecta, type VII, 610682 ",3,"CRTAP, CASP, OI7",605497,3p22.3,CRTAP
"Osteogenesis imperfecta, type VIII, 610915 ",3,"P3H1, LEPRE1, GROS1, OI8",610339,1p34.2,P3H1
"Osteogenesis imperfecta, type XIII, 614856 ",3,"BMP1, OI13",112264,8p21.3,BMP1
"Osteogenesis imperfecta, type XV, 615220 ",3,"WNT1, INT1, OI15, BMND16",164820,12q13.12,WNT1
"Osteogenesis imperfecta, type XVII, 616507 ",3,"SPARC, ON, OI17",182120,5q33.1,SPARC
"Osteoglophonic dysplasia, 166250 ",3,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",136350,8p11.23,FGFR1
"Osteolysis, familial expansile, 174810 ",3,"TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2",603499,18q21.33,TNFRSF11A
"Osteopathia striata with cranial sclerosis, 300373 ",3,"AMER1, FAM123B, WTX, OSCS",300647,Xq11.2,AMER1
"Osteopetrosis, autosomal dominant 1, 607634 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"Osteopetrosis, autosomal dominant 2, 166600 ",3,"CLCN7, CLC7, OPTA2, OPTB4",602727,16p13.3,CLCN7
"Osteopetrosis, autosomal recessive 1, 259700 ",3,"TCIRG1, TIRC7, OC116, OPTB1",604592,11q13.2,TCIRG1
"Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 ",3,CA2,611492,8q21.2,CA2
"Osteopetrosis, autosomal recessive 4, 611490 ",3,"CLCN7, CLC7, OPTA2, OPTB4",602727,16p13.3,CLCN7
"Osteopetrosis, autosomal recessive 7, 612301 ",3,"TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2",603499,18q21.33,TNFRSF11A
"Osteopoikilosis, 166700 ",3,"LEMD3, MAN1",607844,12q14.3,LEMD3
"Osteoporosis-pseudoglioma syndrome, 259770 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"Osteosarcoma, 259500 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Osteosarcoma, somatic, 259500 ",3,"CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,CHEK2
"Osteosarcoma, somatic, 259500 ",3,RB1,614041,13q14.2,RB1
"Osteosclerosis, 144750 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"Otopalatodigital syndrome, type I, 311300 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Otopalatodigital syndrome, type II, 304120 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Otospondylomegaepiphyseal dysplasia, 215150 ",3,"COL11A2, STL3, DFNA13, DFNB53, FBCG2",120290,6p21.32,COL11A2
"Otospondylomegaepiphyseal dysplasia, 215150 ",3,COL2A1,120140,12q13.11,COL2A1
"Ovalocytosis, SA type, 166900 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Ovarian cancer, somatic, 167000 ",3,"AKT1, CWS6",164730,14q32.33,AKT1
"Ovarian cancer, somatic, 167000 ",3,"CTNNB1, MRD19",116806,3p22.1,CTNNB1
"Ovarian cancer, somatic, 167000 ",3,"PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5",171834,3q26.32,PIK3CA
"Ovarian carcinoma, somatic, 167000 ",3,"CDH1, UVO, LCAM, ECAD",192090,16q22.1,CDH1
"Ovarian dysgenesis 1, 233300 ",3,"FSHR, ODG1",136435,2p16.3,FSHR
"Ovarian dysgenesis 3, 614324 ",3,"PSMC3IP, TBPIP, GT198, HOP2, ODG3",608665,17q21.2,PSMC3IP
"Ovarian hyperstimulation syndrome, 608115 ",3,"FSHR, ODG1",136435,2p16.3,FSHR
"Ovarian response to FSH stimulation, 276400 ",3,"FSHR, ODG1",136435,2p16.3,FSHR
"Ovarioleukodystrophy, 603896 ",3,EIF2B2,606454,14q24.3,EIF2B2
"Ovarioleukodystrophy, 603896 ",3,EIF2B4,606687,2p23.3,EIF2B4
"Ovarioleukodystrophy, 603896 ",3,"EIF2B5, LVWM, CACH, CLE",603945,3q27.1,EIF2B5
"Overhydrated hereditary stomatocytosis, 185000 ",3,"RHAG, RH50A, OHST",180297,6p12.3,RHAG
"PCWH syndrome, 609136 ",3,"SOX10, WS4, WS4C, PCWH",602229,22q13.1,SOX10
"Pachyonychia congenita 1, 167200 ",3,"KRT16, FNEPPK, PC1",148067,17q21.2,KRT16
"Pachyonychia congenita 2, 167210 ",3,"KRT17, PC2, PCHC1",148069,17q21.2,KRT17
"Paget disease of bone 3, 167250 ",3,"SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV",601530,5q35.3,SQSTM1
"Paget disease of bone 5, juvenile-onset, 239000 ",3,"TNFRSF11B, OPG, OCIF, PDB5",602643,8q24.12,TNFRSF11B
"Pallister-Hall syndrome, 146510 ",3,"GLI3, PAPA, PAPB",165240,7p14.1,GLI3
"Palmoplantar keratoderma with congenital alopecia, 104100 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Palmoplantar keratoderma, epidermolytic, 144200 ",3,"KRT1, EPPK, NEPPK, EHK",139350,12q13.13,KRT1
"Palmoplantar keratoderma, epidermolytic, 144200 ",3,"KRT9, EPPK",607606,17q21.2,KRT9
"Palmoplantar keratoderma, nonepidermolytic, 600962 ",3,"KRT1, EPPK, NEPPK, EHK",139350,12q13.13,KRT1
"Palmoplantar keratoderma, nonepidermolytic, focal, 613000 ",3,"KRT16, FNEPPK, PC1",148067,17q21.2,KRT16
"Pancreatic agenesis 2, 615935 ",3,"PTF1A, PACA, PAGEN2",607194,10p12.2,PTF1A
"Pancreatic and cerebellar agenesis, 609069 ",3,"PTF1A, PACA, PAGEN2",607194,10p12.2,PTF1A
"Pancreatic cancer, 260350 ",3,"STK11, PJS, LKB1",602216,19p13.3,STK11
"Pancreatic cancer, 260350 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Pancreatic cancer, somatic, 260350 ",3,"SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS",600993,18q21.2,SMAD4
"Pancreatic cancer/melanoma syndrome, 606719 ",3,"CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21.3,CDKN2A
"Pancreatic carcinoma, somatic, 260350 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Pancreatitis, hereditary, 167800 ",3,"PRSS1, TRY1",276000,7q34,PRSS1
"Pancreatitis, hereditary, 167800 ",3,"SPINK1, PSTI, PCTT, TATI, TCP",167790,5q32,SPINK1
"Panhypopituitarism, X-linked, 312000 ",3,"SOX3, MRGH",313430,Xq27.1,SOX3
"Papillon-Lefevre syndrome, 245000 ",3,"CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD",602365,11q14.2,CTSC
"Papillorenal syndrome, 120330 ",3,"PAX2, PAPRS, FSGS7",167409,10q24.31,PAX2
"Paraganglioma and gastric stromal sarcoma, 606864 ",3,"SDHB, SDH2, SDHIP, PGL4, CWS2",185470,1p36.13,SDHB
"Paraganglioma and gastric stromal sarcoma, 606864 ",3,"SDHC, PGL3",602413,1q23.3,SDHC
"Paraganglioma and gastric stromal sarcoma, 606864 ",3,"SDHD, PGL1, CWS3",602690,11q23.1,SDHD
"Paragangliomas 1, with or without deafness, 168000 ",3,"SDHD, PGL1, CWS3",602690,11q23.1,SDHD
"Paragangliomas 3, 605373 ",3,"SDHC, PGL3",602413,1q23.3,SDHC
"Paragangliomas 4, 115310 ",3,"SDHB, SDH2, SDHIP, PGL4, CWS2",185470,1p36.13,SDHB
"Paragangliomas 5, 614165 ",3,"SDHA, SDH1, SDHF, CMD1GG, PGL5",600857,5p15.33,SDHA
"Paramyotonia congenita, 168300 ",3,"SCN4A, HYPP, NAC1A, HOKPP2, CMS16",603967,17q23.3,SCN4A
"Parastremmatic dwarfism, 168400 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Parathyroid adenoma with cystic changes, 145001 ",3,"HRPT2, C1orf28",607393,1q31.2,HRPT2
"Parathyroid carcinoma, 608266 ",3,"HRPT2, C1orf28",607393,1q31.2,HRPT2
"Parietal foramina 1, 168500 ",3,"MSX2, CRS2, HOX8",123101,5q35.2,MSX2
"Parietal foramina with cleidocranial dysplasia, 168550 ",3,"MSX2, CRS2, HOX8",123101,5q35.2,MSX2
"Parkes Weber syndrome, 608355 ",3,"RASA1, GAP, CMAVM, PKWS",139150,5q14.3,RASA1
"Parkinson disease 1, 168601 ",3,"SNCA, NACP, PARK1, PARK4",163890,4q22.1,SNCA
"Parkinson disease 14, autosomal recessive, 612953 ",3,"PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14",603604,22q13.1,PLA2G6
"Parkinson disease 15, autosomal recessive, 260300 ",3,"FBXO7, FBX7, FBX, PKPS, PARK15",605648,22q12.3,FBXO7
"Parkinson disease 4, 605543 ",3,"SNCA, NACP, PARK1, PARK4",163890,4q22.1,SNCA
"Parkinson disease 6, early onset, 605909 ",3,"PINK1, PARK6",608309,1p36.12,PINK1
"Parkinson disease, juvenile, type 2, 600116 ",3,"PRKN, PARK2, PDJ, LPRS2",602544,6q26,PRKN
"Parkinsonism-dystonia, infantile, 613135 ",3,"SLC6A3, DAT1, PKDYS",126455,5p15.33,SLC6A3
"Paroxysmal extreme pain disorder, 167400, ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Paroxysmal nonkinesigenic dyskinesia, 118800 ",3,"MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8",609023,2q35,MR1
"Partington syndrome, 309510 ",3,"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32",300382,Xp21.3,ARX
"Patent ductus arteriosus 2, 617035 ",3,"TFAP2B, CHAR, PDA2",601601,6p12.3,TFAP2B
"Peeling skin syndrome 1, 270300 ",3,"CDSN, HTSS1, HYPT2, PSS1",602593,6p21.33,CDSN
"Peeling skin syndrome 2, 609796 ",3,"TGM5, TGX, PSS2",603805,15q15.2,TGM5
"Pelger-Huet anomaly, 169400 ",3,"LBR, PHA",600024,1q42.12,LBR
"Pelizaeus-Merzbacher disease, 312080 ",3,"PLP1, PMD, HLD1, SPG2",300401,Xq22.2,PLP1
"Pendred syndrome, 274600 ",3,"SLC26A4, PDS, DFNB4, EVA, TDH2B",605646,7q22.3,SLC26A4
"Periodic fever, familial, 142680 ",3,"TNFRSF1A, TNFR1, TNFAR, FPF, MS5",191190,12p13.31,TNFRSF1A
"Periodic fever, menstrual cycle dependent, 614674 ",3,"HTR1A, ADRB2RL1, PFMCD",109760,5q12.3,HTR1A
"Periodontitis 1, juvenile, 170650 ",3,"CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD",602365,11q14.2,CTSC
"Periventricular heterotopia with microcephaly, 608097 ",3,"ARFGEF2, BIG2, PVNH2",605371,20q13.13,ARFGEF2
"Periventricular nodular heterotopia 7, 617201 ",3,"NEDD4L, KIAA0439, RSP5, PVNH7",606384,18q21.31,NEDD4L
"Peroxisomal acyl-CoA oxidase deficiency, 264470 ",3,"ACOX1, ACOX, SCOX",609751,17q25.1,ACOX1
"Peroxisome biogenesis disorder 2B, 202370 ",3,"PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5",600414,12p13.31,PEX5
"Peroxisome biogenesis disorder 4B, 614863 ",3,"PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2",601498,6p21.1,PEX6
"Peroxisome biogenesis disorder 5B, 614867 ",3,"PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3",170993,8q21.13,PEX2
"Peroxisome biogenesis disorder 6B, 614871 ",3,"PEX10, NALD, PBD6A, PBD6B",602859,1p36.32,PEX10
"Peroxisome biogenesis disorder 7B, 614873 ",3,"PEX26, PBD7A, PBD7B",608666,22q11.21,PEX26
"Perrault syndrome 3, 614129 ",3,"CLPP, PRLTS3, DFNB81",601119,19p13.3,CLPP
"Perrault syndrome 5, 616138 ",3,"C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5",606075,10q24.31,C10orf2
"Perry syndrome, 168605 ",3,"DCTN1, HMN7B",601143,2p13.1,DCTN1
"Persistent truncus arteriosus, 217095 ",3,"GATA6, AVSD5, ASD9, AVSD5, PACHD",601656,18q11.2,GATA6
"Persistent truncus arteriosus, 217095 ",3,"NKX2-6, CSX2, CTHM",611770,8p21.2,NKX2-6
"Peters anomaly, 604229 ",3,"CYP1B1, GLC3A",601771,2p22.2,CYP1B1
"Peters anomaly, 604229 ",3,"PAX6, AN2, MGDA, FVH1",607108,11p13,PAX6
"Peters anomaly, 604229 ",3,"PITX2, IDG2, RIEG1, RGS, IGDS2",601542,4q25,PITX2
"Peutz-Jeghers syndrome, 175200 ",3,"STK11, PJS, LKB1",602216,19p13.3,STK11
"Pfeiffer syndrome, 101600 ",3,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",136350,8p11.23,FGFR1
"Pfeiffer syndrome, 101600 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Phelan-McDermid syndrome, 606232 ",3,"SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15",606230,22q13.33,SHANK3
"Phenylketonuria, 261600 ",3,"PAH, PKU1",612349,12q23.2,PAH
"Pheochromocytoma, 171300 ",3,"KIF1B, CMT2A, CMT2A1, NBLST1",605995,1p36.22,KIF1B
"Pheochromocytoma, 171300 ",3,"RET, MEN2A, HSCR1",164761,10q11.21,RET
"Pheochromocytoma, 171300 ",3,"SDHB, SDH2, SDHIP, PGL4, CWS2",185470,1p36.13,SDHB
"Pheochromocytoma, 171300 ",3,"SDHD, PGL1, CWS3",602690,11q23.1,SDHD
"Pheochromocytoma, 171300 ",3,VHL,608537,3p25.3,VHL
"Phosphoglycerate kinase 1 deficiency, 300653 ",3,"PGK1, PGKA",311800,Xq21.1,PGK1
"Phosphoribosylpyrophosphate synthetase superactivity, 300661 ",3,"PRPS1, CMTX5, DFNX1, DFN2",311850,Xq22.3,PRPS1
"Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 ",3,PHKB,172490,16q12.1,PHKB
"Phosphoserine phosphatase deficiency, 614023 ",3,"PSPH, PSP, PSPHD",172480,7p11.2,PSPH
"Pick disease, 172700 ",3,"MAPT, MTBT1, DDPAC, MSTD",157140,17q21.31,MAPT
"Pick disease, 172700 ",3,"PSEN1, AD3",104311,14q24.2,PSEN1
"Piebaldism, 172800 ",3,"KIT, PBT",164920,4q12,KIT
"Piebaldism, 172800 ",3,"SNAI2, SLUG, WS2D",602150,8q11.21,SNAI2
"Pierson syndrome, 609049 ",3,"LAMB2, LAMS, NPHS5",150325,3p21.31,LAMB2
"Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 ",3,POLA1,312040,Xp22.1-p21.3,POLA1
"Pigmented nodular adrenocortical disease, primary, 1, 610489 ",3,"PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1",188830,17q24.2,PRKAR1A
"Pigmented nodular adrenocortical disease, primary, 3, 614190 ",3,"PDE8B, PPNAD3, ADSD",603390,5q13.3,PDE8B
"Pigmented paravenous chorioretinal atrophy, 172870 ",3,"CRB1, RP12, LCA8",604210,1q31.3,CRB1
"Pilomatricoma, somatic, 132600 ",3,"CTNNB1, MRD19",116806,3p22.1,CTNNB1
"Pitt-Hopkins like syndrome 1, 610042 ",3,"CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1",604569,7q35-q36,CNTNAP2
"Pitt-Hopkins syndrome, 610954 ",3,"TCF4, SEF2, ITF2, PTHS, FECD3",602272,18q21.2,TCF4
"Pituitary adenoma, growth hormone-secreting, 102200 ",3,"AIP, XAP2, ARA9",605555,11q13.2,AIP
"Pituitary hormone deficiency, combined, 1, 613038 ",3,"POU1F1, PIT1, CPHD1",173110,3p11.2,POU1F1
"Pituitary hormone deficiency, combined, 4, 262700 ",3,"LHX4, CPHD4",602146,1q25.2,LHX4
"Pituitary hormone deficiency, combined, 6, 613986 ",3,"OTX2, MCOPS5, CPHD6",600037,14q22.3,OTX2
"Pityriasis rubra pilaris, 173200 ",3,"CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP",607211,17q25.3,CARD14
"Plasminogen activator inhibitor-1 deficiency, 613329 ",3,"PAI1, PLANH1, SERPINE1",173360,7q22.1,PAI1
"Plasminogen deficiency, type I, 217090 ",3,PLG,173350,6q26,PLG
"Platelet disorder, familial, with associated myeloid malignancy, 601399 ",3,"RUNX1, CBFA2, AML1",151385,21q22.12,RUNX1
"Platelet glycoprotein IV deficiency, 608404 ",3,"CD36, CHDS7, BDPLT10",173510,7q21.11,CD36
"Platelet-activating factor acetylhydrolase deficiency, 614278 ",3,"PLA2G7, PAFAH, PAFAD",601690,6p12.3,PLA2G7
"Platyspondylic skeletal dysplasia, Torrance type, 151210 ",3,COL2A1,120140,12q13.11,COL2A1
"Pneumothorax, primary spontaneous, 173600 ",3,"FLCN, BHD",607273,17p11.2,FLCN
"Polycystic kidney and hepatic disease, 263200 ",3,"FCYT, PKHD1, ARPKD",606702,6p12.3-p12.2,FCYT
"Polycystic kidney disease 2, 613095 ",3,PKD2,173910,4q22.1,PKD2
"Polycystic kidney disease, adult type I, 173900 ",3,PKD1,601313,16p13.3,PKD1
"Polycystic liver disease 1, 174050 ",3,"PRKCSH, G19P1, PCLD1",177060,19p13.2,PRKCSH
"Polydactyly, postaxial, types A1 and B, 174200 ",3,"GLI3, PAPA, PAPB",165240,7p14.1,GLI3
"Polydactyly, preaxial type II, 174500 ",3,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS",605522,7q36.3,LMBR1
"Polydactyly, preaxial, type IV, 174700 ",3,"GLI3, PAPA, PAPB",165240,7p14.1,GLI3
"Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 ",3,"STRADA, STRAD, LYK5",608626,17q23.3,STRADA
"Polymicrogyria, bilateral frontoparietal, 606854 ",3,"ADGRG1, GPR56, TM7XN1, BFPP, BPPR",604110,16q21,ADGRG1
"Polymicrogyria, bilateral perisylvian, 615752 ",3,"ADGRG1, GPR56, TM7XN1, BFPP, BPPR",604110,16q21,ADGRG1
"Polyposis syndrome, hereditary mixed, 2, 610069 ",3,"BMPR1A, ACVRLK3, ALK3",601299,10q23.2,BMPR1A
"Polyposis, juvenile intestinal, 174900 ",3,"BMPR1A, ACVRLK3, ALK3",601299,10q23.2,BMPR1A
"Polyposis, juvenile intestinal, 174900 ",3,"SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS",600993,18q21.2,SMAD4
"Pontocerebellar hypoplasia, type 6, 611523 ",3,"RARS2, RARSL, PCH6",611524,6q15,RARS2
"Pontocerebellar hypoplasia, type 9, 615809 ",3,"AMPD2, SPG63, PCH9",102771,1p13.3,AMPD2
"Popliteal pterygium syndrome 1, 119500 ",3,"IRF6, VWS, LPS, PIT, PPS1, OFC6",607199,1q32.2,IRF6
"Porencephaly 1, 175780 ",3,"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR",120130,13q34,COL4A1
"Porencephaly 2, 614483 ",3,"COL4A2, POREN2, ICH",120090,13q34,COL4A2
"Porokeratosis 3, multiple types, 175900 ",3,"MVK, MVLK, POROK3",251170,12q24.11,MVK
"Porphyria cutanea tarda, 176100 ",3,UROD,613521,1p34.1,UROD
"Porphyria variegata, 176200 ",3,PPOX,600923,1q23.3,PPOX
"Porphyria, acute hepatic, 612740 ",3,"ALAD, ALADH, PBGS",125270,9q32,ALAD
"Porphyria, acute intermittent, 176000 ",3,"HMBS, PBGD, UPS",609806,11q23.3,HMBS
"Porphyria, acute intermittent, nonerythroid variant, 176000 ",3,"HMBS, PBGD, UPS",609806,11q23.3,HMBS
"Porphyria, hepatoerythropoietic, 176100 ",3,UROD,613521,1p34.1,UROD
"Prader-Willi syndrome, 176270 ",3,NDN,602117,15q11.2,NDN
"Prader-Willi syndrome, 176270 ",3,SNRPN,182279,15q11.2,SNRPN
"Premature aging syndrome, Penttinen type, 601812 ",3,"PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS",173410,5q32,PDGFRB
"Premature ovarian failure 1, 311360 ",3,"FMR1, FRAXA, POF1",309550,Xq27.3,FMR1
"Premature ovarian failure 11, 616946 ",3,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11",609413,10q11.23,ERCC6
"Premature ovarian failure 3, 608996 ",3,"FOXL2, BPES, BPES1, PFRK, POF3",605597,3q22.3,FOXL2
"Premature ovarian failure 5, 611548 ",3,"NOBOX, POF5",610934,7q35,NOBOX
"Premature ovarian failure, 300511 ",3,"DIAPH2, DIA, POF2",300108,Xq21.33,DIAPH2
"Primary aldosteronism, seizures, and neurologic abnormalities, 615474 ",3,"CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA",114206,3p21.1,CACNA1D
"Primary lateral sclerosis, juvenile, 606353 ",3,"ALS2, ALSJ, PLSJ, IAHSP",606352,2q33.1,ALS2
"Primrose syndrome, 259050 ",3,"ZBTB20, ZNF288, DPZF, PRIMS",606025,3q13.31,ZBTB20
"Prion disease with protracted course, 606688 ",3,"PRNP, PRIP, KURU, CJD",176640,20p13,PRNP
"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 ",3,"SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2",103220,4q35.1,SLC25A4
"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 ",3,"C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5",606075,10q24.31,C10orf2
"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 ",3,"RNASEH1, PEOB2",604123,2p25.3,RNASEH1
"Proguanil poor metabolizer, 609535 ",3,"CYP2C, CYP2C19",124020,10q23.33,CYP2C
"Prolidase deficiency, 170100 ",3,PEPD,613230,19q13.11,PEPD
"Properdin deficiency, X-linked, 312060 ",3,"PFC, PFD",300383,Xp11.23,PFC
"Propionicacidemia, 606054 ",3,PCCA,232000,13q32.3,PCCA
"Propionicacidemia, 606054 ",3,PCCB,232050,3q22.3,PCCB
"Prostate cancer 1, 601518 ",3,"RNASEL, RNS4, PRCA1, HPC1",180435,1q25.3,RNASEL
"Prostate cancer, hereditary, 176807 ",3,"MSR1, SCARA1, SRA",153622,8p22,MSR1
"Prostate cancer, somatic, 176807 ",3,"KLF6, COPEB, BCD1, ZF9",602053,10p15.2,KLF6
"Prostate cancer, somatic, 176807 ",3,"MAD1L1, TXBP181",602686,7p22.3,MAD1L1
"Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 ",3,"CLCN5, CLCK2, NPHL2, DENTS, NPHL1",300008,Xp11.23,CLCN5
"Proteus syndrome, somatic, 176920 ",3,"AKT1, CWS6",164730,14q32.33,AKT1
"Protoporphyria, erythropoietic, X-linked, 300752 ",3,"ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1",301300,Xp11.21,ALAS2
"Protoporphyria, erythropoietic, autosomal recessive, 177000 ",3,"FECH, FCE",612386,18q21.31,FECH
"Proud syndrome, 300004 ",3,"ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32",300382,Xp21.3,ARX
"Proximal myopathy and ophthalmoplegia, 605637 ",3,"MYH2, MYPOP",160740,17p13.1,MYH2
"Pseudohypoaldosteronism type I, autosomal dominant, 177735 ",3,"NR3C2, MLR, MCR",600983,4q31.23,NR3C2
"Pseudohypoaldosteronism, type I, 264350 ",3,"SCNN1A, BESC2",600228,12p13.31,SCNN1A
"Pseudohypoaldosteronism, type I, 264350 ",3,"SCNN1B, BESC1",600760,16p12.2,SCNN1B
"Pseudohypoaldosteronism, type I, 264350 ",3,"SCNN1G, PHA1, BESC3",600761,16p12.2,SCNN1G
"Pseudohypoaldosteronism, type IIB, 614491 ",3,"WNK4, PRKWNK4, PHA2B",601844,17q21.2,WNK4
"Pseudohypoaldosteronism, type IIC, 614492 ",3,"WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2",605232,12p13.33,WNK1
"Pseudohypoparathyroidism Ia, 103580 ",3,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C",139320,20q13.32,GNAS
"Pseudohypoparathyroidism Ib, 603233 ",3,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C",139320,20q13.32,GNAS
"Pseudohypoparathyroidism Ic, 612462 ",3,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C",139320,20q13.32,GNAS
"Pseudohypoparathyroidism, type IB, 603233 ",3,"GNASAS1, GNASAS, SANG, NESPAS",610540,20q13.32,GNASAS1
"Pseudohypoparathyroidism, type IB, 603233 ",3,"STX16, SYN16",603666,20q13.32,STX16
"Pseudopseudohypoparathyroidism, 612463 ",3,"GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C",139320,20q13.32,GNAS
"Pseudovaginal perineoscrotal hypospadias, 264600 ",3,SRD5A2,607306,2p23.1,SRD5A2
"Pseudoxanthoma elasticum, 264800 ",3,"ABCC6, ARA, ABC34, MLP1, PXE, GACI2",603234,16p13.11,ABCC6
"Pseudoxanthoma elasticum, forme fruste, 177850 ",3,"ABCC6, ARA, ABC34, MLP1, PXE, GACI2",603234,16p13.11,ABCC6
"Psoriasis 14, pustular, 614204 ",3,"IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14",605507,2q14.1,IL36RN
"Psoriasis 2, 602723 ",3,"CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP",607211,17q25.3,CARD14
"Pulmonary alveolar microlithiasis, 265100 ",3,SLC34A2,604217,4p15.2,SLC34A2
"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 ",3,"RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3",608833,20q13.33,RTEL1
"Pulmonary fibrosis, idiopathic, 178500 ",3,"SFTPA2, SPA2, COLEC5",178642,10q22.3,SFTPA2
"Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 ",3,"BMPR2, PPH1, POVD1",600799,2q33.1-q33.2,BMPR2
"Pulmonary hypertension, primary, 3, 615343 ",3,"CAV1, BSCL3, CGL3, PPH3, LCCNS",601047,7q31.2,CAV1
"Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 ",3,"BMPR2, PPH1, POVD1",600799,2q33.1-q33.2,BMPR2
"Pulmonary venoocclusive disease 1, 265450 ",3,"BMPR2, PPH1, POVD1",600799,2q33.1-q33.2,BMPR2
"Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 ",3,"PSTPIP1, PSTPIP, CD2BP1, PAPAS",606347,15q24.3,PSTPIP1
"Pyropoikilocytosis, 266140 ",3,"SPTA1, EL2, SPH3, HS3, HPP",182860,1q23.1,SPTA1
"Pyruvate carboxylase deficiency, 266150 ",3,PC,608786,11q13.2,PC
"Pyruvate dehydrogenase E1-alpha deficiency, 312170 ",3,"PDHA1, PHE1A, PDHAD",300502,Xp22.12,PDHA1
"Pyruvate kinase deficiency, 266200 ",3,"PKLR, PK1",609712,1q22,PKLR
"Quebec platelet disorder, 601709 ",3,"PLAU, URK, QPD, BDPLT5",191840,10q22.2,PLAU
"Question mark ears, isolated, 612798 ",3,"EDN1, ARCND3, QME, HDLCQ7",131240,6p24.1,EDN1
"RAS-associated autoimmune leukoproliferative disorder, 614470 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Rabson-Mendenhall syndrome, 262190 ",3,"INSR, HHF5",147670,19p13.2,INSR
"Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 ",3,"HOXA11, HOX1I, RUSAT1",142958,7p15.2,HOXA11
"Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 ",3,"MECOM, EVI1, RUSAT2",165215,3q26.2,MECOM
"Raine syndrome, 259775 ",3,"FAM20C, DMP4",611061,7p22.3,FAM20C
"Rapp-Hodgkin syndrome, 129400 ",3,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",603273,3q28,TP63
"Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 ",3,"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B",300163,Xq26.3,FHL1
"Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 ",3,"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B",300163,Xq26.3,FHL1
"Renal carcinoma, chromophobe, somatic, 144700 ",3,"FLCN, BHD",607273,17p11.2,FLCN
"Renal cell carcinoma, 144700 ",3,"HNF1A, TCF1, MODY3, IDDM20",142410,12q24.31,HNF1A
"Renal cell carcinoma, 144700 ",3,"RNF139, TRC8, RCA1",603046,8q24.13,RNF139
"Renal cell carcinoma, clear cell, somatic, 144700 ",3,OGG1,601982,3p25.3,OGG1
"Renal cell carcinoma, papillary, 1, familial and somatic, 605074 ",3,"MET, DFNB97, OSFD",164860,7q31.2,MET
"Renal cell carcinoma, papillary, 605074 ",3,"PRCC, RCCP1",179755,1q23.1,PRCC
"Renal cell carcinoma, somatic, 144700 ",3,VHL,608537,3p25.3,VHL
"Renal cysts and diabetes syndrome, 137920 ",3,"HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11",189907,17q12,HNF1B
"Renal tubular acidosis with deafness, 267300 ",3,"ATP6B1, VPP3",192132,2p13.3,ATP6B1
"Renal tubular acidosis, distal, AD, 179800 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Renal tubular acidosis, distal, AR, 611590 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Renal tubular acidosis, distal, autosomal recessive, 602722 ",3,"ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR",605239,7q34,ATP6V0A4
"Renal tubular dysgenesis, 267430 ",3,"ACE, DCP1, ACE1, MVCD3, ICH",106180,17q23.3,ACE
"Renal tubular dysgenesis, 267430 ",3,"AGT, SERPINA8",106150,1q42.2,AGT
"Renal tubular dysgenesis, 267430 ",3,"AGTR1, AGTR1A, AT2R1",106165,3q24,AGTR1
"Renal tubular dysgenesis, 267430 ",3,"REN, HNFJ2",179820,1q32.1,REN
"Renal-hepatic-pancreatic dysplasia 1, 208540 ",3,"NPHP3, NPH3, RHPD1, MKS7",608002,3q22.1,NPHP3
"Renpenning syndrome, 309500 ",3,"PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8",300463,Xp11.23,PQBP1
"Restrictive dermopathy, lethal, 275210 ",3,"LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B",150330,1q22,LMNA
"Restrictive dermopathy, lethal, 275210 ",3,"ZMPSTE24, FACE1, STE24, MADB",606480,1p34.2,ZMPSTE24
"Reticular dysgenesis, 267500 ",3,AK2,103020,1p35.1,AK2
"Retinal cone dystrophy 3, 610024 ",3,"PDE6H, RCD3, ACHM6",601190,12p12.3,PDE6H
"Retinal cone dystrophy 4, 610478 ",3,"CACNA2D4, RCD4",608171,12p13.33,CACNA2D4
"Retinal degeneration, late-onset, autosomal dominant, 605670 ",3,"C1QTNF5, CTRP5, LORD",608752,11q23.3,C1QTNF5
"Retinal dystrophy, early-onset severe, 248200 ",3,"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2",601691,1p22.1,ABCA4
"Retinal dystrophy, early-onset severe, 613341 ",3,"LRAT, LCA14",604863,4q32.1,LRAT
"Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 ",3,"OTX2, MCOPS5, CPHD6",600037,14q22.3,OTX2
"Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 ",3,"RBP4, RDCCAS, MCOPCB10",180250,10q23.33,RBP4
"Retinitis pigmentosa 1, 180100 ",3,"RP1, ORP1",603937,8q11.2-q12.1,RP1
"Retinitis pigmentosa 10, 180105 ",3,"IMPDH1, RP10, LCA11",146690,7q32.1,IMPDH1
"Retinitis pigmentosa 13, 600059 ",3,"PRPF8, PRPC8, RP13",607300,17p13.3,PRPF8
"Retinitis pigmentosa 14, 600132 ",3,"TULP1, RP14, LCA15",602280,6p21.31,TULP1
"Retinitis pigmentosa 17, 600852 ",3,"CA4, RP17",114760,17q23.1,CA4
"Retinitis pigmentosa 18, 601414 ",3,"PRPF3, HPRP3, RP18",607301,1q21.2,PRPF3
"Retinitis pigmentosa 19, 601718 ",3,"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2",601691,1p22.1,ABCA4
"Retinitis pigmentosa 2, 312600 ",3,RP2,300757,Xp11.3,RP2
"Retinitis pigmentosa 20, 613794 ",3,"RPE65, RP20, LCA2",180069,1p31.3,RPE65
"Retinitis pigmentosa 25, 602772 ",3,"EYS, RP25",612424,6q12,EYS
"Retinitis pigmentosa 27, 613750 ",3,"NRL, D14S46E, RP27",162080,14q11-q12,NRL
"Retinitis pigmentosa 3, 300029 ",3,"RPGR, RP3, CRD, RP15, COD1, CORDX1",312610,Xp11.4,RPGR
"Retinitis pigmentosa 31, 609923 ",3,"TOPORS, P53BP3, LUN, RP31",609507,9p21.1,TOPORS
"Retinitis pigmentosa 37, 611131 ",3,"NR2E3, PNR, ESCS, RP37",604485,15q23,NR2E3
"Retinitis pigmentosa 38, 613862 ",3,"MERTK, RP38",604705,2q13,MERTK
"Retinitis pigmentosa 39, 613809 ",3,"USH2A, RP39",608400,1q41,USH2A
"Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 ",3,"RHO, RP4, OPN2, CSNBAD1",180380,3q22.1,RHO
"Retinitis pigmentosa 41, 612095 ",3,"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",604365,4p15.32,PROM1
"Retinitis pigmentosa 43, 613810 ",3,"PDE6A, PDEA, RP43",180071,5q32,PDE6A
"Retinitis pigmentosa 44, 613769 ",3,"RGR, RP44",600342,10q23.1,RGR
"Retinitis pigmentosa 47, 613758 ",3,"SAG, RP47",181031,2q37.1,SAG
"Retinitis pigmentosa 49, 613756 ",3,"CNGA1, CNCG1, RP49",123825,4p12,CNGA1
"Retinitis pigmentosa 57, 613582 ",3,"PDE6G, PDEG, RP57",180073,17q25.3,PDE6G
"Retinitis pigmentosa 61, 614180 ",3,"CLRN1, USH3A, USH3, RP61",606397,3q25.1,CLRN1
"Retinitis pigmentosa 65, 613660 ",3,"CDHR1, PCDH21, PRCAD, CORD15, RP65",609502,10q23.1,CDHR1
"Retinitis pigmentosa 7 and digenic, 608133 ",3,"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1",179605,6p21.1,PRPH2
"Retinitis pigmentosa 7, digenic, 608133 ",3,"ROM1, ROSP1, RP7",180721,11q12.3,ROM1
"Retinitis pigmentosa 73, 616544 ",3,"HGSNAT, TMEM76, MPS3C, RP73",610453,8p11.2-p11.1,HGSNAT
"Retinitis pigmentosa 74, 616562 ",3,"BBS2, RP74",606151,16q13,BBS2
"Retinitis pigmentosa 76, 617123 ",3,"POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76",606822,1p34.1,POMGNT1
"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 ",3,"RPGR, RP3, CRD, RP15, COD1, CORDX1",312610,Xp11.4,RPGR
"Retinitis pigmentosa, concentric, 613194 ",3,"BEST1, VMD2, ARB, RP50",607854,11q12.3,BEST1
"Retinitis pigmentosa, juvenile, 604393 ",3,"AIPL1, LCA4",604392,17p13.2,AIPL1
"Retinitis pigmentosa, juvenile, 613341 ",3,"LRAT, LCA14",604863,4q32.1,LRAT
"Retinitis pigmentosa, juvenile, autosomal recessive, 604232 ",3,"SPATA7, HSD3, LCA3",609868,14q31.3,SPATA7
"Retinitis pigmentosa-12, autosomal recessive, 600105 ",3,"CRB1, RP12, LCA8",604210,1q31.3,CRB1
"Retinitis pigmentosa-40, 613801 ",3,"PDE6B, PDEB, RP40, CSNBAD2",180072,4p16.3,PDE6B
"Retinitis pigmentosa-50, 613194 ",3,"BEST1, VMD2, ARB, RP50",607854,11q12.3,BEST1
"Retinitis punctata albescens, 136880 ",3,"PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1",179605,6p21.1,PRPH2
"Retinitis punctata albescens, 136880 ",3,"RHO, RP4, OPN2, CSNBAD1",180380,3q22.1,RHO
"Retinitis punctata albescens, 136880 ",3,RLBP1,180090,15q26.1,RLBP1
"Retinoblastoma, 180200 ",3,RB1,614041,13q14.2,RB1
"Retinoblastoma, trilateral, 180200 ",3,RB1,614041,13q14.2,RB1
"Retinopathy of prematurity, 133780 ",3,"FZD4, EVR1",604579,11q14.2,FZD4
"Retinoschisis, 312700 ",3,"RS1, XLRS1",300839,Xp22.13,RS1
"Rett syndrome, 312750 ",3,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16",300005,Xq28,MECP2
"Rett syndrome, atypical, 312750 ",3,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16",300005,Xq28,MECP2
"Rett syndrome, congenital variant, 613454 ",3,"FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1",164874,14q12,FOXG1
"Rett syndrome, preserved speech variant, 312750 ",3,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16",300005,Xq28,MECP2
"Rhabdoid tumors, somatic, 609322 ",3,"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3",601607,22q11.23,SMARCB1
"Rhabdomyosarcoma 2, alveolar, 268220 ",3,"PAX3, WS1, HUP2, CDHS, WS3",606597,2q36.1,PAX3
"Rhabdomyosarcoma 2, alveolar, 268220 ",3,"PAX7, RMS2",167410,1p36.13,PAX7
"Rhabdomyosarcoma, alveolar, 268220 ",3,"FOXO1A, FKHR",136533,13q14.11,FOXO1A
"Rhizomelic chondrodysplasia punctata, type 5, 616716 ",3,"PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5",600414,12p13.31,PEX5
"Rieger or Axenfeld anomalies, 602482 ",3,"FOXC1, FKHL7, FREAC3, IRID1, RIEG3",601090,6p25.3,FOXC1
"Ring dermoid of cornea, 180550 ",3,"PITX2, IDG2, RIEG1, RGS, IGDS2",601542,4q25,PITX2
"Rippling muscle disease, 606072 ",3,"CAV3, LGMD1C, LQT9",601253,3p25.3,CAV3
"Ritscher-Schinzel syndrome 1, 220210 ",3,"KIAA0196, SPG8, RTSC1",610657,8q24.13,KIAA0196
"Roberts syndrome, 268300 ",3,ESCO2,609353,8p21.1,ESCO2
"Robinow syndrome, autosomal dominant 2, 616331 ",3,"DVL1, DRS2",601365,1p36.33,DVL1
"Robinow syndrome, autosomal dominant 3, 616894 ",3,"DVL3, DRS3",601368,3q27.1,DVL3
"Robinow syndrome, autosomal recessive, 268310 ",3,"ROR2, BDB1, BDB, NTRKR2",602337,9q22.31,ROR2
"Robinow-Sorauf syndrome, 180750 ",3,"TWIST1, ACS3, SCS, CRS1",601622,7p21.1,TWIST1
"Roussy-Levy syndrome, 180800 ",3,"MPZ, CMT1B, CMTDID, CHM, DSS",159440,1q23.3,MPZ
"Roussy-Levy syndrome, 180800 ",3,"PMP22, CMT1A, CMT1E, DSS",601097,17p12,PMP22
"Rubinstein-Taybi syndrome, 180849 ",3,"CREBBP, CBP, RSTS",600140,16p13.3,CREBBP
"SADDAN, 616482 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"SC phocomelia syndrome, 269000 ",3,ESCO2,609353,8p21.1,ESCO2
"SED congenita, 183900 ",3,COL2A1,120140,12q13.11,COL2A1
"SED, Maroteaux type, 184095 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"SESAME syndrome, 612780 ",3,"KCNJ10, SESAME",602208,1q23.2,KCNJ10
"SMED Strudwick type, 184250 ",3,COL2A1,120140,12q13.11,COL2A1
"Saethre-Chotzen syndrome with eyelid anomalies, 101400 ",3,"TWIST1, ACS3, SCS, CRS1",601622,7p21.1,TWIST1
"Saethre-Chotzen syndrome, 101400 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Saethre-Chotzen syndrome, 101400 ",3,"TWIST1, ACS3, SCS, CRS1",601622,7p21.1,TWIST1
"Salla disease, 604369 ",3,"SLC17A5, SIASD, SLD",604322,6q13,SLC17A5
"Salt and pepper developmental regression syndrome, 609056 ",3,"SIAT9, ST3GALV, SPDRS",604402,2p11.2,SIAT9
"Sandhoff disease, infantile, juvenile, and adult forms, 268800 ",3,HEXB,606873,5q13.3,HEXB
"Sarcoidosis, early-onset, 609464 ",3,"NOD2, CARD15, IBD1, CD, ACUG, PSORAS1",605956,16q12.1,NOD2
"Scaphocephaly, maxillary retrusion, and mental retardation, 609579 ",3,"FGFR2, BEK, CFD1, JWS, TK14, BBDS",176943,10q26.13,FGFR2
"Scapuloperoneal myopathy, X-linked dominant, 300695 ",3,"FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B",300163,Xq26.3,FHL1
"Scapuloperoneal spinal muscular atrophy, 181405 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Scapuloperoneal syndrome, myopathic type, 181430 ",3,"MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD",160760,14q11.2,MYH7
"Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 ",3,"DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R",125660,2q35,DES
"Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 ",3,HRAS,190020,11p15.5,HRAS
"Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 ",3,"KRAS, KRAS2, RASK2, NS, CFC2, RALD",190070,12p12.1,KRAS
"Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Schindler disease, type I, 609241 ",3,NAGA,104170,22q13.2,NAGA
"Schindler disease, type III, 609241 ",3,NAGA,104170,22q13.2,NAGA
"Schinzel-Giedion midface retraction syndrome, 269150 ",3,"SETBP1, KIAA0437, SEB, MRD29",611060,18q12.3,SETBP1
"Schizencephaly, 269160 ",3,EMX2,600035,10q26.11,EMX2
"Schizencephaly, 269160 ",3,"SHH, HPE3, HLP3, SMMCI, MCOPCB5",600725,7q36.3,SHH
"Schizencephaly, 269160 ",3,"SIX3, HPE2",603714,2p21,SIX3
"Schneckenbecken dysplasia, 269250 ",3,"SLC35D1, UGTREL7, KIAA0260",610804,1p31.3,SLC35D1
"Schopf-Schulz-Passarge syndrome, 224750 ",3,"WNT10A, SSPS, STHAG4, OODD",606268,2q35,WNT10A
"Schwannomatosis, 162091 ",3,NF2,607379,22q12.2,NF2
"Schwartz-Jampel syndrome, type 1, 255800 ",3,"HSPG2, PLC, SJS, SJA, SJS1",142461,1p36.12,HSPG2
"Sclerosteosis 1, 269500 ",3,"SOST, VBCH, CDD, SOST1",605740,17q21.31,SOST
"Sea-blue histiocyte disease, 269600 ",3,"APOE, AD2, LPG, LDLCQ5",107741,19q13.32,APOE
"Sebastian syndrome, 605249 ",3,"MYH9, MHA, FTNS, DFNA17, BDPLT6",160775,22q12.3,MYH9
"Seborrhea-like dermatitis with psoriasiform elements, 610227 ",3,"ZNF750, FLJ13841",610226,17q25.3,ZNF750
"Seckel syndrome 1, 210600 ",3,"ATR, FRP1, SCKL1, FCTCS",601215,3q23,ATR
"Seckel syndrome 9, 616777 ",3,"TRAIP, TRIP, RNF206, SCKL9",605958,3p21.31,TRAIP
"Segawa syndrome, recessive, 605407 ",3,"TH, TYH",191290,11p15.5,TH
"Seizures, benign familial infantile, 3, 607745 ",3,"SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS",182390,2q24.3,SCN2A
"Seizures, benign neonatal, 1, 121200 ",3,"KCNQ2, EBN1, EIEE7, BFNS1",602235,20q13.33,KCNQ2
"Seizures, benign neonatal, type 2, 121201 ",3,"KCNQ3, EBN2, BFNC2",602232,8q24.22,KCNQ3
"Seizures, cortical blindness, microcephaly syndrome, 616632 ",3,"DIAPH1, DFNA1, LFHL1, SCBMS",602121,5q31.3,DIAPH1
"Senior-Loken syndrome 6, 610189 ",3,"CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14",610142,12q21.32,CEP290
"Senior-Loken syndrome-1, 266900 ",3,"NPHP1, NPH1, SLSN1, JBTS4",607100,2q13,NPHP1
"Severe combined immunodeficiency due to ADA deficiency, 102700 ",3,ADA,608958,20q13.12,ADA
"Severe combined immunodeficiency, Athabascan type, 602450 ",3,"DCLRE1C, ARTEMIS, SCIDA",605988,10p13,DCLRE1C
"Severe combined immunodeficiency, B cell-negative, 601457 ",3,RAG1,179615,11p12,RAG1
"Severe combined immunodeficiency, B cell-negative, 601457 ",3,RAG2,179616,11p12,RAG2
"Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 ",3,"PTPRC, CD45, LCA",151460,1q31.3-q32.1,PTPRC
"Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 ",3,"IL7R, IL7RA, CD127",146661,5p13.2,IL7R
"Severe combined immunodeficiency, X-linked, 300400 ",3,"IL2RG, SCIDX1, SCIDX, IMD4",308380,Xq13.1,IL2RG
"Short QT syndrome 1, 609620 ",3,"KCNH2, LQT2, HERG, SQT1",152427,7q36.1,KCNH2
"Short QT syndrome 2, 609621 ",3,"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2",607542,11p15.5-p15.4,KCNQ1
"Short QT syndrome 3, 609622 ",3,"KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9",600681,17q24.3,KCNJ2
"Short stature, idiopathic familial, 300582 ",3,"SHOX, GCFX, SS, PHOG",312865,Xp22.33,SHOX
"Short stature, idiopathic familial, 300582 ",3,SHOXY,400020,Yp11.2,SHOXY
"Short stature, microcephaly, and endocrine dysfunction, 616541 ",3,"XRCC4, SSMED",194363,5q14.2,XRCC4
"Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 ",3,IFT52,617094,20q13.12,IFT52
"Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 ",3,"IFT80, KIAA1374, WDR56, SRTD2, ATD2",611177,3q25.33,IFT80
"Shprintzen-Goldberg syndrome, 182212 ",3,"SKI, SGS",164780,1p36.33-p36.32,SKI
"Shwachman-Diamond syndrome, 260400 ",3,"SBDS, SDS",607444,7q11.21,SBDS
"Sialic acid storage disorder, infantile, 269920 ",3,"SLC17A5, SIASD, SLD",604322,6q13,SLC17A5
"Sialidosis, type I, 256550 ",3,"NEU1, NEU, SIAL1",608272,6p21.33,NEU1
"Sialidosis, type II, 256550 ",3,"NEU1, NEU, SIAL1",608272,6p21.33,NEU1
"Sialuria, 269921 ",3,"GNE, GLCNE, IBM2, DMRV, NM",603824,9p13.3,GNE
"Sick sinus syndrome 1, 608567 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Sickle cell anemia, 603903 ",3,HBB,141900,11p15.4,HBB
"Silver spastic paraplegia syndrome, 270685 ",3,"BSCL2, SPG17, HMN5, PELD",606158,11q12.3,BSCL2
"Silver-Russell syndrome, 180860 ",3,"H19, D11S813E, ASM1, BWS, WT2",103280,11p15.5,H19
"Simpson-Golabi-Behmel syndrome, type 1, 312870 ",3,"GPC3, SDYS, SGBS1",300037,Xq26.2,GPC3
"Simpson-Golabi-Behmel syndrome, type 2, 300209 ",3,"OFD1, CXorf5, SGBS2, JBTS10, RP23",300170,Xp22.2,OFD1
"Single median maxillary central incisor, 147250 ",3,"SHH, HPE3, HLP3, SMMCI, MCOPCB5",600725,7q36.3,SHH
"Singleton-Merten syndrome 1, 182250 ",3,"IFIH1, MDA5, AGS7, SGMRT1",606951,2q24.2,IFIH1
"Sinoatrial node dysfunction and deafness, 614896 ",3,"CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA",114206,3p21.1,CACNA1D
"Sjogren-Larsson syndrome, 270200 ",3,"ALDH3A2, ALDH10, SLS, FALDH",609523,17p11.2,ALDH3A2
"Skeletal defects, genital hypoplasia, and mental retardation, 612447 ",3,"ZBTB16, ZNF145, PLZF",176797,11q23.2,ZBTB16
"Skin fragility-woolly hair syndrome, 607655 ",3,"DSP, KPPS2, PPKS2, DCWHKTA",125647,6p24.3,DSP
"Small cell cancer of the lung, somatic, 182280 ",3,RB1,614041,13q14.2,RB1
"Small fiber neuropathy, 133020 ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Smith-Lemli-Opitz syndrome, 270400 ",3,"DHCR7, SLOS",602858,11q13.4,DHCR7
"Smith-Magenis syndrome, 182290 ",3,"RAI1, SMCR, SMS",607642,17p11.2,RAI1
"Smith-McCort dysplasia, 607326 ",3,"DYM, FLJ90130, DMC, SMC",607461,18q21.1,DYM
"Snowflake vitreoretinal degeneration, 193230 ",3,"KCNJ13, SVD, LCA16",603208,2q37.1,KCNJ13
"Sorsby fundus dystrophy, 136900 ",3,"TIMP3, SFD",188826,22q12.3,TIMP3
"Sotos syndrome 1, 117550 ",3,"NSD1, ARA267, STO, SOTOS1",606681,5q35.3,NSD1
"Sotos syndrome 2, 614753 ",3,"NFIX, NF1A, SOTOS2, MRSHSS",164005,19p13.13,NFIX
"Spastic ataxia 1, autosomal dominant, 108600 ",3,"VAMP1, SYB1, SPAX1",185880,12p13.31,VAMP1
"Spastic ataxia 5, autosomal recessive, 614487 ",3,"AFG3L2, SCA28, SPAX5",604581,18p11.21,AFG3L2
"Spastic paralysis, infantile onset ascending, 607225 ",3,"ALS2, ALSJ, PLSJ, IAHSP",606352,2q33.1,ALS2
"Spastic paraplegia 10, autosomal dominant, 604187 ",3,"KIF5A, NKHC, SPG10",602821,12q13.3,KIF5A
"Spastic paraplegia 11, autosomal recessive, 604360 ",3,"SPG11, KIAA1840, FLJ21439, ALS5, CMT2X",610844,15q21.1,SPG11
"Spastic paraplegia 13, autosomal dominant, 605280 ",3,"HSPD1, SPG13, HSP60, HLD4",118190,2q33.1,HSPD1
"Spastic paraplegia 15, autosomal recessive, 270700 ",3,"ZFYVE26, KIAA0321, SPG15",612012,14q24.1,ZFYVE26
"Spastic paraplegia 2, X-linked, 312920 ",3,"PLP1, PMD, HLD1, SPG2",300401,Xq22.2,PLP1
"Spastic paraplegia 28, autosomal recessive, 609340 ",3,"DDHD1, PAPLA1, KIAA1705, SPG28",614603,14q22.1,DDHD1
"Spastic paraplegia 39, autosomal recessive, 612020 ",3,"PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS",603197,19p13.2,PNPLA6
"Spastic paraplegia 3A, autosomal dominant, 182600 ",3,"ATL1, SPG3A, HSN1D",606439,14q22.1,ATL1
"Spastic paraplegia 4, autosomal dominant, 182601 ",3,"SPAST, SPG4",604277,2p22.3,SPAST
"Spastic paraplegia 42, autosomal dominant, 612539 ",3,"SLC33A1, ACATN, AT1, SPG42, CCHLND",603690,3q25.31,SLC33A1
"Spastic paraplegia 44, autosomal recessive, 613206 ",3,"GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C",608803,1q42.13,GJC2
"Spastic paraplegia 48, autosomal recessive, 613647 ",3,"AP5Z1, KIAA0415, SPG48",613653,7p22.1,AP5Z1
"Spastic paraplegia 50, autosomal recessive, 612936 ",3,"AP4M1, SPG50, CPSQ3",602296,7q22.1,AP4M1
"Spastic paraplegia 5A, autosomal recessive, 270800 ",3,"CYP7B1, CBAS3, SPG5A",603711,8q12.3,CYP7B1
"Spastic paraplegia 6, autosomal dominant, 600363 ",3,"NIPA1, SPG6",608145,15q11.2,NIPA1
"Spastic paraplegia 75, autosomal recessive, 616680 ",3,"MAG, GMA, SPG75",159460,19q13.12,MAG
"Spastic paraplegia 76, autosomal recessive, 616907 ",3,"CAPN1, SPG76",114220,11q13.1,CAPN1
"Spastic paraplegia 8, autosomal dominant, 603563 ",3,"KIAA0196, SPG8, RTSC1",610657,8q24.13,KIAA0196
"Spastic paraplegia 9A, autosomal dominant, 601162 ",3,"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3",138250,10q24.1,ALDH18A1
"Spastic paraplegia 9B, autosomal recessive, 616586 ",3,"ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3",138250,10q24.1,ALDH18A1
"Spasticity, childhood-onset, with hyperglycinemia, 616859 ",3,"GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC",609588,14q32.13,GLRX5
"Speech-language disorder-1, 602081 ",3,"FOXP2, SPCH1, TNRC10, CAGH44",605317,7q31.1,FOXP2
"Spermatocytic seminoma, somatic, 273300 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Spermatogenic failure 5, 243060 ",3,"AURKC, STK13, AIE2, SPGF5",603495,19q13.43,AURKC
"Spherocytosis, type 1, 182900 ",3,"ANK1, SPH1",612641,8p11.21,ANK1
"Spherocytosis, type 2, 616649 ",3,"SPTB, SPH2, EL3, HS2",182870,14q23.3,SPTB
"Spherocytosis, type 3, 270970 ",3,"SPTA1, EL2, SPH3, HS3, HPP",182860,1q23.1,SPTA1
"Spherocytosis, type 4, 612653 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Spherocytosis, type 5, 612690 ",3,"EPB42, SPH5",177070,15q15.2,EPB42
"Spinal and bulbar muscular atrophy of Kennedy, 313200 ",3,"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",313700,Xq12,AR
"Spinal muscular atrophy, X-linked 2, infantile, 301830 ",3,"UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1",314370,Xp11.3,UBA1
"Spinal muscular atrophy, distal, X-linked 3, 300489 ",3,"ATP7A, MNK, MK, OHS, SMAX3",300011,Xq21.1,ATP7A
"Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 ",3,"PLEKHG5, KIAA0720, DSMA4, CMTRIC",611101,1p36.31,PLEKHG5
"Spinal muscular atrophy, distal, congenital nonprogressive, 600175 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Spinal muscular atrophy, late-onset, Finkel type, 182980 ",3,"VAPB, VAPC, ALS8",605704,20q13.32,VAPB
"Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 ",3,"DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1",600112,14q32.31,DYNC1H1
"Spinal muscular atrophy-1, 253300 ",3,"SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q13.2,SMN1
"Spinal muscular atrophy-2, 253550 ",3,"SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q13.2,SMN1
"Spinal muscular atrophy-3, 253400 ",3,"SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q13.2,SMN1
"Spinal muscular atrophy-4, 271150 ",3,"SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q13.2,SMN1
"Spinocerebellar ataxia 1, 164400 ",3,"ATXN1, ATX1, SCA1",601556,6p22.3,ATXN1
"Spinocerebellar ataxia 10, 603516 ",3,"ATXN10, SCA10",611150,22q13.31,ATXN10
"Spinocerebellar ataxia 11, 604432 ",3,"TTBK2, SCA11",611695,15q15.2,TTBK2
"Spinocerebellar ataxia 13, 605259 ",3,"KCNC3, SCA13",176264,19q13.33,KCNC3
"Spinocerebellar ataxia 14, 605361 ",3,"PRKCG, PKCC, PKCG, SCA14",176980,19q13.42,PRKCG
"Spinocerebellar ataxia 15, 606658 ",3,"ITPR1, SCA15, SCA16, SCA29",147265,3p26.1,ITPR1
"Spinocerebellar ataxia 17, 607136 ",3,"TBP, SCA17, HDL4",600075,6q27,TBP
"Spinocerebellar ataxia 19, 607346 ",3,"KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9",605411,1p13.2,KCND3
"Spinocerebellar ataxia 2, 183090 ",3,"ATXN2, ATX2, SCA2, ASL13",601517,12q24.12,ATXN2
"Spinocerebellar ataxia 21, 607454 ",3,"TMEM240, C1orf70, SCA21",616101,1p36.33,TMEM240
"Spinocerebellar ataxia 23, 610245 ",3,"PDYN, SCA23",131340,20p13,PDYN
"Spinocerebellar ataxia 27, 609307 ",3,"FGF14, FHF4, SCA27",601515,13q33.1,FGF14
"Spinocerebellar ataxia 28, 610246 ",3,"AFG3L2, SCA28, SPAX5",604581,18p11.21,AFG3L2
"Spinocerebellar ataxia 29, congenital nonprogressive, 117360 ",3,"ITPR1, SCA15, SCA16, SCA29",147265,3p26.1,ITPR1
"Spinocerebellar ataxia 5, 600224 ",3,"SPTBN2, SCA5, SCAR14",604985,11q13.2,SPTBN2
"Spinocerebellar ataxia 6, 183086 ",3,"CACNA1A, CACNL1A4, SCA6, EIEE42",601011,19p13.13,CACNA1A
"Spinocerebellar ataxia 7, 164500 ",3,"ATXN7, SCA7, OPCA3",607640,3p14.1,ATXN7
"Spinocerebellar ataxia 8, 608768 ",3,ATXN8,613289,13q21,ATXN8
"Spinocerebellar ataxia 8, 608768 ",3,"ATXN8OS, SCA8, KLHL1AS",603680,13q21.33,ATXN8OS
"Spinocerebellar ataxia, autosomal recessive 1, 606002 ",3,"SETX, SCAR1, AOA2, ALS4",608465,9q34.13,SETX
"Spinocerebellar ataxia, autosomal recessive 13, 614831 ",3,"GRM1, MGLUR1, GRM1A, SCAR13",604473,6q24.3,GRM1
"Spinocerebellar ataxia, autosomal recessive 14, 615386 ",3,"SPTBN2, SCA5, SCAR14",604985,11q13.2,SPTBN2
"Spinocerebellar ataxia, autosomal recessive 18, 616204 ",3,"GRID2, SCAR18",602368,4q22.1-q22.2,GRID2
"Spinocerebellar ataxia, autosomal recessive 7, 609270 ",3,"TPP1, CLN2, SCAR7",607998,11p15.4,TPP1
"Spinocerebellar ataxia, autosomal recessive 8, 610743 ",3,"SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4",608441,6q25.2,SYNE1
"Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 ",3,TDP1,607198,14q32.11,TDP1
"Spinocrebellar ataxia, autosomal recessive 12, 614322 ",3,"WWOX, FOR, SCAR12, EIEE28",605131,16q23.1-q23.2,WWOX
"Split-hand/foot malformation 4, 605289 ",3,"TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8",603273,3q28,TP63
"Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 ",3,"NKX3-2, BAPX1, SMMD",602183,4p15.33,NKX3-2
"Spondylocarpotarsal synostosis syndrome, 272460 ",3,"FLNB, SCT, AOI, LRS1",603381,3p14.3,FLNB
"Spondylocostal dysostosis 1, autosomal recessive, 277300 ",3,"DLL3, SCDO1",602768,19q13.2,DLL3
"Spondylocostal dysostosis 5, 122600 ",3,"TBX6, SCDO5",602427,16p11.2,TBX6
"Spondyloenchondrodysplasia with immune dysregulation, 607944 ",3,"ACP5, SPENCDI",171640,19p13.2,ACP5
"Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 ",3,"KIF22, KNSL4, KID, OBP, SEMDJL2",603213,16p11.2,KIF22
"Spondyloepimetaphyseal dysplasia, 608728 ",3,"MATN3, EDM5, HOA, OS2",602109,2p24.1,MATN3
"Spondyloepimetaphyseal dysplasia, Missouri type, 602111 ",3,"MMP13, CLG3, MANDP1, MDST",600108,11q22.2,MMP13
"Spondyloepimetaphyseal dysplasia, X-linked, 300106 ",3,"BGN, SEMDX",301870,Xq28,BGN
"Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 ",3,"ACAN, AGC1, CSPG1, MSK16, SEDK",155760,15q26.1,ACAN
"Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 ",3,"WISP3, PPAC, PPD",603400,6q21,WISP3
"Spondyloepiphyseal dysplasia tarda, 313400 ",3,"TRAPPC2, SEDL, SEDT",300202,Xp22.2,TRAPPC2
"Spondyloepiphyseal dysplasia, Kimberley type, 608361 ",3,"ACAN, AGC1, CSPG1, MSK16, SEDK",155760,15q26.1,ACAN
"Spondyloepiphyseal dysplasia, Stanescu type, 616583 ",3,COL2A1,120140,12q13.11,COL2A1
"Spondylometaphyseal dysplasia, Kozlowski type, 184252 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Spondylometaphyseal dysplasia, Sedaghatian type, 250220 ",3,"GPX4, SMDS",138322,19p13.3,GPX4
"Spondyloperipheral dysplasia, 271700 ",3,COL2A1,120140,12q13.11,COL2A1
"Squamous cell carcinoma, head and neck, 275355 ",3,"TNFRSF10B, DR5, TRAILR2",603612,8p21.3,TNFRSF10B
"Squamous cell carcinoma, head and neck, somatic, 275355 ",3,ING1,601566,13q34,ING1
"Squamous cell carcinoma, head and neck, somatic, 275355 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Stapes ankylosis with broad thumb and toes, 184460 ",3,"NOG, SYM1, SYNS1A",602991,17q22,NOG
"Stargardt disease 1, 248200 ",3,"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2",601691,1p22.1,ABCA4
"Stargardt disease 4, 603786 ",3,"PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4",604365,4p15.32,PROM1
"Steatocystoma multiplex, 184500 ",3,"KRT17, PC2, PCHC1",148069,17q21.2,KRT17
"Stickler sydrome, type I, nonsyndromic ocular, 609508 ",3,COL2A1,120140,12q13.11,COL2A1
"Stickler syndrome, type I, 108300 ",3,COL2A1,120140,12q13.11,COL2A1
"Stickler syndrome, type II, 604841 ",3,"COL11A1, STL2",120280,1p21.1,COL11A1
"Stickler syndrome, type III, 184840 ",3,"COL11A2, STL3, DFNA13, DFNB53, FBCG2",120290,6p21.32,COL11A2
"Stickler syndrome, type IV, 614134 ",3,"COL9A1, EDM6, STL4",120210,6q13,COL9A1
"Stiff skin syndrome, 184900 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 ",3,"SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN",138140,1p34.2,SLC2A1
"Striatal degeneration, autosomal dominant, 609161 ",3,"PDE8B, PPNAD3, ADSD",603390,5q13.3,PDE8B
"Striatal degeneration, autosomal dominant, 616922 ",3,"PDE10A, IOLOD, ADSD2",610652,6q27,PDE10A
"Striatonigral degeneration, infantile, 271930 ",3,"NUP62, SNDI, IBSN",605815,19q13.33,NUP62
"Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 ",3,"LIFR, STWS, SWS, SJS2",151443,5p13.1,LIFR
"Subcortical laminal heteropia, X-linked, 300067 ",3,"DCX, DBCN, LISX",300121,Xq23,DCX
"Subcortical laminar heterotopia, 607432 ",3,"PAFAH1B1, LIS1",601545,17p13.3,PAFAH1B1
"Succinic semialdehyde dehydrogenase deficiency, 271980 ",3,"ALDH5A1, SSADH",610045,6p22.3,ALDH5A1
"Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 ",3,"OXCT1, OXCT, SCOT",601424,5p13.1,OXCT1
"Sucrase-isomaltase deficiency, congenital, 222900 ",3,SI,609845,3q26.1,SI
"Sudden infant death with dysgenesis of the testes syndrome, 608800 ",3,"TSPYL1, TSPYL, SIDDT",604714,6q22.1,TSPYL1
"Supranuclear palsy, progressive atypical, 260540 ",3,"MAPT, MTBT1, DDPAC, MSTD",157140,17q21.31,MAPT
"Supranuclear palsy, progressive, 601104 ",3,"MAPT, MTBT1, DDPAC, MSTD",157140,17q21.31,MAPT
"Supravalvar aortic stenosis, 185500 ",3,ELN,130160,7q11.23,ELN
"Surfactant metabolism dysfunction, pulmonary, 1, 265120 ",3,"SFTPB, SFTB3, SMDP1",178640,2p11.2,SFTPB
"Surfactant metabolism dysfunction, pulmonary, 2, 610913 ",3,"SFTPC, SFTP2, SMDP2",178620,8p21.3,SFTPC
"Surfactant metabolism dysfunction, pulmonary, 4, 300770 ",3,"CSF2RA, SMDP4",306250,Xp22.33,CSF2RA
"Sveinsson chorioretinal atrophy, 108985 ",3,"TEAD1, TCF13, REF1",189967,11p15.3,TEAD1
"Symmetric circumferential skin creases, congenital, 1, 156610 ",3,"TUBB, TUBB5, M40, CDCBM6, CSCSC1",191130,6p21.33,TUBB
"Symmetric circumferential skin creases, congenital, 2, 616734 ",3,"MAPRE2, EB2, RP1, CSCSC2",605789,18q12.1-q12.2,MAPRE2
"Symphalangism, proximal, 1A, 185800 ",3,"NOG, SYM1, SYNS1A",602991,17q22,NOG
"Symphalangism, proximal, 1B, 615298 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Syndactyly, type III, 186100 ",3,"GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP",121014,6q22.31,GJA1
"Syndactyly, type IV, 186200 ",3,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS",605522,7q36.3,LMBR1
"Syndactyly, type V, 186300 ",3,"HOXD13, HOX4I, SPD1, BDSD",142989,2q31.1,HOXD13
"Synpolydactyly 1, 186000 ",3,"HOXD13, HOX4I, SPD1, BDSD",142989,2q31.1,HOXD13
"T-cell acute lymphoblastic leukemia, somatic, 613065 ",3,BAX,600040,19q13.33,BAX
"T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 ",3,"STK4, MST1, KRS2, TIIAC",604965,20q13.12,STK4
"Tangier disease, 205400 ",3,"ABCA1, ABC1, HDLDT1, TGD",600046,9q31.1,ABCA1
"Tarsal-carpal coalition syndrome, 186570 ",3,"NOG, SYM1, SYNS1A",602991,17q22,NOG
"Tay-Sachs disease, 272800 ",3,"HEXA, TSD",606869,15q23,HEXA
"Telangiectasia, hereditary hemorrhagic, type 1, 187300 ",3,"ENG, END, HHT1, ORW",131195,9q34.11,ENG
"Telangiectasia, hereditary hemorrhagic, type 2, 600376 ",3,"ACVRL1, ACVRLK1, ALK1, HHT2",601284,12q13.13,ACVRL1
"Temtamy syndrome, 218340 ",3,"C12orf57, C10, TEMTYS",615140,12p13.31,C12orf57
"Terminal osseous dysplasia, 300244 ",3,"FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS",300017,Xq28,FLNA
"Testicular tumor, somatic, 273300 ",3,"STK11, PJS, LKB1",602216,19p13.3,STK11
"Tetralogy of Fallot, 187500 ",3,"GATA4, ASD2, VSD1, TACHD, TOF",600576,8p23.1,GATA4
"Tetralogy of Fallot, 187500 ",3,"GATA6, AVSD5, ASD9, AVSD5, PACHD",601656,18q11.2,GATA6
"Tetralogy of Fallot, 187500 ",3,"GDF1, DTGA3, DORV, RAI",602880,19p13.11,GDF1
"Tetralogy of Fallot, 187500 ",3,"JAG1, AGS1, AHD",601920,20p12.2,JAG1
"Tetralogy of Fallot, 187500 ",3,"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",600584,5q35.1,NKX2-5
"Tetralogy of Fallot, 187500 ",3,"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",602054,22q11.21,TBX1
"Tetralogy of Fallot, 187500 ",3,"ZFPM2, FOG2, DIH3, SRXY9",603693,8q23.1,ZFPM2
"Thalassemia, Hispanic gamma-delta-beta, 613985 ",3,LCRB,152424,11p15.4,LCRB
"Thalassemia, alpha-, 604131 ",3,"HBA2, HBH",141850,16p13.3,HBA2
"Thalassemia-beta, dominant inclusion-body, 603902 ",3,HBB,141900,11p15.4,HBB
"Thalassemias, alpha-, 604131 ",3,"HBA1, HBH",141800,16p13.3,HBA1
"Thalassemias, beta-, 613985 ",3,HBB,141900,11p15.4,HBB
"Thanatophoric dysplasia, type I, 187600 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Thanatophoric dysplasia, type II, 187601 ",3,"FGFR3, ACH",134934,4p16.3,FGFR3
"Thiamine-responsive megaloblastic anemia syndrome, 249270 ",3,"SLC19A2, THTR1, TRMA, THMD1",603941,1q24.2,SLC19A2
"Thrombocythemia 1, 187950 ",3,"THPO, MGDF, MPLLG, TPO, THCYT1",600044,3q27.1,THPO
"Thrombocythemia 2, 601977 ",3,"MPL, TPOR, MPLV, THCYT2",159530,1p34.2,MPL
"Thrombocythemia, somatic, 187950 ",3,"CALR, SSA",109091,19p13.13,CALR
"Thrombocythemia, somatic, 187950 ",3,"SH2B3, LNK",605093,12q24.12,SH2B3
"Thrombocytopenia 4, 612004 ",3,"CYCS, CYC, THC4",123970,7p15.3,CYCS
"Thrombocytopenia 5, 616216 ",3,"ETV6, TEL, THC5",600618,12p13.2,ETV6
"Thrombocytopenia with beta-thalassemia, X-linked, 314050 ",3,"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",305371,Xp11.23,GATA1
"Thrombocytopenia, X-linked, 313900 ",3,"WAS, IMD2, THC1, SCNX",300392,Xp11.23,WAS
"Thrombocytopenia, X-linked, intermittent, 313900 ",3,"WAS, IMD2, THC1, SCNX",300392,Xp11.23,WAS
"Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 ",3,"GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP",305371,Xp11.23,GATA1
"Thrombocytopenia, congenital amegakaryocytic, 604498 ",3,"MPL, TPOR, MPLV, THCYT2",159530,1p34.2,MPL
"Thrombophilia due to HRG deficiency, 613116 ",3,"HRG, THPH11",142640,3q27.3,HRG
"Thrombophilia due to activated protein C resistance, 188055 ",3,"F5, THPH2, RPRGL1",612309,1q24.2,F5
"Thrombophilia due to antithrombin III deficiency, 613118 ",3,"SERPINC1, AT3, AT3D, THPH7",107300,1q25.1,SERPINC1
"Thrombophilia due to heparin cofactor II deficiency, 612356 ",3,"HCF2, HC2, SERPIND1, THPH10",142360,22q11.21,HCF2
"Thrombophilia due to protein C deficiency, autosomal dominant, 176860 ",3,"PROC, PC, THPH3, THPH4",612283,2q14.3,PROC
"Thrombophilia due to protein C deficiency, autosomal recessive, 612304 ",3,"PROC, PC, THPH3, THPH4",612283,2q14.3,PROC
"Thrombophilia due to protein S deficiency, autosomal dominant, 612336 ",3,"PROS1, THPH5, THPH6",176880,3q11.1,PROS1
"Thrombophilia due to protein S deficiency, autosomal recessive, 614514 ",3,"PROS1, THPH5, THPH6",176880,3q11.1,PROS1
"Thrombophilia due to thrombin defect, 188050 ",3,"F2, THPH1, RPRGL2",176930,11p11.2,F2
"Thrombophilia due to thrombomodulin defect, 614486 ",3,"THBD, THRM, AHUS6, THPH12",188040,20p11.21,THBD
"Thrombophilia, X-linked, due to factor IX defect, 300807 ",3,"F9, HEMB, THPH8",300746,Xq27.1,F9
"Thrombosis, hyperhomocysteinemic, 236200 ",3,CBS,613381,21q22.3,CBS
"Thryoid dyshormonogenesis 6, 607200 ",3,"DUOX2, THOX2, TDH6",606759,15q21.1,DUOX2
"Thyroid carcinoma, follicular, 188470 ",3,"MINPP1, HIPER1",605391,10q23.2,MINPP1
"Thyroid carcinoma, follicular, somatic, 188470 ",3,"NRAS, ALPS4, NS6, CMNS, NCMS",164790,1p13.2,NRAS
"Thyroid dyshormonogenesis 2A, 274500 ",3,"TPO, TPX, TDH2A",606765,2p25.3,TPO
"Thyroid dyshormonogenesis 3, 274700 ",3,"TG, AITD3, TDH3",188450,8q24.22,TG
"Thyroid hormone metabolism, abnormal, 609698 ",3,"SECISBP2, SBP2",607693,9q22.2,SECISBP2
"Thyroid hormone resistance, 188570 ",3,"THRB, ERBA2, THR1, PRTH",190160,3p24.2,THRB
"Thyroid hormone resistance, autosomal recessive, 274300 ",3,"THRB, ERBA2, THR1, PRTH",190160,3p24.2,THRB
"Thyroid hormone resistance, selective pituitary, 145650 ",3,"THRB, ERBA2, THR1, PRTH",190160,3p24.2,THRB
"Tibial muscular dystrophy, tardive, 600334 ",3,"TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC",188840,2q31.2,TTN
"Tietz albinism-deafness syndrome, 103500 ",3,"MITF, WS2A, CMM8",156845,3p13,MITF
"Timothy syndrome, 601005 ",3,"CACNA1C, CACNL1A1, CCHL1A1, TS",114205,12p13.33,CACNA1C
"Toenail dystrophy, isolated, 607523 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 ",3,"MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3",142983,4p16.2,MSX1
"Tooth agenesis, selective, 4, 150400 ",3,"WNT10A, SSPS, STHAG4, OODD",606268,2q35,WNT10A
"Tooth agenesis, selective, 7, 616724 ",3,"LRP6, ADCAD2, STHAG7",603507,12p13.2,LRP6
"Tooth agenesis, selective, X-linked 1, 313500 ",3,"EDA, ED1, ECTD1, EDA, HED1, STHAGX1",300451,Xq13.1,EDA
"Tourette syndrome, 137580 ",3,"SLITRK1, KIAA1910, TTM",609678,13q31.1,SLITRK1
"Traboulsi syndrome, 601552 ",3,"ASPH, HAAH, FDLAB",600582,8q12.3,ASPH
"Transcobalamin II deficiency, 275350 ",3,"TCN2, TC2",613441,22q12.2,TCN2
"Transient bullous of the newborn, 131705 ",3,"COL7A1, NDNC8",120120,3p21.31,COL7A1
"Treacher Collins syndrome 1, 154500 ",3,"TCOF1, MFD1, TCS1",606847,5q32-q33,TCOF1
"Tremor, hereditary essential, 4, 614782 ",3,"FUS, TLS, ALS6, ETM4",137070,16p11.2,FUS
"Trichodontoosseous syndrome, 190320 ",3,"DLX3, TDO, AI4",600525,17q21.33,DLX3
"Trichomegaly, 190330 ",3,"FGF5, TCMGLY",165190,4q21.21,FGF5
"Trichorhinophalangeal syndrome, type I, 190350 ",3,TRPS1,604386,8q23.3,TRPS1
"Trichorhinophalangeal syndrome, type III, 190351 ",3,TRPS1,604386,8q23.3,TRPS1
"Trichothiodystrophy 1, photosensitive, 601675 ",3,"ERCC2, EM9, XPD, COFS2, TTD1",126340,19q13.32,ERCC2
"Trichothiodystrophy 2, photosensitive, 616390 ",3,"ERCC3, XPB, TTD2",133510,2q14.3,ERCC3
"Trichothiodystrophy 3, photosensitive, 616395 ",3,"GTF2H5, TTD3, TFB5, C6orf175, TTDA",608780,6q25.3,GTF2H5
"Trichothiodystrophy 4, nonphotosensitive, 234050 ",3,"MPLKIP, C7orf11, ABHS, TTDN1, TTD4",609188,7p14.1,MPLKIP
"Trifunctional protein deficiency, 609015 ",3,"HADHA, MTPA",600890,2p23.3,HADHA
"Trifunctional protein deficiency, 609015 ",3,HADHB,143450,2p23.3,HADHB
"Trigonocephaly 1, 190440 ",3,"FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL",136350,8p11.23,FGFR1
"Triphalangeal thumb, type I, 174500 ",3,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS",605522,7q36.3,LMBR1
"Triphalangeal thumb-polysyndactyly syndrome, 174500 ",3,"LMBR1, ACHP, C7orf2, PPD2, THYP, LSS",605522,7q36.3,LMBR1
"Trismus-pseudocamptodactyly syndrome, 158300 ",3,"MYH8, DA7",160741,17p13.1,MYH8
"Tropical calcific pancreatitis, 608189 ",3,"SPINK1, PSTI, PCTT, TATI, TCP",167790,5q32,SPINK1
"Tuberous sclerosis-1, 191100 ",3,"TSC1, LAM",605284,9q34.13,TSC1
"Tuberous sclerosis-2, 613254 ",3,"TSC2, LAM",191092,16p13.3,TSC2
"Tumor predisposition syndrome, 614327 ",3,"BAP1, TPDS",603089,3p21.1,BAP1
"Tumoral calcinosis, familial, normophosphatemic, 610455 ",3,"SAMD9, NFTC, MIRAGE",610456,7q21.2,SAMD9
"Tumoral calcinosis, hyperphosphatemic, 211900 ",3,"KL, KLOTHO",604824,13q13.1,KL
"Tumoral calcinosis, hyperphosphatemic, familial, 211900 ",3,"FGF23, ADHR, HPDR2, PHPTC",605380,12p13.32,FGF23
"Tumoral calcinosis, hyperphosphatemic, familial, 211900 ",3,"GALNT3, HHS, HFTC",601756,2q24.3,GALNT3
"Tyrosinemia, type I, 276700 ",3,FAH,613871,15q25.1,FAH
"Tyrosinemia, type II, 276600 ",3,TAT,613018,16q22.2,TAT
"Tyrosinemia, type III, 276710 ",3,HPD,609695,12q24.31,HPD
"UV-sensitive syndrome 1, 600630 ",3,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11",609413,10q11.23,ERCC6
"UV-sensitive syndrome 2, 614621 ",3,"ERCC8, CKN1, CSA, UVSS2",609412,5q12.1,ERCC8
"UV-sensitive syndrome 3, 614640 ",3,"UVSSA, KIAA1530, UVSS3",614632,4p16.3,UVSSA
"Ullrich congenital muscular dystrophy 1, 254090 ",3,"COL6A1, BTHLM1, UCHMD1",120220,21q22.3,COL6A1
"Ullrich congenital muscular dystrophy 1, 254090 ",3,"COL6A2, BTHLM1, UCMD1",120240,21q22.3,COL6A2
"Ullrich congenital muscular dystrophy 1, 254090 ",3,"COL6A3, DYT27, BTHLM1, UCMD1",120250,2q37.3,COL6A3
"Ulna and fibula, absence of, with severe limb deficiency, 276820 ",3,WNT7A,601570,3p25.1,WNT7A
"Ulnar-mammary syndrome, 181450 ",3,TBX3,601621,12q24.21,TBX3
"Urbach-Wiethe disease, 247100 ",3,"ECM1, URBWD",602201,1q21.2,ECM1
"Urofacial syndrome 2, 615112 ",3,"LRIG2, LIG2, KIAA0806, UFS2",608869,1p13.2,LRIG2
"Usher syndrome, type 1B, 276900 ",3,"MYO7A, USH1B, DFNB2, DFNA11",276903,11q13.5,MYO7A
"Usher syndrome, type 1C, 276904 ",3,"USH1C, DFNB18A",605242,11p15.1,USH1C
"Usher syndrome, type 1D, 601067 ",3,"CDH23, USH1D",605516,10q22.1,CDH23
"Usher syndrome, type 1D/F digenic, 601067 ",3,"CDH23, USH1D",605516,10q22.1,CDH23
"Usher syndrome, type 1D/F digenic, 601067 ",3,"PCDH15, DFNB23, USH1F",605514,10q21.1,PCDH15
"Usher syndrome, type 1F, 602083 ",3,"PCDH15, DFNB23, USH1F",605514,10q21.1,PCDH15
"Usher syndrome, type 1G, 606943 ",3,"SANS, USH1G",607696,17q25.1,SANS
"Usher syndrome, type 2A, 276901 ",3,"USH2A, RP39",608400,1q41,USH2A
"Usher syndrome, type 2C, 605472 ",3,"ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C",602851,5q14.3,ADGRV1
"Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 ",3,"ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C",602851,5q14.3,ADGRV1
"Usher syndrome, type 2D, 611383 ",3,"WHRN, CIP98, KIAA1526, DFNB31, USH2D",607928,9q32,WHRN
"Usher syndrome, type 3A, 276902 ",3,"CLRN1, USH3A, USH3, RP61",606397,3q25.1,CLRN1
"Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 ",3,PDZD7,612971,10q24.31,PDZD7
"Usher syndrome, type IJ, 614869 ",3,"CIB2, KIP2",605564,15q25.1,CIB2
"VACTERL association, X-linked, 314390 ",3,"ZIC3, HTX1, HTX, VACTERLX",300265,Xq26.3,ZIC3
"VATER association with macrocephaly and ventriculomegaly, 276950 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"VLCAD deficiency, 201475 ",3,"ACADVL, VLCAD",609575,17p13.1,ACADVL
"Van Buchem disease, 239100 ",3,"SOST, VBCH, CDD, SOST1",605740,17q21.31,SOST
"Van der Woude syndrome 2, 606713 ",3,"GRHL3, SOM, TFCP2L4, VWS2",608317,1p36.11,GRHL3
"Vasculopathy, retinal, with cerebral leukodystrophy, 192315 ",3,"TREX1, AGS1, CRV, HERNS",606609,3p21.31,TREX1
"Velocardiofacial syndrome, 192430 ",3,"TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR",602054,22q11.21,TBX1
"Venous malformations, multiple cutaneous and mucosal, 600195 ",3,"TEK, TIE2, VMCM",600221,9p21.2,TEK
"Ventricular fibrillation, familial, 1, 603829 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Ventricular septal defect 1, 614429 ",3,"GATA4, ASD2, VSD1, TACHD, TOF",600576,8p23.1,GATA4
"Ventricular septal defect 3, 614432 ",3,"NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2",600584,5q35.1,NKX2-5
"Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 ",3,"RYR2, VTSIP, ARVD2, ARVC2",180902,1q43,RYR2
"Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 ",3,"CALM1, PHKD, CPVT4, LQT14",114180,14q32.11,CALM1
"Ventricular tachycardia, idiopathic, 192605 ",3,"GNAI2, GNAI2B, GIP",139360,3p21.31,GNAI2
"Vertical talus, congenital, 192950 ",3,"HOXD10, HOX4D",142984,2q31.1,HOXD10
"Vici syndrome, 242840 ",3,"EPG5, KIAA1632, HEEW1, VICIS",615068,18q12.3-q21.1,EPG5
"Visceral myopathy, 155310 ",3,"ACTG2, ACTA3, VSCM",102545,2p13.1,ACTG2
"Vitamin D-dependent rickets, type I, 264700 ",3,"CYP27B1, VDD1, PDDR",609506,12q14.1,CYP27B1
"Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 ",3,"VKORC1, VKOR, VKCFD2, FLJ00289",608547,16p11.2,VKORC1
"Vitreoretinochoroidopathy, 193220 ",3,"BEST1, VMD2, ARB, RP50",607854,11q12.3,BEST1
"Vitreoretinopathy, neovascular inflammatory, 193235 ",3,"CAPN5, HTRA3, VRNI",602537,11q13.5,CAPN5
"Vohwinkel syndrome with ichthyosis, 604117 ",3,LOR,152445,1q21.3,LOR
"Vohwinkel syndrome, 124500 ",3,"GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID",121011,13q12.11,GJB2
"WHIM syndrome, 193670 ",3,"CXCR4, D2S201E, NPY3R, WHIMS",162643,2q22.1,CXCR4
"Waardenburg syndrome, type 1, 193500 ",3,"PAX3, WS1, HUP2, CDHS, WS3",606597,2q36.1,PAX3
"Waardenburg syndrome, type 2A, 193510 ",3,"MITF, WS2A, CMM8",156845,3p13,MITF
"Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 ",3,"SOX10, WS4, WS4C, PCWH",602229,22q13.1,SOX10
"Waardenburg syndrome, type 3, 148820 ",3,"PAX3, WS1, HUP2, CDHS, WS3",606597,2q36.1,PAX3
"Waardenburg syndrome, type 4A, 277580 ",3,"EDNRB, HSCR2, ABCDS, WS4A",131244,13q22.3,EDNRB
"Waardenburg syndrome, type 4B, 613265 ",3,"EDN3, WS4B, HSCR4",131242,20q13.32,EDN3
"Waardenburg syndrome, type 4C, 613266 ",3,"SOX10, WS4, WS4C, PCWH",602229,22q13.1,SOX10
"Waardenburg syndrome/albinism, digenic, 103470 ",3,"TYR, SHEP3, CMM8, OCA1A, ATN",606933,11q14.3,TYR
"Waardenburg syndrome/ocular albinism, digenic, 103470 ",3,"MITF, WS2A, CMM8",156845,3p13,MITF
"Wagner syndrome 1, 143200 ",3,"VCAN, CSPG2, WGN, WGN1, ERVR",118661,5q14.2-q14.3,VCAN
"Warfarin resistance, 122700 ",3,"VKORC1, VKOR, VKCFD2, FLJ00289",608547,16p11.2,VKORC1
"Warfarin sensitivity, 122700 ",3,CYP2C9,601130,10q23.33,CYP2C9
"Watson syndrome, 193520 ",3,"NF1, VRNF, WSS, NFNS",613113,17q11.2,NF1
"Weaver syndrome, 277590 ",3,"EZH2, EZH1, WVS",601573,7q36.1,EZH2
"Weill-Marchesani syndrome 1, recessive, 277600 ",3,"ADAMTS10, WMS1",608990,19p13.2,ADAMTS10
"Weill-Marchesani syndrome 2, dominant, 608328 ",3,"FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS",134797,15q21.1,FBN1
"Weissenbacher-Zweymuller syndrome, 277610 ",3,"COL11A2, STL3, DFNA13, DFNB53, FBCG2",120290,6p21.32,COL11A2
"Werner syndrome, 277700 ",3,"RECQL2, RECQ3, WRN",604611,8p12,RECQL2
"Weyers acrodental dysostosis, 193530 ",3,EVC,604831,4p16.2,EVC
"Weyers acrofacial dysostosis, 193530 ",3,"LBN, EVC2, WAD",607261,4p16.2,LBN
"White sponge nevus 1, 193900 ",3,"KRT4, CYK4, WSN1",123940,12q13.13,KRT4
"Wieacker-Wolff syndrome, 314580 ",3,"ZC4H2, KIAA1166, WRWF",300897,Xq11.2,ZC4H2
"Wiedemann-Steiner syndrome, 605130 ",3,"KMT2A, MLL, HRX, HTRX1, WDSTS",159555,11q23.3,KMT2A
"Wilms tumor 2, 194071 ",3,"H19, D11S813E, ASM1, BWS, WT2",103280,11p15.5,H19
"Wilms tumor, 194070 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Wilms tumor, somatic, 194070 ",3,"GPC3, SDYS, SGBS1",300037,Xq26.2,GPC3
"Wilms tumor, type 1, 194070 ",3,"WT1, NPHS4",607102,11p13,WT1
"Wilson disease, 277900 ",3,"ATP7B, WND",606882,13q14.3,ATP7B
"Wiskott-Aldrich syndrome, 301000 ",3,"WAS, IMD2, THC1, SCNX",300392,Xp11.23,WAS
"Wolcott-Rallison syndrome, 226980 ",3,"EIF2AK3, PEK, PERK, WRS",604032,2p11.2,EIF2AK3
"Wolff-Parkinson-White syndrome, 194200 ",3,"PRKAG2, WPWS, CMH6",602743,7q36.1,PRKAG2
"Wolfram syndrome 2, 604928 ",3,"CISD2, WFS2, ZCD2, ERIS",611507,4q24,CISD2
"Wolfram syndrome, 222300 ",3,"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",606201,4p16.1,WFS1
"Wolfram-like syndrome, autosomal dominant, 614296 ",3,"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",606201,4p16.1,WFS1
"Wolman disease, 278000 ",3,"LIPA, CESD",613497,10q23.31,LIPA
"Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 ",3,"LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8",609239,13q14.2,LPAR6
"Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 ",3,"LIPH, LAH2, ARWH2, HYPT7",607365,3q27.2,LIPH
"Wrinkly skin syndrome, 278250 ",3,"ATP6V0A2, WSS, ARCL2A",611716,12q24.31,ATP6V0A2
"X-inactivation, familial skewed, 300087 ",3,"XIC, XCE, XIST, SXI1",314670,Xq13.2,XIC
"Xanthinuria, type I, 278300 ",3,"XDH, XAN1",607633,2p23.1,XDH
"Xeroderma pigmentosum, group A, 278700 ",3,"XPA, XPAC",611153,9q22.33,XPA
"Xeroderma pigmentosum, group B, 610651 ",3,"ERCC3, XPB, TTD2",133510,2q14.3,ERCC3
"Xeroderma pigmentosum, group C, 278720 ",3,"XPC, XPCC",613208,3p25.1,XPC
"Xeroderma pigmentosum, group D, 278730 ",3,"ERCC2, EM9, XPD, COFS2, TTD1",126340,19q13.32,ERCC2
"Xeroderma pigmentosum, group F, 278760 ",3,"ERCC4, XPF, FANCQ, XFEPS",133520,16p13.12,ERCC4
"Xeroderma pigmentosum, group G, 278780 ",3,"ERCC5, XPG, COFS3",133530,13q33.1,ERCC5
"Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 ",3,"ERCC5, XPG, COFS3",133530,13q33.1,ERCC5
"Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 ",3,"ERCC4, XPF, FANCQ, XFEPS",133520,16p13.12,ERCC4
"Xeroderma pigmentosum, variant type, 278750 ",3,"POLH, XPV",603968,6p21.1,POLH
"Acetylation, slow, 243400 ",3,"NAT2, AAC2",612182,8p22,NAT2
"Analgesia from kappa-opioid receptor agonist, female-specific, 613098 ",3,"MC1R, SHEP2, CMM5",155555,16q24.3,MC1R
"Anhaptoglobinemia, 614081 ",3,HP,140100,16q22.2,HP
"Axillary odor, variation in, 117800 ",3,"ABCC11, MRP8, EWWD, WW",607040,16q12.1,ABCC11
"Bilirubin, serum level of, QTL1, 601816 ",3,"UGT1A1, UGT1, GNT1, BILIQTL1",191740,2q37.1,UGT1A1
"Blood group Cromer, 613793 ",3,"CD55, DAF, CROM",125240,1q32.2,CD55
"Blood group GIL, 607457 ",3,AQP3,600170,9p13.3,AQP3
"Blood group, ABO system, 616093 ",3,ABO,110300,9q34.2,ABO
"Blood group, Auberger system, 111200 ",3,"LU, AU, BCAM",612773,19q13.32,LU
"Blood group, Colton, 110450 ",3,"AQP1, CHIP28, CO",107776,7p14.3,AQP1
"Blood group, Diego, 110500 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Blood group, Dombrock, 616060 ",3,"ART4, DO, DOK1",110600,12p12.3,ART4
"Blood group, Duffy system, 110700 ",3,"DARC, FY, GPD, WBCQ1",613665,1q23.2,DARC
"Blood group, Froese, 601551 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Blood group, Ii, 110800 ",3,"GCNT2, Ii, CTRCT13",600429,6p24.3-p24.2,GCNT2
"Blood group, John-Milton-Hagen system, 614745 ",3,"SEMA7A, SEMAL, SEMAK1, CDW108, JMH",607961,15q24.1,SEMA7A
"Blood group, Kell, 110900 ",3,KEL,613883,7q34,KEL
"Blood group, Kidd, 111000 ",3,"SLC14A1, JK, UTE, UT1",613868,18q12.3,SLC14A1
"Blood group, Knops system, 607486 ",3,"CR1, C3BR",120620,1q32.2,CR1
"Blood group, Landsteiner-Wiener, 111250 ",3,"ICAM4, CD242, LW",614088,19p13.2,ICAM4
"Blood group, Lutheran null, 247420 ",3,"LU, AU, BCAM",612773,19q13.32,LU
"Blood group, Lutheran system, 111200 ",3,"LU, AU, BCAM",612773,19q13.32,LU
"Blood group, Radin, 111620 ",3,"ERMAP, SC, RD",609017,1p34.2,ERMAP
"Blood group, Raph, 179620 ",3,"CD151, PETA3, SFA1, MER2",602243,11p15.5,CD151
"Blood group, Rhesus, 111690 ",3,RHCE,111700,1p36.11,RHCE
"Blood group, Rodgers, 614374 ",3,"C4A, C4S, C4AD",120810,6p21.33,C4A
"Blood group, Scianna system, 111750 ",3,"ERMAP, SC, RD",609017,1p34.2,ERMAP
"Blood group, Swann, 601550 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Blood group, Waldner, 112010 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Blood group, Wright, 112050 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Blood group, Yt system, 112100 ",3,"ACHE, YT",100740,7q22.1,ACHE
"Bombay phenotype, 616754 ",3,"FUT1, H, HH",211100,19q13.33,FUT1
"Bone mineral density variability 1, 601884 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"Chitotriosidase deficiency, 614122 ",3,"CHIT, CHITD",600031,1q32.1,CHIT
"Colostrum secretion, variation in, 117800 ",3,"ABCC11, MRP8, EWWD, WW",607040,16q12.1,ABCC11
"Dysalbuminemic hyperthyroxinemia, 615999 ",3,"ALB, ANALBA, FDAH",103600,4q13.3,ALB
"Dystransthyretinemic hyperthyroxinemia, 145680 ",3,"TTR, PALB",176300,18q12.1,TTR
"Earwax, wet/dry, 117800 ",3,"ABCC11, MRP8, EWWD, WW",607040,16q12.1,ABCC11
"Eculizumab, poor response to, 615749 ",3,"C5, C5D, ECLZB",120900,9q33.2,C5
"Erythrocytosis, familial, 1, 133100 ",3,EPOR,133171,19p13.2,EPOR
"Fasting plasma glucose level QTL 5, 613463 ",3,"GCKR, GKRP, FGQTL5",600842,2p23.3,GCKR
"Gilbert syndrome, 143500 ",3,"UGT1A1, UGT1, GNT1, BILIQTL1",191740,2q37.1,UGT1A1
"Glycerol quantitative trait locus, 614411 ",3,"AQP7, GLYCQTL",602974,9p13.3,AQP7
"Hair morphology 1, hair thickness, 612630 ",3,"EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B",604095,2q13,EDAR
"Hemoglobin, high altitude adaptation, 609070 ",3,"EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH",606425,1q42.2,EGLN1
"Hereditary persistence of alpha-fetoprotein, 615970 ",3,"AFP, HPAFP, AFPD",104150,4q13.3,AFP
"Hex A pseudodeficiency, 272800 ",3,"HEXA, TSD",606869,15q23,HEXA
"High density lipoprotein cholesterol level QTL 10, 143470 ",3,"CETP, HDLCQ10",118470,16q13,CETP
"High density lipoprotein cholesterol level QTL 12, 612797 ",3,"LIPC, HL, LIPH, HDLCQ12",151670,15q21.3,LIPC
"High density lipoprotein cholesterol level QTL6, 610762 ",3,"SCARB1, CD36L1, CLA1, HDLQTL6",601040,12q24.31,SCARB1
"High molecular weight kininogen deficiency, 228960 ",3,"KNG1, KNG",612358,3q27.3,KNG1
"Histidinemia, 235800 ",3,"HAL, HSTD",609457,12q23.1,HAL
"Hyperphenylalaninemia, non-PKU mild, 261600 ",3,"PAH, PKU1",612349,12q23.2,PAH
"Hypoceruloplasminemia, hereditary, 604290 ",3,CP,117700,3q24-q25,CP
"Hypohaptoglobinemia, 614081 ",3,HP,140100,16q22.2,HP
"IgE levels QTL, 147050 ",3,"PHF11, NYREN34",607796,13q14.2,PHF11
"IgE, elevated level of, 147050 ",3,IL21R,605383,16p12.1,IL21R
"Inosine triphosphatase deficiency, 613850 ",3,"ITPA, EIEE35",147520,20p13,ITPA
"Interleukin 6, serum level of, QTL, 614752 ",3,"IL6R, IL6RQ, IL6Q",147880,1q21.3,IL6R
"Interleukin-6 receptor, soluble, serum level of, QTL, 614689 ",3,"IL6R, IL6RQ, IL6Q",147880,1q21.3,IL6R
"Kallikrein, decreased urinary activity of, 615953 ",3,"KLK1, KLKR",147910,19q13.33,KLK1
"Kininogen deficiency, 228960 ",3,"KNG1, KNG",612358,3q27.3,KNG1
"Lactate dehydrogenase-B deficiency, 614128 ",3,"LDHB, LDHBD",150100,12p12.1,LDHB
"Malaria, resistance to, 611162 ",3,"SLC4A1, AE1, EPB3, SPH4, SAO, CHC",109270,17q21.31,SLC4A1
"Phenylthiocarbamide tasting, 171200 ",3,"TAS2R38, T2R61, PTC",607751,7q34,TAS2R38
"Premature chromatid separation trait, 176430 ",3,"BUB1B, BUBR1, MVA1",602860,15q15.1,BUB1B
"Resting heart rate, 607276 ",3,"ADRB1, ADRB1R, RHR",109630,10q25.3,ADRB1
"Skin/hair/eye pigmentation 1, blond/brown hair, 227220 ",3,"HERC2, SHEP1, MRT38",605837,15q13.1,HERC2
"Skin/hair/eye pigmentation 1, blond/brown hair, 227220 ",3,"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1",611409,15q12-q13,OCA2
"Skin/hair/eye pigmentation 1, blue/nonblue eyes, 227220 ",3,"HERC2, SHEP1, MRT38",605837,15q13.1,HERC2
"Skin/hair/eye pigmentation 1, blue/nonblue eyes, 227220 ",3,"OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1",611409,15q12-q13,OCA2
"Skin/hair/eye pigmentation 10, blond/brown hair, 612267 ",3,"TPCN2, TPC2, SHEP10",612163,11q13.3,TPCN2
"Skin/hair/eye pigmentation 2, blond hair/fair skin, 266300 ",3,"MC1R, SHEP2, CMM5",155555,16q24.3,MC1R
"Skin/hair/eye pigmentation 2, red hair/fair skin, 266300 ",3,"MC1R, SHEP2, CMM5",155555,16q24.3,MC1R
"Skin/hair/eye pigmentation 3, blue/green eyes, 601800 ",3,"TYR, SHEP3, CMM8, OCA1A, ATN",606933,11q14.3,TYR
"Skin/hair/eye pigmentation 3, light/dark/freckling skin, 601800 ",3,"TYR, SHEP3, CMM8, OCA1A, ATN",606933,11q14.3,TYR
"Skin/hair/eye pigmentation 6, blond/brown hair, 210750 ",3,"SLC24A4, NCKX4, SHEP6, AI2A5",609840,14q32.12,SLC24A4
"Skin/hair/eye pigmentation 6, blue/green eyes, 210750 ",3,"SLC24A4, NCKX4, SHEP6, AI2A5",609840,14q32.12,SLC24A4
"Skin/hair/eye pigmentation 7, blond/brown hair, 611664 ",3,"KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69",184745,12q21.32,KITLG
"Skin/hair/eye pigmentation 9, brown/nonbrown eyes, 611742 ",3,"ASIP, AGTIL, SHEP9",600201,20q11.22,ASIP
"Skin/hair/eye pigmentation 9, dark/light hair, 611742 ",3,"ASIP, AGTIL, SHEP9",600201,20q11.22,ASIP
"Skin/hair/eye pigmentation, variation in, 8, 611724 ",3,"IRF4, LSIRF, SHEP8",601900,6p25.3,IRF4
"Sodium serum level QTL 1, 613508 ",3,"TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3",605427,12q24.11,TRPV4
"Thyroxine-binding globulin QTL, 300932 ",3,"TBG, TBGQTL",314200,Xq22.3,TBG
"Transferrin serum level QTL2, 614193 ",3,"HFE, HLA-H, HFE1, MVCD7, TFQTL2",613609,6p22.2,HFE
"White blood cell count QTL, 611862 ",3,"DARC, FY, GPD, WBCQ1",613665,1q23.2,DARC
"van Buchem disease, type 2, 607636 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"van der Woude syndrome, 119300 ",3,"IRF6, VWS, LPS, PIT, PPS1, OFC6",607199,1q32.2,IRF6
"von Hippel-Lindau syndrome, 193300 ",3,VHL,608537,3p25.3,VHL
"von Willebrand disease, platelet-type, 177820 ",3,"GP1BA, BSS, BDPLT1, VWDP, BDPLT3",606672,17p13.2,GP1BA
"von Willebrand disease, type 1, 193400 ",3,"VWF, F8VWF",613160,12p13.31,VWF
"von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 ",3,"VWF, F8VWF",613160,12p13.31,VWF
"von Willibrand disease, type 3, 277480 ",3,"VWF, F8VWF",613160,12p13.31,VWF
"IgA nephropathy, susceptibility to, 3, 616818 ",3,"SPRY2, IGAN3",602466,13q31.1,SPRY2
"Macular degeneration, age-related, 603075 ",3,"APOE, AD2, LPG, LDLCQ5",107741,19q13.32,APOE
"Obesity, susceptibility to, 601665 ",3,"CARTPT, CART",602606,5q13.2,CARTPT
"AIDS, delayed/rapid progression to, 609423 ",3,"KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1",604946,19q13.42,KIR3DL1
"AIDS, rapid progression to, 609423 ",3,"IFNG, IFG, IFI",147570,12q15,IFNG
"AIDS, resistance to, 609423 ",3,"CXCL12, SDF1",600835,10q11.21,CXCL12
"AIDS, slow progression to, 609423 ",3,"CXCR1, IL8RA",146929,2q35,CXCR1
"AIDS, slow progression to, 609423 ",3,"IL4R, IL4RA",147781,16p12.1,IL4R
"Accelerated tumor formation, susceptibility to, 614401 ",3,"MDM2, ACTFS",164785,12q15,MDM2
"Albinism, oculocutaneous, type II, modifier of, 203200 ",3,"MC1R, SHEP2, CMM5",155555,16q24.3,MC1R
"Alcohol dependence, protection against, 103780 ",3,"ADH1B, ADH2",103720,4q23,ADH1B
"Alcohol dependence, protection against, 103780 ",3,"ADH1C, ADH3",103730,4q23,ADH1C
"Alcohol dependence, susceptibility to, 103780 ",3,GABRA2,137140,4p12,GABRA2
"Alcohol dependence, susceptibility to, 103780 ",3,HTR2A,182135,13q14.2,HTR2A
"Alcohol dependence, susceptibility to, 103780 ",3,"TAS2R16, T2R16",604867,7q31.32,TAS2R16
"Allergic rhinitis, susceptibility to, 607154 ",3,"IL13, ALRH, BHR1",147683,5q31.1,IL13
"Alzheimer disease, late-onset, susceptibility to, 104300 ",3,NOS3,163729,7q36.1,NOS3
"Alzheimer disease, late-onset, susceptibility to, 104300 ",3,"PLAU, URK, QPD, BDPLT5",191840,10q22.2,PLAU
"Alzheimer disease, susceptibility to, 104300 ",3,"A2M , A2MD",103950,12p13.31,A2M 
"Alzheimer disease, susceptibility to, 104300 ",3,"HFE, HLA-H, HFE1, MVCD7, TFQTL2",613609,6p22.2,HFE
"Alzheimer disease, susceptibility to, 104300 ",3,MPO,606989,17q22,MPO
"Amyotrophic lateral sclerosis, susceptibility to, 13, 183090 ",3,"ATXN2, ATX2, SCA2, ASL13",601517,12q24.12,ATXN2
"Amyotrophic lateral sclerosis, susceptibility to, 105400 ",3,"DCTN1, HMN7B",601143,2p13.1,DCTN1
"Amyotrophic lateral sclerosis, susceptibility to, 105400 ",3,PRPH,170710,12q13.12,PRPH
"Angioedema induced by ACE inhibitors, susceptibility to, 300909 ",3,"XPNPEP2, AEACEI",300145,Xq26.1,XPNPEP2
"Anorexia nervosa, susceptibility to, 606788 ",3,HTR2A,182135,13q14.2,HTR2A
"Anorexia nervosa, susceptibility to, 610269 ",3,"BDNF, BULN2, ANON2",113505,11p14.1,BDNF
"Antisocial behavior, 300615 ",3,"MAOA, BRNRS",309850,Xp11.3,MAOA
"Anxiety-related personality traits, 607834 ",3,"SLC6A4, HTT, OCD1",182138,17q11.2,SLC6A4
"Aplastic anemia, susceptibility to, 609135 ",3,"SBDS, SDS",607444,7q11.21,SBDS
"Aplastic anemia, 609135 ",3,"IFNG, IFG, IFI",147570,12q15,IFNG
"Aspergillosis, susceptibility to, 614079 ",3,"CLEC7A, CLECSF12, DECTIN1, CANDF4",606264,12p13.2,CLEC7A
"Asthma susceptibility 5, 611064 ",3,"IRAK3, IRAKM, ASRT5",604459,12q14.3,IRAK3
"Asthma, aspirin-induced, susceptibility to, 208550 ",3,PTGER2,176804,14q22.1,PTGER2
"Asthma, aspirin-induced, susceptibility to, 208550 ",3,"TBX21, TBET",604895,17q21.32,TBX21
"Asthma, diminished response to antileukotriene treatment in, 600807 ",3,ALOX5,152390,10q11.21,ALOX5
"Asthma, nocturnal, susceptibility to, 600807 ",3,ADRB2,109690,5q32,ADRB2
"Asthma, protection against, 600807 ",3,MUC7,158375,4q13.3,MUC7
"Asthma, susceptibility to, 1, 607277 ",3,"PTGDR, AS1, ASRT1",604687,14q22.1,PTGDR
"Asthma, susceptibility to, 600807 ",3,"CCL11, SCYA11",601156,17q12,CCL11
"Asthma, susceptibility to, 600807 ",3,"HNMT, MRT51",605238,2q22.1,HNMT
"Asthma, susceptibility to, 600807 ",3,"IL13, ALRH, BHR1",147683,5q31.1,IL13
"Asthma, susceptibility to, 600807 ",3,"PLA2G7, PAFAH, PAFAD",601690,6p12.3,PLA2G7
"Asthma, susceptibility to, 600807 ",3,"SCGB3A2, UGRP1",606531,5q32,SCGB3A2
"Asthma, susceptibility to, 600807 ",3,"TNF, TNFA",191160,6p21.33,TNF
"Asthma-related traits, susceptibility to, 7, 611960 ",3,"CHI3L1, GP39, YKL40, ASRT7",601525,1q32.1,CHI3L1
"Asthma, 600807 ",3,"PHF11, NYREN34",607796,13q14.2,PHF11
"Atopy, resistance to, 147050 ",3,"HAVCR1, HAVCR",606518,5q33.3,HAVCR1
"Atopy, susceptibility to, 147050 ",3,"IL4R, IL4RA",147781,16p12.1,IL4R
"Atopy, susceptibility to, 147050 ",3,"MS4A2, FCER1B",147138,11q12.1,MS4A2
"Atopy, susceptibility to, 147050 ",3,"PLA2G7, PAFAH, PAFAD",601690,6p12.3,PLA2G7
"Atopy, susceptibility to, 147050 ",3,"SELP, GRMP",173610,1q24.2,SELP
"Atrioventricular septal defect, susceptibility to, 2, 606217 ",3,"CRELD1, AVSD2",607170,3p25.3,CRELD1
"Attention deficit-hyperactivity disorder, susceptibility to, 143465 ",3,"DRD5, DRD1B, DRD1L2",126453,4p16.1,DRD5
"Attention deficit-hyperactivity disorder, 143465 ",3,DRD4,126452,11p15.5,DRD4
"Autism susceptibility 15, 612100 ",3,"CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1",604569,7q35-q36,CNTNAP2
"Autism susceptibility, X-linked 3, 300496 ",3,"MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16",300005,Xq28,MECP2
"Autism, susceptibility to, 19, 615091 ",3,"EIF4E, EIF4EL1, AUTS19",133440,4q23,EIF4E
"Autism, susceptibility to, X-linked 5, 300847 ",3,"RPL10, DXS648, QM, AUTSX5",312173,Xq28,RPL10
"Autoimmune disease, susceptibility to, 1, 607836 ",3,"FOXD3, AIS1, VAMAS2",611539,1p31.3,FOXD3
"Autoimmune lymphoproliferative syndrome, 601859 ",3,"FAS, TNFRSF6, APT1, CD95, ALPS1A",134637,10q23.31,FAS
"Autoimmune thyroid disease, susceptibility to, 3, 608175 ",3,"TG, AITD3, TDH3",188450,8q24.22,TG
"Autoimmune thyroid disease, susceptibility to, 3, 608175 ",3,"ZFAT1, ZNF406, AITD3",610931,8q24.22,ZFAT1
"Bardet-Biedl syndrome 1, modifier of, 209900 ",3,"ARL6, BBS3, RP55",608845,3q11.2,ARL6
"Bardet-Biedl syndrome 1, modifier of, 209900 ",3,"CCDC28B, MGC1203",610162,1p35.2,CCDC28B
"Bardet-Biedl syndrome 14, modifier of, 615991 ",3,"TMEM67, MKS3, JBTS6, NPHP11",609884,8q22.1,TMEM67
"Basal cell carcinoma 7, 614740 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Bladder cancer, somatic, 109800 ",3,HRAS,190020,11p15.5,HRAS
"Bleeding disorder, platelet-type, 13, susceptibility to, 614009 ",3,"TBXA2R, BDPLT13",188070,19p13.3,TBXA2R
"Blepharospasm, primary benign, 606798 ",3,"DRD5, DRD1B, DRD1L2",126453,4p16.1,DRD5
"Bone mineral density variation QTL, osteoporosis, 166710 ",3,"COL1A1, OI1, OI2, OI3, OI4, EDSC",120150,17q21.33,COL1A1
"Breast cancer, invasive ductal, 114480 ",3,"RAD54L, HR54, HRAD54",603615,1p34.1,RAD54L
"Breast cancer, lobular, 114480 ",3,"CDH1, UVO, LCAM, ECAD",192090,16q22.1,CDH1
"Breast cancer, male, susceptibility to, 114480 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Breast cancer, protection against, 114480 ",3,"CASP8, MCH5, ALPS2B",601763,2q33.1,CASP8
"Breast cancer, susceptibility to, 114480 ",3,"ATM, ATA, AT1",607585,11q22.3,ATM
"Breast cancer, susceptibility to, 114480 ",3,BARD1,601593,2q35,BARD1
"Breast cancer, susceptibility to, 114480 ",3,"CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,CHEK2
"Breast cancer, susceptibility to, 114480 ",3,HMMR,600936,5q34,HMMR
"Breast cancer, susceptibility to, 114480 ",3,"PALB2, FANCN, PNCA3",610355,16p12.2,PALB2
"Breast cancer, susceptibility to, 114480 ",3,PHB,176705,17q21.33,PHB
"Breast cancer, susceptibility to, 114480 ",3,"RAD51A, RECA, MRMV2",179617,15q15.1,RAD51A
"Breast cancer, susceptibility to, 114480 ",3,"XRCC3, CMM6",600675,14q32.33,XRCC3
"Breast-ovarian cancer, familial, 1, 604370 ",3,"BRCA1, PSCP, BROVCA1, PNCA4",113705,17q21.31,BRCA1
"Breast-ovarian cancer, familial, 2, 612555 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Bronchiectasis with or without elevated sweat chloride 1, modifier of, 211400 ",3,"CFTR, ABCC7, CF, MRP7",602421,7q31.2,CFTR
"Budd-Chiari syndrome, 600880 ",3,"F5, THPH2, RPRGL1",612309,1q24.2,F5
"Bulimia nervosa, age of onset of weight loss in, 607499 ",3,"BDNF, BULN2, ANON2",113505,11p14.1,BDNF
"Buruli ulcer, susceptibility to, 610446 ",3,"NRAMP1, NRAMP, SLC11A1",600266,2q35,NRAMP1
"Celiac disease, susceptibility to, 3, 609755 ",3,"CTLA4, IDDM12, CELIAC3, ALPS5",123890,2q33.2,CTLA4
"Celiac disease, susceptibility to, 212750 ",3,"HLA-DQA1, CELIAC1",146880,6p21.32,HLA-DQA1
"Celiac disease, susceptibility to, 212750 ",3,"HLA-DQB1, CELIAC1",604305,6p21.32,HLA-DQB1
"Centronuclear myopathy, autosomal, modifier of, 160150 ",3,"MTMR14, C3orf29, HJUMPY",611089,3p25.3,MTMR14
"Cerebral infarction, susceptibility to, 601367 ",3,"PRKCH, PKCL, PRKCL",605437,14q23.1,PRKCH
"Chronic infections, due to MBL deficiency, 614372 ",3,"MBL2, MBL, MBP1, MBL2D, MBPD",154545,10q21.1,MBL2
"Cirrhosis, noncryptogenic, susceptibility to, 215600 ",3,KRT18,148070,12q13.13,KRT18
"Cirrhosis, noncryptogenic, susceptibility to, 215600 ",3,KRT8,148060,12q13.13,KRT8
"Codeine sensitivity, 608902 ",3,"CYP2D6, CPD6, P450DB1",124030,22q13.2,CYP2D6
"Colchicine resistance, 120080 ",3,"ABCB1, PGY1, MDR1, IBD13, CLCs",171050,7q21.12,ABCB1
"Colon cancer, susceptibility to, 114500 ",3,"AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK",603072,20q13.2,AURKA
"Colonic adenoma recurrence, reduced risk of, 114500 ",3,ODC1,165640,2p25.1,ODC1
"Colorectal cancer, susceptibility to, 10, 612591 ",3,"POLD1, CRCS10, MDPL",174761,19q13.33,POLD1
"Colorectal cancer, susceptibility to, 3, 612229 ",3,"SMAD7, MADH7, CRCS3",602932,18q21.1,SMAD7
"Colorectal cancer, susceptibility to, 114500 ",3,"CCND1, PRAD1, BCL1",168461,11q13.3,CCND1
"Colorectal cancer, susceptibility to, 114500 ",3,"TLR2, TIL4",603028,4q31.3,TLR2
"Colorectal cancer, 114500 ",3,"PLA2G2A, PLA2B, PLA2L, MOM1",172411,1p36.13,PLA2G2A
"Coronary artery disease in familial hypercholesterolemia, protection against, 143890 ",3,"ABCA1, ABC1, HDLDT1, TGD",600046,9q31.1,ABCA1
"Coronary artery disease, autosomal dominant, 1, 608320 ",3,"MEF2A, ADCAD1",600660,15q26.3,MEF2A
"Coronary artery disease, autosomal dominant, 2, 610947 ",3,"LRP6, ADCAD2, STHAG7",603507,12p13.2,LRP6
"Coronary heart disease, susceptibility to, 5, 608901 ",3,"KALRN, HAPIP, DUO, CHDS5",604605,3q21.1-q21.2,KALRN
"Coronary heart disease, susceptibility to, 6, 614466 ",3,"MMP3, STMY1, CHDS6",185250,11q22.2,MMP3
"Coronary heart disease, susceptibility to, 7, 610938 ",3,"CD36, CHDS7, BDPLT10",173510,7q21.11,CD36
"Creutzfeldt-Jakob disease, variant, resistance to, 123400 ",3,"HLA-DQB1, CELIAC1",604305,6p21.32,HLA-DQB1
"Crohn disease-associated growth failure, 266600 ",3,"IL6, IFNB2, BSF2, HSF, HGF",147620,7p15.3,IL6
"Cystic fibrosis lung disease, modifier of, 219700 ",3,"TGFB1, DPD1, CED",190180,19q13.2,TGFB1
"Deafness, autosomal recessive 12, modifier of, 601386 ",3,"ATP2B2, PMCA2",108733,3p25.3,ATP2B2
"Debrisoquine sensitivity, 608902 ",3,"CYP2D6, CPD6, P450DB1",124030,22q13.2,CYP2D6
"Deep venous thrombosis, protection against, 300807 ",3,"F9, HEMB, THPH8",300746,Xq27.1,F9
"Dengue fever, protection against, 614371 ",3,"CD209, CDSIGN",604672,19p13.2,CD209
"Dermatitis, atopic, susceptibility to, 2, 605803 ",3,"FLG, ATOD2",135940,1q21.3,FLG
"Diabetes mellitus, insulin-dependent, 12, 601388 ",3,"CTLA4, IDDM12, CELIAC3, ALPS5",123890,2q33.2,CTLA4
"Diabetes mellitus, insulin-dependent, 22, 612522 ",3,"CCR5, CMKBR5, CCCKR5, IDDM22",601373,3p21.31,CCR5
"Diabetes mellitus, insulin-dependent, 5, 600320 ",3,"SUMO4, IDDM5",608829,6q25.1,SUMO4
"Diabetes mellitus, insulin-dependent, 222100 ",3,"HNF1A, TCF1, MODY3, IDDM20",142410,12q24.31,HNF1A
"Diabetes mellitus, ketosis-prone, susceptibility to, 612227 ",3,"PAX4, MODY9, KPD",167413,7q32.1,PAX4
"Diabetes mellitus, non-insulin-dependent, susceptibility to, 125853 ",3,"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED",173335,6q23.2,ENPP1
"Diabetes mellitus, noninsulin-dependent 1, 601283 ",3,"CAPN10, NIDDM1",605286,2q37.3,CAPN10
"Diabetes mellitus, noninsulin-dependent, 2, 125853 ",3,"HNF1A, TCF1, MODY3, IDDM20",142410,12q24.31,HNF1A
"Diabetes mellitus, noninsulin-dependent, association with, 125853 ",3,"WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41",606201,4p16.1,WFS1
"Diabetes mellitus, noninsulin-dependent, susceptibility to, 125853 ",3,CDKAL1,611259,6p22.3,CDKAL1
"Diabetes mellitus, noninsulin-dependent, susceptibility to, 125853 ",3,"HMGA1, HMGIY",600701,6p21.31,HMGA1
"Diabetes mellitus, noninsulin-dependent, susceptibility to, 125853 ",3,"IGF2BP2, IMP2",608289,3q27.2,IGF2BP2
"Diabetes mellitus, noninsulin-dependent, susceptibility to, 125853 ",3,"RETN, RSTN, FIZZ3",605565,19p13.2,RETN
"Diabetes mellitus, noninsulin-dependent, susceptibility to, 125853 ",3,"SLC30A8, ZNT8",611145,8q24.11,SLC30A8
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,GCGR,138033,17q25.3,GCGR
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,"HNF4A, TCF14, MODY1, FRTS4",600281,20q13.12,HNF4A
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,IRS1,147545,2q36.3,IRS1
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,IRS2,600797,13q34,IRS2
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,"LIPC, HL, LIPH, HDLCQ12",151670,15q21.3,LIPC
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,"MAPK8IP1, IB1",604641,11p11.2,MAPK8IP1
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,"NEUROD1, NIDDM",601724,2q31.3,NEUROD1
"Diabetes mellitus, noninsulin-dependent, 125853 ",3,"SLC2A2, GLUT2",138160,3q26.2,SLC2A2
"Diabetes mellitus, type 1, susceptibility to, 222100 ",3,"OAS1, OIAS",164350,12q24.13,OAS1
"Diabetes mellitus, type 2, susceptibility to, 125853 ",3,"KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13",600937,11p15.1,KCNJ11
"Diabetes mellitus, type 2, susceptibility to, 125853 ",3,MTNR1B,600804,11q14.3,MTNR1B
"Diabetes mellitus, type 2, susceptibility to, 125853 ",3,"TCF7L2, TCF4",602228,10q25.2-q25.3,TCF7L2
"Diabetes mellitus, type I, susceptibility to, 222100 ",3,"FOXP3, IPEX, AIID, XPID, PIDX",300292,Xp11.23,FOXP3
"Diabetes mellitus, type II, susceptibility to, 125853 ",3,"PDX1, IPF1, MODY4, PAGEN1",600733,13q12.2,PDX1
"Diabetes, mellitus, insulin-dependent, susceptibility to, 10, 601942 ",3,"IL2RA, CD25, IL2R, IDDM10, IMD41",147730,10p15.1,IL2RA
"Diabetes, susceptibility to, 222100, 125853 ",3,"IL6, IFNB2, BSF2, HSF, HGF",147620,7p15.3,IL6
"Diabetes, type 1, susceptibility to, 222100 ",3,"PTPN22, PEP, PTPN8, LYP",600716,1p13.2,PTPN22
"Diabetes, type 2, susceptibility to, 125853 ",3,GPD2,138430,2q24.1,GPD2
"Diabetes, type 2, 125853 ",3,"PPARG, PPARG1, PPARG2, CIMT1, GLM1",601487,3p25.2,PPARG
"Dravet syndrome, modifier of, 607208 ",3,"SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D",603415,2q24.3,SCN9A
"Drug addiction, susceptibility to, 606581 ",3,FAAH,602935,1p33,FAAH
"Dyskeratosis congenita, autosomal dominant 2, 613989 ",3,"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",187270,5p15.33,TERT
"Dyskeratosis congenita, autosomal recessive 4, 613989 ",3,"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",187270,5p15.33,TERT
"Dyslexia, susceptibility to, 1, 127700 ",3,"DYX1C1, DYXC1, DYX1, CILD25",608706,15q21.3,DYX1C1
"Dyslexia, susceptibility to, 2, 600202 ",3,"KIAA0319, DYX2, DYLX2, DLX2",609269,6p22.3,KIAA0319
"Efavirenz central nervous system toxicity, susceptibility to, 614546 ",3,"CYP2B6, CYP2B, EFVM",123930,19q13.2,CYP2B6
"Encephalopathy, acute, infection-induced, 4, susceptibility to, 614212 ",3,"CPT2, IIAE4",600650,1p32.3,CPT2
"End-stage renal disease, nondiabetic, susceptibility to, 612551 ",3,"APOL1, FSGS4",603743,22q12.3,APOL1
"Endometrial cancer, susceptibility to, 608089 ",3,"MLH3, HNPCC7",604395,14q24.3,MLH3
"Epidermolysis bullosa dystrophica, autosomal recessive, modifier of, 226600 ",3,"MMP1, CLG",120353,11q22.2,MMP1
"Epilepsy idiopathic generalized, susceptibility to, 8, 612899 ",3,"CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1",601199,3q13.3-q21.1,CASR
"Epilepsy, childhood absence, susceptibility to, 2, 607681 ",3,"GABRG2, GEFSP3, CAE2, ECA2",137164,5q34,GABRG2
"Epilepsy, childhood absence, susceptibility to, 4, 611136 ",3,"GABRA1, EJM5, ECA4, EIEE19",137160,5q34,GABRA1
"Epilepsy, childhood absence, susceptibility to, 5, 612269 ",3,"GABRB3, ECA5, EIEE43",137192,15q12,GABRB3
"Epilepsy, familial temporal lobe, 7, 616436 ",3,"RELN, RL, LIS2, ETL7",600514,7q22.1,RELN
"Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to, 613060 ",3,"GABRD, GEFSP5, EIG10, EJM7",137163,1p36.33,GABRD
"Epilepsy, idiopathic generalized, 10, 613060 ",3,"GABRD, GEFSP5, EIG10, EJM7",137163,1p36.33,GABRD
"Epilepsy, idiopathic generalized, susceptibility to, 11, 607628 ",3,"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",600570,3q27.1,CLCN2
"Epilepsy, idiopathic generalized, susceptibility to, 12, 614847 ",3,"SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN",138140,1p34.2,SLC2A1
"Epilepsy, idiopathic generalized, susceptibility to, 14, 616685 ",3,"SLC12A5, KCC2, KIAA1176, EIEE34, EIG14",606726,20q13.12,SLC12A5
"Epilepsy, idiopathic generalized, susceptibility to, 9, 607682 ",3,"CACNB4, EJM6, EA5, EIG9",601949,2q23.3,CACNB4
"Epilepsy, juvenile absence, susceptibility to, 1, 607631 ",3,"EFHC1, FLJ10466, EJM1, JAE, EJA1",608815,6p12.2,EFHC1
"Epilepsy, juvenile absence, susceptibility to, 2, 607628 ",3,"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",600570,3q27.1,CLCN2
"Epilepsy, juvenile myoclonic, susceptibility to, 5, 611136 ",3,"GABRA1, EJM5, ECA4, EIEE19",137160,5q34,GABRA1
"Epilepsy, juvenile myoclonic, susceptibility to, 6, 607682 ",3,"CACNB4, EJM6, EA5, EIG9",601949,2q23.3,CACNB4
"Epilepsy, juvenile myoclonic, susceptibility to, 8, 607628 ",3,"CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT",600570,3q27.1,CLCN2
"Epilepsy, juvenile myoclonic, susceptibility to, 613060 ",3,"GABRD, GEFSP5, EIG10, EJM7",137163,1p36.33,GABRD
"Exfoliation syndrome, susceptibility to, 177650 ",3,"LOXL1, LOXL",153456,15q24.1,LOXL1
"Fibrocalculous pancreatic diabetes, susceptibility to, 608189 ",3,"SPINK1, PSTI, PCTT, TATI, TCP",167790,5q32,SPINK1
"Gastric cancer risk after H. pylori infection, 137215 ",3,IL1B,147720,2q14.1,IL1B
"Gastric cancer risk after H. pylori infection, 137215 ",3,"IL1RN, MVCD4, DIRA",147679,2q14.1,IL1RN
"Gilles de la Tourette syndrome, susceptibility to, 137580 ",3,HDC,142704,15q21.2,HDC
"Glaucoma, normal tension, susceptibility to, 606657 ",3,"OPA1, NTG, NPG, BERHS, MTDPS14",605290,3q29,OPA1
"Glaucoma, normal tension, susceptibility to, 606657 ",3,"OPTN, GLC1E, FIP2, HYPL, NRP, ALS12",602432,10p13,OPTN
"Glioblastoma 3, 613029 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Glioma susceptibility 1, 137800 ",3,"TP53, P53, LFS1 , BCC7",191170,17p13.1,TP53
"Glioma susceptibility 2, 613028 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Glioma, susceptibility to, somatic, 137800 ",3,IDH1,147700,2q34,IDH1
"Glomerulosclerosis, focal segmental, 4, susceptibility to, 612551 ",3,"APOL1, FSGS4",603743,22q12.3,APOL1
"Graft-versus-host disease, protection against, 614395 ",3,"IL10, CSIF, GVHDS",124092,1q32.1,IL10
"H. pylori infection, susceptibility to, 600263 ",3,"IFNGR1, IMD27A, IMD27B",107470,6q23.3,IFNGR1
"HFE hemochromatosis, modifier of, 235200 ",3,"BMP2, BMP2A, BDA2",112261,20p12.3,BMP2
"HIV type 1, susceptibility to, 609423 ",3,"CD209, CDSIGN",604672,19p13.2,CD209
"HIV-1 viremia, susceptibility to, 609423 ",3,"HLA-C, PSORS1",142840,6p21.33,HLA-C
"HIV-1, resistance to, 609423 ",3,"CCL2, SCYA2, MCP1, MCAF",158105,17q12,CCL2
"HIV-1, susceptibility to, 609423 ",3,"IL10, CSIF, GVHDS",124092,1q32.1,IL10
"HIV/AIDS, susceptibility to, 609423 ",3,"CCL3L1, SCYA3L1, LD78",601395,17q11.2,CCL3L1
"HIV1 infection, resistance to, 609423 ",3,"TLR3, IIAE2",603029,4q35.1,TLR3
"HIV1, resistance to, 609423 ",3,"CCL11, SCYA11",601156,17q12,CCL11
"Hangover, susceptibility to, 610251 ",3,ALDH2,100650,12q24.12,ALDH2
"Hashimoto thyroiditis, 140300 ",3,"CTLA4, IDDM12, CELIAC3, ALPS5",123890,2q33.2,CTLA4
"Hemangioma, capillary infantile, susceptibility to, 602089 ",3,"ANTXR1, TEM8, ATR, GAPO",606410,2p13.3,ANTXR1
"Hemangioma, capillary infantile, susceptibility to, 602089 ",3,KDR,191306,4q12,KDR
"Hemolytic uremic syndrome, atypical, susceptibility to, 1, 235400 ",3,"CFH, HF1, HUS, ARMD4, AHUS1",134370,1q31.3,CFH
"Hemolytic uremic syndrome, atypical, susceptibility to, 2, 612922 ",3,"MCP, CD46, AHUS2",120920,1q32.2,MCP
"Hemolytic uremic syndrome, atypical, susceptibility to, 3, 612923 ",3,"CFI, FI, AHUS3, ARMD13",217030,4q25,CFI
"Hemolytic uremic syndrome, atypical, susceptibility to, 4, 612924 ",3,"CFB, BF, GBG, AHUS4, ARMD14, CFBD",138470,6p21.33,CFB
"Hemolytic uremic syndrome, atypical, susceptibility to, 5, 612925 ",3,"C3, ARMD9, AHUS5",120700,19p13.3,C3
"Hemolytic uremic syndrome, atypical, susceptibility to, 6, 612926 ",3,"THBD, THRM, AHUS6, THPH12",188040,20p11.21,THBD
"Hemolytic uremic syndrome, atypical, susceptibility to, 235400 ",3,"CFHR1, FHR1, HFL1, CFHL1",134371,1q31.3,CFHR1
"Hemolytic uremic syndrome, atypical, susceptibility to, 235400 ",3,"CFHR3, FHR3, HLF4, CFHL3",605336,1q31.3,CFHR3
"Hemorrhage, intracerebral, susceptibility to, 614519 ",3,"COL4A1, POREN1, HANAC, ICH, BSVD, RATOR",120130,13q34,COL4A1
"Hemorrhage, intracerebral, susceptibility to, 614519 ",3,"COL4A2, POREN2, ICH",120090,13q34,COL4A2
"Hepatitic C virus, susceptibility to, 609532 ",3,"PTPRC, CD45, LCA",151460,1q31.3-q32.1,PTPRC
"Hepatitis B virus infection, susceptibility to, 610424 ",3,"IFNGR1, IMD27A, IMD27B",107470,6q23.3,IFNGR1
"Hepatitis B virus, susceptibility to, 610424 ",3,"CRFB4, IBD25",123889,21q22.11,CRFB4
"Hepatitis B virus, susceptibility to, 610424 ",3,"IFNAR2, IMD45",602376,21q22.11,IFNAR2
"Hepatitis C virus infection, response to therapy of, 609532 ",3,"IFNL3, IL28B",607402,19q13.2,IFNL3
"Hepatitis C virus, resistance to, 609532 ",3,"CCR5, CMKBR5, CCCKR5, IDDM22",601373,3p21.31,CCR5
"Hepatitis C virus, response to therapy of, 609532 ",3,"IFNG, IFG, IFI",147570,12q15,IFNG
"Herpes simplex encephalitis, susceptibility to, 1, 610551 ",3,"UNC93B1, IIAE1",608204,11q13.2,UNC93B1
"Herpes simplex encephalitis, susceptibility to, 2 613002 ",3,"TLR3, IIAE2",603029,4q35.1,TLR3
"Hirschsprung disease, susceptibility to, 1, 142623 ",3,"RET, MEN2A, HSCR1",164761,10q11.21,RET
"Hirschsprung disease, susceptibility to, 2, 600155 ",3,"EDNRB, HSCR2, ABCDS, WS4A",131244,13q22.3,EDNRB
"Hirschsprung disease, susceptibility to, 3, 613711 ",3,"GDNF, HSCR3",600837,5p13.2,GDNF
"Hirschsprung disease, susceptibility to, 4, 613712 ",3,"EDN3, WS4B, HSCR4",131242,20q13.32,EDN3
"Hypercholesterolemia, familial, due to LDLR defect, modifier of, 143890 ",3,EPHX2,132811,8p21.2-p21.1,EPHX2
"Hypercholesterolemia, familial, modifier of, 143890 ",3,APOA2,107670,1q23.3,APOA2
"Hypercholesterolemia, familial, modifier of, 143890 ",3,"GHR, GHIP",600946,5p13-p12,GHR
"Hypercholesterolemia, susceptibility to, 143890 ",3,GSBS,604088,7p14.3,GSBS
"Hypercholesterolemia, susceptibility to, 143890 ",3,"ITIH4, PK120, ITIHL1",600564,3p21.1,ITIH4
"Hyperlipidemia, familial combined, susceptibility to, 602491 ",3,"USF1, HYPLIP1",191523,1q23.3,USF1
"Hypersensitivity syndrome, carbamazepine-induced, susceptibility to, 608579 ",3,HLA-A,142800,6p22.1,HLA-A
"Hypertension, diastolic, resistance to, 608622 ",3,KCNMB1,603951,5q35.1,KCNMB1
"Hypertension, essential, salt-sensitive, 145500 ",3,ADD1,102680,4p16.3,ADD1
"Hypertension, essential, susceptibility to, 145500 ",3,"AGT, SERPINA8",106150,1q42.2,AGT
"Hypertension, essential, susceptibility to, 145500 ",3,ECE1,600423,1p36.12,ECE1
"Hypertension, essential, susceptibility to, 145500 ",3,"GNB3, CSNB1H",139130,12p13.31,GNB3
"Hypertension, essential, 145500 ",3,"AGTR1, AGTR1A, AT2R1",106165,3q24,AGTR1
"Hypertension, insulin resistance-related, susceptibility to, 125853 ",3,"RETN, RSTN, FIZZ3",605565,19p13.2,RETN
"Hypertension, pregnancy-induced, 189800 ",3,NOS3,163729,7q36.1,NOS3
"Hypertension, salt-sensitive essential, susceptibility to, 145500 ",3,"CYP3A5, P450PCN3",605325,7q22.1,CYP3A5
"Hypertension, susceptibility to, 145500 ",3,NOS3,163729,7q36.1,NOS3
"Hypertriglyceridemia, susceptibility to, 145750 ",3,APOA5,606368,11q23.3,APOA5
"Hypertriglyceridemia, susceptibility to, 145750 ",3,"LIPI, LPDL, PRED5",609252,21q11.2,LIPI
"Hypothalamic hamartomas, somatic, 241800 ",3,"GLI3, PAPA, PAPB",165240,7p14.1,GLI3
"Inflammatory bowel disease 13, 612244 ",3,"ABCB1, PGY1, MDR1, IBD13, CLCs",171050,7q21.12,ABCB1
"Inflammatory bowel disease 14, 612245 ",3,"IRF5, IBD14, SLEB10",607218,7q32.1,IRF5
"Insulin resistance, susceptibility to, 125853 ",3,"PTPN1, PTP1B",176885,20q13.13,PTPN1
"Intervertebral disc disease, susceptibility to, 603932 ",3,"COL9A3, EDM3, IDD",120270,20q13.33,COL9A3
"Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to, 108010 ",3,"IL6, IFNB2, BSF2, HSF, HGF",147620,7p15.3,IL6
"Ischemic stroke, susceptibility to, 601367 ",3,NOS3,163729,7q36.1,NOS3
"Kaposi sarcoma, susceptibility to, 148000 ",3,"IL6, IFNB2, BSF2, HSF, HGF",147620,7p15.3,IL6
"Kawasaki disease, susceptibility to, 611775 ",3,ITPKC,606476,19q13.2,ITPKC
"Kuru, susceptibility to, 245300 ",3,"PRNP, PRIP, KURU, CJD",176640,20p13,PRNP
"Lead poisoning, susceptibility to, 612740 ",3,"ALAD, ALADH, PBGS",125270,9q32,ALAD
"Legionaire disease, susceptibility to, 608556 ",3,"TLR5, TIL3, SLEB1, MELIOS",603031,1q41,TLR5
"Leprosy, susceptibility to, 4, 610988 ",3,"LTA, TNFB",153440,6p21.33,LTA
"Leprosy, susceptibility to, 246300 ",3,"TLR2, TIL4",603028,4q31.3,TLR2
"Leprosy, susceptibility to, 607572 ",3,"PRKN, PARK2, PDJ, LPRS2",602544,6q26,PRKN
"Leukemia, acute lymphoblastic, susceptibility to, 3, 615545 ",3,"PAX5, BSAP, ALL3",167414,9p13.2,PAX5
"Leukemia, acute myeloid, susceptibility to, 601626 ",3,"GATA2, DCML, MONOMAC, IMD21",137295,3q21.3,GATA2
"Leukemia, acute myeloid, 601626 ",3,"CHIC2, BTL",604332,4q12,CHIC2
"Leukemia, acute myeloid, 601626 ",3,"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",187270,5p15.33,TERT
"Lewy body dementia, susceptibility to, 127750 ",3,GBA,606463,1q22,GBA
"Long QT syndrome 1, acquired, susceptibility to, 192500 ",3,"KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2",607542,11p15.5-p15.4,KCNQ1
"Long QT syndrome 2, acquired, susceptibility to, 613688 ",3,"KCNH2, LQT2, HERG, SQT1",152427,7q36.1,KCNH2
"Long QT syndrome, acquired, reduced susceptibility to, 613688 ",3,"ALG10, KCR1",603313,12p11.1,ALG10
"Low density lipoprotein cholesterol level QTL 1, 603776 ",3,"PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1",607786,1p32.3,PCSK9
"Lumbar disc degeneration, 603932 ",3,"ASPN, PLAP1, OS3",608135,9q22.31,ASPN
"Lumbar disc disease, susceptibility to, 603932 ",3,CILP,603489,15q22.31,CILP
"Lumbar disc herniation, susceptibility to, 603932 ",3,"COL11A1, STL2",120280,1p21.1,COL11A1
"Lumbar disc herniation, susceptibility to, 603932 ",3,THBS2,188061,6q27,THBS2
"Lung cancer susceptibility 2, 612052 ",3,"CHRNA3, LNCR2, PAOD2",118503,15q25.1,CHRNA3
"Lung cancer susceptibility 2, 612052 ",3,"CHRNA5, LNCR2",118505,15q25.1,CHRNA5
"Lung cancer, protection against, 211980 ",3,"CASP8, MCH5, ALPS2B",601763,2q33.1,CASP8
"Lung cancer, resistance to, 211980 ",3,"CYP2A6, CYP2A3, CYP2A, P450C2A",122720,19q13.2,CYP2A6
"Lung cancer, susceptibility to, 211980 ",3,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11",609413,10q11.23,ERCC6
"Lung cancer, susceptibility to, 211980 ",3,"FASLG, TNFSF6, APT1LG1, FASL, ALPS1B",134638,1q24.3,FASLG
"Lupus nephritis, susceptibility to, 152700 ",3,"FCGR2A, IGFR2, CD32",146790,1q23.3,FCGR2A
"Lymphoma, follicular, somatic, 605027 ",3,"BCL10, IMD37",603517,1p22.3,BCL10
"Macular degeneration, age-related, 11, 611953 ",3,"CST3, ARMD11",604312,20p11.21,CST3
"Macular degeneration, age-related, 13, susceptibility to, 615439 ",3,"CFI, FI, AHUS3, ARMD13",217030,4q25,CFI
"Macular degeneration, age-related, 14, reduced risk of, 615489 ",3,"C2, ARMD14",613927,6p21.33,C2
"Macular degeneration, age-related, 14, reduced risk of, 615489 ",3,"CFB, BF, GBG, AHUS4, ARMD14, CFBD",138470,6p21.33,CFB
"Macular degeneration, age-related, 15, susceptibility to, 615591 ",3,"C9, C9D, ARMD15",120940,5p13.1,C9
"Macular degeneration, age-related, 1, 603075 ",3,"HMCN1, FBLN6, FIBL6, ARMD1",608548,1q25.3-q31.1,HMCN1
"Macular degeneration, age-related, 2, 153800 ",3,"ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2",601691,1p22.1,ABCA4
"Macular degeneration, age-related, 4, 610698 ",3,"CFH, HF1, HUS, ARMD4, AHUS1",134370,1q31.3,CFH
"Macular degeneration, age-related, 9, 611378 ",3,"C3, ARMD9, AHUS5",120700,19p13.3,C3
"Macular degeneration, age-related, reduced risk of, 603075 ",3,"CFHR1, FHR1, HFL1, CFHL1",134371,1q31.3,CFHR1
"Macular degeneration, age-related, reduced risk of, 603075 ",3,"CFHR3, FHR3, HLF4, CFHL3",605336,1q31.3,CFHR3
"Macular degeneration, age-related, susceptibility to 5, 613761 ",3,"ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11",609413,10q11.23,ERCC6
"Major affective disorder-7, susceptibility to, 612371 ",3,"XBP1, XBP2",194355,22q12.1,XBP1
"Major depressive disorder and accelerated response to antidepressant drug treatment, 608516 ",3,"FKBP5, FKBP51",602623,6p21.31,FKBP5
"Major depressive disorder, response to citalopram therapy in, 608516 ",3,HTR2A,182135,13q14.2,HTR2A
"Malaria, cerebral, reduced risk of, 611162 ",3,"CD36, CHDS7, BDPLT10",173510,7q21.11,CD36
"Malaria, cerebral, susceptibility to, 611162 ",3,"CD36, CHDS7, BDPLT10",173510,7q21.11,CD36
"Malaria, cerebral, susceptibility to, 611162 ",3,ICAM1,147840,19p13.2,ICAM1
"Malaria, cerebral, susceptibility to, 611162 ",3,"TNF, TNFA",191160,6p21.33,TNF
"Malaria, protection against, 611162 ",3,"TIRAP, BACTS1",606252,11q24.2,TIRAP
"Malaria, resistance to, 611162 ",3,"FCGR2B, CD32",604590,1q23.3,FCGR2B
"Malaria, resistance to, 611162 ",3,"GYPA, MN, GPA",111300,4q31.21,GYPA
"Malaria, resistance to, 611162 ",3,"GYPB, SS, MNS",111740,4q31.21,GYPB
"Malaria, resistance to, 611162 ",3,"GYPC, GE, GPC",110750,2q14.3,GYPC
"Malaria, resistance to, 611162 ",3,HBB,141900,11p15.4,HBB
"Malaria, resistance to, 611162 ",3,"NOS2A, NOS2",163730,17q11.2,NOS2A
"Malaria, severe, resistance to, 611162 ",3,"CR1, C3BR",120620,1q32.2,CR1
"Malaria, severe, susceptibility to, 611162 ",3,"FCGR2A, IGFR2, CD32",146790,1q23.3,FCGR2A
"Malaria, susceptibility to, 611162 ",3,"CISH, BACTS2",602441,3p21.2,CISH
"Malaria, vivax, protection against, 611162 ",3,"DARC, FY, GPD, WBCQ1",613665,1q23.2,DARC
"Male germ cell tumor, somatic, 273300, ",3,"BCL10, IMD37",603517,1p22.3,BCL10
"Malignant hyperthermia susceptibility 1, 145600 ",3,"RYR1, MHS, CCO",180901,19q13.2,RYR1
"Malignant hyperthermia susceptibility 5, 601887 ",3,"CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1",114208,1q32.1,CACNA1S
"Medulloblastoma, 155255 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Melanoma, cutaneous malignant, 2, 155601 ",3,"CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21.3,CDKN2A
"Melanoma, cutaneous malignant, 3, 609048 ",3,"CDK4, CMM3",123829,12q14.1,CDK4
"Melanoma, cutaneous malignant, 5, 613099 ",3,"MC1R, SHEP2, CMM5",155555,16q24.3,MC1R
"Melanoma, cutaneous malignant, 9, 615134 ",3,"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",187270,5p15.33,TERT
"Melanoma, cutaneous malignant, susceptibility to, 8, 601800 ",3,"TYR, SHEP3, CMM8, OCA1A, ATN",606933,11q14.3,TYR
"Melanoma, cutaneous malignant, susceptibility to, 8, 614456 ",3,"MITF, WS2A, CMM8",156845,3p13,MITF
"Melioidosis, susceptibility to, 615557 ",3,"TLR5, TIL3, SLEB1, MELIOS",603031,1q41,TLR5
"Meningioma, familial, susceptibility to, 607174 ",3,"SMARCE1, BAF57, CSS5",603111,17q21.2,SMARCE1
"Meningioma, familial, susceptibility to, 607174 ",3,"SUFU, SUFUXL, SUFUH",607035,10q24.32,SUFU
"Meningioma, 607174 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Mesothelioma, somatic, 156240 ",3,"BCL10, IMD37",603517,1p22.3,BCL10
"Microvascular complications of diabetes 1, 603933 ",3,"VEGF, MVCD1",192240,6p21.1,VEGF
"Microvascular complications of diabetes 2, 612623 ",3,"EPO, MVCD2",133170,7q22.1,EPO
"Microvascular complications of diabetes 3, 612624 ",3,"ACE, DCP1, ACE1, MVCD3, ICH",106180,17q23.3,ACE
"Microvascular complications of diabetes 4, 612628 ",3,"IL1RN, MVCD4, DIRA",147679,2q14.1,IL1RN
"Microvascular complications of diabetes 5, 612633 ",3,"PON1, PON, ESA, MVCD5",168820,7q21.3,PON1
"Microvascular complications of diabetes 6, 612634 ",3,"SOD2, MNSOD, MVCD6",147460,6q25.3,SOD2
"Microvascular complications of diabetes 7, 612635 ",3,"HFE, HLA-H, HFE1, MVCD7, TFQTL2",613609,6p22.2,HFE
"Migraine without aura, susceptibility to, 157300 ",3,"TNF, TNFA",191160,6p21.33,TNF
"Migraine, resistance to, 157300 ",3,"EDNRA, MFDA",131243,4q31.22-q31.23,EDNRA
"Migraine, susceptibility to, 157300 ",3,"ESR1, ESR, ESTRR",133430,6q25.1-q25.2,ESR1
"Multiple myeloma, resistance to, 254500 ",3,"LIG4, LIG4S",601837,13q33.3,LIG4
"Multiple myeloma, susceptibility to, 254500 ",3,"CCND1, PRAD1, BCL1",168461,11q13.3,CCND1
"Multiple sclerosis, disease progression, modifier of, 126200 ",3,"PDCD1, SLEB2",600244,2q37.3,PDCD1
"Multiple sclerosis, susceptibility to, 1, 126200 ",3,"HLA-DQB1, CELIAC1",604305,6p21.32,HLA-DQB1
"Multiple sclerosis, susceptibility to, 1, 126200 ",3,"HLA-DRB1, SS1",142857,6p21.32,HLA-DRB1
"Multiple sclerosis, susceptibility to, 5, 614810 ",3,"TNFRSF1A, TNFR1, TNFAR, FPF, MS5",191190,12p13.31,TNFRSF1A
"Multiple self-healing squamous epithelioma, susceptibility to, 132800 ",3,"TGFBR1, ALK5, AAT5, LDS1, MSSE",190181,9q22.33,TGFBR1
"Mycobacterium tuberculosis, protection against, 607948 ",3,"IRGM, LRG47, IFI1, IBD19",608212,5q33.1,IRGM
"Mycobacterium tuberculosis, protection against, 607948 ",3,"MC3R, BMIQ9",155540,20q13.2,MC3R
"Mycobacterium tuberculosis, susceptibility to infection by, 607948 ",3,"NRAMP1, NRAMP, SLC11A1",600266,2q35,NRAMP1
"Mycobacterium tuberculosis, susceptibility to, 607948 ",3,"CCL2, SCYA2, MCP1, MCAF",158105,17q12,CCL2
"Mycobacterium tuberculosis, susceptibility to, 607948 ",3,"CD209, CDSIGN",604672,19p13.2,CD209
"Mycobacterium tuberculosis, susceptibility to, 607948 ",3,"SP110, IFI41, IFI75, VODI",604457,2q37.1,SP110
"Mycobacterium tuberculosis, susceptibility to, 607948 ",3,"TLR2, TIL4",603028,4q31.3,TLR2
"Myocardial infarcation, susceptibility to, 608446 ",3,"PSMA6, PROS27, P27K",602855,14q13.2,PSMA6
"Myocardial infarction, decreased susceptibility to, 608446 ",3,F7,613878,13q34,F7
"Myocardial infarction, protection against, 608446 ",3,"F13A1, F13A",134570,6p25.1,F13A1
"Myocardial infarction, susceptibility to, 608446 ",3,"ESR1, ESR, ESTRR",133430,6q25.1-q25.2,ESR1
"Myocardial infarction, susceptibility to, 608446 ",3,"GCLC, GLCLC",606857,6p12.1,GCLC
"Myocardial infarction, susceptibility to, 608446 ",3,"GCLM, GLCLR",601176,1p22.1,GCLM
"Myocardial infarction, susceptibility to, 608446 ",3,"ITGB3, GP3A, GT, BDPLT2, BDPLT16",173470,17q21.32,ITGB3
"Myocardial infarction, susceptibility to, 608446 ",3,LGALS2,150571,22q13.1,LGALS2
"Myocardial infarction, susceptibility to, 608446 ",3,"LRP8, APOER2, MCI1",602600,1p32.3,LRP8
"Myocardial infarction, susceptibility to, 608446 ",3,"LTA, TNFB",153440,6p21.33,LTA
"Myocardial infarction, susceptibility to, 608446 ",3,"MIAT, C22orf35",611082,22q12.1,MIAT
"Myocardial infarction, susceptibility to, 608446 ",3,"OLR1, LOX1",602601,12p13.2,OLR1
"Myocardial infarction, susceptibility to, 608446 ",3,"TNFSF4, GP34, OX4OL",603594,1q25.1,TNFSF4
"Myoclonic epilepsy, juvenile, susceptibility to, 1, 254770 ",3,"EFHC1, FLJ10466, EJM1, JAE, EJA1",608815,6p12.2,EFHC1
"Nephrolithiasis, uric acid, susceptibility to, 605990 ",3,"ZNF365, UAN",607818,10q21.2,ZNF365
"Neural tube defects, folate-sensitive, susceptibility to, 601634 ",3,"MTR, HMAG",156570,1q43,MTR
"Neural tube defects, folate-sensitive, susceptibility to, 601634 ",3,MTRR,602568,5p15.31,MTRR
"Neural tube defects, susceptibility to, 182940 ",3,"T, TFT, SAVA",601397,6q27,T
"Neural tube defects, susceptibility to, 182940 ",3,"VANGL1, STBM2",610132,1p13.1,VANGL1
"Neural tube defects, susceptibility to, 601634 ",3,MTHFR,607093,1p36.22,MTHFR
"Neuroblastoma, susceptibility to, 1, 256700 ",3,"KIF1B, CMT2A, CMT2A1, NBLST1",605995,1p36.22,KIF1B
"Neuroblastoma, susceptibility to, 3, 613014 ",3,"ALK, NBLST3",105590,2p23.2-p23.1,ALK
"Nevus sebaceous or woolly hair nevus, somatic, 162900 ",3,HRAS,190020,11p15.5,HRAS
"Nicotine addiction, protection from, 188890 ",3,"CYP2A6, CYP2A3, CYP2A, P450C2A",122720,19q13.2,CYP2A6
"Nicotine addiction, susceptibility to, 188890 ",3,"CHRNA4, ENFL1",118504,20q13.33,CHRNA4
"Nicotine dependence, protection against, 188890 ",3,"GPR51, GABBR2",607340,9q22.33,GPR51
"Nicotine dependence, protection against, 188890 ",3,"SLC6A3, DAT1, PKDYS",126455,5p15.33,SLC6A3
"Nicotine dependence, susceptibility to, 188890 ",3,"GPR51, GABBR2",607340,9q22.33,GPR51
"Nicotine dependence, susceptibility to, 612052 ",3,"CHRNA5, LNCR2",118505,15q25.1,CHRNA5
"Nonarteritic anterior ischemic optic neuropathy, susceptibility to, 258660 ",3,"GP1BA, BSS, BDPLT1, VWDP, BDPLT3",606672,17p13.2,GP1BA
"Nonsmall cell lung cancer, susceptibility to, 211980 ",3,"EGFR, NISBD2",131550,7p11.2,EGFR
"Obesity, association with, 601665 ",3,"SDC3, SYND3, SDCN",186357,1p35.2,SDC3
"Obesity, early-onset, susceptibility to, 601665 ",3,POMC,176830,2p23.3,POMC
"Obesity, late-onset, 601665 ",3,"AGRP, ART, AGRT",602311,16q22.1,AGRP
"Obesity, severe, and type II diabetes, 601665 ",3,UCP3,602044,11q13.4,UCP3
"Obesity, severe, susceptibility to, BMIQ9, 602025 ",3,"MC3R, BMIQ9",155540,20q13.2,MC3R
"Obesity, susceptibility to, BMIQ11, 300306 ",3,"SLC6A14, OBX, BMIQ11",300444,Xq23,SLC6A14
"Obesity, susceptibility to, 601665 ",3,ADRB2,109690,5q32,ADRB2
"Obesity, susceptibility to, 601665 ",3,ADRB3,109691,8p11.23,ADRB3
"Obesity, susceptibility to, 601665 ",3,"ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED",173335,6q23.2,ENPP1
"Obesity, susceptibility to, 601665 ",3,GHRL,605353,3p25.3,GHRL
"Obesity, susceptibility to, 601665 ",3,UCP1,113730,4q31.1,UCP1
"Obesity, variation in, 601665 ",3,"PPARGC1B, PGC1B, PERC",608886,5q32,PPARGC1B
"Obsessive-compulsive disorder, protection against, 164230 ",3,"BDNF, BULN2, ANON2",113505,11p14.1,BDNF
"Obsessive-compulsive disorder, susceptibility to, 164230 ",3,HTR2A,182135,13q14.2,HTR2A
"Obsessive-compulsive disorder, 164230 ",3,"SLC6A4, HTT, OCD1",182138,17q11.2,SLC6A4
"Orofacial cleft 6, 608864 ",3,"IRF6, VWS, LPS, PIT, PPS1, OFC6",607199,1q32.2,IRF6
"Osteoarthritis susceptibility 2, 140600 ",3,"MATN3, EDM5, HOA, OS2",602109,2p24.1,MATN3
"Osteoarthritis susceptibility 3, 607850 ",3,"ASPN, PLAP1, OS3",608135,9q22.31,ASPN
"Osteoarthritis-5, 612400 ",3,"GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B",601146,20q11.22,GDF5
"Osteofibrous dysplasia, susceptibility to, 607278 ",3,"MET, DFNB97, OSFD",164860,7q31.2,MET
"Osteoporosis, early-onset, susceptibility to, autosomal dominant, 615221 ",3,"WNT1, INT1, OI15, BMND16",164820,12q13.12,WNT1
"Osteoporosis, postmenopausal, susceptibility, 166710 ",3,"CALCR, CRT",114131,7q21.3,CALCR
"Osteoporosis, postmenopausal, 166710 ",3,COL1A2,120160,7q21.3,COL1A2
"Osteoporosis, susceptibility to, 166710 ",3,RIL,603422,5q31.1,RIL
"Osteoporosis, 166710 ",3,"LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4",603506,11q13.2,LRP5
"Ovarian cancer, somatic, 167000 ",3,OPCML,600632,11q25,OPCML
"Paget disease of bone 2, early-onset, 602080 ",3,"TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2",603499,18q21.33,TNFRSF11A
"Pancreatic cancer 2, 613347 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Pancreatic cancer, susceptibility to, 1, 606856 ",3,"PALLD, KIAA0992, PNCA1",608092,4q32.3,PALLD
"Pancreatic cancer, susceptibility to, 4, 614320 ",3,"BRCA1, PSCP, BROVCA1, PNCA4",113705,17q21.31,BRCA1
"Pancreatitis, chronic, protection against, 167800 ",3,"PRSS2, TRY2",601564,7q34,PRSS2
"Pancreatitis, chronic, susceptibility to, 167800 ",3,"CTRC, CLCR",601405,1p36.21,CTRC
"Pancreatitis, idiopathic, 167800 ",3,"CFTR, ABCC7, CF, MRP7",602421,7q31.2,CFTR
"Panic disorder, susceptibility to, 167870 ",3,COMT,116790,22q11.21,COMT
"Parkinson disease 11, 607688 ",3,"GIGYF2, KIAA0642, PARK11",612003,2q37.1,GIGYF2
"Parkinson disease 13, 610297 ",3,"HTRA2, OMI, PARK13, PRSS25",606441,2p13.1,HTRA2
"Parkinson disease 18, 614251 ",3,"EIF4G1, EIF4G, PARK18",600495,3q27.1,EIF4G1
"Parkinson disease 8, 607060 ",3,"LRRK2, PARK8",609007,12q12,LRRK2
"Parkinson disease, age of onset, modifier, 168600 ",3,GLUD2,300144,Xq24,GLUD2
"Parkinson disease, late-onset, susceptibility to, 168600 ",3,"ATXN2, ATX2, SCA2, ASL13",601517,12q24.12,ATXN2
"Parkinson disease, late-onset, susceptibility to, 168600 ",3,GBA,606463,1q22,GBA
"Parkinson disease, susceptibility to, 168600 ",3,"ADH1C, ADH3",103730,4q23,ADH1C
"Parkinson disease, susceptibility to, 168600 ",3,"MAPT, MTBT1, DDPAC, MSTD",157140,17q21.31,MAPT
"Parkinson disease, susceptibility to, 168600 ",3,"TBP, SCA17, HDL4",600075,6q27,TBP
"Pheochromocytoma, modifier of, 171300 ",3,"GDNF, HSCR3",600837,5p13.2,GDNF
"Pheochromocytoma, susceptibility to, 171300 ",3,MAX,154950,14q23.3,MAX
"Pheochromocytoma, susceptibility to, 171300 ",3,TMEM127,613403,2q11.2,TMEM127
"Porphyria cutanea tarda, susceptibility to, 176100 ",3,"HFE, HLA-H, HFE1, MVCD7, TFQTL2",613609,6p22.2,HFE
"Porphyria variegata, susceptibility to, 176200 ",3,"HFE, HLA-H, HFE1, MVCD7, TFQTL2",613609,6p22.2,HFE
"Preeclampsia, susceptibility to, 189800 ",3,EPHX1,132810,1q42.12,EPHX1
"Pregnancy loss, recurrent, susceptibility to, 1, 614389 ",3,"F5, THPH2, RPRGL1",612309,1q24.2,F5
"Pregnancy loss, recurrent, susceptibility to, 2, 614390 ",3,"F2, THPH1, RPRGL2",176930,11p11.2,F2
"Pregnancy loss, recurrent, susceptibility to, 3, 614391 ",3,"ANXA5, ENX2, RPRGL3",131230,4q27,ANXA5
"Prostate cancer, familial, susceptibility to, 176807 ",3,"CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,CHEK2
"Prostate cancer, hereditary, 13, 611928 ",3,"MSMB, HPC13",157145,10q11.22,MSMB
"Prostate cancer, hereditary, 2, susceptibility to, 614731 ",3,"ELAC2, HPC2, COXPD17",605367,17p12,ELAC2
"Prostate cancer, somatic, 176807 ",3,"PTEN, MMAC1, GLM2, CWS1",601728,10q23.31,PTEN
"Prostate cancer, susceptibility to, somatic, 176807 ",3,"ZFHX3, ATBF1",104155,16q22.2-q22.3,ZFHX3
"Prostate cancer, susceptibility to, 176807 ",3,"AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1",313700,Xq12,AR
"Prostate cancer, susceptibility to, 176807 ",3,"CDH1, UVO, LCAM, ECAD",192090,16q22.1,CDH1
"Prostate cancer, susceptibility to, 176807 ",3,MXI1,600020,10q25.2,MXI1
"Prostate cancer/brain cancer susceptibility, somatic, 603688 ",3,"EPHB2, EPHT3, DRT, ERK, PCBC, CAPB",600997,1p36.12,EPHB2
"Prostate cancer, 176807 ",3,"BRCA2, FANCD1, BROVCA2, GLM3, PNCA2",600185,13q13.1,BRCA2
"Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis, 219700 ",3,"FCGR2A, IGFR2, CD32",146790,1q23.3,FCGR2A
"Pseudoxanthoma elasticum, modifier of severity of, 264800 ",3,"XYLT1, XT1, DBQD2",608124,16p12.3,XYLT1
"Pseudoxanthoma elasticum, modifier of severity of, 264800 ",3,"XYLT2, XT2, SOS",608125,17q21.33,XYLT2
"Psoriasis susceptibility 1, 177900 ",3,"HLA-C, PSORS1",142840,6p21.33,HLA-C
"Psoriatic arthritis, susceptibility to, 607507 ",3,"LTA, TNFB",153440,6p21.33,LTA
"Psoriatic arthritis, susceptibility to, 607507 ",3,"NOD2, CARD15, IBD1, CD, ACUG, PSORAS1",605956,16q12.1,NOD2
"Pulmonary disease, chronic obstructive, susceptibility to, 606963 ",3,"HMOX1, HMOX1D",141250,22q12.3,HMOX1
"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1, 614742 ",3,"TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9",187270,5p15.33,TERT
"Pulmonary fibrosis, idiopathic, susceptibility to, 178500 ",3,MUC5B,600770,11p15.5,MUC5B
"Pulmonary fibrosis, idiopathic, susceptibility to, 178500 ",3,"SFTPA1, SFTP1",178630,10q22.3,SFTPA1
"Pulmonary hypertension, neonatal, susceptibility to, 615371 ",3,"CPS1, PHN",608307,2q34,CPS1
"Rapid progression to AIDS from HIV1 infection, 609423 ",3,"CX3CR1, GPR13, V28",601470,3p22.2,CX3CR1
"Renal cell carcinoma, 144700 ",3,"HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11",189907,17q12,HNF1B
"Resistance to malaria due to G6PD deficiency, 611162 ",3,"G6PD, G6PD1",305900,Xq28,G6PD
"Retinal disease in Usher syndrome type IIA, modifier of, 276901 ",3,PDZD7,612971,10q24.31,PDZD7
"Rhabdoid predisposition syndrome 1, 609322 ",3,"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3",601607,22q11.23,SMARCB1
"Rheumatoid arthritis, progression of, 180300 ",3,"IL10, CSIF, GVHDS",124092,1q32.1,IL10
"Rheumatoid arthritis, susceptibility to, 180300 ",3,"CD244, NAIL, NKR2B4, SLAMF4",605554,1q23.3,CD244
"Rheumatoid arthritis, susceptibility to, 180300 ",3,"CIITA, MHC2TA, C2TA",600005,16p13.13,CIITA
"Rheumatoid arthritis, susceptibility to, 180300 ",3,"HLA-DRB1, SS1",142857,6p21.32,HLA-DRB1
"Rheumatoid arthritis, susceptibility to, 180300 ",3,NFKBIL1,601022,6p21.33,NFKBIL1
"Rheumatoid arthritis, susceptibility to, 180300 ",3,"PADI4, PADI5, PAD",605347,1p36.13,PADI4
"Rheumatoid arthritis, susceptibility to, 180300 ",3,"PTPN22, PEP, PTPN8, LYP",600716,1p13.2,PTPN22
"Rheumatoid arthritis, susceptibility to, 180300 ",3,"SLC22A4, OCTN1",604190,5q31.1,SLC22A4
"Rheumatoid arthritis, systemic juvenile, susceptibility to, 604302 ",3,MIF,153620,22q11.23,MIF
"Rheumatoid arthritis, systemic juvenile, 604302 ",3,"IL6, IFNB2, BSF2, HSF, HGF",147620,7p15.3,IL6
"Sarcoidosis, susceptibility to, 1, 181000 ",3,"HLA-DRB1, SS1",142857,6p21.32,HLA-DRB1
"Schizoaffective disorder, susceptibility to, 181500 ",3,"DISC1, SCZD9",605210,1q42.2,DISC1
"Schizophrenia 15, 613950 ",3,"SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15",606230,22q13.33,SHANK3
"Schizophrenia, susceptibility to, 4, 600850 ",3,"PRODH, PRODH2, SCZD4",606810,22q11.21,PRODH
"Schizophrenia, susceptibility to, 181500 ",3,"CHI3L1, GP39, YKL40, ASRT7",601525,1q32.1,CHI3L1
"Schizophrenia, susceptibility to, 181500 ",3,COMT,116790,22q11.21,COMT
"Schizophrenia, susceptibility to, 181500 ",3,"DRD3, ETM1, FET1",126451,3q13.31,DRD3
"Schizophrenia, susceptibility to, 181500 ",3,HTR2A,182135,13q14.2,HTR2A
"Schizophrenia, susceptibility to, 181500 ",3,MTHFR,607093,1p36.22,MTHFR
"Schizophrenia, susceptibility to, 181500 ",3,"RTN4R, NOGOR",605566,22q11.21,RTN4R
"Schizophrenia, susceptibility to, 181500 ",3,SYN2,600755,3p25.2,SYN2
"Schizophrenia, susceptibility to, 604906 ",3,"DISC1, SCZD9",605210,1q42.2,DISC1
"Schwannomatosis-1, susceptibility to, 162091 ",3,"SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3",601607,22q11.23,SMARCB1
"Seasonal affective disorder, susceptibility to, 608516 ",3,HTR2A,182135,13q14.2,HTR2A
"Sick sinus syndrome 3, 614090 ",3,"MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3",160710,14q11.2,MYH6
"Spina bifida, folate-sensitive, susceptibility to, 601634 ",3,"MTHFD, MTHFC",172460,14q23.3,MTHFD
"Spina bifida, susceptibility to, 182940 ",3,"CCL2, SCYA2, MCP1, MCAF",158105,17q12,CCL2
"Spinal muscular atrophy, type III, modifier of, 253400 ",3,SMN2,601627,5q13.2,SMN2
"Spitz nevus or nevus spilus, somatic, 137550 ",3,HRAS,190020,11p15.5,HRAS
"Spondyloarthropathy, susceptibility to, 1, 106300 ",3,"HLA-B, SPDA1",142830,6p21.33,HLA-B
"Stevens-Johnson syndrome, susceptibility to, 608579 ",3,"HLA-B, SPDA1",142830,6p21.33,HLA-B
"Stroke, hemorrhagic, 614519 ",3,"ACE, DCP1, ACE1, MVCD3, ICH",106180,17q23.3,ACE
"Stroke, ischemic, susceptibility to, 601367 ",3,"F2, THPH1, RPRGL2",176930,11p11.2,F2
"Stroke, ischemic, susceptibility to, 601367 ",3,"F5, THPH2, RPRGL1",612309,1q24.2,F5
"Stroke, susceptibility to, 1, 606799 ",3,"PDE4D, DPDE3, STRK1, ACRDYS2",600129,5q11.2-q12.1,PDE4D
"Stroke, susceptibility to, 601367 ",3,"ALOX5AP, FLAP",603700,13q12.3,ALOX5AP
"Sudden infant death syndrome, susceptibility to, 272120 ",3,"SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2",600163,3p22.2,SCN5A
"Systemic lupus erythematosus susceptibility to, 152700 ",3,"PTPN22, PEP, PTPN8, LYP",600716,1p13.2,PTPN22
"Systemic lupus erythematosus, resistance to, 601744 ",3,"TLR5, TIL3, SLEB1, MELIOS",603031,1q41,TLR5
"Systemic lupus erythematosus, susceptibility to, 10, 612251 ",3,"IRF5, IBD14, SLEB10",607218,7q32.1,IRF5
"Systemic lupus erythematosus, susceptibility to, 1, 601744 ",3,"TLR5, TIL3, SLEB1, MELIOS",603031,1q41,TLR5
"Systemic lupus erythematosus, susceptibility to, 2, 605218 ",3,"PDCD1, SLEB2",600244,2q37.3,PDCD1
"Systemic lupus erythematosus, susceptibility to, 9, 610927 ",3,"CR2, C3DR, SLEB9, CVID7",120650,1q32.2,CR2
"Systemic lupus erythematosus, susceptibility to, 152700 ",3,"CTLA4, IDDM12, CELIAC3, ALPS5",123890,2q33.2,CTLA4
"Systemic lupus erythematosus, susceptibility to, 152700 ",3,"DNASE1, DNL1",125505,16p13.3,DNASE1
"Systemic lupus erythematosus, susceptibility to, 152700 ",3,"FCGR2B, CD32",604590,1q23.3,FCGR2B
"Systemic lupus erythematosus, susceptibility to, 152700 ",3,"TREX1, AGS1, CRV, HERNS",606609,3p21.31,TREX1
"Systemic lupus erythematous, association with susceptibility to, 6, 609939 ",3,"ITGAM, CR3A, CD11B, MAC1A, SLEB6",120980,16p11.2,ITGAM
"TSC2 angiomyolipomas, renal, modifier of, 613254 ",3,"IFNG, IFG, IFI",147570,12q15,IFNG
"Thromboembolism, susceptibility to, 188050 ",3,MTHFR,607093,1p36.22,MTHFR
"Thrombophilia, susceptibility to, due to factor V Leiden, 188055 ",3,"F5, THPH2, RPRGL1",612309,1q24.2,F5
"Thyroid cancer, nonmedullary, 2, 188470 ",3,"SRGAP1, KIAA1304, NMTC2",606523,12q14.2,SRGAP1
"Thyroid cancer, nonmedullary, 4, 616534 ",3,"FOXE1, FKHL15, TITF2, TTF2, NMTC4",602617,9q22.33,FOXE1
"Thyroid carcinoma, follicular, somatic, 188470 ",3,HRAS,190020,11p15.5,HRAS
"Thyrotoxic periodic paralysis, susceptibility to, 1, 188580 ",3,"CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1",114208,1q32.1,CACNA1S
"Toxic epidermal necrolysis, susceptibility to, 608579 ",3,"HLA-B, SPDA1",142830,6p21.33,HLA-B
"Tuberculosis infection, protection against, 607948 ",3,"IFNGR1, IMD27A, IMD27B",107470,6q23.3,IFNGR1
"Tuberculosis, protection against, 607948 ",3,"IFNG, IFG, IFI",147570,12q15,IFNG
"Tuberculosis, protection against, 607948 ",3,"TIRAP, BACTS1",606252,11q24.2,TIRAP
"Tuberculosis, susceptibility to, 607948 ",3,"CISH, BACTS2",602441,3p21.2,CISH
"Tuberculosis, susceptibility to, 607948 ",3,"IFNGR1, IMD27A, IMD27B",107470,6q23.3,IFNGR1
"UV-induced skin damage, 266300 ",3,"MC1R, SHEP2, CMM5",155555,16q24.3,MC1R
"Unipolar depression, susceptibility to, 608516 ",3,"TPH2, NTPH, ADHD7",607478,12q21.1,TPH2
"Venous thromboembolism, susceptibility to, 188050 ",3,"HABP2, PHBP, HGFAL, FSAP, NMTC5",603924,10q25.3,HABP2
"Venous thrombosis, protection against, 188050 ",3,"F13A1, F13A",134570,6p25.1,F13A1
"Vitamin B12 plasma level QTL1, 612542 ",3,"FUT2, SE, B12QTL1",182100,19q13.33,FUT2
"Vitiligo-associated multiple autoimmune disease susceptibility 1, 606579 ",3,"NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED",606636,17p13.2,NLRP1
"Warfarin sensitivity, 122700 ",3,"F9, HEMB, THPH8",300746,Xq27.1,F9
"West nile virus, susceptibility to, 610379 ",3,"CCR5, CMKBR5, CCCKR5, IDDM22",601373,3p21.31,CCR5
"Wilms tumor susceptibility-5, 601583 ",3,"POU6F2, WTSL, WT5",609062,7p14.1,POU6F2
"von Hippel-Lindau syndrome, modifier of, 193300 ",3,"CCND1, PRAD1, BCL1",168461,11q13.3,CCND1
